Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AATF "BFR2, CHE-1, CHE1, DED" ENSG00000275700 "Apoptosis antagonizing transcription factor" Q9NY61 17 36948925-37056871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004940, HPA075963" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoli Nucleoplasm "HPA004940: AB_1078075, HPA075963: " "unprognostic (1.10e-1)" "unprognostic (5.46e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-3)" "unprognostic (5.54e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (3.06e-2)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (2.48e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.14e-5)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" "unprognostic (7.53e-3)" "unprognostic (3.21e-3)" 29.8 24.4 22.2 26.3 25.6 34.7 26.6 23.6 24.9 24.6 19.8 28.3 18.5 25.6 17.5 24.4 24.7 15.4 26.1 21.0 23.2 22.1 22.5 23.4 34.1 24.0 23.4 29.5 37.5 20.3 15.9 23.2 24.5 20.3 24.0 17.3 21.0 24.1 40.8 37.1 24.2 24.5 22.8 27.1 30.0 22.9 23.5 35.3 20.4 14.2 39.2 31.2 23.4 26.8 107.2 174.2 37.0 73.8 49.3 57.0 67.3 61.2 50.4 76.0 67.3 120.3 74.3 178.2 79.5 60.5 123.4 89.9 141.8 80.0 102.6 83.4 97.3 77.1 65.6 85.8 59.4 121.9 73.4 49.5 138.7 98.4 88.4 68.2 56.6 92.3 114.4 51.7 68.6 81.6 162.4 105.0 46.0 62.8 63.3 104.0 96.7 105.6 62.6 93.7 79.0 33.8 90.9 40.8 95.5 79.6 69.6 72.3 50.4 58.1 96.2 122.5 211.9 61.3 83.1 124.2 72.2 101.9 107.1 48.9 55.2 90.2 60.0 74.0 59.6 46.8 53.9 64.0 51.0 51.0 48.1 47.7 67.5 58.1 77.7 45.5 75.7 57.2 22.2 25.6 23.6 24.9 21.0 23.2 24.0 23.4 24.5 22.8 23.5 26.8 24.5 22.4 34.6 25.1 41.2 43.7 46.3 39.7 29.6 13.4 14.7 13.1 17.8 32.9 37.8 25.8 22.9 72.9 48.5 26.4 9.8 41.6 32.0 23.4 22.9 30.1 16.1 33.7 28.5 48.1 59.8 30.3 23.0 22.0 47.5 37.4 14.6 16.9 46.8 18.5 24.6 26.4 6.1 33.9 30.3 62.0 23.6 33.4 28.4 30.0 54.9 34.3 53.5 29.1 57.7 51.1 26.3 23.3 38.4 52.1 48.8 52.0 31.1 24.0 32.9 32.3 39.0 52.5 40.8 28.2 43.9 163.9 44.3 27.4 31.9 43.6 AC012254.7 ENSG00000288631 "Elongin A3" Q8NG57 18 47028202-47029842 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "brain: 3.9;choroid plexus: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048971, HPA049178, HPA050086, HPA053158" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 2.0 0.0 2.8 0.0 0.0 1.5 1.8 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.0 0.0 0.0 0.0 3.9 3.8 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.8 1.5 1.8 1.6 1.9 3.9 3.8 2.7 1.1 3.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621337-88632281 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 62.7" "Cancer enhanced" "Detected in all" "testis cancer: 38.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.1 12.2 6.8 10.7 7.1 17.7 6.0 6.6 6.8 6.8 7.0 8.4 5.1 7.6 9.6 9.6 7.0 12.5 7.3 6.3 11.5 9.0 13.5 10.1 12.8 8.6 7.7 8.0 20.9 4.4 22.4 6.9 7.7 12.1 8.6 1.0 8.3 8.2 15.1 7.2 9.1 10.1 8.1 15.2 13.2 9.8 9.5 10.7 10.3 3.7 11.9 11.5 5.9 7.7 14.9 64.5 39.6 34.2 17.4 20.7 83.7 51.5 46.8 39.1 47.8 53.8 28.2 63.6 16.1 28.3 35.0 20.9 148.0 42.1 32.6 15.7 58.2 34.0 26.4 89.9 42.0 28.5 32.8 25.6 36.4 48.5 39.7 14.0 33.0 20.6 54.6 35.2 48.3 34.4 35.5 24.0 96.0 30.8 36.9 45.4 28.2 46.9 16.5 31.9 31.1 28.5 20.8 23.7 40.1 90.7 19.7 32.0 29.9 39.5 55.1 16.2 70.5 67.0 48.5 54.7 36.0 31.5 79.1 0.0 2.3 0.8 6.2 3.7 12.0 10.9 10.8 8.4 5.2 10.3 11.6 10.6 0.6 3.9 4.9 3.1 19.6 9.2 6.8 7.1 6.6 6.8 6.3 11.5 8.6 7.7 7.7 8.1 9.5 7.7 6.9 6.4 8.1 4.2 21.0 18.6 25.8 6.2 12.0 1.2 21.4 15.4 3.9 8.6 12.9 1.8 0.0 4.7 8.4 5.6 3.9 11.4 23.6 22.5 5.3 7.6 9.0 11.8 20.5 7.6 16.3 9.0 11.7 17.7 2.5 12.3 2.5 6.3 4.5 1.7 16.0 9.9 26.4 4.7 26.4 62.7 4.4 7.8 14.2 3.7 14.2 3.1 9.2 9.0 2.5 11.5 6.2 2.6 26.9 27.8 2.3 5.5 5.4 0.9 13.1 12.0 11.6 10.2 18.2 10.9 28.3 6.2 14.9 6.8 9.7 25.4 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 52 "liver: 3018.1" "Cell type enriched" "Detected in many" 24 "Hepatocytes: 4816.3" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 24.5;myeloid DC: 14.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Hep G2: 152.2;OE19: 116.1" "Low region specificity" "Detected in all" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 410000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 37.6 3.0 3.6 6.0 3.5 1.0 37.8 3.5 4.9 38.2 5.6 32.6 23.2 23.4 17.9 9.8 30.5 28.5 16.9 3.6 4.9 18.4 3018.1 18.5 3.5 4.5 4.2 58.1 30.8 5.3 5.0 3.8 4.3 32.7 45.7 2.2 52.6 13.3 6.2 27.4 27.1 10.4 4.5 7.4 58.2 10.2 3.7 1.5 8.8 10.5 4.1 24.8 31.4 4.8 3.7 9.9 2.3 0.0 23.9 27.8 0.3 4.8 8.8 1.1 4.0 5.9 5.1 0.4 1.5 12.0 8.0 3.8 2.8 3.1 1.3 18.4 3.8 0.9 5.1 152.2 5.0 4.0 0.5 22.2 2.5 1.5 5.1 11.8 5.7 4.2 0.2 27.0 3.5 0.7 0.9 1.2 0.7 116.1 10.7 0.7 3.9 11.3 2.3 2.9 0.0 0.4 4.6 1.7 6.5 5.1 4.0 0.7 6.0 1.9 2.8 1.7 0.7 5.9 4.8 0.5 3.2 2.0 5.0 0.0 24.5 0.0 0.6 2.9 0.4 5.8 1.2 1.1 14.5 4.9 0.3 0.2 0.4 0.0 0.1 2.3 0.8 7.1 3.6 3.5 3.5 4.9 3.6 4.9 4.5 4.2 4.3 4.5 3.7 4.8 9.7 28.9 17.7 0.0 9.7 27.1 43.3 39.2 14.2 0.1 33.8 24.8 0.8 194.5 24.6 11.0 0.0 1.6 0.7 32.5 11.7 40.0 1.0 6.2 9.7 11.0 71.0 27.8 0.0 31.6 5.3 48.8 56.1 24.9 0.0 10.7 62.4 4816.3 15.9 0.0 0.0 171.9 12.2 95.9 18.7 2.9 71.1 13.8 23.2 0.0 4.9 10.1 0.0 0.0 0.0 21.6 33.3 24.0 11.7 43.7 91.3 61.2 76.5 0.6 13.1 29.7 17.7 1.0 1.3 9.4 52.4 9.3 5.6 0.5 51.6 39.2 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32886601-33025130 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nucleoli" "HPA064930: AB_2685386" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favorable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 9.7 14.8 14.6 7.0 14.8 11.0 10.4 14.8 20.2 9.1 13.9 10.2 8.6 8.6 7.6 14.7 8.9 4.9 9.9 14.8 15.0 13.6 15.6 9.3 8.1 14.7 14.6 8.5 9.6 12.1 7.6 7.8 15.0 9.6 11.2 8.0 9.0 6.6 9.8 15.3 8.3 8.6 14.2 8.9 9.7 14.7 15.2 9.3 7.0 6.9 11.0 10.4 9.6 15.0 36.2 26.1 18.4 17.1 19.0 17.4 25.6 24.8 26.0 28.7 31.5 35.1 12.7 27.8 14.6 21.1 18.4 19.4 33.7 32.8 35.1 39.2 11.2 17.9 32.5 37.8 24.4 29.4 15.1 23.8 36.3 32.5 37.9 16.9 26.8 20.2 27.0 24.2 26.0 15.6 24.4 43.2 33.5 24.4 29.0 21.2 14.4 21.5 25.2 21.2 15.6 11.1 21.4 18.0 15.5 17.9 23.0 11.4 17.7 16.2 21.1 29.9 25.0 11.1 21.2 27.5 23.4 23.8 13.2 3.3 14.7 13.4 12.2 15.6 15.2 16.3 12.8 14.6 17.6 16.1 16.0 12.1 5.9 23.1 21.7 15.2 17.3 16.1 14.6 14.8 14.8 20.2 14.8 15.0 14.7 14.6 15.0 14.2 15.2 15.0 14.8 19.2 29.0 31.3 16.9 16.7 23.1 32.9 22.2 15.2 17.9 17.0 14.9 21.5 23.1 9.2 10.4 27.7 15.1 12.6 29.4 25.3 55.6 19.7 18.3 13.3 16.8 20.0 27.3 28.2 27.7 15.6 19.4 18.1 16.5 17.8 8.9 21.4 18.8 13.5 29.0 15.3 34.6 14.7 9.9 48.7 13.4 15.0 14.2 15.9 19.3 18.3 15.5 23.6 43.0 31.9 6.8 10.5 28.3 24.0 13.9 31.7 25.4 16.6 13.1 13.5 20.2 42.2 26.9 25.8 21.2 27.9 15.9 20.5 16.3 23.1 ARID5A "MRF-1, RP11-363D14" ENSG00000196843 "AT-rich interaction domain 5A" Q03989 2 96536743-96552634 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 295.3;RPMI-8226: 117.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002860, HPA023879" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Nucleoli "HPA002860: , HPA023879: AB_1845014" "prognostic favorable (2.05e-6)" "unprognostic (1.08e-3)" "unprognostic (1.69e-2)" "unprognostic (3.89e-3)" "unprognostic (1.90e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.24e-8)" "unprognostic (2.74e-2)" "unprognostic (9.79e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" 32.6 4.5 8.1 19.5 8.9 11.8 38.8 8.7 11.1 18.5 7.7 25.9 5.0 25.2 2.0 7.8 24.1 12.3 28.8 7.8 8.7 12.3 8.5 48.1 19.0 14.3 10.8 10.8 6.9 2.2 9.3 9.6 11.5 23.2 2.3 2.2 10.2 2.6 23.5 11.3 19.8 7.3 10.6 22.8 14.6 5.6 10.2 10.3 13.0 2.3 9.9 19.9 15.4 9.6 3.4 1.9 1.6 5.4 2.7 3.0 7.5 5.1 17.2 6.1 5.3 3.1 0.9 1.1 3.8 2.9 9.1 4.6 1.4 0.3 2.1 295.3 4.1 6.9 1.1 5.8 3.4 4.7 4.9 2.1 5.7 5.0 0.9 5.3 5.4 8.1 5.4 38.5 2.4 2.9 8.7 16.1 3.3 1.5 0.2 12.2 11.3 117.5 0.7 2.5 2.2 1.1 0.5 0.6 4.3 1.3 0.2 10.0 6.0 5.4 6.7 6.2 4.6 24.7 21.5 3.1 3.0 11.1 4.9 10.5 7.9 32.8 15.3 6.9 14.9 5.9 13.1 14.6 10.3 6.5 14.1 14.4 21.5 27.5 5.5 18.4 16.0 14.9 8.1 8.9 8.7 11.1 7.8 8.7 14.3 10.8 11.5 10.6 10.2 9.6 97.1 3.2 18.3 3.9 59.9 52.4 46.5 17.0 5.7 24.8 80.3 44.7 14.7 8.6 14.7 3.7 31.3 4.9 121.1 10.8 3.9 33.7 14.2 16.7 26.8 82.2 0.0 3.4 1.5 30.9 9.0 41.2 11.2 32.4 61.9 2.1 38.6 28.7 72.6 0.0 1.6 10.7 20.3 41.5 137.1 36.7 3.7 61.6 58.7 15.9 66.6 6.5 123.6 3.5 1.3 29.1 23.9 6.4 54.5 28.2 0.6 10.6 8.3 25.7 46.0 49.1 120.1 3.2 17.9 1.1 32.5 4.0 98.2 2.1 7.8 26.9 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.1;lymphoid tissue: 22.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 45.6;Excitatory neurons: 78.8;Pancreatic endocrine cells: 86.9;Prostatic glandular cells: 109.0;Urothelial cells: 128.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 6.4" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 121.9;U-2197: 159.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli No No "Cluster 17: Basophils - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 18: U-2197 - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nucleoli" "HPA059074: AB_2683897" "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.0 1.0 1.3 10.0 6.4 2.3 2.1 0.0 3.6 5.8 0.0 2.5 2.8 1.2 0.2 28.1 0.9 3.6 0.8 2.8 1.6 1.1 4.7 2.3 5.2 0.0 0.5 0.2 1.3 1.5 0.8 2.8 0.0 1.1 3.2 0.4 7.2 0.6 0.2 7.6 2.6 4.6 0.0 1.0 10.9 2.7 0.6 4.4 0.6 0.8 22.2 14.7 11.9 2.2 76.0 19.2 4.2 1.6 3.6 11.0 58.3 26.3 34.5 16.8 26.2 18.2 57.4 0.6 14.4 12.6 51.9 30.6 12.3 92.1 42.7 121.9 15.7 14.6 11.7 15.2 4.8 29.6 6.1 4.0 8.1 58.8 45.6 28.9 80.0 17.7 7.5 29.8 19.6 9.2 16.2 16.2 32.1 25.7 65.8 29.8 68.2 4.7 14.1 42.8 13.6 2.2 13.5 2.1 0.4 10.0 2.9 9.7 54.6 54.2 31.4 159.5 110.0 4.4 8.4 0.1 46.5 23.5 10.9 1.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 1.3 6.4 0.0 3.6 2.8 1.6 0.0 0.5 0.0 0.0 0.6 2.2 2.1 3.2 1.3 1.3 0.4 0.8 45.6 8.6 1.2 0.9 1.6 0.8 0.9 11.5 7.5 9.2 0.0 1.9 0.3 1.5 0.0 22.1 3.8 7.9 0.7 6.9 1.2 3.4 78.8 27.4 4.0 3.2 28.1 11.8 0.0 5.3 2.5 3.5 1.4 0.0 24.8 3.3 2.0 2.5 5.4 4.4 0.0 2.9 1.8 7.5 15.7 0.0 0.0 8.5 2.3 86.9 1.4 0.0 3.4 109.0 1.7 0.6 2.7 0.1 0.0 1.7 3.6 3.1 4.7 6.6 2.3 4.2 1.3 0.2 2.1 128.2 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 15 "dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 9.3" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 7: Monocytes - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 176.1 82.8 14.2 63.3 17.7 45.3 97.6 16.5 18.7 106.2 17.1 66.6 21.0 108.6 9.3 128.4 122.6 135.0 113.7 14.4 20.2 98.1 139.9 116.0 20.8 21.1 16.7 40.2 67.2 48.8 45.0 66.3 17.2 116.3 60.0 16.2 33.1 24.1 30.7 154.9 45.6 313.0 15.4 24.4 104.8 3.9 18.8 84.5 181.1 30.0 3.1 281.2 55.2 25.0 21.1 1.2 40.7 8.7 3.9 10.4 131.5 14.7 11.9 12.5 29.8 27.7 15.5 0.4 6.5 0.9 68.0 11.6 24.6 4.0 20.5 100.4 24.6 1.6 11.6 10.0 72.9 9.0 22.7 18.3 65.3 34.9 80.4 2.4 2.6 23.9 10.0 77.0 1.9 2.8 27.5 5.9 29.2 11.5 9.2 8.1 27.1 18.4 1.8 3.0 18.3 18.4 19.1 34.2 59.0 155.0 19.9 6.5 2.4 3.6 19.5 12.3 6.7 60.4 27.9 7.4 11.9 4.8 10.8 6.4 0.7 0.0 0.3 4.0 0.3 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.2 0.0 6.3 0.8 0.0 0.7 14.2 17.7 16.5 18.7 14.4 20.2 21.1 16.7 17.2 15.4 18.8 25.0 568.2 423.1 146.5 1.6 55.3 202.8 866.2 236.1 1462.0 4.4 753.9 510.9 689.3 92.9 136.0 55.2 0.0 178.9 100.3 611.7 1.9 186.2 3.7 1049.4 318.2 176.2 889.6 2.7 2.6 122.7 330.8 452.6 966.9 1429.3 78.6 5.6 30.7 25.8 103.7 1.7 2.4 758.4 114.0 29.8 282.8 2.8 17.4 351.8 174.3 3.7 32.3 39.9 0.0 1.5 10.8 185.7 484.8 1.2 161.0 457.5 421.3 3.3 133.2 5.3 98.6 279.4 573.7 2.2 3.1 474.6 202.7 420.6 97.1 5.8 349.6 263.6 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 14.4" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/70: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: AB_2686306" "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 4.1 4.0 3.2 5.9 5.3 2.6 4.1 0.0 14.4 8.4 0.0 8.8 3.8 10.9 4.3 5.0 6.2 5.7 5.8 8.4 0.0 4.1 4.7 6.9 4.2 0.0 1.3 5.4 4.8 5.5 6.5 4.9 0.0 7.4 3.8 13.9 4.6 6.2 14.6 5.7 4.8 7.5 0.0 5.7 5.3 3.0 3.9 2.6 6.1 14.8 3.1 6.7 6.6 0.8 4.5 2.6 0.9 0.0 4.4 5.9 5.8 4.8 11.2 2.9 3.3 2.8 2.8 0.2 6.3 9.3 3.7 4.2 0.3 3.0 4.2 2.6 4.7 0.7 4.4 9.0 7.0 4.2 7.0 4.6 5.7 6.1 5.1 11.2 5.9 0.9 0.0 5.3 2.4 2.3 0.3 4.8 0.9 1.4 4.3 0.3 5.8 4.0 4.0 7.6 0.3 2.5 4.4 5.5 9.1 8.4 3.6 7.2 9.1 4.0 6.1 4.8 4.4 30.7 19.2 0.2 2.6 4.3 10.0 0.2 0.5 0.1 0.7 0.4 0.5 0.1 0.5 0.7 0.2 0.0 0.0 0.4 1.3 0.0 0.2 0.1 0.4 0.3 3.2 5.3 0.0 14.4 8.4 0.0 0.0 1.3 0.0 0.0 3.9 0.8 16.0 48.1 25.9 206.3 20.7 91.4 72.2 22.8 48.9 39.8 20.7 14.4 35.9 25.8 26.0 11.0 100.1 0.6 48.4 23.6 7.9 16.7 4.3 80.5 144.4 21.7 1.2 5.7 582.5 8.5 4.0 32.9 22.4 75.8 38.7 67.4 17.2 25.2 22.4 38.7 519.0 16.5 2.0 39.6 79.1 3.3 10.5 41.7 32.0 217.4 42.3 24.1 33.0 318.2 466.8 32.3 16.3 28.2 82.6 56.6 13.9 8.8 33.2 99.9 52.6 19.0 41.6 1.0 6.9 60.9 48.7 0.4 61.5 6.4 7.7 63.8 AXIN1 PPP1R49 ENSG00000103126 "Axin 1" O15169 16 287440-352723 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012987 Approved Supported Nucleoli,Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoli, Vesicles" "CAB012987: AB_2533178" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (7.64e-2)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (1.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (4.41e-2)" "unprognostic (1.94e-1)" "unprognostic (1.23e-2)" "unprognostic (1.03e-1)" 11.9 9.3 10.5 9.2 10.8 23.0 11.5 14.8 12.5 12.9 9.1 17.1 12.3 13.2 3.1 16.3 11.8 6.2 11.6 10.0 9.2 11.6 11.2 13.7 10.5 10.2 10.2 13.8 13.0 7.2 12.6 5.8 9.8 12.9 6.9 2.6 11.5 6.0 21.1 20.1 15.0 5.4 9.2 15.0 12.9 11.8 10.1 12.5 11.9 7.0 6.6 14.5 13.1 11.9 18.1 25.6 13.4 23.7 9.8 9.0 28.0 11.9 10.8 16.1 13.8 37.9 20.4 27.7 18.0 12.3 19.4 25.4 21.1 18.5 7.2 27.5 34.6 18.0 21.9 27.6 16.6 20.9 19.3 9.0 31.7 16.6 20.3 14.1 10.7 19.8 45.6 14.8 7.4 48.1 22.7 14.5 30.6 21.6 15.4 42.4 12.2 38.8 12.2 10.5 30.4 18.6 22.6 24.9 38.3 10.0 16.5 26.1 12.4 15.9 17.0 18.5 17.5 17.3 18.1 34.2 7.5 13.7 15.9 1.2 0.9 5.0 8.3 0.8 7.6 1.5 2.4 5.8 0.7 1.2 2.4 3.4 2.7 3.5 0.6 1.2 2.6 2.3 10.5 10.8 14.8 12.5 10.0 9.2 10.2 10.2 9.8 9.2 10.1 11.9 7.9 3.2 8.6 4.9 5.7 18.4 7.6 8.5 5.7 4.3 11.2 9.5 4.9 5.7 7.2 3.7 0.0 3.5 30.1 27.4 0.0 7.2 1.4 10.2 7.0 6.3 10.8 8.6 18.5 6.9 27.5 6.7 15.3 14.4 10.8 10.5 5.7 5.1 7.5 5.0 12.7 15.1 6.1 6.2 9.0 2.1 5.3 6.7 10.6 1.0 5.7 4.5 28.8 8.5 8.9 11.0 12.2 4.9 7.0 13.4 11.1 2.4 7.7 5.7 13.1 8.7 7.6 5.5 8.8 7.2 15.2 3.7 12.4 5.0 15.7 10.5 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686417-212699840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 41.0;Langerhans cells: 50.4;Macrophages: 24.4;monocytes: 65.7;Smooth muscle cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 65.9;myeloid DC: 55.3;non-classical monocyte: 99.3" "Group enriched" "Detected in many" 34 "dendritic cells: 55.3;monocytes: 99.3" "Cell line enriched" "Detected in many" 11 "HDLM-2: 497.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 5.9 1.1 1.9 3.6 2.9 3.0 3.0 1.4 2.8 1.8 9.1 1.7 0.6 1.3 0.0 1.1 2.0 2.0 2.1 2.2 1.9 5.1 1.1 5.8 5.9 1.8 1.8 0.6 1.7 0.4 0.9 2.5 1.9 1.8 0.6 0.0 0.9 0.4 0.5 0.9 2.3 1.8 2.3 7.3 1.5 0.5 1.7 4.2 1.6 0.6 2.6 4.9 1.4 2.0 2.4 6.6 0.7 0.0 0.2 3.1 4.3 2.3 7.4 6.5 7.0 0.0 1.7 0.0 0.9 0.4 10.6 0.0 7.0 1.1 4.5 497.4 12.5 0.1 1.9 0.0 1.2 22.6 3.9 0.5 0.0 12.5 1.8 1.0 0.1 43.5 1.1 6.5 1.3 0.0 17.8 9.3 2.7 0.0 8.4 3.5 2.4 0.3 6.0 0.0 1.4 0.9 1.6 0.0 0.5 2.3 0.0 17.8 0.0 2.7 11.1 0.5 13.4 0.5 1.4 2.7 8.7 21.3 6.2 0.0 13.6 0.0 0.0 65.9 0.0 0.7 0.2 0.3 55.3 0.0 0.0 0.0 2.2 1.5 99.3 0.2 1.8 8.8 1.9 2.9 1.4 2.8 2.2 1.9 1.8 1.8 1.9 2.3 1.7 2.0 9.6 3.2 0.6 0.3 2.4 5.7 2.3 0.9 0.0 0.2 5.2 5.5 0.5 0.0 1.6 0.0 0.0 2.1 0.7 0.0 0.0 0.7 0.7 1.5 3.1 8.2 0.0 0.4 4.5 0.4 41.0 6.8 0.0 2.3 5.1 1.0 6.1 0.4 5.8 0.0 0.6 0.1 0.0 14.4 50.4 0.8 0.9 24.4 1.8 7.5 65.7 0.1 0.0 0.5 0.9 1.1 0.0 0.0 0.0 18.9 0.0 0.4 2.7 0.4 0.0 5.2 20.0 1.0 4.1 0.1 2.8 4.5 1.9 0.1 0.0 1.4 BRF2 "BRFU, FLJ11052, TFIIIB50" ENSG00000104221 "BRF2 RNA polymerase III transcription initiation factor subunit" Q9HAW0 8 37843268-37849861 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019269, HPA023378" Supported Supported Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoli "CAB019269: , HPA023378: AB_1845446" "unprognostic (9.85e-3)" "unprognostic (2.74e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-3)" "unprognostic (3.91e-2)" "unprognostic (2.35e-2)" "unprognostic (9.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (2.52e-3)" "unprognostic (1.33e-1)" "unprognostic (1.93e-1)" "unprognostic (7.41e-2)" 12.0 8.0 6.6 4.6 7.2 14.3 11.0 6.6 7.6 15.2 6.4 11.3 4.1 12.6 6.3 8.2 11.9 4.6 10.8 7.8 6.7 9.8 7.9 7.6 6.7 6.9 7.1 12.8 8.4 6.5 9.7 7.6 7.7 13.7 5.3 5.9 7.9 7.0 28.5 11.2 7.7 5.7 6.6 9.8 8.9 7.8 7.1 11.0 7.2 12.8 5.4 14.0 10.7 7.4 13.1 9.9 9.6 12.4 13.0 9.5 11.2 15.1 12.0 20.1 13.7 12.9 9.2 16.0 21.3 9.6 7.6 13.3 12.5 9.5 10.0 10.0 12.5 19.7 8.3 10.6 13.6 7.9 11.3 12.8 12.3 20.1 8.5 9.8 6.6 14.0 24.6 13.9 6.6 7.5 25.2 9.9 16.1 9.6 13.1 14.7 10.4 8.1 7.4 8.7 8.1 9.7 7.1 10.5 18.3 11.6 22.1 15.0 8.8 10.0 13.7 25.5 15.4 16.5 24.8 18.8 14.5 10.3 18.2 13.9 10.1 11.7 13.5 9.5 13.7 14.2 14.3 13.8 7.9 14.9 20.3 16.6 4.2 20.0 8.7 9.5 13.7 11.7 6.6 7.2 6.6 7.6 7.8 6.7 6.9 7.1 7.7 6.6 7.1 7.4 6.9 12.8 4.8 2.0 4.2 4.5 4.2 6.4 0.6 9.8 6.9 7.5 0.3 7.2 4.7 9.2 0.0 22.6 6.2 5.5 7.9 8.7 0.4 14.2 7.9 7.8 6.6 8.6 3.3 11.0 10.4 8.1 5.6 24.7 2.5 8.6 6.8 2.1 11.6 8.4 3.1 8.6 8.2 7.1 5.4 1.4 9.3 3.9 3.6 1.0 7.1 11.4 10.3 2.5 2.3 6.5 2.2 10.5 7.2 4.3 9.3 5.8 7.1 6.9 6.6 5.5 7.5 12.5 12.4 4.6 3.8 14.1 7.5 11.5 7.2 3.0 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23 rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 712.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA052185: AB_2681753" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 39.8 49.2 34.5 40.0 36.7 58.7 43.4 36.4 39.8 36.3 41.0 48.6 47.0 38.6 72.3 41.7 58.9 34.5 87.9 36.1 39.0 53.3 47.2 38.5 52.6 37.0 36.1 37.8 70.8 49.2 45.1 30.7 36.3 37.8 47.7 20.3 55.9 42.2 128.0 43.8 40.3 41.4 36.4 42.1 44.9 130.0 36.6 44.7 56.5 78.4 51.7 51.9 32.8 38.5 142.1 151.8 53.6 429.2 72.0 64.2 91.1 95.1 83.3 118.5 96.1 211.4 182.6 163.6 48.9 99.5 204.0 97.0 124.8 91.0 108.4 116.6 147.1 72.0 174.8 86.7 91.2 200.3 98.8 57.3 102.2 103.2 93.9 59.7 77.4 130.3 285.4 288.9 103.7 219.6 128.0 277.8 130.2 317.8 172.2 110.5 106.8 712.0 132.5 100.2 163.4 124.4 126.3 329.2 146.5 53.0 207.9 159.0 85.2 101.8 130.3 130.0 208.3 99.5 192.6 275.5 232.3 155.6 218.0 54.8 64.9 60.6 112.0 74.2 124.9 175.3 127.1 122.5 122.9 153.5 132.8 121.5 11.9 125.4 68.0 190.9 150.6 132.6 34.5 36.7 36.4 39.8 36.1 39.0 37.0 36.1 36.3 36.4 36.6 38.5 67.0 44.8 64.5 0.0 26.5 0.0 0.0 0.0 0.0 0.0 75.4 85.7 0.0 0.0 42.7 46.0 0.0 75.7 64.1 0.0 97.8 119.9 0.0 133.6 51.2 28.6 0.0 0.0 0.0 140.8 82.7 24.5 0.0 79.6 46.7 49.2 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 21.2 0.0 0.0 0.0 0.0 126.0 0.0 0.0 16.5 0.0 0.0 103.5 78.7 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 106.7 28.1 73.0 0.0 0.0 C1D "LRP1, Rrp47, SUN-CoR, SUNCOR" ENSG00000197223 "C1D nuclear receptor corepressor" Q13901 2 68041130-68110948 "Predicted intracellular proteins" "Apoptosis, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037413, HPA037588" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 34: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA037413: AB_2675463, HPA037588: AB_10672907" "unprognostic (1.84e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.03e-1)" "unprognostic (1.49e-2)" "unprognostic (4.01e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.90e-2)" "unprognostic (1.29e-2)" "unprognostic (4.24e-3)" "unprognostic (6.18e-2)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.01e-1)" 21.7 25.3 11.6 17.0 11.8 48.1 21.4 11.9 19.0 19.9 12.8 19.1 16.6 20.0 17.0 19.3 18.3 14.7 22.2 12.0 12.8 31.5 33.4 19.0 21.4 11.3 11.8 19.3 15.8 24.0 15.3 17.5 11.6 19.5 14.7 16.6 18.7 15.5 46.9 17.5 18.5 13.7 12.0 21.7 21.4 14.8 12.0 17.5 19.6 31.9 16.5 17.4 28.2 13.9 36.6 20.3 22.0 21.0 22.2 27.0 29.6 48.7 28.1 29.3 22.4 40.8 45.0 45.2 27.2 28.9 28.1 18.0 24.7 20.4 43.1 43.0 36.6 43.5 17.6 46.3 22.3 68.1 54.4 25.0 32.4 22.1 20.9 36.3 22.0 41.4 44.8 41.1 26.6 22.2 51.3 69.6 25.4 29.8 24.4 29.6 28.3 39.9 28.2 29.2 20.5 25.4 15.1 30.0 51.6 26.7 22.2 41.2 30.9 27.9 34.5 34.0 38.9 38.0 40.8 58.6 38.9 41.3 34.2 45.3 17.6 43.7 19.0 23.3 22.5 24.2 22.0 16.6 20.6 21.3 23.4 24.3 34.9 30.3 25.2 19.2 25.3 15.2 11.6 11.8 11.9 19.0 12.0 12.8 11.3 11.8 11.6 12.0 12.0 13.9 65.2 76.9 47.9 13.1 70.7 85.0 83.2 132.8 33.6 34.3 52.9 58.4 36.5 64.3 86.3 64.4 22.9 98.9 76.2 48.1 234.8 83.4 52.4 53.7 47.2 42.9 51.6 121.2 17.7 59.4 82.7 60.2 44.9 46.6 44.3 32.8 43.5 81.7 87.5 35.3 15.9 42.6 109.9 61.9 46.1 21.7 55.6 66.9 56.9 8.4 80.1 57.4 88.6 14.1 21.9 65.6 63.3 59.0 58.5 78.1 57.0 251.4 95.4 36.8 98.6 54.2 65.3 164.5 100.3 44.5 86.2 107.8 62.9 52.2 32.8 109.0 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 50.2;Suprabasal keratinocytes: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavorable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 8.8 10.7 7.7 7.3 6.8 8.0 9.7 7.1 7.5 8.9 5.9 7.2 8.2 10.2 10.0 10.1 9.8 6.9 8.3 7.0 7.5 9.2 7.8 5.5 11.9 7.0 8.1 13.4 14.6 15.0 6.1 10.4 7.6 10.6 5.6 5.3 12.3 10.1 9.7 10.5 5.7 8.2 7.9 7.7 6.9 8.3 10.3 9.1 11.4 10.0 9.7 8.1 7.9 8.2 17.7 20.1 16.9 27.8 14.5 10.4 38.5 20.9 14.7 30.7 22.6 30.8 20.8 25.0 24.4 9.2 14.2 25.3 31.5 21.2 31.3 40.3 35.1 28.3 20.7 19.5 27.9 31.6 18.0 14.2 25.7 30.4 39.8 13.4 15.7 21.6 57.2 29.5 17.7 12.1 30.9 13.9 52.9 18.1 38.0 30.2 35.4 69.0 16.4 14.9 50.8 24.4 18.4 27.9 43.1 16.9 15.7 13.9 10.6 30.7 19.3 25.0 40.8 24.0 29.0 52.0 15.4 30.4 33.0 3.5 9.7 6.9 18.9 7.9 29.9 21.2 22.8 18.3 11.6 18.7 28.8 25.0 1.9 24.8 8.8 54.1 12.5 15.0 7.7 6.8 7.1 7.5 7.0 7.5 7.0 8.1 7.6 7.9 10.3 8.2 10.9 6.4 7.9 4.2 12.9 50.2 24.1 5.9 22.8 10.1 15.6 15.1 5.5 5.7 10.8 3.7 10.4 14.9 12.2 6.7 13.7 10.5 1.5 5.8 12.8 11.5 4.2 45.3 9.5 7.3 14.0 14.4 6.1 6.2 11.4 9.6 6.4 6.6 5.4 16.8 7.2 5.1 8.2 4.4 9.0 1.0 9.9 4.8 12.4 4.7 7.3 10.4 17.5 5.0 5.0 10.2 8.1 13.9 10.9 21.3 5.5 8.9 5.6 14.6 0.0 17.5 8.5 25.7 25.5 15.5 62.1 7.9 12.0 11.9 8.3 13.2 C2CD4A "FAM148A, NLF1" ENSG00000198535 "C2 calcium dependent domain containing 4A" Q8NCU7 15 62066977-62070917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.1;pituitary gland: 13.5" "Cell type enriched" "Detected in many" 5 "Glandular and luminal cells: 107.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "OE19: 34.4;RPTEC TERT1: 29.9" HPA078864 Supported Nucleoplasm,Nucleoli NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "HPA078864: " "unprognostic (3.85e-2)" "unprognostic (6.68e-2)" "unprognostic (5.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.32e-1)" "unprognostic (5.38e-3)" "unprognostic (5.49e-3)" "unprognostic (3.85e-1)" "unprognostic (1.67e-1)" "unprognostic (9.21e-2)" "unprognostic (3.89e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.72e-2)" "unprognostic (2.07e-2)" "unprognostic (6.26e-2)" "unprognostic (3.35e-1)" 0.2 0.4 0.2 0.6 0.2 0.2 0.2 0.2 2.2 0.7 0.3 0.5 1.0 1.3 0.0 0.1 0.0 0.4 0.1 0.2 2.5 5.1 2.4 0.5 0.2 1.0 0.8 0.1 4.0 0.0 13.5 0.1 0.7 0.6 0.6 0.2 1.2 0.1 0.3 0.5 0.5 0.0 0.1 0.1 2.0 0.1 0.3 2.1 0.1 0.0 0.5 3.6 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 34.4 0.2 0.1 0.0 0.2 29.9 0.7 1.3 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.2 2.2 0.2 2.5 1.0 0.8 0.7 0.1 0.3 0.1 0.6 0.0 0.0 0.3 0.3 0.5 1.8 3.8 0.0 0.9 4.3 6.2 1.4 0.0 2.7 0.0 0.0 0.0 0.0 1.2 1.9 2.8 0.0 11.7 14.6 3.9 20.8 0.0 0.0 6.6 0.0 1.2 3.6 107.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.2 14.2 0.0 0.8 0.0 0.0 0.8 0.0 0.0 1.0 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.8 2.2 0.3 0.0 1.1 0.2 0.0 1.0 1.4 0.0 0.0 0.0 1.1 0.0 1.1 0.1 1.0 1.1 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330955-68819023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;fallopian tube: 9.1;parathyroid gland: 7.4" "Cell type enriched" "Detected in some" 5 "Inhibitory neurons: 396.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 2.7 0.3 4.0 0.2 5.4 0.5 0.7 3.6 3.9 2.1 2.0 0.2 0.2 0.6 0.6 1.0 9.1 0.6 0.7 6.2 3.8 0.4 0.2 2.5 0.2 6.4 10.2 0.4 1.1 7.4 1.7 0.3 4.6 2.1 0.3 1.0 0.6 1.0 0.3 0.9 0.2 0.1 4.0 0.2 0.8 0.7 6.7 0.8 0.4 0.9 0.2 0.4 0.2 6.1 0.1 0.0 0.3 0.1 0.6 1.0 0.1 0.9 2.3 0.3 0.3 0.1 0.2 0.1 0.3 0.5 0.1 0.1 0.1 0.3 0.1 0.0 2.3 0.3 0.5 0.2 0.1 0.0 0.2 0.1 0.3 0.4 0.8 0.1 0.0 0.3 0.1 0.4 2.7 0.3 0.0 0.2 1.0 0.0 0.0 0.1 2.7 0.0 0.2 0.2 0.5 0.0 0.1 0.1 0.0 0.2 1.4 0.1 0.0 0.4 0.2 1.6 0.0 0.4 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.3 0.5 0.2 0.1 0.4 0.1 0.1 4.0 5.4 3.6 3.9 6.2 3.8 6.4 10.2 4.6 4.0 6.7 6.1 0.2 16.0 18.7 9.4 0.0 1.7 0.8 0.2 0.0 1.5 0.2 0.0 1.2 0.0 3.9 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.5 26.4 0.7 0.5 0.0 0.0 79.2 0.0 0.3 1.9 0.0 4.3 1.3 0.1 0.0 0.0 0.3 0.0 396.6 0.1 0.0 0.0 1.2 1.3 0.3 0.4 1.8 3.7 0.1 0.0 0.0 9.5 10.1 0.5 0.0 0.4 0.0 0.8 0.0 0.0 20.8 0.7 0.0 0.6 1.7 0.6 0.4 0.1 0.9 0.4 0.4 0.2 0.0 0.4 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900899-21945903 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 51.0;Spermatogonia: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 101.0;naive B-cell: 124.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "olfactory bulb: 10.1" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No Yes "Cluster 21: B-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 5.9 1.4 3.9 15.0 9.1 51.7 15.7 5.7 5.2 8.7 17.8 17.0 10.7 13.8 5.5 11.2 11.5 8.1 25.3 3.9 3.5 2.8 4.8 14.0 37.1 6.9 4.8 21.8 13.0 1.8 1.1 4.7 3.8 7.3 19.0 5.1 9.0 7.6 6.2 18.5 13.6 11.9 5.0 13.3 17.8 18.5 7.8 49.0 29.8 3.4 31.8 6.3 8.1 9.8 84.5 27.6 26.0 0.6 14.5 17.9 0.0 65.9 58.2 51.8 73.5 11.3 75.4 173.6 21.8 59.3 102.4 51.1 41.4 69.4 103.6 0.3 28.6 42.3 83.8 7.4 21.1 111.1 0.4 35.2 12.7 40.0 116.9 54.9 104.8 133.5 58.3 0.1 41.4 34.5 146.1 46.1 153.2 17.4 36.2 141.0 94.0 119.8 15.4 14.8 96.9 79.7 30.3 19.9 29.9 34.4 45.6 54.6 43.0 57.1 68.5 101.3 83.8 90.6 63.6 223.0 55.7 154.6 54.5 1.1 2.3 43.2 2.2 3.8 0.3 101.0 6.4 3.2 14.9 124.5 30.9 12.8 3.8 3.4 4.9 75.9 9.9 12.2 3.9 9.1 5.7 5.2 3.9 3.5 6.9 4.8 3.8 5.0 7.8 9.8 1.0 19.2 31.5 7.5 51.0 27.1 23.7 6.9 17.1 1.5 12.5 20.7 38.7 11.5 19.0 0.0 2.1 0.5 30.7 8.4 3.9 8.9 7.3 5.4 2.7 4.8 10.7 21.9 0.5 6.2 0.3 13.4 18.3 5.3 8.8 14.9 1.4 4.0 10.8 13.5 1.0 26.1 8.2 15.2 3.5 5.2 4.1 7.0 8.8 1.9 1.6 2.4 1.0 15.1 8.7 3.9 7.4 2.6 20.2 14.2 1.5 0.1 4.2 2.7 13.1 6.8 12.4 4.6 63.5 9.6 7.7 0.3 5.4 8.3 23.0 6.2 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692481-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.0 1.1 0.7 7.9 1.0 33.5 2.0 0.2 0.9 1.7 0.0 9.4 8.3 1.3 1.8 9.2 1.0 1.1 0.6 0.5 0.4 0.8 1.3 1.5 19.5 0.6 0.4 0.6 0.8 0.5 0.6 4.4 0.5 0.7 11.3 1.9 1.8 0.5 0.3 6.3 7.3 2.8 0.3 4.9 4.9 22.5 0.6 38.8 0.6 0.5 22.7 2.0 2.9 0.7 108.5 45.5 84.4 62.1 3.6 7.0 57.2 79.6 39.5 137.2 96.6 71.9 78.8 130.2 31.5 50.5 54.5 59.4 97.8 52.4 141.9 86.8 44.9 116.8 49.2 57.3 0.8 113.8 58.4 2.8 3.8 77.1 67.3 15.3 60.9 91.1 100.7 135.6 99.1 47.7 106.1 68.9 98.8 61.7 62.8 102.2 115.6 74.4 31.0 43.8 75.4 33.3 87.5 40.6 52.4 71.7 60.1 42.4 37.3 67.8 70.6 39.2 126.0 91.4 128.1 176.3 31.6 104.7 79.6 0.0 0.7 1.3 1.5 1.6 2.8 1.7 3.6 2.2 0.7 1.4 1.1 2.3 3.0 4.1 3.9 1.2 5.9 1.7 0.7 1.0 0.2 0.9 0.5 0.4 0.6 0.4 0.5 0.3 0.6 0.7 0.8 0.0 0.5 1.3 4.8 3.3 0.8 2.4 1.8 1.3 1.9 1.5 0.7 2.8 0.4 0.0 0.0 17.1 1.9 12.4 0.0 1.2 1.0 1.7 1.6 1.9 3.6 34.1 1.2 0.6 26.0 2.9 6.6 2.5 0.0 12.0 3.6 1.0 11.6 1.7 0.9 8.2 2.0 3.5 1.9 2.8 1.5 3.7 1.8 0.0 1.6 0.1 2.1 0.5 0.9 2.4 4.0 1.2 15.8 1.3 1.9 0.6 4.7 1.0 19.7 0.2 6.3 76.8 42.0 17.1 2.7 2.9 5.5 1.2 13.2 1.2 CDK4 PSK-J3 ENSG00000135446 "Cyclin dependent kinase 4" P11802 12 57747727-57756013 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "glioma: 175.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006024, CAB013116, CAB069405" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 89: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "Nucleoplasm, Nuclear membrane, Nucleoli" "CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497" "unprognostic (8.88e-2)" "unprognostic (2.53e-1)" "unprognostic (5.27e-2)" "unprognostic (9.01e-2)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.09e-7)" "unprognostic (7.39e-2)" "unprognostic (3.23e-3)" "unprognostic (2.93e-2)" "unprognostic (3.19e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.32e-1)" "unprognostic (1.67e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-2)" 69.7 87.8 35.0 52.8 37.9 72.0 76.6 37.7 36.9 84.3 35.9 62.6 40.2 97.4 64.2 57.2 69.4 57.1 58.9 33.6 37.1 58.5 51.5 58.0 66.8 37.1 36.9 97.3 70.9 63.5 67.7 52.4 36.8 52.7 63.3 14.5 54.4 54.1 48.2 58.9 47.2 80.4 37.3 51.5 54.8 24.1 37.3 67.6 66.0 52.7 70.6 71.6 60.7 37.6 207.1 235.7 295.7 268.0 253.7 220.7 210.4 116.1 347.9 468.5 385.7 338.2 189.1 297.4 200.2 173.6 293.2 158.0 396.3 2594.8 354.9 150.9 209.0 275.4 149.5 237.9 297.0 309.7 182.5 221.5 180.9 294.2 326.7 326.4 304.8 280.0 301.3 242.7 2819.4 304.9 296.7 256.5 347.0 208.0 249.8 267.3 8902.5 272.1 147.2 320.6 271.2 251.7 205.3 150.2 310.0 195.1 202.8 380.7 146.1 233.6 217.0 265.8 233.1 122.2 206.1 450.8 214.1 291.3 286.9 9.5 46.5 10.3 79.6 65.6 81.8 93.5 70.0 72.5 66.7 90.0 93.0 84.4 4.4 56.6 41.9 84.9 57.0 73.6 35.0 37.9 37.7 36.9 33.6 37.1 37.1 36.9 36.8 37.3 37.3 37.6 47.1 22.4 30.8 7.8 40.0 89.7 78.6 83.4 74.0 15.9 67.2 82.2 0.7 51.5 35.3 47.8 10.4 82.9 26.1 15.9 70.5 93.1 13.5 14.9 77.7 50.8 45.6 98.0 5.2 62.5 134.5 79.4 28.5 22.6 69.1 60.2 39.7 35.8 132.9 18.5 6.7 42.2 40.7 25.1 44.1 8.0 64.0 31.2 53.4 6.5 41.9 51.4 29.9 5.5 8.0 48.3 18.9 63.2 57.8 113.9 14.0 80.9 7.4 17.9 32.9 62.1 61.9 32.1 48.3 74.5 86.1 46.8 32.3 78.8 78.7 49.4 CDKN2A "ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf" ENSG00000147889 "Cyclin dependent kinase inhibitor 2A" "P42771, Q8N726" 9 21967752-21995301 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 31.7;pituitary gland: 33.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9" "Cancer enhanced" "Detected in all" "cervical cancer: 49.9;ovarian cancer: 57.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 37.4" "Group enriched" "Detected in many" 6 "B-cells: 15.6;T-cells: 37.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7" "Low region specificity" "Detected in some" "CAB000093, CAB000445, CAB018232, HPA047838" Enhanced Supported Nucleoli NA NA 18000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoli "CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174" "unprognostic (3.41e-2)" "unprognostic (4.51e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (1.82e-7)" "unprognostic (5.22e-2)" "prognostic favorable (5.19e-4)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.41e-2)" "unprognostic (1.22e-2)" "unprognostic (3.05e-2)" "unprognostic (3.55e-1)" 3.7 10.1 7.4 1.7 8.3 1.3 3.1 5.9 8.5 1.1 31.7 1.9 0.8 0.7 1.0 7.4 2.2 0.5 0.7 6.7 6.4 0.5 0.7 2.3 2.1 7.4 5.8 0.8 1.5 2.1 33.7 2.6 7.2 2.1 0.7 0.1 1.6 1.6 0.6 0.9 3.6 0.3 6.2 5.5 3.9 14.8 8.0 2.1 1.3 0.0 2.5 2.4 2.3 9.2 11.8 0.0 1.7 82.2 0.8 0.9 39.1 15.9 0.0 111.7 196.0 19.1 289.2 47.1 167.7 9.5 0.0 36.0 34.3 211.0 91.4 212.2 389.7 0.1 311.1 13.6 8.8 22.4 17.3 21.2 0.0 112.2 61.9 236.3 11.7 0.0 0.1 188.4 105.7 0.8 1.9 0.0 2.6 24.2 185.9 0.2 80.2 166.3 23.4 0.0 195.2 14.0 219.9 36.6 318.7 9.4 42.8 0.7 39.5 0.9 2.6 0.3 0.5 84.7 49.6 177.8 0.2 62.9 1.0 1.5 2.1 0.3 9.9 1.3 14.1 11.1 11.4 17.6 0.3 15.6 0.6 6.7 0.5 0.8 4.2 0.0 37.4 3.6 7.4 8.3 5.9 8.5 6.7 6.4 7.4 5.8 7.2 6.2 8.0 9.2 1.6 0.0 0.0 1.0 11.5 1.8 2.3 170.1 0.0 0.6 6.1 10.4 4.2 0.0 145.9 11.0 0.0 27.9 6.2 8.1 0.0 29.7 227.5 36.4 6.7 2.6 70.9 0.0 1.2 26.4 43.8 7.7 0.0 6.2 4.5 4.6 1.4 0.3 7.6 0.0 3.5 6.3 122.1 10.5 4.2 447.9 3.1 2.9 8.8 7.5 16.2 0.9 5.2 4.5 6.6 417.7 12.1 1.9 38.7 35.4 32.8 0.0 221.9 0.1 0.0 1.1 20.8 7.2 6.2 7.2 0.4 9.2 12.7 11.0 3.8 54.4 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234200-26278808 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.9;tongue: 65.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.0;Oligodendrocytes: 28.8;Spermatocytes: 40.9;Spermatogonia: 34.2;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 19.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.8 3.5 3.9 5.3 8.3 20.8 3.8 5.6 6.7 4.1 3.7 5.4 3.4 3.2 3.2 8.6 2.7 2.7 25.5 4.3 5.9 6.0 5.8 4.7 6.9 7.1 6.8 3.3 5.0 8.8 6.1 3.2 8.9 2.9 6.0 14.1 5.3 2.4 132.9 9.8 5.2 3.7 3.7 6.3 4.7 31.1 7.1 13.6 7.8 65.9 7.8 3.2 6.2 14.3 29.6 12.5 30.2 22.6 7.3 8.9 52.5 18.8 11.5 31.9 28.5 17.4 28.2 34.3 20.1 9.2 14.6 25.5 41.0 14.4 29.9 23.5 20.9 49.7 31.9 19.4 6.6 46.2 43.8 3.8 13.7 24.9 16.4 12.8 14.5 47.7 57.4 39.9 19.2 9.8 38.7 35.2 23.0 17.4 20.8 39.8 31.3 29.7 10.4 5.5 41.4 16.7 24.5 19.8 15.7 21.5 14.5 26.4 14.3 17.1 26.7 19.3 24.7 30.0 48.4 38.9 9.8 65.2 27.5 5.0 6.4 19.2 3.5 6.1 2.8 2.6 2.6 2.7 4.9 1.8 2.2 3.5 0.6 2.3 7.4 2.1 3.6 3.6 3.9 8.3 5.6 6.7 4.3 5.9 7.1 6.8 8.9 3.7 7.1 14.3 1.0 0.0 2.2 3.6 2.7 6.9 4.0 2.5 6.2 11.2 3.7 2.9 29.0 1.5 3.7 5.5 12.5 3.4 5.1 6.9 7.9 1.7 1.0 3.4 2.3 2.0 1.8 16.8 12.8 1.3 3.9 2.3 3.6 4.9 2.5 9.1 1.4 3.1 4.8 0.0 9.9 3.7 2.0 5.0 3.7 2.9 1.5 4.3 1.8 4.7 4.0 1.8 2.1 3.0 28.8 2.7 3.4 0.4 4.4 2.5 2.3 1.1 2.0 11.1 0.0 2.4 2.3 40.9 34.2 8.6 6.1 41.7 3.4 2.3 4.5 4.5 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884796-7912760 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Supported "Nucleoplasm,Nucleoli,Centriolar satellite" No No "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "Centriolar satellite" "HPA043368: AB_2678448, HPA076524: AB_2686804" "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavorable (2.43e-4)" "prognostic favorable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favorable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 28.2 29.3 19.9 35.0 27.9 42.7 28.4 0.0 39.9 71.6 0.0 55.3 16.7 63.9 31.2 35.1 56.8 27.8 21.2 35.8 7.0 38.3 5.7 32.4 41.3 4.9 2.4 60.0 34.8 44.7 47.7 16.6 1.1 68.7 22.1 19.0 40.3 38.0 8.0 32.7 34.6 45.0 3.1 31.5 36.3 20.9 8.0 58.2 44.9 9.1 36.7 41.2 42.8 21.4 44.9 108.7 61.6 81.2 72.2 60.9 32.8 51.7 66.1 40.8 43.5 21.1 36.7 122.8 38.3 73.0 34.0 59.6 117.7 52.5 53.0 65.5 67.2 62.7 148.5 2.7 38.3 17.8 112.1 79.2 27.5 55.4 36.9 108.7 76.9 54.1 41.5 2.0 38.8 42.6 48.2 19.6 9.8 45.3 40.3 137.8 82.1 19.3 40.0 107.7 41.9 56.3 126.4 47.9 24.6 16.9 55.7 27.1 99.7 89.4 68.8 22.3 72.5 8.8 1.6 68.3 46.1 47.4 77.6 1.7 2.6 3.3 4.1 1.4 3.6 1.1 4.2 4.0 1.3 1.2 4.6 3.1 2.8 3.2 3.2 3.0 2.5 2.5 19.9 27.9 0.0 39.9 35.8 7.0 4.9 2.4 1.1 3.1 8.0 21.4 20.9 32.1 63.2 10.4 19.6 36.6 47.6 21.1 65.4 60.7 43.8 34.2 14.3 17.2 35.2 80.9 8.4 16.8 57.3 39.8 17.6 22.9 11.3 48.6 51.9 29.4 56.8 19.1 20.6 23.4 20.5 39.9 31.1 70.7 39.9 59.7 22.9 2.7 9.0 45.4 25.2 17.0 12.2 24.7 34.7 18.5 44.4 26.7 8.8 6.5 43.7 12.4 59.8 12.1 2.5 20.9 10.8 57.2 17.4 55.5 10.9 9.7 24.8 17.3 26.3 31.8 43.5 25.5 46.8 52.8 20.5 16.4 62.9 52.0 30.3 60.3 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678740-60868028 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6" "Cell line enhanced" "Detected in many" "AF22: 51.5;SCLC-21H: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053075 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Nucleoli "HPA053075: AB_2682035" "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.6 1.9 10.3 3.9 17.2 22.1 3.5 71.5 11.0 2.0 2.5 4.6 4.6 2.2 2.2 4.9 2.3 1.9 3.8 9.4 11.5 3.8 3.2 4.6 5.8 19.7 17.2 1.0 4.4 5.3 6.1 4.3 18.8 2.7 4.0 23.7 3.9 1.7 10.4 5.2 6.4 1.7 11.4 5.6 3.5 2.9 15.6 2.6 4.1 4.1 5.7 3.4 3.2 17.7 8.0 4.0 51.5 9.2 0.1 0.0 16.2 0.4 0.1 1.8 1.6 10.0 7.3 15.5 0.9 0.1 2.3 4.8 26.7 7.9 1.6 5.9 14.3 36.5 7.0 13.2 2.1 11.1 6.5 1.0 5.9 0.0 8.5 3.1 7.7 12.5 2.7 13.4 1.2 8.3 17.5 12.7 35.4 8.1 1.8 36.0 12.1 5.0 4.1 9.1 46.9 23.2 1.4 5.9 14.9 18.0 10.5 10.5 9.0 0.5 8.3 0.5 4.3 14.2 8.7 23.7 3.0 1.2 13.4 14.9 0.4 17.6 3.2 0.2 4.1 10.1 3.6 1.1 0.1 14.9 6.6 2.4 9.3 0.0 0.8 0.8 0.3 0.6 10.3 17.2 71.5 11.0 9.4 11.5 19.7 17.2 18.8 11.4 15.6 17.7 35.9 32.1 17.5 68.6 64.3 30.3 35.9 10.8 9.6 36.3 16.6 14.6 35.8 27.1 20.7 16.5 241.8 8.2 17.4 31.8 1.9 17.7 15.9 34.0 4.1 40.5 87.3 3.8 6.8 11.3 8.6 6.4 28.5 37.6 41.0 39.8 21.4 12.6 14.9 70.7 17.8 39.9 32.6 10.8 10.4 8.9 0.9 13.6 21.4 118.0 13.9 121.3 15.5 298.6 255.7 16.9 27.4 0.4 29.1 42.9 17.4 5.4 20.4 198.5 0.0 49.7 9.8 8.0 12.9 25.5 32.4 6.2 21.4 3.0 34.1 35.8 CHP2 ENSG00000166869 "Calcineurin like EF-hand protein 2" O43745 16 23755026-23758935 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "intestine: 305.0;skin 1: 149.7" "Group enriched" "Detected in some" 5 "Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055198, CAB072806" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Nucleoli, Cytosol" "CAB072806: , HPA055198: " "unprognostic (4.82e-1)" "unprognostic (3.40e-1)" "unprognostic (4.93e-2)" "unprognostic (1.01e-2)" "unprognostic (8.85e-2)" "unprognostic (3.54e-1)" "unprognostic (4.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.38e-1)" "unprognostic (5.31e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-5)" "unprognostic (2.21e-1)" "unprognostic (5.97e-2)" "unprognostic (7.84e-2)" "unprognostic (9.01e-2)" 0.4 0.2 1.1 3.8 1.1 2.2 4.3 3.6 1.3 14.0 0.0 146.7 305.0 0.9 1.1 0.6 0.9 0.4 0.4 0.7 1.6 4.1 0.7 0.6 0.8 0.5 0.1 0.4 0.5 0.1 0.0 1.4 0.9 3.8 147.4 1.3 0.8 4.5 1.2 149.7 250.5 6.5 0.1 0.3 1.1 7.3 0.9 0.5 0.6 0.2 0.4 9.0 4.2 2.9 1.0 2.2 0.5 0.6 1.2 1.3 1.2 2.9 1.1 0.3 1.0 0.5 2.3 0.4 0.9 2.5 1.2 1.4 0.4 2.9 0.6 0.7 0.2 0.5 4.1 1.6 1.7 0.3 0.7 0.9 0.8 2.5 7.3 10.2 1.1 0.3 1.2 1.0 1.2 0.1 0.1 8.7 0.3 0.5 2.1 0.2 0.1 1.4 1.1 0.7 0.6 0.7 0.8 0.2 0.0 0.6 0.2 0.2 1.3 0.5 0.6 0.7 0.1 0.4 0.1 0.2 0.0 0.5 0.5 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 1.1 1.1 3.6 1.3 0.7 1.6 0.5 0.1 0.9 0.1 0.9 2.9 0.0 0.0 0.0 0.0 0.0 10.3 8.7 6.1 0.0 0.0 0.0 0.1 0.1 0.0 24.4 1.8 0.0 0.9 0.0 345.0 0.0 0.0 0.6 1.3 0.5 0.2 9.1 0.0 0.0 0.0 4.1 0.2 0.0 3.6 4.5 0.7 0.0 0.0 0.1 0.0 0.0 70.0 12.2 0.0 1.6 0.5 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 274.0 0.0 0.0 2.5 654.2 12.9 4.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 67.5 0.7 0.2 0.2 205.4 29.9 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046218-22065674 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 532.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 19.7 57.0 46.6 23.2 51.1 47.9 32.9 40.3 57.8 29.2 35.8 77.8 66.2 23.5 69.0 71.6 21.8 24.4 42.6 51.2 57.3 28.9 72.2 18.1 24.2 43.8 57.1 25.3 42.5 79.4 30.0 34.0 57.1 36.7 71.9 24.8 32.6 26.7 44.0 29.3 63.6 27.7 41.8 20.1 29.7 69.9 49.0 19.8 23.8 41.1 26.1 24.2 40.3 44.0 63.4 50.2 59.5 29.3 47.0 57.5 88.8 43.2 46.2 45.0 47.2 114.1 72.0 56.5 41.3 37.3 83.9 50.9 35.8 60.1 60.7 75.0 45.4 169.1 38.8 57.2 43.2 45.4 85.5 38.5 56.4 58.1 86.3 61.5 61.3 58.7 108.8 28.1 80.9 83.8 52.0 105.3 147.5 69.4 69.5 36.2 63.6 53.7 56.0 67.8 23.8 42.0 34.2 59.6 51.9 120.2 82.3 62.0 45.5 51.2 42.4 46.2 81.1 19.4 26.0 74.9 83.6 34.6 54.3 22.7 27.3 32.1 20.4 29.7 26.1 19.0 26.9 27.0 31.5 18.2 24.2 24.6 2.8 36.9 27.4 20.2 33.8 25.5 46.6 51.1 40.3 57.8 51.2 57.3 43.8 57.1 57.1 41.8 49.0 44.0 21.5 12.8 17.5 12.4 19.2 29.2 76.8 117.2 14.8 38.3 31.9 21.2 72.7 41.5 102.3 23.9 4.2 175.2 17.8 158.1 76.3 56.6 12.4 17.2 19.6 36.8 41.6 153.9 38.7 83.6 141.3 41.7 21.9 20.0 22.8 28.2 34.2 63.6 66.2 35.3 29.2 118.2 93.6 29.8 22.0 19.0 25.4 32.5 44.4 8.4 45.3 33.4 26.8 16.6 25.5 79.7 156.2 27.8 16.7 112.3 133.6 87.0 82.5 20.4 19.7 30.4 42.3 112.2 97.1 52.3 44.5 532.6 24.6 63.0 90.8 190.6 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938199-56961050 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 98.5" "Cell type enhanced" "Detected in all" "Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA057480, CAB069400" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Nucleoli "CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 7.7 7.2 6.6 8.8 6.8 19.9 12.2 9.7 8.9 9.2 7.3 9.2 10.2 10.4 11.6 9.7 9.8 7.1 8.0 6.6 7.0 8.7 13.0 7.6 12.8 6.7 6.7 11.9 8.7 12.3 6.2 13.0 7.4 9.3 10.6 12.6 9.8 7.7 11.5 9.8 10.0 8.5 6.8 10.3 9.2 98.5 6.6 13.2 12.1 9.1 13.5 9.3 8.7 8.1 25.0 18.6 37.4 14.5 12.5 14.9 25.8 17.5 16.4 26.1 27.7 25.6 21.0 29.9 34.6 14.0 19.5 14.1 25.6 20.2 37.1 36.1 32.3 48.7 17.4 29.2 13.5 41.5 28.5 13.9 24.7 19.7 21.1 15.5 22.6 17.4 42.9 24.3 24.8 31.6 32.9 26.3 22.0 27.4 18.4 15.5 45.9 23.9 18.1 24.7 31.6 31.2 11.7 11.5 30.1 21.5 41.8 40.0 16.0 30.2 22.7 14.8 23.0 35.6 47.7 34.5 15.8 22.7 18.8 22.3 13.3 17.5 15.5 12.6 17.5 27.6 17.0 16.6 13.5 25.0 19.5 18.9 8.1 16.0 17.2 16.4 18.6 10.1 6.6 6.8 9.7 8.9 6.6 7.0 6.7 6.7 7.4 6.8 6.6 8.1 21.3 12.8 21.0 6.8 26.5 18.7 39.5 34.0 21.1 35.9 21.6 22.5 14.1 22.8 28.3 14.7 37.5 42.2 26.2 12.5 13.7 30.1 249.2 22.7 23.1 26.6 23.9 17.5 8.8 27.7 32.3 23.5 18.3 19.9 22.2 20.3 22.5 23.9 22.7 25.2 10.9 16.5 16.2 16.5 10.4 591.1 42.3 12.3 3.6 10.3 19.6 28.5 34.0 9.5 13.3 23.5 17.3 30.5 15.1 32.2 16.6 23.0 22.0 52.4 13.1 24.9 21.9 142.2 46.8 20.3 22.7 29.1 23.3 17.1 20.8 29.0 CPS1 ENSG00000021826 "Carbamoyl-phosphate synthase 1" P31327 2 210477682-210679107 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Urea cycle" "Allosteric enzyme, Ligase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 1063.2" "Cell type enriched" "Detected in many" 19 "Hepatocytes: 2075.1" "Cancer enriched" "Detected in many" 8 "liver cancer: 136.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB003781, HPA021400" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA 8300000 "Cluster 85: Liver - Metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "Nucleoli, Nucleoli rim" "CAB003781: , HPA021400: AB_1847197" "unprognostic (1.67e-2)" "unprognostic (3.72e-2)" "unprognostic (4.02e-2)" "unprognostic (7.21e-7)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "prognostic favorable (6.93e-5)" "unprognostic (1.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.35e-2)" "unprognostic (5.38e-2)" "unprognostic (1.94e-3)" "unprognostic (2.38e-4)" "unprognostic (5.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.14e-2)" "unprognostic (3.74e-2)" 2.5 0.4 1.0 0.4 10.0 0.1 1.5 4.9 1.7 0.9 0.1 0.8 211.8 1.6 2.8 1.5 0.9 1.6 1.2 0.7 2.3 1.9 1063.2 1.0 0.3 6.9 8.7 2.9 0.8 0.1 0.9 2.5 6.0 0.8 0.4 0.3 0.5 0.8 0.6 1.4 123.4 2.1 3.4 1.2 0.6 6.0 5.8 0.3 1.7 0.5 0.2 0.6 0.7 6.3 0.9 9.7 14.0 11.7 11.6 16.5 18.0 6.1 6.4 6.3 9.2 1.8 0.0 2.7 0.4 5.3 9.6 3.0 0.5 10.8 15.9 0.0 4.5 10.0 347.6 15.2 2.8 4.0 0.0 9.2 6.2 12.8 13.0 18.7 0.4 4.2 10.3 0.8 10.4 2.8 0.3 0.7 6.3 0.0 1.8 0.7 14.6 1.6 13.2 0.2 0.5 1.1 65.1 98.9 8.1 20.0 0.1 1.6 7.7 17.5 5.8 5.9 13.0 0.0 0.7 0.0 12.5 11.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.0 4.9 1.7 0.7 2.3 6.9 8.7 6.0 3.4 5.8 6.3 0.4 12.8 8.4 6.2 3.6 2.2 0.6 0.9 1.2 1.4 1.3 1.5 1.1 15.7 3.9 1.8 8.4 0.4 0.4 0.1 0.0 0.2 35.5 1.0 2.1 2.0 0.0 18.7 12.1 0.2 0.4 2.6 0.0 1.6 3.8 0.3 16.8 2075.1 0.2 0.0 6.2 13.5 0.0 27.2 2.9 6.5 2.5 0.8 1.8 3.7 0.2 0.7 0.0 3.0 8.8 0.0 2.5 1.2 0.1 1.1 105.6 1.0 1.3 2.3 0.0 1.8 2.3 0.6 1.8 1.5 1.8 20.8 1.8 3.5 41.2 0.4 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: AB_2678963" "prognostic unfavorable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavorable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 16.7 19.2 10.3 22.9 11.0 15.2 23.9 11.3 15.6 17.7 12.8 20.7 16.1 16.2 19.1 21.3 18.0 12.7 16.2 10.9 11.1 32.4 20.7 12.9 24.7 10.8 13.7 13.6 18.5 20.0 15.6 18.7 11.4 14.7 21.4 13.8 14.3 12.8 18.8 15.7 14.5 18.2 11.3 14.3 15.6 32.2 10.4 24.7 18.1 16.0 30.5 33.6 14.6 11.9 96.5 84.2 76.9 79.0 54.7 62.7 57.6 70.1 53.2 64.4 65.9 83.1 90.9 132.2 116.1 73.3 64.0 69.9 105.8 89.0 124.1 127.7 74.9 183.0 48.0 95.9 62.2 76.1 75.7 51.8 59.9 95.9 157.5 40.3 91.4 89.6 125.3 56.7 99.9 78.0 144.9 79.3 118.0 268.9 129.6 92.6 93.3 136.4 95.3 78.6 97.6 92.3 43.5 67.3 83.1 67.4 103.9 51.2 60.6 65.3 105.3 85.5 94.7 61.7 116.5 188.0 88.0 162.8 85.7 19.6 37.6 22.1 35.5 46.5 48.8 60.8 37.5 38.2 54.4 50.8 37.0 38.2 4.2 52.8 35.2 28.3 58.0 44.9 10.3 11.0 11.3 15.6 10.9 11.1 10.8 13.7 11.4 11.3 10.4 11.9 40.0 16.0 17.0 9.1 39.7 79.5 76.6 92.4 38.1 19.6 21.6 24.9 20.8 12.8 53.8 33.1 25.0 57.9 34.8 11.0 39.2 55.0 54.6 26.9 35.4 39.9 14.5 22.1 9.5 48.4 75.0 37.4 17.9 24.7 40.6 49.3 17.5 16.9 42.7 16.8 9.0 17.5 69.2 14.8 23.9 16.7 24.2 22.9 26.6 11.2 28.5 28.8 27.8 16.1 20.0 43.6 12.3 17.7 30.3 51.1 24.3 79.1 36.0 23.7 13.1 50.2 48.0 102.0 86.3 37.1 77.0 33.9 33.1 41.7 28.1 56.9 DCTN6 WS-3 ENSG00000104671 "Dynactin subunit 6" O00399 8 30156319-30183639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024049, HPA024558" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Cytosol" "Plasma membrane" "HPA024049: AB_1847524, HPA024558: AB_1847525" "unprognostic (1.28e-1)" "unprognostic (8.32e-3)" "unprognostic (1.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.69e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (7.84e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-2)" "unprognostic (9.26e-2)" "prognostic favorable (5.42e-4)" "unprognostic (1.06e-1)" "unprognostic (3.10e-1)" "unprognostic (7.54e-2)" "unprognostic (1.43e-1)" 50.6 54.1 48.0 26.6 51.1 43.7 53.0 51.8 74.1 32.3 42.3 37.5 23.8 38.2 43.5 34.3 30.1 32.8 75.6 50.4 54.8 54.2 46.7 34.0 28.3 50.8 49.8 41.5 32.0 72.8 29.7 53.6 51.1 34.7 36.2 42.4 33.6 36.7 36.6 29.0 26.1 42.6 52.9 27.6 31.9 21.9 50.5 37.8 54.6 43.5 31.2 45.8 31.6 58.6 53.6 51.9 64.4 33.8 59.3 80.7 42.1 72.8 87.0 70.4 74.9 33.6 35.8 41.0 76.0 78.8 64.9 39.6 46.1 64.2 83.8 32.4 34.3 57.8 40.9 54.5 45.8 33.6 47.4 68.2 90.4 51.2 54.8 61.5 65.2 58.0 66.4 44.3 77.0 41.7 62.4 53.0 51.6 93.8 32.0 32.4 48.7 35.3 104.6 54.1 105.4 60.0 42.7 53.0 77.9 32.4 50.4 48.3 60.8 37.4 128.9 31.9 52.4 18.1 22.2 51.8 69.7 38.1 68.1 16.7 13.5 5.0 8.1 15.8 9.1 7.1 7.5 9.8 15.9 5.3 9.5 11.4 3.7 11.2 15.9 20.8 8.1 6.8 48.0 51.1 51.8 74.1 50.4 54.8 50.8 49.8 51.1 52.9 50.5 58.6 61.3 25.6 39.7 19.9 34.9 57.2 91.3 127.1 25.6 36.4 45.4 43.2 83.4 47.1 85.3 44.1 14.6 88.5 48.9 28.1 123.3 94.5 18.0 32.5 37.2 58.7 40.8 28.2 19.0 84.5 87.7 56.6 25.0 39.6 46.9 44.0 45.7 42.7 71.4 26.9 17.3 31.6 91.6 43.9 54.8 12.5 80.8 43.2 69.4 15.0 58.4 63.3 17.5 17.6 21.3 91.1 43.1 75.2 32.3 48.8 36.3 147.1 71.6 40.3 52.6 63.1 66.0 44.2 47.3 38.0 63.5 203.6 59.8 49.5 33.0 95.0 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073860-31104799 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA065197 Supported Supported Nucleoplasm,Nucleoli No Yes "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 5: NTERA-2 - Transcription" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 5.9 6.4 6.0 10.2 6.8 29.2 7.2 6.9 7.3 10.7 7.1 9.6 8.0 7.5 4.3 9.5 8.0 5.9 5.3 6.0 6.1 9.2 9.3 6.1 13.2 6.9 6.4 11.0 17.5 5.8 9.4 5.4 6.9 10.0 10.1 6.6 8.6 5.3 10.6 16.7 13.4 3.6 6.1 13.8 9.6 8.8 6.7 24.0 8.0 6.6 11.1 6.9 9.8 6.9 36.5 35.0 42.2 34.5 5.8 11.0 58.7 21.8 10.4 25.2 28.5 44.1 58.6 49.2 23.9 10.8 23.6 35.0 31.7 28.9 21.3 43.4 66.6 47.4 71.0 25.4 2.1 37.4 35.0 11.9 13.0 32.6 24.8 16.9 12.6 55.2 26.6 103.3 17.6 30.9 64.5 60.7 84.0 39.9 19.5 55.0 53.3 66.2 13.3 38.5 30.2 21.7 23.4 33.2 10.4 65.0 27.3 25.5 8.2 22.0 42.1 42.2 40.0 39.4 29.6 95.3 24.6 32.5 20.3 0.0 1.3 0.8 2.0 1.2 1.5 2.5 1.9 1.5 1.5 2.6 2.0 2.6 0.5 2.2 4.4 2.4 2.0 1.3 6.0 6.8 6.9 7.3 6.0 6.1 6.9 6.4 6.9 6.1 6.7 6.9 10.1 3.2 9.5 1.6 9.0 6.0 4.0 6.0 2.2 9.4 8.3 7.1 2.5 4.3 6.0 0.0 14.6 7.6 8.8 7.8 0.0 2.0 1.7 5.5 8.9 5.4 0.0 15.3 2.5 3.3 7.5 5.7 9.7 7.4 5.7 15.6 6.1 7.7 5.2 8.4 3.6 6.5 10.2 4.1 5.4 1.3 7.2 4.4 7.2 3.7 3.5 2.7 4.1 1.5 1.7 3.2 2.7 4.5 17.2 6.0 2.3 1.4 6.7 25.8 0.0 4.9 4.8 5.3 18.0 5.5 6.5 2.6 8.4 4.1 9.5 5.1 DDX23 "prp28, PRPF28, SNRNP100, U5-100K" ENSG00000174243 "DEAD-box helicase 23" Q9BUQ8 12 48829756-48852842 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038680, HPA039037" Approved Supported Nucleoplasm,Nucleoli NA NA 21000 "Cluster 2: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 39: CACO-2 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA038680: AB_10795401, HPA039037: AB_2676317" "unprognostic (1.32e-3)" "unprognostic (8.90e-2)" "unprognostic (8.92e-2)" "unprognostic (7.12e-2)" "unprognostic (5.34e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.03e-5)" "unprognostic (3.54e-2)" "unprognostic (5.68e-2)" "unprognostic (2.19e-2)" "unprognostic (1.69e-1)" "unprognostic (8.34e-2)" "unprognostic (5.94e-2)" "unprognostic (9.78e-2)" "unprognostic (6.88e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-1)" 33.2 30.7 28.7 36.9 30.8 26.5 33.1 29.7 29.6 35.3 33.1 39.3 33.5 35.1 25.0 37.5 35.4 25.4 30.1 28.0 29.9 33.0 43.0 33.8 46.6 30.7 29.9 40.6 36.7 34.5 28.4 33.7 29.7 36.1 37.6 27.8 37.3 29.7 54.4 39.2 41.2 34.0 30.1 47.6 38.3 26.7 30.8 63.3 32.9 35.8 48.1 36.1 34.7 30.4 74.0 165.1 76.6 81.5 74.7 51.4 81.3 89.1 68.1 98.9 62.5 162.0 95.7 92.5 95.6 74.4 93.3 64.9 168.1 81.1 84.0 146.1 89.2 122.7 139.0 73.8 40.3 125.3 106.9 49.9 71.7 105.1 62.6 67.6 82.4 80.4 165.6 80.3 72.9 102.1 119.8 118.2 114.4 104.0 77.4 125.9 90.7 73.5 58.3 101.9 94.1 54.9 89.4 101.0 38.4 78.0 99.0 113.7 74.5 74.4 54.1 37.2 71.8 60.1 89.8 109.5 63.3 86.8 41.8 20.9 11.8 21.9 19.3 13.6 19.6 12.6 14.1 17.5 11.3 10.5 13.5 16.6 12.2 12.8 9.8 11.9 14.3 12.0 28.7 30.8 29.7 29.6 28.0 29.9 30.7 29.9 29.7 30.1 30.8 30.4 22.7 25.6 36.5 11.8 25.5 12.9 13.7 12.7 25.6 17.5 18.6 19.4 20.0 22.8 25.8 12.9 25.0 25.9 30.7 33.0 15.6 25.9 14.4 24.4 25.2 27.2 13.9 21.7 6.9 38.9 29.1 19.2 25.5 26.6 18.3 29.8 17.9 18.7 19.1 15.2 8.7 26.6 16.2 13.2 10.3 6.3 24.5 16.5 14.2 9.4 25.5 26.2 35.0 7.5 8.4 33.9 32.3 22.2 32.0 26.7 24.3 12.5 34.4 26.1 19.7 20.8 20.0 43.8 33.1 24.4 15.2 26.5 28.6 21.1 27.3 21.6 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68020916-68023232 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 5.8 10.0 3.9 4.8 4.1 16.8 5.6 4.0 4.3 3.9 4.0 5.7 3.9 6.0 5.1 8.2 5.0 2.8 8.3 4.1 4.7 6.4 8.7 4.3 7.7 4.0 3.9 5.5 5.6 7.0 3.6 4.7 4.3 3.5 4.3 1.6 5.0 3.5 15.4 9.7 7.0 3.7 4.0 9.0 6.3 9.7 4.1 5.6 4.0 7.7 6.4 5.5 4.3 4.1 10.2 14.7 7.1 8.5 9.5 5.3 16.5 6.9 9.8 16.4 11.6 14.4 15.5 37.6 10.2 8.3 9.0 17.9 10.1 16.1 9.6 5.1 16.7 13.6 7.4 14.9 12.8 21.7 14.1 10.3 17.2 13.5 12.4 5.7 9.2 24.9 24.5 5.7 7.4 22.4 22.9 30.0 17.2 10.2 10.7 22.1 6.6 40.3 11.6 11.4 14.8 9.9 27.6 7.8 15.3 8.0 14.9 23.1 7.0 7.3 6.3 10.6 11.2 12.8 16.9 36.7 9.0 16.4 10.1 24.0 22.3 27.4 17.0 22.4 18.7 14.3 15.6 18.5 20.8 19.0 24.2 18.2 7.2 21.5 23.4 10.2 16.0 20.8 3.9 4.1 4.0 4.3 4.1 4.7 4.0 3.9 4.3 4.0 4.1 4.1 4.4 6.4 6.8 0.7 10.9 9.2 14.2 11.7 8.0 5.6 4.8 4.3 4.1 8.6 8.3 3.7 0.0 27.9 4.0 2.9 13.7 12.0 6.6 5.4 4.4 5.7 4.8 9.5 0.9 9.7 12.5 4.4 5.1 5.4 3.8 8.0 6.8 11.6 17.1 3.3 1.0 3.5 6.1 8.5 3.1 4.0 5.0 6.8 7.2 0.0 13.3 7.5 25.7 0.5 1.4 7.4 4.2 3.4 4.2 5.7 2.0 19.7 5.3 4.3 13.1 4.4 9.4 22.7 14.1 6.7 10.7 99.9 7.6 12.5 6.1 8.8 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavorable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 3.9 3.8 3.3 5.3 3.9 4.2 6.3 8.8 3.2 4.8 4.0 3.9 3.1 4.5 5.0 5.7 5.2 3.6 3.3 2.8 3.7 6.0 5.5 4.5 6.6 5.1 3.8 9.9 5.8 5.4 4.2 3.5 5.7 5.4 4.7 3.2 8.2 4.3 6.1 8.4 4.2 4.2 2.9 4.8 4.0 6.0 3.6 5.5 13.8 4.2 7.2 5.2 4.9 4.7 12.4 22.2 10.8 14.4 12.4 11.1 20.4 12.9 12.2 19.2 14.5 24.9 24.1 29.9 11.2 11.7 20.8 33.5 32.8 14.6 15.4 18.4 12.3 16.4 19.5 13.1 14.9 29.7 12.8 9.9 19.5 19.7 27.5 7.5 12.7 22.1 30.6 11.4 16.1 26.3 20.6 15.9 26.2 35.4 22.2 21.4 19.3 34.6 17.5 11.4 18.8 13.5 23.4 20.2 18.0 12.2 42.8 8.4 11.1 32.5 15.0 18.7 19.8 5.5 18.8 23.5 12.0 18.2 25.2 0.0 1.1 1.2 3.1 1.6 2.4 2.1 2.9 2.4 2.5 2.7 3.6 2.7 0.2 2.0 1.1 1.6 2.0 1.7 3.3 3.9 8.8 3.2 2.8 3.7 5.1 3.8 5.7 2.9 3.6 4.7 3.3 6.4 6.0 16.6 7.2 5.6 4.5 3.0 9.1 4.3 5.9 8.1 4.4 0.0 10.2 7.3 4.2 5.7 4.7 3.6 1.9 6.2 4.1 3.9 6.6 3.6 24.6 1.7 9.7 5.4 6.8 4.4 4.1 4.6 1.3 6.1 2.9 4.1 5.2 1.7 13.9 5.8 6.1 2.9 1.8 3.0 18.0 2.9 1.8 5.6 4.5 1.7 8.2 26.7 17.1 5.9 1.2 13.2 5.7 5.8 0.7 7.1 5.7 3.7 0.0 4.1 3.4 14.0 13.7 8.8 6.3 3.0 5.0 5.7 6.1 3.5 DDX47 "DKFZp564O176, FLJ30012, HQ0256, RRP3" ENSG00000213782 "DEAD-box helicase 47" Q9H0S4 12 12813316-12829981 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014855 Approved Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA014855: AB_1847567" "unprognostic (3.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-2)" "unprognostic (2.38e-1)" "unprognostic (4.91e-2)" "unprognostic (5.84e-4)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-3)" "unprognostic (2.79e-1)" "unprognostic (3.49e-3)" "unprognostic (6.55e-9)" "unprognostic (1.68e-1)" "unprognostic (1.27e-1)" "unprognostic (3.24e-1)" "unprognostic (8.20e-6)" 28.8 24.1 23.2 22.7 23.7 41.2 32.1 24.6 30.8 27.8 24.5 29.3 18.2 30.8 22.3 29.1 29.8 19.9 23.0 22.6 24.0 32.1 37.8 24.8 32.7 23.8 23.6 35.6 30.8 36.5 17.5 28.9 24.1 26.4 26.3 16.9 24.5 29.0 44.6 30.5 21.7 33.4 24.4 23.4 29.3 23.1 23.2 35.5 33.3 41.7 39.8 47.6 25.5 25.2 161.7 68.3 65.6 53.7 63.1 61.7 111.8 67.8 77.0 141.0 131.0 104.1 101.0 82.4 25.9 92.2 87.4 102.6 95.2 78.0 157.7 117.2 68.1 75.5 45.3 59.7 53.5 87.0 46.5 60.0 72.4 84.0 68.8 110.7 110.4 63.9 74.3 18.2 78.3 57.7 71.0 60.1 288.7 74.4 41.4 77.7 127.2 50.0 86.5 114.2 28.6 72.5 82.3 52.1 69.2 161.4 21.4 64.9 49.9 56.5 136.5 36.8 103.4 25.2 49.1 148.1 60.2 44.9 66.8 10.5 32.9 8.4 46.6 43.8 55.5 48.0 40.9 43.2 56.8 44.9 53.0 51.5 3.8 40.6 44.4 33.3 43.4 35.8 23.2 23.7 24.6 30.8 22.6 24.0 23.8 23.6 24.1 24.4 23.2 25.2 5.1 3.2 8.2 9.1 8.4 2.2 2.7 2.4 14.2 0.6 1.4 1.0 0.1 0.0 8.5 0.0 0.0 1.7 2.3 3.2 1.9 22.6 0.1 3.0 4.1 4.3 4.8 3.4 8.2 17.8 1.9 3.2 4.6 5.7 12.0 0.9 1.1 0.9 0.9 0.0 9.4 4.2 2.0 1.0 1.6 0.4 0.6 2.5 0.0 12.2 9.7 0.9 2.1 8.0 12.6 19.0 4.2 0.4 12.3 1.9 2.8 1.1 6.3 1.6 6.6 1.6 3.4 0.7 0.7 9.0 1.8 1.4 6.2 0.6 6.5 2.8 DDX5 "G17P1, HLR1, p68" ENSG00000108654 "DEAD-box helicase 5" P17844 17 64498254-64508199 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005868, HPA020043, HPA071154" Supported Supported Nucleoplasm,Nucleoli No No 310000 "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: " "unprognostic (6.64e-2)" "unprognostic (6.98e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.94e-2)" "unprognostic (5.08e-2)" "unprognostic (9.85e-2)" "unprognostic (5.80e-2)" "unprognostic (1.61e-2)" "unprognostic (3.17e-2)" "unprognostic (4.71e-2)" "unprognostic (3.03e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-1)" "unprognostic (2.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (9.28e-3)" 202.9 124.0 75.2 75.7 80.0 219.5 163.4 93.4 91.3 190.4 122.8 176.8 36.1 181.7 61.9 136.9 181.2 186.4 109.8 83.6 83.8 113.6 157.5 185.9 124.7 85.5 79.7 134.2 83.3 177.7 118.9 119.4 79.0 122.8 157.7 211.7 112.0 144.8 165.7 130.6 116.3 274.6 65.4 127.5 137.1 88.7 83.2 272.5 172.8 107.5 157.5 228.2 128.9 100.2 204.7 85.5 353.1 144.4 316.2 316.7 134.1 221.4 349.8 306.9 300.3 98.2 105.3 299.7 102.0 364.8 238.1 87.1 361.6 291.5 428.2 107.7 76.0 211.2 84.5 81.6 216.6 383.9 186.3 301.4 306.8 270.2 264.1 241.5 362.2 303.6 174.3 247.3 284.0 108.7 520.4 44.8 159.5 294.5 32.0 310.1 286.7 239.1 201.8 145.6 151.0 305.7 181.5 167.6 284.0 326.5 138.5 132.1 158.2 123.0 146.3 170.0 207.3 112.2 283.9 622.0 166.6 140.5 184.2 232.6 160.6 170.0 117.2 143.3 149.8 111.5 105.4 125.4 148.5 106.3 107.6 109.4 86.6 112.2 197.1 85.5 135.9 319.9 75.2 80.0 93.4 91.3 83.6 83.8 85.5 79.7 79.0 65.4 83.2 100.2 990.8 535.2 690.9 200.8 909.4 879.5 1536.4 837.0 618.1 403.5 433.3 393.7 249.6 346.0 855.7 369.6 335.7 439.9 1284.6 521.5 334.6 476.2 603.0 1021.9 987.2 767.7 664.1 309.7 187.9 419.2 371.3 733.5 452.1 1288.8 874.3 647.9 528.7 254.3 445.8 420.6 165.7 475.9 801.5 577.8 629.4 136.9 415.4 833.2 432.2 280.1 800.2 587.1 777.5 291.6 325.7 464.2 598.6 437.8 661.5 537.7 552.6 287.5 737.9 550.4 493.0 1437.7 961.5 407.6 399.1 466.4 746.0 887.3 1043.4 745.0 424.7 1056.4 DDX52 ROK1 ENSG00000278053 "DExD-box helicase 52" Q9Y2R4 17 37609739-37643446 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 245.1;Glandular and luminal cells: 360.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056173 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA056173: AB_2683056" "unprognostic (1.05e-2)" "unprognostic (1.85e-1)" "prognostic favorable (9.41e-4)" "unprognostic (4.26e-2)" "unprognostic (9.96e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (2.44e-6)" "unprognostic (5.10e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (6.95e-2)" "unprognostic (5.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" 1.8 2.5 1.6 1.0 1.6 4.2 1.7 2.3 2.0 2.0 2.1 2.2 2.0 2.2 3.9 3.1 1.6 1.8 1.8 1.6 1.7 2.6 2.8 1.8 2.1 1.7 1.6 1.5 2.9 2.2 1.4 1.7 1.9 1.7 2.2 2.1 1.9 1.7 2.5 2.8 3.3 1.8 1.4 2.0 2.4 1.8 1.7 1.5 1.3 1.8 2.1 2.4 1.9 2.2 4.7 10.2 1.0 9.4 5.2 4.6 4.0 6.3 5.4 8.1 7.7 6.6 1.7 2.8 4.2 4.3 1.5 4.4 10.5 7.2 11.0 6.5 12.8 5.9 6.6 4.6 5.1 7.8 3.1 4.5 7.6 5.5 6.3 4.1 9.4 2.7 0.9 1.7 4.7 1.6 11.9 4.3 5.4 2.6 0.8 7.3 8.4 4.9 9.9 5.8 6.6 5.5 7.5 1.8 5.2 5.0 3.3 6.1 6.7 6.6 4.2 3.6 7.3 2.2 3.8 4.9 5.3 4.6 5.2 0.9 0.5 0.7 0.8 0.7 0.6 0.6 0.8 0.6 0.4 0.6 0.7 0.9 0.4 0.8 0.4 1.2 0.5 0.2 1.6 1.6 2.3 2.0 1.6 1.7 1.7 1.6 1.9 1.4 1.7 2.2 28.5 41.7 19.7 17.3 29.4 34.5 33.9 41.2 26.2 34.0 25.4 22.7 33.3 18.6 41.4 27.6 33.3 35.4 47.4 28.7 35.2 76.6 245.1 105.8 77.7 32.3 26.3 42.7 19.4 52.3 31.1 28.1 29.6 360.4 27.3 40.8 28.5 37.2 26.1 47.1 19.3 30.1 34.6 25.8 12.6 97.8 24.5 24.1 17.8 19.7 53.8 26.0 33.0 29.7 23.0 56.8 20.5 24.0 25.4 35.8 35.7 40.2 32.0 36.0 26.3 26.7 34.1 29.6 56.0 33.4 33.2 25.0 30.3 43.7 46.8 49.5 DDX56 NOH61 ENSG00000136271 "DEAD-box helicase 56" Q9NY93 7 44565804-44575051 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019749, CAB037320" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "Mitotic chromosome" "CAB037320: , HPA019749: AB_1847579" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (5.00e-2)" "unprognostic (1.93e-1)" "unprognostic (6.08e-3)" "unprognostic (2.12e-3)" "prognostic unfavorable (1.38e-5)" "unprognostic (5.17e-2)" "unprognostic (2.76e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-2)" "unprognostic (6.01e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (2.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 21.3 21.8 24.8 21.5 25.6 16.6 17.1 25.5 29.0 19.2 25.3 18.6 20.8 15.4 17.3 25.9 27.2 15.8 20.3 25.1 25.3 16.2 30.1 15.7 29.4 25.6 25.2 22.1 28.2 27.1 7.9 20.1 25.7 18.2 15.7 7.3 24.6 20.2 27.4 32.2 16.4 21.2 25.2 19.5 20.8 10.4 25.2 24.5 23.5 21.5 27.1 28.4 7.3 26.0 69.5 118.8 32.0 70.0 36.6 40.3 62.3 60.9 43.7 107.6 83.9 139.2 90.7 109.8 65.0 59.4 143.5 111.4 70.9 97.5 38.5 45.9 99.2 64.3 90.9 86.1 59.9 77.0 66.4 57.9 78.8 105.8 82.2 35.5 62.0 55.8 150.2 42.8 78.3 103.7 67.3 104.4 108.8 127.8 103.6 70.7 54.3 76.7 69.8 65.4 68.8 90.6 64.2 199.4 58.9 21.3 120.6 105.5 52.4 71.0 86.0 52.6 155.1 88.7 135.0 167.1 75.2 115.1 146.1 36.3 50.8 21.1 37.6 66.3 47.7 48.3 40.9 41.6 63.8 55.0 49.2 38.7 3.6 63.2 67.7 34.8 44.9 59.7 24.8 25.6 25.5 29.0 25.1 25.3 25.6 25.2 25.7 25.2 25.2 26.0 21.5 16.0 29.0 13.1 22.8 17.1 23.9 45.1 21.1 26.6 18.4 14.7 12.3 11.5 40.3 22.0 14.6 57.0 19.1 29.0 27.4 39.4 41.4 21.0 21.1 26.4 18.5 35.8 6.1 32.3 48.5 24.6 30.5 20.6 28.5 35.3 16.8 30.1 35.4 6.7 8.0 24.9 38.7 13.2 17.5 37.5 21.1 17.9 14.2 3.7 28.8 22.4 23.7 6.6 6.2 37.5 18.8 19.9 18.2 24.8 37.2 63.0 31.8 26.9 13.1 22.4 25.1 36.2 25.6 30.1 19.9 47.2 23.6 40.3 36.8 21.3 DFFB "CAD, CPAN, DFF-40, DFF40" ENSG00000169598 "DNA fragmentation factor subunit beta" O76075 1 3857267-3885429 "Predicted intracellular proteins" Apoptosis "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 4.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Extravillous trophoblasts: 29.5;Oligodendrocytes: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004328, HPA052904" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli Nucleoplasm "CAB004328: AB_626776, HPA052904: AB_2681985" "unprognostic (2.98e-1)" "unprognostic (5.09e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-3)" "unprognostic (6.12e-2)" "unprognostic (1.83e-2)" "unprognostic (1.38e-2)" "unprognostic (1.28e-3)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-3)" "unprognostic (4.07e-1)" "unprognostic (1.90e-2)" "unprognostic (9.86e-3)" "unprognostic (3.39e-1)" "unprognostic (2.27e-1)" "prognostic favorable (6.29e-5)" 1.3 1.1 0.6 1.2 0.7 1.0 1.1 0.5 0.9 1.7 0.0 1.5 4.6 1.6 0.0 0.8 1.3 1.4 0.7 0.7 0.5 0.7 0.4 1.0 1.6 1.5 0.9 1.7 2.4 0.5 0.6 1.3 0.7 0.8 0.8 0.2 1.3 0.7 0.5 0.6 2.0 0.4 0.4 1.9 1.2 0.4 0.6 1.2 0.8 0.5 0.9 1.4 1.0 1.5 3.2 3.3 2.0 4.7 0.6 1.6 1.1 2.7 1.2 4.1 2.8 2.6 2.8 2.6 2.2 0.5 0.8 1.7 0.7 3.2 0.2 9.0 9.7 10.7 1.2 3.2 3.3 8.7 7.9 0.4 0.8 2.4 1.9 0.8 4.1 7.5 7.4 1.6 0.1 1.8 6.1 4.8 2.2 3.9 7.4 4.9 1.2 4.4 1.3 0.6 3.3 5.1 2.3 6.5 10.7 0.0 1.1 3.8 4.1 1.5 1.1 6.5 2.5 2.9 4.6 5.4 1.2 9.0 2.0 3.6 3.7 5.0 3.4 3.8 2.0 2.1 2.5 3.1 5.1 1.0 2.1 3.2 1.2 2.3 7.4 0.0 4.7 2.9 0.6 0.7 0.5 0.9 0.7 0.5 1.5 0.9 0.7 0.4 0.6 1.5 3.3 3.2 4.6 4.2 3.0 0.6 1.0 1.4 1.8 5.5 1.9 2.7 1.3 2.8 1.7 1.8 45.9 3.5 7.3 1.6 1.9 1.9 1.4 3.3 4.6 3.1 2.4 2.5 17.0 1.6 29.5 3.2 1.5 2.5 0.0 4.6 2.5 1.8 2.9 15.2 18.0 4.2 0.0 5.4 1.4 1.2 1.2 3.7 0.0 8.4 2.5 3.9 15.5 5.5 22.7 1.8 1.5 4.9 3.1 0.6 5.0 2.4 1.1 17.9 0.0 1.7 3.2 1.7 2.5 1.7 0.3 1.4 6.0 3.3 4.4 0.7 DHX33 "DDX33, DKFZp762F2011, FLJ21972" ENSG00000005100 "DEAH-box helicase 33" Q9H6R0 17 5440917-5468982 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 81.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073875 Supported Supported Nucleoli NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoli "HPA073875: AB_2686638" "unprognostic (4.96e-2)" "unprognostic (1.35e-1)" "unprognostic (3.41e-2)" "unprognostic (2.51e-2)" "unprognostic (9.24e-2)" "unprognostic (1.90e-1)" "unprognostic (1.49e-2)" "unprognostic (6.15e-2)" "unprognostic (3.11e-2)" "unprognostic (3.80e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.03e-1)" "unprognostic (4.66e-1)" "unprognostic (3.55e-1)" "unprognostic (4.69e-2)" "unprognostic (3.37e-2)" 6.2 5.9 5.5 6.3 5.8 4.4 7.0 5.1 6.0 5.4 3.9 5.3 4.8 6.4 4.1 6.2 5.8 4.1 4.5 5.7 4.9 5.2 7.8 4.4 6.0 4.9 5.2 5.6 6.7 7.6 3.9 6.3 4.8 5.4 5.6 6.4 5.6 5.4 8.0 6.9 5.0 5.9 5.0 6.0 5.5 4.5 5.7 5.2 5.1 5.6 5.9 6.5 5.4 5.5 19.0 27.7 17.4 31.1 7.2 14.4 21.6 18.4 11.4 27.6 22.1 17.6 8.1 46.7 12.5 15.1 11.0 22.0 35.4 28.7 35.3 15.0 34.1 18.5 22.4 30.0 14.1 24.9 15.9 12.2 17.3 29.8 40.4 8.3 20.9 22.0 24.9 22.3 15.5 13.4 25.5 13.6 38.5 12.5 14.0 33.5 25.5 25.3 12.8 14.7 15.1 21.7 19.2 16.4 28.0 14.6 12.8 12.9 19.5 19.0 20.2 15.3 39.6 8.3 9.5 23.5 13.6 29.1 27.7 0.2 0.9 0.5 0.5 0.4 0.5 0.7 0.6 0.3 0.4 0.8 0.6 0.6 0.6 0.8 0.3 0.9 0.4 0.2 5.5 5.8 5.1 6.0 5.7 4.9 4.9 5.2 4.8 5.0 5.7 5.5 11.4 12.8 8.6 6.5 8.6 21.0 15.3 8.6 19.9 15.6 18.3 15.7 16.3 17.2 9.9 7.3 20.9 8.3 10.2 8.5 1.9 9.3 81.8 7.6 23.3 16.2 9.1 23.3 14.5 15.3 10.1 13.7 10.7 12.7 3.8 21.0 13.2 28.1 6.3 13.5 15.2 10.9 2.0 16.9 8.7 11.3 7.8 9.9 14.2 6.5 6.8 13.3 9.2 11.6 13.0 12.1 5.1 9.8 10.4 20.9 5.9 5.9 6.1 10.5 0.0 25.1 11.5 10.6 15.7 22.0 19.9 5.1 6.6 19.7 11.9 14.9 DHX9 "DDX9, LKP, RHA" ENSG00000135829 "DExH-box helicase 9" Q08211 1 182839347-182887982 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport" "Activator, DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011819, HPA028050, HPA055684" Supported Supported Nucleoplasm,Nucleoli NA NA 360000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885" "unprognostic (8.14e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.58e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.88e-2)" "unprognostic (5.53e-2)" "unprognostic (7.51e-2)" "unprognostic (1.43e-1)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-1)" 38.7 30.5 13.6 47.4 15.8 131.4 53.2 19.0 19.7 43.7 17.0 40.2 32.6 49.4 33.0 32.2 45.9 31.1 28.5 13.1 16.0 49.9 36.9 38.6 56.9 15.2 13.6 52.8 30.5 68.2 21.1 44.6 16.3 39.6 47.1 66.5 32.5 44.3 30.3 31.1 36.3 50.8 16.6 40.9 34.5 50.4 14.6 88.7 48.0 37.7 70.2 54.0 30.0 25.5 165.7 158.8 223.0 122.3 113.7 87.8 219.2 143.5 130.3 203.6 137.0 175.8 124.2 264.3 133.7 129.6 121.7 138.8 342.6 155.2 225.7 108.3 169.5 176.4 121.0 119.6 62.5 258.3 115.0 78.6 75.8 200.4 53.4 91.6 161.7 132.9 281.8 91.9 165.1 142.3 263.6 61.1 282.8 173.9 96.8 236.0 208.0 151.0 127.0 187.8 160.0 183.2 203.2 125.0 83.2 186.4 148.4 140.9 127.6 125.3 138.8 128.9 195.9 93.6 167.2 305.0 79.0 137.0 174.5 7.7 21.3 16.1 23.4 22.5 26.2 20.5 19.8 21.1 29.9 16.6 21.6 23.7 8.0 20.0 19.7 14.2 20.1 21.2 13.6 15.8 19.0 19.7 13.1 16.0 15.2 13.6 16.3 16.6 14.6 25.5 43.6 41.7 74.1 59.1 54.5 53.7 61.2 42.7 38.7 59.6 43.3 38.9 43.9 30.0 60.8 51.5 52.1 50.9 70.2 38.6 19.6 49.0 26.8 79.2 67.4 50.7 53.8 74.5 49.4 50.8 47.5 48.0 37.8 109.8 44.9 67.7 36.0 28.0 40.8 28.6 55.5 40.9 30.5 35.4 35.1 45.8 60.3 44.7 30.2 55.3 55.9 42.7 42.2 55.3 70.3 52.3 28.0 47.0 52.4 48.3 35.4 38.0 67.7 77.1 39.5 73.9 54.1 69.9 68.2 51.7 47.2 49.5 59.2 60.9 54.4 55.4 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIMT1 rRNA methyltransferase and ribosome maturation factor" Q9UNQ2 5 62347284-62403943 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 104.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA042944: AB_2678234" "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavorable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.3 13.6 6.5 13.3 6.5 9.1 19.7 6.7 9.6 17.2 6.4 10.9 8.5 14.6 13.9 17.5 14.5 14.2 17.7 6.6 6.8 10.6 15.4 9.8 15.9 6.7 6.7 15.5 19.3 13.3 10.3 17.3 6.7 15.9 12.0 2.9 15.2 16.2 9.7 8.5 8.8 21.0 6.7 13.3 8.5 8.2 6.6 15.0 13.4 12.8 16.8 26.0 11.4 6.7 33.1 19.9 24.2 44.1 37.7 57.4 35.0 57.3 33.7 57.3 55.8 45.1 36.3 61.4 48.4 61.9 45.4 20.2 38.7 35.8 61.3 46.4 34.0 27.2 15.0 33.8 48.1 32.4 34.7 46.7 31.1 54.1 57.3 28.1 46.1 37.0 49.3 27.9 47.3 43.5 50.1 58.6 36.1 18.9 49.7 28.2 33.3 119.2 45.8 29.9 31.5 19.8 38.5 32.2 35.5 19.6 27.0 29.2 40.3 21.0 29.5 33.7 71.2 27.4 46.7 62.6 27.0 61.6 45.1 7.9 5.3 2.7 6.7 9.1 12.7 10.4 11.2 9.1 9.3 6.1 11.6 9.7 0.1 7.7 6.8 12.1 7.8 6.3 6.5 6.5 6.7 9.6 6.6 6.8 6.7 6.7 6.7 6.7 6.6 6.7 25.3 3.2 9.5 6.5 37.8 50.9 90.3 54.8 69.4 6.2 29.9 20.2 35.3 17.2 36.3 14.7 10.4 45.3 21.9 5.0 21.5 28.6 10.1 23.8 28.3 32.0 4.8 20.4 11.1 22.5 48.1 35.6 13.7 23.2 13.3 13.3 17.5 13.4 33.1 0.0 10.5 12.1 32.6 16.4 22.8 4.4 28.9 18.5 28.4 2.8 19.7 7.4 13.4 8.0 12.9 19.8 7.5 20.3 29.3 104.3 4.0 32.5 24.0 4.7 6.6 51.8 49.8 16.5 20.4 58.7 37.8 35.7 31.1 28.6 18.3 76.6 DNAJC21 "DNAJA5, GS3, JJJ1" ENSG00000168724 "DnaJ heat shock protein family (Hsp40) member C21" Q5F1R6 5 34929559-34958964 "Disease related genes, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040789 Approved Supported Nucleoli,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "HPA040789: AB_10794147" "unprognostic (1.37e-1)" "unprognostic (6.01e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (1.42e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.77e-3)" "unprognostic (3.04e-2)" "unprognostic (6.68e-3)" "unprognostic (5.99e-2)" "unprognostic (6.02e-2)" "unprognostic (9.27e-3)" "unprognostic (1.54e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" "unprognostic (6.02e-2)" 18.2 12.7 9.5 13.8 10.9 24.1 16.1 10.0 12.1 22.2 9.9 20.1 15.2 16.3 14.3 20.7 11.4 13.6 32.0 8.3 11.0 23.0 23.0 17.5 18.5 10.7 10.5 11.8 20.0 19.4 8.1 24.5 10.7 18.1 18.5 9.3 15.8 17.5 58.4 15.1 15.8 18.2 10.2 12.6 18.8 61.4 10.6 18.0 18.0 42.3 19.7 20.8 16.7 11.0 36.2 25.3 32.0 41.6 39.1 46.4 57.1 47.4 38.9 37.7 25.2 41.6 42.8 75.9 20.1 44.3 46.6 24.3 37.9 49.0 43.8 45.2 27.8 41.7 90.7 35.2 64.6 60.7 37.7 33.2 44.8 41.6 67.7 26.2 35.3 27.8 65.6 59.7 28.1 30.4 51.3 45.2 22.6 39.8 21.4 45.5 79.2 33.7 37.9 44.9 16.5 17.5 128.1 59.4 40.2 35.2 40.1 64.4 43.4 46.5 44.7 27.8 37.7 40.2 40.0 51.0 37.6 71.8 25.1 2.2 1.5 4.7 1.7 1.2 2.5 3.1 2.5 1.6 2.5 2.0 2.5 2.5 0.4 4.0 2.0 2.3 3.4 1.0 9.5 10.9 10.0 12.1 8.3 11.0 10.7 10.5 10.7 10.2 10.6 11.0 53.5 76.9 111.3 23.8 42.0 37.0 73.9 22.4 33.6 52.6 57.0 56.6 151.1 47.1 36.1 36.8 43.8 51.2 59.1 34.6 88.0 21.5 117.5 49.2 77.8 44.9 18.0 40.0 26.9 30.5 25.7 44.4 32.6 68.4 8.2 42.0 37.5 59.5 24.3 75.7 40.4 36.9 6.1 31.4 32.9 47.7 40.4 38.8 37.4 15.0 50.8 31.2 45.3 20.1 32.1 26.6 27.7 38.0 41.4 85.8 28.2 62.5 22.8 73.0 13.1 57.0 44.0 117.4 50.3 43.4 46.7 65.7 52.7 51.4 41.4 77.1 DNTTIP1 "C20orf167, dJ447F3.4, Tdif1" ENSG00000101457 "Deoxynucleotidyltransferase terminal interacting protein 1" Q9H147 20 45791954-45811427 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 124.8" "Group enriched" "Detected in all" 6 "dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9" "Cell line enhanced" "Detected in all" "PC-3: 280.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045496 Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 52: Eosinophils - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 3: Monocytes - Immune response regulation" "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA045496: " "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (4.52e-2)" "unprognostic (2.50e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (6.29e-2)" "unprognostic (7.16e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-3)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.18e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" 19.9 19.4 22.8 24.7 23.2 44.1 20.0 23.3 26.1 21.0 23.9 33.2 17.5 27.2 25.0 19.5 24.7 21.7 27.3 23.1 24.2 19.2 19.3 22.3 23.7 23.2 24.3 20.6 15.8 26.1 20.8 23.1 23.4 22.0 38.7 21.7 19.4 22.8 62.0 28.2 21.0 24.4 23.4 25.3 24.6 30.4 23.8 30.1 19.6 31.0 28.0 34.0 19.3 24.4 79.8 41.6 42.1 40.2 31.7 34.1 43.7 29.2 47.1 92.7 83.4 134.8 126.1 32.8 93.2 42.9 147.1 58.4 37.3 62.8 61.1 18.0 47.2 36.0 45.2 87.2 64.4 70.0 56.7 34.4 58.0 60.8 58.2 42.4 55.1 46.9 33.9 32.6 56.0 107.5 57.9 108.2 28.7 44.8 280.7 46.0 52.3 34.4 47.4 37.9 39.5 35.6 59.7 48.2 65.2 32.7 47.6 111.4 32.6 55.4 41.1 54.0 71.0 35.5 24.8 41.0 120.5 44.8 48.1 16.7 50.9 71.0 4.1 22.0 4.2 12.0 5.5 7.0 43.3 11.1 10.1 4.7 124.8 3.3 13.6 16.6 9.3 13.5 22.8 23.2 23.3 26.1 23.1 24.2 23.2 24.3 23.4 23.4 23.8 24.4 21.2 16.0 22.9 10.1 22.0 25.5 44.8 43.1 22.2 19.8 20.3 23.0 19.9 21.5 37.1 25.8 4.2 60.7 14.3 37.2 50.9 57.6 37.9 35.1 19.4 22.6 22.2 9.7 11.2 75.4 43.0 25.7 26.5 20.6 6.3 26.4 25.0 16.6 70.8 20.2 9.5 92.7 59.0 26.3 34.7 15.7 28.3 32.4 16.0 11.2 68.3 53.1 15.5 7.5 10.6 105.0 50.5 27.1 21.9 38.2 33.3 44.2 48.0 29.7 0.0 20.8 26.5 92.9 35.4 19.4 27.6 57.7 16.3 32.9 34.8 60.7 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947603 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 9.6 14.3 6.6 6.3 6.3 1.5 7.8 6.7 6.7 7.4 8.6 7.5 7.6 9.3 13.5 8.6 8.9 7.9 10.5 6.5 7.1 9.1 10.5 9.1 6.8 6.9 7.6 6.7 14.5 16.8 5.9 9.3 7.3 10.0 6.6 4.4 12.0 10.0 6.7 9.9 7.5 9.4 6.5 8.0 10.6 14.5 7.6 5.1 7.8 7.1 6.6 8.6 5.9 6.8 11.7 42.5 14.8 22.0 42.6 22.2 20.0 23.7 38.1 28.5 21.0 33.7 17.9 6.4 12.3 34.6 40.3 80.3 20.3 29.6 14.7 10.7 17.8 8.0 27.4 24.5 43.0 8.8 13.5 31.1 27.0 30.8 16.8 16.7 28.1 9.1 19.7 10.0 31.3 56.9 7.3 7.3 19.0 33.0 26.0 7.2 19.5 25.1 25.7 17.3 13.5 15.1 31.4 25.6 14.1 13.7 44.8 11.4 23.6 25.6 9.2 32.5 19.8 9.4 25.0 6.4 24.2 8.0 19.9 2.7 15.4 6.9 11.2 15.3 10.1 11.8 9.9 12.3 16.6 12.5 12.8 13.2 2.2 13.0 21.2 9.3 16.8 10.5 6.6 6.3 6.7 6.7 6.5 7.1 6.9 7.6 7.3 6.5 7.6 6.8 8.5 6.4 4.1 2.9 2.6 1.8 3.6 13.9 4.6 9.1 4.4 4.3 3.5 10.0 10.9 7.3 8.4 25.6 3.5 5.2 0.0 15.7 15.1 5.9 7.2 9.2 1.2 3.6 1.2 14.2 16.4 8.1 5.1 3.6 1.3 7.5 16.1 9.2 13.5 5.0 2.2 3.5 12.2 5.2 2.7 3.7 12.2 2.9 3.6 1.9 2.8 10.7 5.2 2.5 1.7 11.1 7.5 6.0 1.5 4.4 7.5 9.0 11.4 7.1 0.0 7.0 15.7 33.8 15.1 3.3 1.3 18.2 2.3 15.8 5.7 2.1 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Group enriched" "Detected in some" 26 "Early spermatids: 4.9;Late spermatids: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5" "Low region specificity" "Detected in some" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 2.2 0.4 0.0 4.7 6.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYNC1I2 "DIC74, DNCI2" ENSG00000077380 "Dynein cytoplasmic 1 intermediate chain 2" Q13409 2 171687409-171750158 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transport" "Motor protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033836, HPA040619, HPA053987" Supported Supported "Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol" NA NA 82000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Cytosol" "Nucleoli, Microtubules" "CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-2)" "unprognostic (8.15e-2)" "unprognostic (8.90e-2)" "unprognostic (1.37e-3)" "unprognostic (2.51e-3)" "unprognostic (6.30e-3)" "unprognostic (1.23e-1)" "unprognostic (1.89e-2)" "unprognostic (1.40e-2)" "unprognostic (4.19e-1)" "prognostic favorable (8.04e-4)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (1.35e-3)" "unprognostic (6.42e-2)" 65.1 58.5 89.2 44.4 121.1 23.1 65.3 122.6 185.9 62.3 70.4 62.3 54.3 74.5 51.0 68.3 47.1 58.6 65.9 89.2 101.4 80.0 41.3 51.7 38.7 130.5 116.2 71.7 38.7 68.2 29.4 76.2 124.1 59.9 64.7 63.5 46.7 60.3 51.0 48.8 51.0 80.4 104.0 41.4 49.3 55.9 112.9 60.0 56.3 57.7 47.4 72.3 53.3 155.5 87.5 55.0 167.0 61.9 151.2 144.0 94.2 149.2 115.7 122.9 133.7 96.5 84.4 79.2 127.7 178.8 168.0 86.2 132.5 143.5 159.8 30.1 59.7 69.3 65.7 109.6 75.5 80.0 71.7 113.0 133.4 152.3 97.3 171.7 219.1 76.5 112.1 21.3 246.1 54.4 68.9 65.7 77.0 127.0 55.5 68.7 149.8 58.3 163.3 138.0 105.8 116.6 82.7 65.6 90.6 126.0 64.1 77.3 238.3 185.9 91.9 75.2 90.9 26.3 54.0 64.5 126.8 64.2 139.2 209.6 93.9 49.2 50.7 98.0 54.3 77.2 58.1 59.4 68.7 71.1 51.7 49.5 5.8 64.4 100.1 111.8 66.2 39.6 89.2 121.1 122.6 185.9 89.2 101.4 130.5 116.2 124.1 104.0 112.9 155.5 146.2 198.7 60.6 30.3 49.2 50.6 59.2 138.5 19.9 73.1 101.7 87.1 75.4 158.7 124.8 169.2 64.6 101.9 46.3 169.5 131.0 207.6 129.5 118.2 147.3 117.1 84.3 95.2 102.4 161.5 107.5 91.2 42.8 172.6 102.3 69.3 174.9 150.7 101.1 80.8 104.9 140.0 116.0 148.1 39.8 48.0 128.6 75.9 35.6 45.9 156.2 91.3 70.0 35.7 182.4 189.2 126.9 138.0 22.7 44.7 139.2 270.3 108.0 128.9 111.7 61.4 111.0 248.4 95.2 43.2 60.0 115.6 46.7 60.6 123.9 58.5 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6" "Cell type enhanced" "Detected in some" "Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 0.3 0.1 0.0 2.8 0.0 14.2 0.5 0.1 0.1 1.0 0.0 4.0 3.8 0.4 0.0 4.9 0.9 0.4 2.1 0.0 0.0 0.1 0.3 0.3 7.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 5.1 0.0 0.9 0.2 12.6 3.0 3.0 0.6 0.0 1.3 5.6 1.7 0.0 11.8 0.1 0.4 7.3 1.8 1.3 0.1 23.3 7.2 7.1 9.8 0.4 1.1 31.7 13.0 3.7 15.3 16.4 25.4 7.8 23.5 5.5 4.3 9.0 20.2 17.2 1.6 13.5 15.9 14.9 8.0 4.1 7.1 0.0 12.7 19.2 0.3 0.1 3.1 1.0 0.9 21.0 17.2 17.6 22.1 6.3 11.6 25.8 16.6 6.9 26.3 10.1 26.9 12.8 16.0 6.6 16.8 6.0 7.0 5.5 11.3 1.3 4.0 7.7 13.7 4.2 7.3 9.0 18.3 11.8 7.7 16.2 30.6 9.0 24.4 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.1 0.1 1.3 0.0 0.0 0.3 0.1 3.8 0.0 0.5 0.0 0.0 0.9 0.8 2.5 0.0 0.0 0.4 3.3 0.8 0.8 1.2 34.1 0.1 0.0 1.7 1.0 10.2 3.3 0.0 3.1 0.0 0.0 2.4 0.0 0.0 3.9 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 1.2 0.0 9.7 0.1 0.4 0.2 5.6 0.0 0.0 1.5 0.9 4.0 3.1 10.0 0.3 0.3 2.2 0.5 6.3 0.9 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 61.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8" "Cancer enhanced" "Detected in many" "testis cancer: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9" "Not detected" "Not detected" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059367: AB_2683992" "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 2.8 3.1 1.8 3.5 1.7 5.3 2.4 2.1 2.2 3.2 2.8 3.1 0.8 2.7 2.7 1.8 3.1 2.7 2.0 1.9 2.4 1.8 1.4 3.0 6.2 6.6 3.1 4.1 2.5 1.2 3.7 1.7 2.2 3.3 0.9 6.6 1.4 5.5 0.6 2.7 2.7 2.3 1.6 3.0 2.2 61.2 2.4 3.7 1.5 0.9 3.9 2.4 2.1 2.0 0.3 9.1 0.3 0.9 2.0 2.0 1.7 8.5 6.9 4.0 6.8 0.2 0.5 0.1 0.0 1.9 1.8 0.2 0.3 0.7 5.9 0.5 0.1 1.7 8.9 1.4 2.9 0.1 0.5 2.7 0.0 2.5 0.5 0.4 0.6 0.4 0.1 0.5 2.5 0.1 3.1 1.3 0.4 0.1 1.8 0.2 0.0 0.1 2.2 0.3 0.1 0.0 5.6 0.4 0.2 0.2 0.0 0.0 1.3 0.1 0.3 2.0 0.4 0.4 0.2 0.1 0.2 0.0 0.9 0.0 0.3 0.5 4.4 1.4 4.6 2.3 5.6 5.4 0.2 2.3 7.9 5.0 0.7 6.2 0.9 0.5 7.3 2.2 1.8 1.7 2.1 2.2 1.9 2.4 6.6 3.1 2.2 1.6 2.4 2.0 4.7 0.0 6.0 0.0 5.9 13.4 78.5 5.9 1.8 4.9 2.4 3.9 1.4 2.8 2.7 1.8 27.1 2.4 11.1 2.4 0.0 3.5 72.8 13.8 9.6 14.0 0.0 6.6 0.0 1.3 1.6 12.7 5.1 21.1 1.3 6.1 5.3 3.0 1.9 11.8 0.0 1.2 4.1 4.7 26.8 23.5 8.7 6.8 1.8 0.0 4.0 7.5 6.2 0.0 0.0 4.9 4.5 4.5 4.3 47.6 1.2 1.7 7.5 18.6 6.6 7.6 8.4 306.8 44.3 1.4 7.7 2.5 11.1 15.6 1.0 46.9 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 8.5 15.2 24.8 13.8 25.6 18.2 9.8 24.3 27.3 9.3 20.5 13.6 12.2 9.9 19.4 19.7 13.2 7.7 11.9 26.0 26.2 17.9 16.5 9.3 19.2 22.2 23.2 6.9 10.5 15.8 27.8 9.1 23.9 9.5 11.8 15.9 11.2 7.8 14.0 13.9 10.6 10.6 22.9 14.6 10.8 11.6 25.1 22.2 22.4 15.2 18.0 10.8 11.1 23.6 25.4 48.2 25.9 28.2 15.7 21.1 56.2 26.8 27.8 32.0 24.2 32.5 32.6 45.3 46.8 28.3 30.1 25.9 20.9 39.3 17.3 35.5 37.5 40.7 28.4 76.2 29.9 40.2 49.9 19.5 35.1 32.2 43.6 17.6 41.9 79.0 45.2 30.9 29.7 48.5 37.6 57.9 29.4 61.5 38.1 43.6 26.6 61.6 39.6 35.7 54.5 62.6 18.5 31.7 30.1 13.8 29.0 36.9 29.9 25.3 13.1 21.2 36.9 34.9 88.0 37.8 30.0 40.8 24.1 22.2 15.2 12.8 19.7 17.9 19.6 16.8 16.1 20.6 27.4 20.6 17.6 18.8 6.5 22.2 16.7 30.3 22.2 18.6 24.8 25.6 24.3 27.3 26.0 26.2 22.2 23.2 23.9 22.9 25.1 23.6 5.6 3.2 9.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 8.5 7.0 0.0 0.0 6.2 20.2 0.0 48.6 7.0 0.0 50.9 28.7 0.0 14.9 7.5 7.0 0.0 0.0 0.0 16.0 36.9 5.0 0.0 11.5 3.8 13.7 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 16.5 0.0 0.0 0.0 0.0 20.7 0.0 0.0 2.3 0.0 0.0 41.6 4.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 26.7 5.7 24.5 0.0 0.0 ELAVL1 "Hua, HUR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958573-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 227.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 230000 "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: AB_2679618" "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favorable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 27.5 27.7 14.5 33.1 15.6 27.8 25.0 16.0 15.7 29.4 19.5 27.9 25.2 31.6 25.9 30.0 34.3 22.4 34.0 15.3 15.9 24.8 29.0 24.2 40.2 13.7 15.6 31.8 28.4 37.5 21.4 32.7 13.8 26.9 27.2 19.0 29.6 29.4 37.7 24.9 25.1 35.9 16.2 30.1 24.6 46.1 15.1 52.7 27.9 32.2 44.1 37.4 25.2 16.6 127.5 84.1 137.9 104.5 52.9 52.7 76.5 89.5 78.4 136.9 106.3 122.4 73.2 153.2 125.5 104.0 76.9 86.0 155.2 107.9 114.8 134.9 131.8 135.5 58.9 115.7 77.4 129.9 103.1 65.8 63.6 95.7 57.7 64.8 106.2 115.6 140.7 112.6 95.7 95.8 215.3 103.7 122.1 96.4 101.6 239.0 89.6 100.9 87.5 93.9 98.0 70.8 88.9 89.1 71.7 82.6 101.8 101.4 79.7 127.3 87.3 119.2 161.8 109.8 114.7 161.9 71.3 154.2 112.2 29.9 19.7 37.2 16.4 17.2 17.0 20.8 24.0 26.3 25.0 27.7 21.8 16.6 5.3 33.1 22.1 12.5 20.9 16.3 14.5 15.6 16.0 15.7 15.3 15.9 13.7 15.6 13.8 16.2 15.1 16.6 45.7 25.6 23.1 18.6 56.0 72.4 79.5 29.0 51.2 47.2 54.9 37.2 31.3 30.0 20.7 47.8 56.3 86.8 48.1 32.9 66.5 37.1 227.7 41.6 46.5 52.2 42.0 95.7 20.3 33.8 102.3 53.1 40.2 47.2 21.0 59.5 47.2 89.2 64.2 60.6 21.5 52.9 18.3 57.5 79.2 164.1 50.4 47.3 51.6 23.4 43.9 43.4 57.7 33.7 26.9 35.3 45.7 56.8 88.7 98.2 38.3 65.8 27.3 55.7 52.6 45.5 71.0 164.7 61.2 72.0 71.0 74.8 50.9 44.7 60.2 84.6 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 13.1;kidney: 36.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7" "Cancer enriched" "Detected in some" 5 "renal cancer: 3.7" "Region enriched" "Detected in some" 10 "cerebral cortex: 13.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8" "HPA006230, HPA006421" Approved Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 7: Kidney - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA006230: AB_2667542, HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.1 0.1 0.0 1.3 0.0 0.0 0.0 13.1 0.0 0.0 0.4 0.8 0.0 0.7 0.1 0.0 0.0 0.0 1.3 0.0 36.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 5.9 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.3 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 13.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 55.2 0.0 0.1 0.0 1.2 5.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 13.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.0 1.6 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 35.7 0.0 0.0 0.0 0.0 0.0 1.5 5.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "brain: 19.2" "Group enriched" "Detected in some" 4 "Endometrial ciliated cells: 3.6;Glandular and luminal cells: 8.7" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Group enriched" "Detected in many" 6 "cerebellum: 19.2;midbrain: 8.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 41.1;AN3-CA: 15.2;HAP1: 9.0;HEK 293: 25.1;SK-MEL-30: 12.9" "Region enriched" "Detected in some" 8 "cerebellum: 27.8" "Region enriched" "Detected in some" 5 "cerebellum: 52.3" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" No No "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Nucleoli, Nucleoli fibrillar center" "HPA045646: AB_2679404, HPA069809: AB_2686205" "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavorable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.1 0.1 0.1 0.0 0.2 0.0 0.1 19.2 0.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.2 8.0 0.6 0.3 0.5 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.7 41.1 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.1 0.0 1.4 0.0 9.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 5.5 0.0 0.0 0.0 0.0 2.0 0.0 3.2 0.0 0.1 0.3 0.0 0.0 3.0 0.0 12.9 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 19.2 0.7 0.2 0.4 0.2 8.0 2.3 0.3 0.9 2.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.6 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.4 1.5 0.6 0.0 0.1 0.0 0.1 0.3 0.0 0.0 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099869 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favorable (5.27e-4)" "unprognostic (1.33e-1)" 31.8 21.4 18.3 25.9 18.4 39.4 30.8 23.1 22.2 32.5 14.7 27.6 20.7 28.7 23.9 27.3 26.4 19.2 20.3 17.7 15.9 21.8 20.0 24.3 31.1 17.2 15.2 35.8 24.0 25.2 26.1 26.1 16.6 25.3 27.6 35.4 25.4 21.0 33.3 37.0 26.1 27.5 13.7 27.4 26.1 23.4 17.9 32.7 23.3 22.6 34.2 24.6 28.4 19.1 66.4 41.5 84.9 33.0 44.3 48.7 48.5 63.8 46.8 109.8 99.1 61.6 94.1 66.3 40.3 61.0 48.8 64.2 95.0 71.2 100.1 74.9 95.0 96.5 80.5 63.2 43.4 79.5 73.7 38.4 60.2 108.1 63.1 40.9 69.4 58.0 103.2 59.3 61.4 37.4 78.5 73.1 56.5 50.3 49.1 79.8 72.2 58.1 64.8 33.3 54.5 53.3 68.8 58.9 77.0 59.4 51.5 72.1 63.6 58.2 60.4 53.0 76.2 35.7 60.0 130.0 59.4 116.2 71.5 57.7 32.0 26.6 36.2 41.5 43.0 36.4 37.7 36.7 37.9 36.5 31.9 35.4 6.2 49.3 51.2 19.3 39.4 43.3 18.3 18.4 23.1 22.2 17.7 15.9 17.2 15.2 16.6 13.7 17.9 19.1 18.4 28.9 18.3 17.0 26.1 13.3 14.3 19.8 26.2 14.9 11.0 23.6 6.4 12.8 29.2 5.5 47.9 26.5 18.8 16.4 9.8 25.0 16.4 14.3 21.0 20.1 9.0 28.0 20.3 31.9 34.3 17.2 31.1 19.2 20.2 26.2 13.9 11.1 24.7 21.9 24.3 16.5 22.4 15.1 14.1 7.1 29.5 18.7 12.4 9.4 24.0 6.1 28.8 30.2 15.2 30.2 9.4 23.0 26.8 8.5 12.7 8.8 27.3 34.8 13.1 18.4 17.6 21.9 20.8 28.7 13.4 22.7 21.2 19.7 20.1 10.0 EXOSC2 "hRrp4p, p7, RRP4, Rrp4p" ENSG00000130713 "Exosome component 2" Q13868 9 130693721-130704894 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Deafness, Disease variant, Dwarfism, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021756, HPA021790" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA021756: AB_2670809, HPA021790: AB_1848320" "unprognostic (8.19e-2)" "unprognostic (1.93e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (8.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.48e-1)" "unprognostic (8.55e-2)" "unprognostic (1.20e-3)" "unprognostic (4.73e-2)" "unprognostic (6.57e-2)" "unprognostic (3.01e-1)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" 9.1 8.2 8.6 13.8 8.7 9.9 12.6 8.9 11.1 8.9 8.6 10.3 7.7 12.8 6.8 10.0 12.8 5.6 8.8 8.9 8.9 9.7 13.0 6.7 13.0 8.5 8.6 14.8 9.9 11.5 3.2 9.2 8.4 9.3 11.9 10.6 7.1 9.0 15.0 8.4 8.3 12.9 8.9 8.3 8.2 4.1 8.6 14.6 8.4 12.0 15.8 10.1 8.6 9.3 39.9 79.7 46.6 41.2 16.8 18.9 34.0 58.6 28.1 57.4 44.1 64.4 33.7 79.0 31.2 31.8 62.9 71.0 75.8 58.8 62.9 46.9 36.7 63.1 75.2 45.3 31.3 96.7 39.9 24.0 21.7 80.8 94.1 21.1 41.6 52.3 70.1 33.1 41.0 70.3 68.2 27.3 57.8 109.3 51.0 52.3 85.8 85.5 27.5 36.4 28.6 31.8 68.3 51.4 31.1 32.8 53.5 34.1 25.5 56.1 43.5 50.2 83.3 16.8 71.4 117.2 40.0 55.0 44.7 1.7 7.3 6.0 10.0 8.3 10.6 11.6 10.2 8.9 10.4 10.0 11.1 9.4 1.6 16.5 5.7 7.1 10.1 7.7 8.6 8.7 8.9 11.1 8.9 8.9 8.5 8.6 8.4 8.9 8.6 9.3 7.6 6.4 20.5 3.6 13.5 10.6 12.6 7.7 8.0 12.4 6.1 8.3 8.7 4.3 5.7 3.7 6.2 19.1 10.6 6.0 5.9 13.4 1.4 3.8 11.4 8.0 1.2 23.5 5.3 11.3 22.8 9.8 5.1 4.5 12.7 14.0 7.1 10.7 12.8 5.0 5.2 7.9 4.1 2.5 5.7 1.7 8.4 7.8 7.2 1.9 5.4 14.7 13.4 4.5 4.0 8.3 2.7 7.9 13.7 14.2 5.0 10.4 6.7 15.0 6.6 11.7 10.2 5.8 10.9 10.6 8.4 8.3 10.1 11.9 10.0 8.1 FAM207A "C21orf70, PRED56" ENSG00000160256 "Family with sequence similarity 207 member A" Q9NSI2 21 44940012-44976989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034178, HPA036354, HPA036559" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 36: HEL - Hemostasis" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "CAB034178: AB_1564323, HPA036354: AB_10672242, HPA036559: " "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "unprognostic (4.99e-3)" "unprognostic (1.05e-2)" "unprognostic (1.37e-2)" "unprognostic (1.14e-3)" "prognostic unfavorable (7.04e-4)" "unprognostic (3.23e-2)" "unprognostic (4.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.84e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (4.12e-1)" "unprognostic (5.77e-2)" 19.8 20.9 9.8 11.3 11.0 12.6 17.6 13.9 16.1 14.3 5.7 22.3 11.1 15.1 2.1 17.9 14.5 2.2 53.6 10.6 9.8 20.3 31.1 13.0 9.3 11.1 10.8 11.6 21.5 6.0 9.4 5.3 10.7 14.2 3.7 6.1 15.7 5.7 43.3 18.5 14.3 4.8 7.7 23.8 20.2 27.3 12.3 9.4 10.5 14.4 6.5 21.4 13.4 10.0 48.4 51.9 17.2 22.2 8.3 11.4 40.9 32.4 8.7 24.4 19.6 88.1 14.8 49.0 68.7 11.5 35.5 31.8 23.9 35.5 9.7 35.9 72.8 144.6 36.4 75.2 33.1 47.7 18.1 19.9 20.4 22.0 19.2 10.5 26.7 41.6 83.9 33.5 18.6 86.7 45.2 74.3 58.2 36.0 72.1 44.0 18.4 85.7 23.5 19.0 84.0 35.7 43.0 50.7 51.4 12.2 35.4 33.8 35.2 20.4 42.3 27.5 70.8 70.0 65.5 47.6 16.3 81.1 29.1 3.1 4.0 4.1 1.8 4.1 1.8 7.7 3.2 4.3 3.8 5.0 3.5 3.5 2.4 4.4 4.7 8.9 4.0 2.3 9.8 11.0 13.9 16.1 10.6 9.8 11.1 10.8 10.7 7.7 12.3 10.0 13.8 0.0 7.5 5.5 25.6 19.2 31.7 35.3 27.9 22.7 41.4 57.7 22.6 34.3 22.7 18.4 4.2 36.9 28.8 60.0 46.9 68.1 14.8 30.6 30.1 23.3 26.4 29.2 3.2 63.5 70.7 23.3 16.8 20.9 10.2 48.6 26.4 56.3 68.4 6.7 3.8 34.3 12.2 33.3 18.4 38.5 14.6 24.9 24.9 1.0 51.7 36.9 41.2 6.0 2.9 59.3 34.8 12.8 29.4 77.9 84.1 90.2 15.2 18.3 32.9 17.7 36.2 82.0 42.0 35.1 21.0 30.8 19.5 70.7 44.3 39.9 FAM32A "DKFZP586O0120, OTAG-12" ENSG00000105058 "Family with sequence similarity 32 member A" Q9Y421 19 16185380-16192046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051712 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA051712: AB_2681582" "unprognostic (3.20e-2)" "unprognostic (1.44e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-3)" "unprognostic (1.23e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (1.37e-2)" "unprognostic (3.86e-3)" "unprognostic (1.18e-3)" "unprognostic (1.56e-1)" "unprognostic (9.31e-2)" "unprognostic (3.23e-2)" "unprognostic (4.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (6.49e-3)" 64.5 69.9 64.9 48.2 66.4 94.6 57.1 60.5 69.3 44.6 57.3 68.8 78.2 57.2 49.5 69.6 45.3 53.8 54.8 66.2 62.1 60.7 95.3 51.4 60.9 62.9 63.1 43.3 52.8 54.0 37.8 61.4 63.5 50.0 57.8 28.1 56.3 47.4 50.8 73.3 74.9 52.9 60.1 67.7 68.9 30.6 65.8 64.1 48.6 49.1 59.5 63.4 49.8 64.3 102.8 76.7 118.3 76.8 137.1 104.7 111.8 97.1 109.8 117.5 128.3 106.1 120.4 67.6 165.2 126.4 84.4 76.8 122.4 106.2 102.6 89.6 134.2 125.5 66.2 95.6 110.4 159.4 141.0 121.6 109.4 94.5 86.2 103.8 128.4 137.2 100.2 96.6 117.6 136.0 124.4 165.9 170.6 168.9 187.7 129.3 81.9 111.6 129.6 100.6 101.6 154.3 82.3 77.2 107.8 84.5 65.5 179.5 120.5 90.8 53.9 167.4 123.5 114.5 204.5 107.8 132.0 191.7 80.2 278.1 266.5 547.9 127.5 339.2 136.3 152.9 122.0 140.3 228.8 159.1 146.2 160.5 220.6 161.5 390.0 157.5 185.6 343.3 64.9 66.4 60.5 69.3 66.2 62.1 62.9 63.1 63.5 60.1 65.8 64.3 59.2 44.8 46.2 3.3 54.7 46.7 32.4 61.7 40.9 26.8 56.5 51.9 36.8 55.8 45.6 36.8 20.9 100.9 65.3 119.8 92.0 102.1 17.9 39.5 56.5 58.7 67.8 49.6 6.2 103.5 108.2 52.5 40.2 53.3 62.7 55.0 45.7 99.8 86.5 42.1 6.9 63.8 34.6 75.5 45.8 40.7 38.8 57.2 58.7 6.5 93.4 56.4 84.5 7.1 7.1 136.4 157.3 52.3 49.1 49.6 120.1 85.5 37.8 24.5 26.3 27.9 61.0 26.5 44.3 47.7 53.3 105.8 53.5 56.0 59.6 54.8 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "FA complementation group D2" Q9BXW9 3 10026414-10101932 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 120.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 1.1 0.7 2.7 7.7 2.1 17.8 3.4 1.6 5.3 1.5 1.1 4.0 3.2 2.0 0.7 2.5 2.6 2.0 0.5 3.4 1.6 0.9 1.1 1.9 12.2 3.9 1.4 3.6 0.8 0.8 0.5 4.7 3.0 1.9 6.4 3.1 4.9 1.0 4.8 4.5 4.0 2.0 2.4 6.4 3.5 11.8 2.3 9.8 1.9 0.4 13.0 2.3 1.3 5.1 24.1 25.4 46.5 13.2 2.4 3.5 120.7 22.0 9.8 31.3 25.4 18.8 23.0 46.7 9.8 7.0 25.1 20.2 48.8 16.7 31.0 22.6 33.0 63.6 39.6 17.9 0.4 48.1 37.9 1.2 2.6 34.1 18.4 4.2 18.4 39.3 39.6 51.6 23.1 27.2 40.6 17.9 56.1 18.1 17.6 43.4 37.7 32.5 10.3 26.7 13.0 25.3 26.4 20.1 8.3 33.5 31.0 29.4 10.6 24.6 28.4 15.1 31.5 21.7 46.4 77.2 14.1 47.7 43.2 2.7 0.6 1.9 0.6 0.5 0.6 2.4 0.9 0.5 0.4 3.2 1.1 0.9 1.5 1.0 1.4 1.8 1.5 0.5 2.7 2.1 1.6 5.3 3.4 1.6 3.9 1.4 3.0 2.4 2.3 5.1 0.7 0.0 0.5 0.7 12.5 4.6 3.5 2.9 2.8 3.1 4.5 2.7 2.0 1.5 1.9 1.8 10.4 12.7 5.6 3.1 0.0 1.9 5.9 2.6 1.5 2.1 1.2 25.2 3.0 3.5 15.2 2.6 2.0 3.4 1.3 11.8 3.3 1.5 5.7 0.0 2.6 3.2 6.1 3.8 7.0 8.0 2.1 3.7 3.6 1.9 4.9 0.6 1.0 1.5 2.4 1.8 3.6 1.5 8.1 2.2 0.5 0.7 2.0 5.6 19.7 2.6 2.1 62.5 30.2 4.1 2.7 7.0 5.2 1.6 7.6 3.1 FBXO11 "FBX11, UBR6" ENSG00000138081 "F-box protein 11" Q86XK2 2 47789316-47906498 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002690 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA002690: AB_1848448" "unprognostic (1.18e-1)" "unprognostic (8.65e-3)" "unprognostic (3.93e-2)" "unprognostic (2.05e-2)" "unprognostic (7.92e-2)" "unprognostic (1.42e-1)" "unprognostic (3.85e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-2)" "unprognostic (9.82e-2)" "unprognostic (5.77e-2)" "unprognostic (2.33e-2)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" 27.9 19.6 24.5 19.1 25.9 32.2 20.9 32.7 28.7 21.1 21.0 19.7 16.8 33.1 24.8 18.7 22.2 20.9 22.8 26.5 25.6 21.7 26.8 22.5 25.7 22.8 23.1 34.4 19.6 30.2 17.5 23.0 24.0 22.7 20.1 33.3 16.5 20.4 28.3 19.1 17.3 29.7 22.9 24.2 19.1 41.0 25.9 22.5 26.1 28.7 27.7 22.1 16.9 25.2 52.8 26.9 62.9 53.9 42.6 40.2 37.2 36.0 48.6 32.6 31.9 22.9 25.9 32.8 45.4 50.2 40.5 25.6 42.5 37.1 47.9 22.3 21.5 31.6 21.3 36.6 41.0 33.5 32.1 39.3 41.7 28.8 48.2 51.9 42.1 16.6 31.3 33.9 40.4 25.5 31.7 32.8 38.2 34.7 26.2 40.9 58.3 25.5 47.1 42.5 44.1 52.3 34.2 31.5 54.6 46.4 14.7 27.9 46.4 40.2 37.2 27.5 40.0 28.9 16.5 60.9 27.4 30.8 42.1 4.3 1.1 2.1 1.5 1.2 1.6 2.1 1.4 1.7 1.4 1.5 2.6 1.7 2.6 2.2 1.1 2.0 1.6 1.1 24.5 25.9 32.7 28.7 26.5 25.6 22.8 23.1 24.0 22.9 25.9 25.2 40.6 16.0 39.0 100.9 34.1 67.0 44.4 22.0 24.5 45.1 22.3 15.1 11.0 15.7 24.9 18.4 33.3 19.6 37.8 24.7 11.7 17.2 34.4 38.6 40.3 39.4 23.9 17.1 151.4 15.2 16.0 37.0 23.4 48.6 29.1 37.3 33.2 20.0 25.5 55.5 134.8 17.1 24.4 40.1 81.4 40.4 30.1 51.8 35.6 137.7 30.9 30.2 25.7 138.7 143.8 25.8 17.1 39.9 36.3 44.3 17.3 14.6 37.4 42.5 19.7 42.3 34.6 86.6 50.7 24.2 59.0 36.0 35.6 33.4 19.5 65.1 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109734 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 44.0;salivary gland: 11.4" "Cell type enriched" "Detected in some" 4 "Ionocytes: 132.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Group enriched" "Detected in some" 5 "MCF7: 1.4;SuSa: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Supported Nucleoli,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 12: NES - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Vesicles "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.5 0.1 0.0 0.1 3.0 0.0 0.0 11.4 1.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.5 0.2 0.0 0.0 7.6 6.5 0.3 0.0 0.3 1.8 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 132.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.0 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857680-2877174 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.0;lymphoid tissue: 32.2;testis: 21.4" "Cell type enhanced" "Detected in many" "Early spermatids: 22.4;Erythroid cells: 18.7;Extravillous trophoblasts: 18.2;Late spermatids: 25.5;Plasma cells: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.9 1.1 0.4 9.4 0.5 25.0 1.8 0.8 0.8 1.7 0.2 10.5 9.7 1.7 0.2 11.1 0.8 1.5 0.5 0.8 0.3 0.7 1.2 1.8 11.3 0.4 0.9 0.3 0.4 0.4 0.1 6.1 0.6 0.7 12.5 1.1 1.9 0.8 0.6 6.4 8.8 7.5 0.1 3.1 5.2 21.4 1.0 32.2 0.9 0.3 15.2 3.0 3.2 0.6 133.0 129.5 101.3 92.2 14.2 19.0 129.2 84.0 80.4 165.2 147.2 166.9 114.8 84.5 17.7 119.8 188.5 100.2 153.1 76.1 160.0 159.8 80.3 94.7 121.6 71.6 2.0 79.2 75.0 9.9 8.3 154.4 106.1 39.1 117.8 96.8 55.6 184.9 130.5 122.6 108.3 36.8 225.6 136.1 95.4 77.3 149.8 44.1 38.1 82.7 56.3 89.1 106.7 90.4 46.6 189.4 87.1 87.8 48.0 134.3 200.5 160.4 300.4 24.7 44.3 122.1 63.1 74.3 147.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.8 0.8 0.8 0.3 0.4 0.9 0.6 0.1 1.0 0.6 0.1 0.0 1.3 0.7 2.4 2.9 1.3 1.0 1.2 2.0 1.7 1.3 0.5 1.5 0.8 1.8 4.2 7.1 0.8 6.6 1.9 0.2 22.4 1.2 2.1 2.5 0.0 18.7 1.1 0.0 18.2 3.2 10.2 2.4 0.0 15.4 3.6 0.8 9.1 5.0 0.6 7.5 2.0 4.2 1.2 25.5 0.9 2.4 0.0 0.0 1.1 0.6 1.0 0.5 1.0 0.3 0.3 0.7 19.9 1.0 1.4 0.4 0.2 4.0 0.0 1.2 3.0 15.0 9.9 10.2 1.4 1.9 3.3 0.9 12.9 1.9 FP565260.1 ENSG00000275464 "Periodic tryptophan protein 2 homolog" 21 5130871-5154658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.4" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 9.2 9.2 6.4 9.9 8.8 12.1 7.4 7.2 8.0 5.9 4.9 8.5 9.1 6.8 1.7 8.3 7.8 7.3 7.5 7.1 6.8 9.0 6.8 7.1 13.4 7.6 7.2 6.7 7.7 6.5 6.0 7.9 9.1 6.5 8.4 3.5 6.7 4.7 10.1 8.6 8.2 7.3 6.8 11.5 7.6 7.1 7.2 6.7 6.6 3.2 5.3 11.4 7.1 13.7 32.0 24.0 15.4 24.2 6.6 5.0 9.1 0.2 0.0 0.1 0.1 0.4 20.1 0.3 14.1 10.5 20.8 21.0 42.9 19.0 0.0 7.4 15.1 102.4 12.4 11.9 10.4 47.6 29.1 17.8 22.5 25.5 20.1 5.0 20.1 16.5 56.8 11.6 6.6 28.4 34.4 33.1 60.4 36.5 29.3 54.0 14.2 28.8 13.5 25.3 16.6 27.3 25.5 38.4 14.9 4.2 31.5 24.9 10.2 12.0 29.7 0.3 32.9 13.9 16.0 63.5 20.4 62.3 16.7 3.3 7.3 6.9 18.5 12.6 21.2 11.0 11.3 13.5 8.7 11.2 11.1 15.2 4.1 9.9 18.2 5.5 8.5 11.6 6.4 8.8 7.2 8.0 7.1 6.8 7.6 7.2 9.1 6.8 7.2 13.7 0.9 0.0 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 1.9 0.0 0.0 2.5 0.0 0.0 2.7 1.1 0.8 0.0 9.3 0.0 0.8 1.1 0.9 0.0 0.0 0.0 8.0 1.4 0.9 0.0 0.9 5.1 0.6 0.0 0.0 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.3 1.2 0.4 0.9 0.0 GLI2 "HPE9, THP1, THP2" ENSG00000074047 "GLI family zinc finger 2" P10070 2 120735623-120992653 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 10.9" "Cell type enhanced" "Detected in some" "Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB008558, HPA074275" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 89: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nucleoli" "CAB008558: AB_2111910, HPA074275: AB_2686677" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (9.83e-3)" "unprognostic (4.63e-2)" "unprognostic (2.04e-1)" "unprognostic (9.43e-2)" "unprognostic (1.65e-2)" "unprognostic (2.19e-3)" "unprognostic (2.58e-1)" "unprognostic (9.23e-3)" "unprognostic (1.81e-2)" "unprognostic (4.49e-10)" "unprognostic (1.13e-1)" "unprognostic (8.88e-2)" "unprognostic (2.32e-2)" "unprognostic (1.42e-3)" 1.6 1.0 1.9 0.9 2.2 0.0 1.4 1.4 1.3 4.3 0.6 3.4 0.4 4.7 1.2 0.8 2.8 2.1 2.3 1.1 1.9 1.4 0.4 2.0 0.3 2.1 2.1 10.9 0.3 0.1 1.8 0.8 1.8 2.9 0.6 0.0 1.4 1.1 0.9 2.7 1.6 1.9 1.6 0.8 1.6 2.4 1.8 1.3 1.0 0.4 0.3 3.1 2.4 0.9 0.0 10.3 20.1 5.5 3.2 4.0 0.0 5.8 1.8 2.4 2.4 0.0 0.5 0.0 0.9 5.2 0.9 0.3 4.3 0.2 1.9 0.0 2.1 0.4 6.1 0.2 3.8 0.0 1.2 2.3 0.0 13.1 0.0 2.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 1.6 4.3 0.1 2.2 3.5 0.0 0.0 2.0 2.1 3.8 0.0 0.2 4.3 0.1 0.0 5.1 0.0 17.9 2.5 0.0 0.0 0.1 0.0 7.4 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.2 1.4 1.3 1.1 1.9 2.1 2.1 1.8 1.6 1.8 0.9 0.3 0.0 0.0 39.5 0.0 2.0 0.1 0.5 0.6 0.0 0.1 0.9 1.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.3 6.1 0.5 0.0 0.0 0.7 0.2 0.1 10.4 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.5 2.1 25.1 0.1 0.0 2.8 0.0 0.0 1.0 3.0 0.3 1.0 0.0 30.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 16.0 3.4 0.1 3.6 0.1 1.7 0.0 0.0 7.9 0.0 0.1 GLI3 "ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV" ENSG00000106571 "GLI family zinc finger 3" P10071 7 41960949-42264100 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 8 "Astrocytes: 301.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 47.1;WM-115: 34.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005534 Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "Nucleoli, Vesicles" "HPA005534: AB_1078973" "unprognostic (2.53e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.35e-3)" "unprognostic (2.24e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-1)" "unprognostic (3.54e-2)" "unprognostic (1.48e-5)" "unprognostic (9.13e-3)" "unprognostic (5.41e-2)" "unprognostic (3.21e-3)" "unprognostic (7.00e-2)" 6.1 1.9 9.2 3.6 8.8 0.1 8.9 1.0 5.4 7.2 0.0 11.6 1.2 11.8 2.7 3.7 8.2 3.8 1.6 6.3 5.5 1.7 0.3 3.4 0.9 1.7 10.4 13.2 0.7 0.5 1.1 11.9 3.0 5.5 2.9 1.8 2.8 8.2 1.1 8.3 3.4 10.7 0.5 1.1 2.6 1.7 14.4 3.0 4.6 2.3 1.7 4.8 7.3 2.3 0.0 0.0 47.1 0.4 16.9 23.6 3.5 3.1 9.0 9.3 12.8 0.0 0.0 0.0 1.7 22.1 22.7 10.1 8.7 8.9 10.8 0.0 7.0 0.0 6.0 0.0 9.0 0.0 0.1 21.0 12.9 10.6 6.8 5.7 10.6 5.4 0.0 0.2 5.6 5.6 0.4 0.0 20.9 0.0 21.2 12.4 0.1 1.4 0.2 6.4 1.5 0.0 6.3 7.0 4.1 23.8 8.0 0.1 11.3 13.6 18.8 16.0 6.0 0.1 0.0 0.0 7.3 0.2 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.8 1.0 5.4 6.3 5.5 1.7 10.4 3.0 0.5 14.4 2.3 2.9 0.0 7.7 301.3 0.2 23.5 7.2 8.5 31.9 1.6 20.5 27.1 1.8 0.0 2.3 1.8 0.0 21.1 0.5 0.0 0.0 0.0 16.6 2.4 12.6 3.4 0.0 0.0 0.8 0.0 13.6 25.9 0.0 4.6 1.3 10.5 3.9 0.0 3.3 0.0 3.6 0.1 6.1 0.3 6.3 5.4 19.3 0.4 8.8 22.5 0.0 13.6 0.0 8.5 0.7 0.1 0.0 3.4 1.2 6.6 0.0 3.8 1.5 1.1 13.1 17.0 12.1 0.3 2.2 7.9 15.5 34.2 0.7 5.2 0.1 5.0 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530183-54621521 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 4.6 3.6 2.0 7.0 3.6 8.9 4.8 2.6 2.7 4.8 3.1 4.7 3.9 4.7 3.7 5.7 4.7 4.7 7.2 2.7 2.6 4.4 3.9 5.0 7.6 3.1 3.6 3.8 5.0 5.7 2.3 5.6 3.2 3.7 6.1 3.8 4.0 4.4 7.1 5.7 4.7 7.3 2.7 6.9 5.3 2.3 3.4 8.3 8.5 7.8 8.5 6.7 3.5 5.4 20.7 49.1 9.5 20.9 10.2 8.3 15.2 9.8 8.7 13.4 9.9 43.4 16.6 26.9 21.3 18.2 15.1 18.7 34.6 14.9 19.0 15.9 16.4 30.0 34.0 17.2 7.9 42.6 26.0 10.0 7.1 31.0 17.4 5.7 13.4 16.4 19.2 27.0 14.0 36.5 25.5 11.8 29.6 13.0 26.7 27.7 23.9 27.8 10.3 28.8 17.1 8.4 39.7 24.3 11.7 20.9 30.9 11.4 20.0 22.6 22.1 21.8 18.4 19.9 25.7 35.9 12.8 34.6 27.8 23.6 14.4 15.0 16.5 12.8 15.0 15.1 14.8 13.8 11.1 16.0 10.6 11.7 19.2 21.5 15.0 10.2 9.3 12.5 2.0 3.6 2.6 2.7 2.7 2.6 3.1 3.6 3.2 2.7 3.4 5.4 9.2 12.8 18.5 14.4 15.3 1.3 3.6 3.9 9.6 10.2 6.1 3.9 8.5 8.6 11.8 3.7 12.5 7.1 14.1 7.4 3.9 9.4 0.4 8.2 17.2 9.4 3.5 12.0 14.8 8.7 6.4 7.4 10.7 9.6 10.8 10.9 7.1 4.6 4.9 8.4 14.8 4.7 8.2 9.4 4.2 0.0 5.6 9.4 0.0 14.0 12.0 3.4 25.7 16.1 23.2 9.8 3.9 3.0 10.0 4.2 6.8 5.3 7.8 9.3 6.6 8.5 7.1 1.1 7.7 6.6 2.0 5.5 11.9 9.5 7.6 3.6 GRB2 NCKAP2 ENSG00000177885 "Growth factor receptor bound protein 2" P62993 17 75318076-75405709 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 340.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002589, HPA030749, HPA030750" Approved Supported Nucleoplasm,Nucleoli NA NA 400000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm Nucleoli "CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591" "unprognostic (4.83e-3)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "unprognostic (3.42e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.04e-7)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.89e-2)" "unprognostic (1.08e-2)" "unprognostic (8.13e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.58e-1)" 55.7 58.0 66.1 98.3 64.8 127.1 40.3 56.6 66.1 35.9 49.9 54.7 57.3 46.4 31.5 51.0 39.5 43.2 53.3 71.0 68.7 50.5 54.0 65.5 116.9 64.1 64.8 39.3 35.0 39.8 42.6 64.5 61.5 41.8 52.6 24.1 40.6 45.8 48.8 36.3 60.6 58.9 67.5 92.2 44.6 18.5 68.5 83.1 37.6 39.1 107.3 67.5 36.1 72.3 98.6 87.7 58.9 71.1 64.1 54.5 129.5 91.2 70.5 89.3 87.3 75.8 66.7 128.9 57.9 97.0 77.5 58.5 84.0 76.1 89.8 63.4 76.5 137.2 55.7 111.8 57.3 162.8 259.0 55.2 78.0 112.9 55.8 62.3 128.3 125.3 95.5 88.8 64.9 127.4 160.3 160.5 40.5 98.9 81.3 113.7 123.8 94.9 82.7 75.0 66.6 101.1 83.7 85.4 114.7 102.8 94.4 264.9 83.4 100.0 71.0 81.8 104.9 161.1 127.3 205.5 79.1 125.8 75.3 134.5 136.1 164.9 52.3 160.9 45.0 94.5 48.0 52.2 101.2 96.5 46.8 47.8 273.8 51.5 185.1 71.9 56.5 102.9 66.1 64.8 56.6 66.1 71.0 68.7 64.1 64.8 61.5 67.5 68.5 72.3 73.5 60.9 62.2 18.3 210.5 47.0 45.7 31.0 67.7 35.7 45.6 37.5 59.7 41.5 46.9 16.5 31.3 71.9 137.6 74.4 52.8 64.8 3.0 52.9 56.4 60.9 41.9 55.5 41.5 63.4 340.9 47.2 47.9 57.6 124.4 30.0 41.7 42.3 260.3 35.3 41.1 46.4 22.4 182.0 243.8 5.6 25.1 259.9 46.2 81.5 237.0 47.1 73.2 31.7 41.5 77.2 69.6 41.8 236.3 63.3 60.1 69.9 55.1 46.4 6.6 34.6 50.5 27.4 49.9 76.3 44.8 87.2 109.0 59.7 44.9 92.7 GZF1 "dJ322G13.2, ZBTB23, ZNF336" ENSG00000125812 "GDNF inducible zinc finger protein 1" Q9H116 20 23362182-23373062 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024520 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 32: T-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA024520: AB_10963938" "unprognostic (3.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.81e-7)" "unprognostic (8.98e-2)" "unprognostic (2.66e-1)" "unprognostic (8.70e-2)" "unprognostic (3.88e-2)" "unprognostic (1.92e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-1)" 5.9 18.7 9.6 5.5 10.4 31.5 5.0 11.1 10.9 6.0 9.2 6.5 3.9 6.5 5.3 4.4 6.5 5.5 12.4 9.4 9.8 7.7 6.4 6.0 5.2 10.0 12.8 9.2 5.2 6.7 7.9 6.4 9.9 5.9 4.1 10.5 5.0 6.8 9.4 4.7 4.8 5.7 10.6 5.3 5.4 13.3 11.7 5.5 7.0 8.1 4.4 5.8 4.6 10.4 8.2 14.2 8.9 9.0 10.3 10.0 7.1 9.8 9.0 9.9 9.2 10.9 6.4 16.6 8.5 8.5 19.3 14.3 10.3 13.2 11.2 2.8 6.7 15.4 6.0 14.7 13.4 9.3 9.0 10.1 9.6 10.7 16.3 13.8 6.7 11.4 10.6 25.2 14.3 10.9 14.5 11.6 6.6 11.5 19.3 9.5 21.3 11.6 7.4 8.2 13.7 7.8 8.7 15.4 20.9 7.3 10.2 13.4 8.7 16.0 9.2 12.1 10.6 20.5 9.0 14.4 4.7 41.8 8.8 0.0 1.6 0.8 0.7 0.9 0.5 1.0 1.0 1.0 1.6 0.6 0.9 1.0 1.2 0.5 1.2 1.3 0.3 0.9 9.6 10.4 11.1 10.9 9.4 9.8 10.0 12.8 9.9 10.6 11.7 10.4 9.8 6.4 9.6 5.5 12.6 10.8 3.1 3.8 8.6 12.6 6.0 6.9 19.7 1.5 4.7 3.7 18.8 4.9 8.7 3.9 7.9 3.6 18.9 10.4 9.7 8.4 5.4 4.0 6.6 3.3 3.2 8.3 7.1 17.8 13.9 8.2 2.2 5.2 8.7 6.7 7.6 4.2 4.1 13.2 28.8 27.5 9.3 23.9 1.8 1.0 2.5 10.3 5.2 4.5 5.6 4.0 4.6 8.2 11.6 3.2 2.8 3.8 7.7 13.4 0.0 8.8 11.5 20.7 8.9 7.6 8.4 5.6 7.9 14.0 3.7 1.8 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 275.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032200, HPA065612, HPA068442" Enhanced Supported Nucleoplasm,Nucleoli NA NA 72000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 17: WM-115 - Nervous system development" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 28.1 9.0 22.1 79.6 20.9 184.0 27.4 17.8 27.3 93.3 2.6 59.9 118.7 22.8 16.7 275.1 41.0 39.2 35.8 24.1 23.3 89.2 20.0 46.5 139.3 24.3 19.1 4.7 31.9 15.0 15.4 82.4 21.1 27.7 57.2 32.2 69.7 12.6 119.7 141.6 103.6 9.7 15.4 68.7 73.3 80.1 22.9 156.0 31.5 35.1 154.7 100.1 109.6 25.2 1418.7 547.0 274.2 192.9 124.8 916.6 1193.8 556.0 628.8 421.5 233.4 361.3 960.0 658.9 273.1 229.1 264.0 294.7 326.2 991.8 332.3 146.0 228.2 202.6 177.1 488.2 263.7 732.1 227.3 396.1 109.4 765.1 395.8 1083.8 1290.0 369.3 832.0 32.9 596.0 143.0 650.0 898.8 1340.9 697.5 950.3 947.6 6.2 728.0 286.6 128.4 477.0 202.5 59.3 278.3 533.3 430.2 112.2 775.8 1132.1 218.5 691.2 321.3 528.0 260.5 444.5 867.4 461.2 301.7 1115.0 18.7 26.6 35.5 24.4 26.8 32.2 63.5 45.0 39.0 79.6 39.5 52.0 42.9 6.7 20.1 26.5 86.6 55.8 30.7 22.1 20.9 17.8 27.3 24.1 23.3 24.3 19.1 21.1 15.4 22.9 25.2 11.0 28.9 21.7 2.3 117.8 432.3 947.5 181.3 109.8 29.0 88.8 47.4 30.8 28.6 106.1 40.5 4.2 894.3 70.3 173.5 46.9 755.3 7.2 50.5 14.6 113.9 117.0 268.3 5.4 277.5 799.8 72.0 79.5 115.3 66.7 8.3 18.2 12.3 377.2 11.8 5.7 226.4 97.6 74.0 149.9 24.5 5.6 94.3 90.7 1.0 74.3 44.1 33.0 4.5 2.7 1838.5 249.1 2.6 198.2 1483.3 174.5 15.8 21.7 41.9 0.0 18.6 77.7 40.2 417.6 224.7 361.4 822.8 66.6 0.9 364.3 1681.0 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824460-65966291 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.9;testis: 3.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 16.0;Early spermatids: 18.4;Glandular and luminal cells: 17.3;Granulosa cells: 29.7;Pancreatic endocrine cells: 19.9;Smooth muscle cells: 33.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 324.4;hTERT-RPE1: 232.6;SuSa: 216.1" "CAB017809, HPA039076" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 12: NES - Nervous system development" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB017809: , HPA039076: AB_2676335" "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavorable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.86e-4)" 0.4 0.0 0.3 0.3 0.2 4.9 0.2 0.7 0.5 1.1 0.0 2.1 1.3 0.4 0.0 0.3 1.2 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.4 0.2 0.6 0.9 0.0 0.4 0.2 0.2 0.0 2.4 0.5 0.1 0.1 1.5 0.4 1.0 0.1 0.1 0.1 1.1 3.8 0.2 0.2 0.6 0.2 0.1 0.1 0.1 0.4 47.9 21.4 324.4 45.8 15.0 82.0 0.1 148.5 68.5 26.0 25.8 28.1 19.8 0.0 92.3 7.0 120.0 20.5 54.2 129.3 123.8 0.2 56.2 0.2 0.7 169.3 8.4 4.7 0.4 62.7 8.0 55.2 98.4 232.6 105.0 0.2 0.1 0.6 149.9 0.2 0.4 27.8 190.3 4.6 89.2 12.7 16.1 0.1 68.9 0.3 0.0 0.0 0.1 0.1 85.0 216.1 0.5 0.7 120.8 89.5 26.9 71.2 45.3 0.2 0.2 0.4 112.0 0.3 21.4 1.4 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.3 0.6 0.1 0.0 0.0 0.3 0.2 0.7 0.5 0.2 0.1 0.4 0.2 0.2 0.1 0.2 0.4 0.0 0.0 1.1 5.9 0.2 0.0 3.6 16.0 2.8 0.0 0.1 0.1 1.7 0.0 3.0 0.0 0.0 0.8 0.0 5.0 0.0 2.5 18.4 10.4 0.8 0.6 0.0 7.4 0.8 0.8 0.5 2.3 3.1 17.3 0.0 29.7 0.7 0.0 9.0 0.0 0.9 5.1 4.1 0.0 0.0 9.0 0.3 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.9 19.9 4.5 0.0 0.4 5.5 4.0 0.3 7.3 0.0 0.0 1.1 33.7 13.5 0.6 0.3 0.1 0.8 0.3 0.3 8.4 1.1 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331376-173334432 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "bone marrow: 2347.2;lymphoid tissue: 939.2" "Cell type enhanced" "Detected in all" "Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 798.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 2454.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314, HPA073663" Enhanced Supported Nucleoplasm,Nucleoli "Secreted to blood" NA Yes 1200000 "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: " "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 90.3 31.0 36.3 146.1 38.4 2347.2 89.1 35.4 49.9 79.0 33.0 117.1 93.2 92.3 47.3 115.6 78.8 43.5 85.8 33.2 38.3 74.3 37.8 83.8 390.4 37.5 36.8 118.9 27.2 18.3 35.4 111.0 38.0 46.9 122.2 134.1 59.8 35.2 72.4 75.1 108.7 65.5 36.3 159.5 66.0 136.0 36.1 939.2 56.4 57.0 388.9 68.2 86.1 40.1 498.2 114.6 976.8 444.4 118.2 118.2 375.1 366.3 271.3 386.7 345.7 329.0 673.6 1645.5 79.2 203.0 207.4 190.3 645.0 196.1 601.0 1004.0 303.4 1823.2 308.8 487.8 115.7 1642.8 683.4 114.7 59.2 194.2 439.1 211.5 402.8 866.1 703.9 2282.4 358.9 409.9 2454.9 1513.7 355.4 289.4 199.3 1226.7 499.7 620.4 227.0 208.8 838.6 759.0 365.5 209.6 166.6 340.8 291.1 1173.2 236.0 175.5 513.6 219.0 554.9 734.8 437.1 1869.4 149.1 1178.4 464.4 798.0 135.9 407.0 94.1 57.6 86.2 72.5 137.8 131.1 112.8 57.6 88.4 85.3 316.7 83.0 49.1 43.2 266.4 107.6 36.3 38.4 35.4 49.9 33.2 38.3 37.5 36.8 38.0 36.3 36.1 40.1 167.0 28.9 64.1 5.9 153.2 158.8 141.5 131.8 75.1 48.9 75.3 107.8 229.0 38.6 78.3 55.2 35.5 472.6 222.9 116.5 142.8 25.9 30.4 71.2 71.7 128.0 74.7 1915.4 2.7 16.1 872.5 121.5 63.2 76.5 110.6 210.5 171.7 26.5 210.1 45.4 4.7 191.2 109.9 295.0 142.9 33.1 105.3 233.9 67.6 6.5 241.9 81.8 132.8 1.0 4.8 11.3 75.2 57.6 268.6 114.2 65.4 51.0 149.8 143.5 78.9 71.7 134.4 493.6 400.9 233.6 134.0 128.7 289.5 42.3 284.7 89.0 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990771 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 136.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 11.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 738.7;U-698: 675.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062583, HPA073663" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Nucleoli "HPA062583: AB_2684800, HPA073663: " "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 8.9 13.7 10.5 19.7 10.5 85.6 15.6 10.4 20.3 34.0 6.5 43.9 27.1 16.4 44.8 26.1 16.9 9.7 11.3 14.5 13.9 19.6 101.4 15.9 25.2 13.0 11.2 5.9 17.2 85.4 4.2 136.6 11.3 13.9 32.4 3.1 23.8 15.9 53.5 19.2 28.1 13.8 10.2 21.2 16.1 40.1 13.4 65.2 14.3 8.9 35.8 18.7 10.5 9.5 263.5 115.5 351.9 184.2 14.5 42.9 437.4 112.9 73.6 127.9 66.1 91.6 106.0 183.0 354.8 87.5 72.3 123.3 324.4 738.7 143.3 125.6 94.7 159.4 110.2 145.6 21.5 243.9 78.0 33.9 171.6 52.5 131.5 32.7 168.3 110.5 84.5 105.4 154.2 201.9 269.3 186.2 209.2 171.0 138.1 325.4 286.3 103.6 95.2 125.3 252.7 164.4 167.4 177.7 56.0 199.3 157.8 158.5 128.0 53.0 123.9 169.9 253.1 94.9 128.7 675.7 63.1 121.3 109.9 0.0 4.3 11.3 0.4 3.0 0.1 2.7 2.0 2.9 6.1 0.5 0.0 0.2 0.7 0.8 5.0 3.1 5.8 2.5 10.5 10.5 10.4 20.3 14.5 13.9 13.0 11.2 11.3 10.2 13.4 9.5 10.4 38.5 31.2 0.7 15.1 23.7 18.9 158.6 12.5 0.5 24.2 16.0 16.0 8.6 123.5 31.3 2.1 419.1 4.5 32.1 37.2 82.4 232.3 61.9 18.9 19.6 65.7 136.1 1.3 86.5 820.7 17.6 22.4 55.9 8.2 44.2 13.6 84.4 101.0 0.0 3.7 37.0 219.7 20.8 43.7 75.9 3.7 22.1 21.4 2.8 23.6 4.1 1.0 1.5 0.5 91.5 35.7 3.4 47.1 27.5 31.8 66.5 113.3 1.8 0.0 39.8 29.0 22.7 50.2 41.1 20.3 1400.2 10.1 10.4 60.7 18.5 HMGN2 HMG17 ENSG00000198830 "High mobility group nucleosomal binding domain 2" P05204 1 26472440-26476642 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018371, HPA077364" Supported Supported Nucleoplasm,Nucleoli NA NA 640000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB018371: , HPA077364: AB_2686835" "unprognostic (3.10e-2)" "unprognostic (6.88e-2)" "unprognostic (3.10e-3)" "unprognostic (4.13e-2)" "unprognostic (4.06e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.36e-1)" "unprognostic (2.44e-3)" "unprognostic (2.86e-2)" "unprognostic (1.05e-3)" "unprognostic (5.23e-3)" "prognostic unfavorable (3.92e-4)" "unprognostic (3.00e-2)" "unprognostic (2.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.15e-1)" 216.3 225.6 180.2 254.5 187.3 1137.3 234.8 179.6 251.3 328.1 162.5 280.3 176.3 283.8 359.3 291.1 293.4 142.9 192.5 170.6 183.1 259.7 212.9 259.2 436.5 185.1 178.8 394.6 252.5 160.4 328.7 214.9 188.4 281.6 301.1 285.0 217.1 162.8 251.8 242.8 270.0 235.8 188.7 324.3 224.7 160.4 175.8 916.1 306.1 133.5 534.0 245.1 250.7 211.6 1074.5 304.8 1192.5 496.5 112.0 251.6 390.8 517.2 331.2 1089.4 835.7 305.8 1073.1 1107.2 443.1 482.3 338.4 627.8 1564.6 565.6 1001.7 684.2 906.7 1222.2 401.5 360.2 197.7 2793.6 738.7 254.9 303.4 602.1 369.1 245.1 541.7 866.8 964.3 643.0 623.0 690.8 1906.1 1363.3 922.7 1463.0 619.6 1384.3 1598.6 776.5 380.3 278.6 1064.5 641.1 1384.3 498.7 651.4 304.9 759.0 1508.9 322.3 536.9 920.4 977.1 943.6 641.2 899.2 1266.9 338.9 2989.0 1056.9 331.8 530.8 1430.5 279.2 622.3 267.3 532.2 379.7 343.3 531.5 505.6 412.4 337.7 462.4 355.5 690.4 704.7 746.7 1084.6 180.2 187.3 179.6 251.3 170.6 183.1 185.1 178.8 188.4 188.7 175.8 211.6 128.7 342.9 394.4 28.1 459.3 288.6 323.8 383.2 211.1 180.2 353.0 241.3 93.4 221.6 314.8 261.1 141.8 898.7 325.2 227.2 371.7 218.4 204.3 328.9 291.1 190.3 576.9 980.4 14.4 268.7 606.4 435.4 263.5 278.1 383.0 375.0 185.6 147.5 763.0 94.2 22.2 564.5 193.3 434.3 467.9 53.5 185.8 477.5 227.7 15.0 655.6 376.0 399.6 15.1 36.9 93.7 304.4 151.9 669.5 250.4 238.0 320.4 495.6 370.2 124.9 249.0 325.7 306.4 412.0 585.8 213.4 923.4 369.5 351.9 613.2 314.0 HOMEZ KIAA1443 ENSG00000215271 "Homeobox and leucine zipper encoding" Q8IX15 14 23272422-23299447 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.4" "Group enriched" "Detected in all" 6 "Early spermatids: 309.7;Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036316, HPA036317" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nucleoli" "HPA036316: AB_2675056, HPA036317: AB_10669787" "unprognostic (3.70e-2)" "unprognostic (7.58e-2)" "unprognostic (6.36e-2)" "unprognostic (3.93e-2)" "unprognostic (9.11e-2)" "unprognostic (5.23e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "prognostic favorable (1.17e-11)" "unprognostic (2.62e-1)" "unprognostic (2.00e-1)" "prognostic favorable (1.75e-4)" "unprognostic (3.23e-1)" 6.1 4.9 4.6 4.7 6.2 1.5 6.7 5.9 5.8 6.5 4.0 6.7 7.3 5.3 8.0 9.8 7.0 5.2 7.8 4.8 5.5 9.4 6.2 6.1 4.6 6.8 5.5 9.9 7.8 8.8 3.6 5.7 6.3 6.5 6.2 6.0 7.0 9.6 9.0 7.7 5.0 7.2 4.9 5.6 7.8 34.4 6.7 9.4 7.3 14.9 7.9 10.9 5.7 6.4 7.0 7.2 13.0 12.3 19.8 8.7 14.8 7.2 9.4 6.8 8.7 3.3 14.6 15.2 6.1 7.1 16.0 23.3 17.3 18.0 8.5 8.4 6.6 5.2 6.0 14.1 25.8 7.6 4.4 13.5 17.7 5.4 11.8 15.1 13.1 17.0 15.6 6.0 11.8 16.1 5.9 5.2 5.3 21.3 4.1 9.2 9.7 6.7 12.5 28.5 4.2 5.2 6.9 19.3 7.8 19.7 12.0 8.9 14.6 4.7 2.1 5.9 3.3 25.1 11.3 5.0 2.5 5.5 7.2 2.9 5.0 7.3 3.5 4.5 2.8 2.6 3.0 2.9 4.8 2.3 3.2 3.9 0.8 2.4 3.4 2.9 4.1 2.9 4.6 6.2 5.9 5.8 4.8 5.5 6.8 5.5 6.3 4.9 6.7 6.4 3.7 6.4 7.0 4.6 5.6 2.8 18.4 19.9 9.1 5.8 7.0 5.7 6.9 12.8 14.4 23.9 6.2 6.9 4.6 6.8 13.7 11.0 309.7 4.4 4.2 5.7 3.6 5.0 1.9 10.9 6.6 5.2 13.7 6.9 3.8 8.2 5.3 6.9 8.7 10.1 2.0 9.2 8.2 6.1 5.1 78.9 6.8 5.8 3.6 6.5 15.1 6.9 5.2 3.0 6.8 9.1 5.5 7.5 6.1 16.3 8.6 19.8 12.9 3.7 6.6 4.7 4.7 15.2 5.3 10.1 5.1 9.3 4.2 3.8 7.9 29.1 HOXD9 "HOX4, HOX4C" ENSG00000128709 "Homeobox D9" P28356 2 176122719-176124937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 42.2;endometrium 1: 57.8;kidney: 52.1" "Cell type enhanced" "Detected in many" "Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 80 "spinal cord: 8.0" HPA068683 Supported Nucleoplasm,Nucleoli NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nucleoli" "HPA068683: AB_2686018" "unprognostic (1.89e-1)" "unprognostic (9.41e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.03e-2)" "prognostic favorable (9.58e-4)" "prognostic unfavorable (1.08e-5)" "unprognostic (6.62e-2)" "unprognostic (4.58e-2)" "unprognostic (1.54e-2)" "unprognostic (2.56e-3)" "unprognostic (6.71e-2)" "unprognostic (4.77e-3)" "unprognostic (8.38e-2)" "unprognostic (5.94e-2)" "unprognostic (1.89e-1)" "unprognostic (9.44e-2)" 11.6 6.4 0.0 1.3 0.0 0.0 13.9 0.0 0.0 42.2 0.0 29.3 0.1 57.8 14.8 3.5 16.1 0.9 0.2 0.0 0.0 52.1 0.1 0.7 2.4 0.5 0.0 11.1 0.3 0.3 0.0 0.5 0.1 32.3 2.9 0.0 1.2 8.0 1.6 5.8 3.0 15.2 0.5 2.4 0.5 5.6 0.1 0.5 1.4 0.2 0.8 6.1 35.3 0.8 0.1 0.0 0.0 0.0 0.5 0.4 0.2 1.6 1.1 1.3 1.1 0.0 0.0 0.0 11.3 1.6 0.8 7.6 0.1 0.0 0.9 0.0 16.1 0.0 0.8 0.0 0.1 0.0 0.0 3.6 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 19.0 7.1 4.3 21.7 5.5 0.0 13.2 1.1 0.0 0.0 16.9 0.0 3.6 5.3 6.0 0.0 0.0 0.0 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.1 0.8 38.4 0.0 0.0 0.0 0.4 2.4 1.9 0.0 0.0 0.0 0.8 0.5 0.7 0.0 0.0 23.9 0.0 0.0 1.0 8.5 37.2 0.0 0.2 0.8 10.9 39.2 7.8 0.0 0.0 0.0 0.2 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 3.0 1.3 34.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 26.7 0.0 1.1 0.0 3.0 0.0 0.0 39.5 1.9 3.3 2.2 1.4 0.1 1.8 0.0 1.1 13.9 3.8 0.8 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 378.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002134, CAB016293, HPA073514" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No "Cluster 9: Neutrophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: " "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 95.7 37.9 13.5 114.5 17.5 35.5 72.8 14.3 14.1 56.8 9.1 38.3 23.8 76.5 22.7 63.6 54.2 100.6 35.0 13.7 20.3 30.1 27.7 68.2 140.6 29.9 22.7 76.8 16.7 9.7 9.3 66.7 27.0 26.5 45.0 7.7 63.7 32.0 16.8 58.8 47.9 87.3 23.6 107.8 30.7 18.8 23.8 116.8 37.4 32.6 133.1 113.6 52.8 26.2 43.5 3.2 14.4 0.6 97.4 319.5 0.4 89.9 238.0 245.7 324.2 0.0 54.1 251.7 75.4 55.3 79.2 122.2 2.2 91.1 97.7 78.4 1.1 64.9 17.2 0.1 181.8 22.8 4.2 302.4 159.5 126.5 177.8 117.8 262.8 218.1 1.4 179.4 138.6 0.0 302.2 21.1 38.4 0.0 32.5 140.6 91.4 295.0 34.4 16.1 6.6 0.1 117.7 1.0 259.5 56.9 0.4 26.3 150.2 63.1 29.7 179.9 38.2 165.8 82.8 235.5 181.2 72.7 155.7 9.1 67.7 0.4 57.5 66.4 51.9 88.4 54.3 59.4 68.3 94.6 33.9 43.3 164.4 91.6 65.3 51.1 82.1 63.8 13.5 17.5 14.3 14.1 13.7 20.3 29.9 22.7 27.0 23.6 23.8 26.2 378.4 38.5 54.6 4.2 217.8 95.0 110.7 197.6 174.8 0.4 47.8 43.8 10.7 37.1 130.7 42.3 0.0 3.4 278.3 7.9 1.9 38.0 4.9 41.9 219.1 286.8 12.1 38.7 1.3 47.8 2.9 207.8 9.7 68.0 138.3 27.7 137.4 3.0 214.2 0.0 2.2 19.9 79.3 163.8 135.0 9.8 117.4 187.2 83.6 116.2 202.4 30.8 329.6 37.2 20.7 47.1 23.5 53.0 143.3 32.6 7.9 4.9 76.6 1.4 85.5 185.3 132.7 2.4 13.2 92.6 68.2 3.3 219.2 70.6 26.4 107.5 ILF3 "DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1600000 "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 49.2 58.5 31.6 79.4 31.5 179.5 49.8 44.2 37.5 60.8 38.5 56.0 52.0 64.5 40.9 60.4 61.1 31.9 49.0 31.4 37.9 43.1 32.1 50.5 82.9 30.6 32.8 76.5 52.6 55.5 53.8 47.8 29.7 52.4 44.8 69.5 54.0 48.8 83.6 58.7 56.1 49.8 29.4 61.7 47.8 78.9 35.4 97.3 61.6 58.2 72.3 56.1 52.1 42.8 285.9 226.7 359.5 330.9 76.5 104.0 208.9 178.1 149.6 291.8 226.5 261.8 160.8 353.2 172.1 160.8 178.0 248.9 392.5 240.7 260.9 227.2 349.5 459.3 206.9 247.5 109.2 334.8 219.5 99.0 105.0 232.1 257.4 111.1 253.1 201.7 400.0 269.4 172.3 233.8 558.1 534.0 433.3 149.2 246.2 405.2 342.2 244.2 116.3 297.1 395.1 286.7 229.0 179.4 131.6 161.6 152.2 212.0 205.2 237.6 224.2 249.3 356.5 228.9 339.7 431.4 132.8 351.6 262.2 20.2 18.1 10.2 24.4 14.1 20.6 19.3 20.2 22.3 22.8 22.9 19.5 20.2 2.7 21.3 21.2 25.1 20.6 11.8 31.6 31.5 44.2 37.5 31.4 37.9 30.6 32.8 29.7 29.4 35.4 42.8 63.6 99.3 133.9 34.3 106.2 86.2 110.0 64.2 104.7 95.4 77.5 64.3 69.7 60.1 98.8 42.3 85.5 90.0 100.0 78.4 27.4 89.0 21.2 89.8 105.7 77.4 114.0 124.3 24.4 80.4 111.1 94.8 101.9 121.4 96.8 145.9 36.8 47.9 71.4 94.2 34.0 85.6 50.8 55.0 68.3 21.0 76.4 75.8 39.2 24.4 66.0 69.2 92.7 31.7 28.9 88.2 55.6 62.4 124.9 144.6 38.8 47.2 82.9 103.6 32.9 100.3 80.1 137.2 120.6 113.8 77.0 70.9 103.5 140.8 111.7 94.9 INO80B "hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4" ENSG00000115274 "INO80 complex subunit B" Q9C086 2 74455087-74457944 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA070644, HPA078274" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Nucleoli, Nuclear bodies" "HPA070644: AB_2732159, HPA078274: " "prognostic favorable (2.89e-4)" "unprognostic (2.24e-2)" "unprognostic (5.62e-2)" "unprognostic (6.59e-3)" "unprognostic (9.45e-2)" "unprognostic (3.82e-2)" "unprognostic (2.20e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-2)" "unprognostic (7.52e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.56e-5)" "prognostic favorable (8.44e-4)" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (1.18e-3)" 26.3 30.5 18.9 18.0 20.7 20.6 29.1 17.2 27.6 38.1 15.7 24.1 19.4 30.4 17.1 31.1 31.5 15.1 20.1 19.6 17.5 27.4 32.1 25.9 18.9 18.4 17.1 48.1 41.9 19.6 42.0 11.6 19.2 34.7 12.3 18.7 29.9 17.9 30.1 40.8 23.9 14.8 14.2 24.5 32.7 31.0 16.7 12.8 39.3 9.1 20.1 27.1 32.2 20.9 27.8 29.0 11.0 14.2 21.0 29.6 28.2 25.7 23.0 19.4 16.3 19.9 34.4 46.7 32.2 18.8 18.2 29.1 9.1 20.4 15.8 42.5 28.8 35.9 14.5 20.5 22.4 33.9 17.2 29.5 35.0 27.8 31.2 48.4 26.2 27.4 20.7 18.5 16.5 32.7 44.3 47.7 7.7 20.2 39.7 26.3 34.9 47.4 23.5 18.9 16.7 31.8 13.5 37.3 15.4 12.1 16.1 11.6 22.1 17.7 27.9 29.7 20.0 65.8 48.4 16.9 33.3 21.3 18.9 3.2 2.5 1.0 1.2 1.9 1.6 2.6 1.4 0.7 1.6 2.1 1.2 1.1 3.2 2.1 1.7 3.2 2.2 0.9 18.9 20.7 17.2 27.6 19.6 17.5 18.4 17.1 19.2 14.2 16.7 20.9 4.4 0.0 2.2 0.0 5.4 28.0 2.8 8.5 2.2 14.0 11.3 6.0 0.9 4.3 6.8 3.7 12.5 4.3 7.1 5.8 0.0 15.9 3.0 6.5 5.7 5.4 4.8 9.3 0.0 27.0 4.7 3.4 2.6 3.8 5.7 2.4 6.8 10.8 5.6 13.5 0.0 7.9 12.2 9.7 21.0 6.5 3.1 4.3 5.4 0.0 12.5 4.7 9.2 0.0 0.0 17.4 3.3 3.0 5.1 2.2 11.6 6.5 12.3 15.0 0.0 2.1 4.9 5.6 1.9 3.3 31.7 5.3 7.5 2.2 6.7 2.0 IQSEC1 "ARF-GEP100, BRAG2, GEP100, KIAA0763" ENSG00000144711 "IQ motif and Sec7 domain ArfGEF 1" Q6DN90 3 12897043-13283281 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 183.0;Cone photoreceptor cells: 193.9;Excitatory neurons: 191.3;Horizontal cells: 235.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 66.5;U-266/84: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038143, HPA038144" Uncertain Supported "Nucleoli,Nucleoli rim,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Nucleoli rim, Vesicles" "HPA038143: AB_10697241, HPA038144: AB_2675860" "prognostic unfavorable (3.03e-5)" "unprognostic (1.80e-1)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (8.19e-3)" "unprognostic (2.64e-3)" "unprognostic (5.60e-2)" "unprognostic (1.67e-1)" "unprognostic (3.00e-1)" "unprognostic (1.14e-2)" "prognostic favorable (9.07e-4)" "unprognostic (4.42e-1)" "prognostic favorable (3.58e-6)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.00e-3)" "unprognostic (4.65e-2)" 26.8 38.7 37.0 19.3 49.4 54.9 19.7 13.9 85.6 20.5 0.0 19.6 7.0 19.6 7.4 9.2 19.5 11.0 35.3 42.7 19.9 16.8 30.9 28.4 24.6 48.1 14.2 21.1 19.3 30.9 18.5 19.0 50.6 22.4 7.1 56.3 15.3 13.7 34.4 12.8 22.3 12.3 4.3 46.6 17.7 10.8 17.6 14.0 16.1 27.0 16.4 19.6 15.3 55.1 10.2 13.3 11.4 12.5 9.6 12.8 66.5 10.8 9.1 7.2 5.5 9.1 8.1 21.2 12.0 20.1 7.9 5.8 9.0 5.7 5.3 14.1 19.0 12.6 8.0 38.0 10.3 0.2 5.1 13.0 10.6 14.7 8.3 9.6 6.7 8.6 36.0 20.6 5.1 31.6 8.2 13.1 12.3 7.6 26.4 11.3 3.9 29.6 4.4 12.8 9.5 18.2 7.4 27.5 6.5 10.4 11.6 8.6 17.5 7.5 19.2 6.4 1.5 43.6 64.7 8.1 14.2 6.0 6.1 4.5 2.7 3.9 2.5 2.9 1.9 5.0 1.7 1.9 1.4 4.3 1.7 2.0 8.3 1.3 2.8 4.9 1.3 2.1 37.0 49.4 13.9 85.6 42.7 19.9 48.1 14.2 50.6 4.3 17.6 55.1 29.1 3.2 17.9 59.7 45.6 11.5 7.9 7.8 12.0 110.1 16.1 15.9 183.0 21.5 10.7 3.7 193.9 9.9 48.5 3.4 7.9 6.8 2.9 7.3 13.2 29.8 10.2 46.3 191.3 12.9 42.2 22.8 8.2 5.0 15.2 21.6 24.7 42.7 22.0 235.6 128.4 13.3 4.1 60.4 42.4 4.8 16.8 34.2 7.2 78.7 36.3 16.6 45.3 67.3 78.8 7.8 3.8 22.6 23.3 19.0 3.0 5.8 29.1 123.1 26.3 24.9 30.6 2.2 1.7 3.5 7.7 21.8 24.8 45.2 8.5 13.2 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051994 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Supported "Nucleoli,Nuclear speckles,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: AB_2684973, HPA065052: AB_2685414" "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 14.4 7.1 8.6 15.4 12.7 38.2 12.3 20.1 10.5 13.7 9.7 10.2 9.6 15.6 8.6 13.4 12.0 11.2 9.1 9.1 12.8 9.1 10.0 16.7 16.8 12.7 12.4 21.5 11.7 18.0 6.7 14.9 12.9 11.0 10.6 18.1 9.6 9.7 13.1 16.6 12.1 13.5 8.2 15.7 11.3 11.4 10.1 27.0 14.2 16.0 17.2 12.0 10.7 16.7 19.6 23.2 34.8 21.8 17.8 20.3 9.8 15.4 20.6 17.9 14.2 16.3 11.5 33.4 13.4 19.0 19.5 17.3 27.3 18.6 23.2 16.1 14.4 60.4 14.2 10.3 14.8 27.3 23.6 17.1 19.1 20.4 24.8 14.5 18.8 29.7 36.6 24.2 16.0 10.4 59.9 9.4 12.8 20.4 8.1 37.7 39.1 9.9 11.0 27.1 17.6 16.7 15.8 12.4 13.8 15.8 26.3 12.9 25.5 21.6 15.3 21.1 15.5 16.8 22.1 33.8 12.6 14.1 17.3 2.5 0.8 1.8 1.6 0.9 1.6 1.4 1.6 2.1 0.6 1.6 1.9 1.8 5.1 1.9 0.9 1.1 1.9 1.2 8.6 12.7 20.1 10.5 9.1 12.8 12.7 12.4 12.9 8.2 10.1 16.7 87.5 35.3 34.9 64.0 54.0 50.3 24.2 15.5 18.2 54.8 31.7 25.5 23.7 18.6 25.3 12.9 54.2 14.4 61.5 23.2 3.9 14.2 2.6 30.3 47.5 56.7 24.7 31.2 62.8 11.8 17.0 32.4 21.4 44.8 35.4 31.9 43.5 25.3 17.0 58.9 76.6 24.9 10.2 44.2 34.5 4.8 28.3 43.7 23.2 120.9 30.3 27.9 61.8 93.5 129.2 15.7 20.2 23.0 38.7 30.7 22.9 10.6 22.8 44.9 19.7 49.3 34.6 37.8 37.0 23.0 61.2 21.1 61.4 19.7 19.3 27.2 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859158-87863533 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.5" "Cell type enhanced" "Detected in many" "granulocytes: 5.7;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 5.0;Karpas-707: 5.1" HPA074502 Supported Nucleoplasm,Nucleoli No No "Cluster 42: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA074502: AB_2686695" "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.0 0.7 1.0 0.6 0.7 0.5 0.6 1.5 1.6 0.7 0.6 0.9 0.4 0.5 1.0 0.4 1.4 0.4 0.5 0.7 0.9 0.9 0.9 0.4 0.8 0.5 0.6 0.4 0.2 0.5 0.5 0.6 0.6 0.4 0.8 1.0 0.3 0.5 4.5 0.4 0.4 0.5 0.3 0.8 0.6 1.0 0.6 1.0 0.7 0.5 0.8 0.3 0.3 1.5 0.8 1.0 1.1 0.7 0.5 0.3 0.8 0.7 0.9 0.5 0.7 0.6 2.6 2.0 0.3 0.2 0.5 0.9 0.7 0.8 0.4 0.5 0.3 0.7 1.5 0.6 0.6 1.4 0.5 0.6 0.8 0.7 0.8 0.9 0.3 5.0 0.4 5.1 0.5 1.8 4.1 1.6 0.4 0.6 0.5 2.6 0.1 2.6 0.4 0.8 0.4 1.0 0.9 0.6 0.1 0.7 1.6 1.2 0.3 0.5 0.3 0.9 0.3 2.9 3.3 2.9 0.9 2.9 0.6 1.6 0.3 0.6 0.2 0.5 0.4 0.4 0.3 0.3 0.3 0.5 0.4 0.3 2.5 0.6 0.8 0.5 0.2 0.2 1.0 0.7 1.5 1.6 0.7 0.9 0.5 0.6 0.6 0.3 0.6 1.5 0.6 0.0 0.0 0.3 0.5 0.1 0.3 0.2 0.6 1.7 1.0 1.3 2.7 1.5 1.3 0.0 0.0 0.7 2.0 3.0 0.0 0.2 3.9 0.8 0.9 0.6 0.0 0.8 0.4 0.2 0.4 1.1 3.6 0.4 5.7 0.3 0.7 0.4 0.3 3.3 0.5 1.8 0.0 1.3 0.0 2.0 0.0 0.6 0.0 0.0 0.3 1.6 0.0 0.0 0.1 0.3 2.5 0.0 0.2 0.3 1.8 1.9 2.3 1.0 6.6 1.1 2.9 0.3 1.2 0.6 0.4 0.5 0.7 0.3 1.3 0.2 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL histone methyl-lysine binding protein 3" Q96JM7 6 130013699-130141449 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 63.5;HUVEC TERT2: 62.5;TIME: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 34: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044382: AB_2678920, HPA053035: AB_2682021" "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 4.5 11.0 3.3 9.9 3.3 7.7 4.7 1.7 3.6 9.5 9.6 4.6 2.8 11.2 11.7 2.3 5.5 5.3 2.4 4.1 3.8 4.8 5.8 4.0 11.1 2.5 3.1 10.1 2.3 5.6 5.5 5.7 2.4 7.0 5.0 2.1 4.9 6.2 2.5 2.7 5.1 8.3 2.5 12.6 3.3 7.6 4.5 7.7 6.0 2.1 8.9 5.7 5.3 2.6 1.7 6.5 15.2 2.4 10.4 13.4 3.1 7.8 15.9 3.0 5.5 8.0 8.1 2.7 11.0 9.9 9.3 6.5 8.7 13.6 4.6 6.1 8.8 18.3 3.2 2.0 5.2 10.8 63.5 8.8 9.6 3.6 10.2 15.1 62.5 8.3 13.3 7.1 7.7 0.7 23.2 1.9 7.0 1.7 3.3 8.7 4.2 0.0 9.8 2.5 0.5 2.0 2.9 0.7 6.1 18.2 16.4 9.3 43.0 5.1 6.9 0.9 5.3 1.4 0.1 4.7 2.5 4.5 5.2 8.2 4.9 4.8 3.7 5.5 3.2 10.7 3.5 4.7 1.9 13.4 3.2 4.1 4.9 2.1 22.7 14.8 5.9 1.0 3.3 3.3 1.7 3.6 4.1 3.8 2.5 3.1 2.4 2.5 4.5 2.6 9.1 3.2 6.5 6.5 20.5 5.1 5.1 2.4 10.2 4.2 5.3 2.8 3.9 1.5 3.8 9.2 2.1 13.4 20.7 2.8 1.9 5.6 24.2 6.1 12.8 9.4 3.6 5.0 20.8 5.4 7.1 7.3 4.6 16.1 40.4 24.7 8.9 6.3 4.0 0.0 10.5 9.3 6.1 8.2 4.0 3.1 9.6 9.5 1.8 11.2 12.9 5.3 13.4 15.6 8.5 10.9 5.2 6.0 5.2 4.7 0.5 5.9 4.1 0.7 6.6 11.2 8.6 5.8 7.6 4.0 4.4 6.2 15.6 9.5 5.0 5.5 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898678 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 13 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 13 "NK-cells: 2.0" "Cell line enhanced" "Detected in many" "AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" No NA "Cluster 22: NK-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: AB_2686012" "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 58.9 15.5 13.7 8.0 19.8 0.4 52.2 3.3 45.9 43.5 7.6 12.7 6.5 65.5 23.4 15.8 28.0 31.2 33.7 23.3 7.3 28.0 26.0 58.2 11.5 4.4 10.9 18.2 7.6 17.0 9.0 58.8 4.7 18.0 8.5 5.3 10.8 13.7 14.0 9.4 12.8 53.8 7.1 50.4 11.5 5.0 7.9 8.3 31.3 24.3 4.8 22.5 22.8 19.7 0.0 0.0 18.3 0.1 10.5 16.9 0.0 10.2 8.0 1.2 2.7 0.0 0.0 0.0 0.0 19.0 0.0 0.0 34.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 9.5 0.0 12.5 0.0 2.7 65.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.7 0.0 0.1 8.8 0.0 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.0 4.9 0.0 0.0 17.1 25.7 0.1 1.2 0.0 8.3 0.1 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.2 13.7 19.8 3.3 45.9 23.3 7.3 4.4 10.9 4.7 7.1 7.9 19.7 236.5 0.0 5.5 44.7 1.5 8.7 0.3 0.0 2.8 27.1 1.7 2.2 8.7 2.8 0.0 0.0 0.0 0.2 6.8 0.0 0.0 4.4 1.3 1.4 36.5 194.4 0.0 8.0 1314.4 0.2 0.2 44.4 4.1 1.1 5.7 0.1 364.8 3.1 0.4 0.0 196.5 0.0 0.0 16.4 13.2 2.6 38.2 1.4 8.8 117.1 0.0 10.4 3.1 120.6 36.7 0.2 0.0 50.4 0.0 0.3 0.0 0.1 0.7 2.1 6.6 2.8 19.3 0.2 0.7 1.3 6.8 0.1 4.9 39.7 0.0 0.5 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1 regulator of NFKB signaling" O95751 X 141111605-141177129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 123.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Proximal tubular cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9" "Region enriched" "Detected in many" 5 "cerebellum: 19.2" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 32.3 34.0 4.7 0.9 5.5 0.1 28.0 2.9 8.5 45.8 0.2 18.8 0.9 53.9 1.8 21.4 48.5 1.6 15.1 6.2 5.8 33.2 4.8 19.6 0.8 5.3 5.0 46.8 19.3 10.5 123.3 0.0 5.0 34.3 0.3 3.4 55.1 5.9 5.5 31.5 12.5 2.0 1.2 14.2 18.4 10.8 5.0 0.9 53.7 0.4 0.7 33.1 30.6 6.0 0.0 24.7 3.0 8.4 5.0 6.2 0.0 5.0 5.8 6.3 8.8 0.0 8.0 0.0 4.2 7.7 6.1 10.4 3.4 7.1 4.5 0.0 6.6 0.0 11.7 0.0 2.0 0.0 1.9 10.9 3.6 5.5 2.9 5.1 5.7 0.0 0.1 0.0 5.7 31.9 0.0 0.0 3.3 0.0 34.3 0.0 2.7 0.0 7.7 4.7 0.0 3.2 0.0 4.0 0.0 1.6 5.1 0.0 11.9 0.0 6.8 0.0 21.9 0.0 0.0 0.0 3.5 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.8 0.9 2.5 0.8 0.2 2.1 2.2 1.4 0.0 6.4 0.0 1.4 2.6 1.0 4.7 5.5 2.9 8.5 6.2 5.8 5.3 5.0 5.0 1.2 5.0 6.0 8.6 0.0 5.3 4.2 4.9 6.0 16.8 4.6 16.5 29.3 23.8 20.2 2.2 30.0 8.2 23.9 8.4 2.8 5.7 0.1 43.0 13.8 0.7 7.8 13.5 12.8 5.4 0.8 9.4 14.0 1.8 16.1 3.6 6.0 2.5 8.8 12.8 0.1 0.9 20.2 9.9 0.4 8.2 0.3 1.8 1.1 22.1 1.0 3.6 7.5 0.3 21.2 5.2 7.1 15.0 13.7 0.2 38.7 0.9 11.9 0.0 43.8 4.6 13.0 13.1 15.3 26.2 0.9 7.6 16.7 6.8 1.5 5.2 13.5 0.3 15.0 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "placenta: 65.4" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 75.4;Early spermatids: 27.5;Excitatory neurons: 40.2;Extravillous trophoblasts: 83.0;Late spermatids: 25.2;Syncytiotrophoblasts: 55.8" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 49.1;BEWO: 252.1;Hep G2: 44.0;K-562: 86.9;NTERA-2: 44.8;SuSa: 44.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 0.4 0.0 0.8 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.3 65.4 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 4.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 3.2 49.1 10.0 0.0 0.0 252.1 0.1 0.0 0.0 0.0 16.6 0.1 0.1 0.0 0.1 3.0 0.1 31.2 0.0 0.0 0.0 24.1 36.6 0.0 44.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 86.9 1.2 0.0 0.0 5.6 6.2 44.8 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.1 11.6 0.1 0.3 4.0 44.5 0.0 10.6 1.0 0.1 5.3 0.2 0.1 14.8 22.6 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.8 0.0 1.3 0.6 0.7 0.4 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 6.2 75.4 0.0 0.0 0.0 0.0 27.5 0.0 0.0 8.3 0.0 0.0 40.2 0.0 83.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 9.7 1.7 5.7 0.0 0.0 0.0 0.0 25.2 0.3 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 6.6 0.0 0.0 6.3 9.9 0.0 0.0 55.8 0.0 0.0 0.0 0.0 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 101.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 204.6;Respiratory ciliated cells: 244.2;Rod photoreceptor cells: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli, Nucleoli rim" "HPA037766: AB_10672609, HPA057533: AB_2683459" "prognostic favorable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 2.5 3.2 11.3 1.1 11.4 2.5 3.6 11.1 11.2 5.2 20.5 3.4 0.9 5.0 12.5 1.8 101.8 3.0 4.7 11.3 12.4 6.2 2.5 8.9 1.8 18.6 22.4 4.8 2.1 6.7 7.4 2.2 16.9 3.6 2.1 25.1 2.8 3.7 6.3 2.4 2.0 3.6 16.6 2.4 3.4 26.3 12.6 3.1 6.2 5.8 2.7 2.9 2.6 13.2 5.2 9.9 1.6 3.6 7.2 5.4 5.8 2.0 7.0 3.3 6.3 2.1 10.4 4.5 2.2 5.4 9.6 1.3 2.9 4.3 7.1 3.6 1.5 3.2 3.7 4.1 5.8 1.8 3.0 3.8 7.8 6.4 5.7 8.6 4.6 11.0 1.9 2.5 3.9 5.9 4.0 1.2 1.0 7.7 2.8 3.7 8.1 5.3 6.6 1.5 2.6 6.3 3.2 4.3 6.6 10.2 2.2 4.1 2.0 3.3 8.6 3.8 2.3 2.3 1.6 3.8 8.1 2.3 4.8 0.6 2.7 6.4 2.2 2.6 3.0 5.7 2.2 1.9 2.6 2.8 2.4 2.4 0.5 4.0 2.6 3.9 0.1 1.3 11.3 11.4 11.1 11.2 11.3 12.4 18.6 22.4 16.9 16.6 12.6 13.2 12.6 0.0 22.4 11.4 12.6 6.5 10.0 15.1 11.4 17.8 15.3 19.3 8.2 20.0 34.4 12.9 50.1 8.2 9.4 5.2 37.2 13.6 43.4 204.6 13.1 9.7 18.0 7.4 5.8 17.3 12.5 12.6 10.7 12.9 5.7 12.1 14.6 7.5 13.5 13.5 4.4 8.6 16.2 11.9 8.9 47.0 8.4 13.7 8.8 6.5 11.0 38.6 11.3 1.5 6.4 15.3 4.7 12.4 10.5 6.4 4.5 46.5 244.2 138.1 13.1 21.1 13.5 63.6 13.1 8.4 5.8 4.5 11.8 7.1 5.6 7.3 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464956-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "testis: 275.2" "Group enriched" "Detected in many" 4 "Early spermatids: 1002.6;Spermatocytes: 677.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim" "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 8.2 16.8 10.7 6.8 10.7 14.9 7.9 11.4 13.1 10.4 10.7 8.9 5.3 10.0 2.3 7.7 13.8 3.9 9.7 13.0 11.5 11.4 15.0 10.1 8.1 12.1 14.4 9.4 9.3 8.7 17.6 3.1 12.2 8.6 2.3 3.4 7.6 6.1 13.2 6.7 17.1 4.2 10.8 24.3 9.0 275.2 12.1 8.7 10.0 5.3 7.3 8.9 7.3 10.2 18.6 24.6 13.0 36.8 9.4 7.2 21.0 19.6 11.9 30.5 20.9 23.7 10.3 44.8 27.5 13.9 36.3 19.2 18.7 16.4 9.0 16.6 39.2 10.0 11.1 14.8 12.7 17.6 17.4 6.7 9.9 35.4 7.5 10.2 16.2 33.9 44.5 13.3 16.8 54.3 53.4 42.1 28.7 22.0 37.8 28.2 12.2 48.5 9.2 11.3 17.7 50.7 21.0 20.1 19.3 14.6 11.2 14.4 11.1 17.3 37.7 54.8 30.8 50.5 94.3 43.6 19.3 17.1 31.4 10.6 2.6 9.9 9.7 4.0 9.0 10.0 8.4 8.4 2.7 11.8 5.2 6.9 5.5 10.5 3.8 9.7 9.3 6.0 10.7 10.7 11.4 13.1 13.0 11.5 12.1 14.4 12.2 10.8 12.1 10.2 9.1 0.0 1.1 5.5 10.6 10.5 6.4 16.5 3.4 11.7 5.5 5.0 0.8 2.8 12.8 12.9 2.1 9.2 10.8 8.6 7.9 12.3 1002.6 54.4 7.3 6.5 7.8 13.7 4.7 10.5 12.4 7.0 10.7 13.7 0.0 14.8 5.7 7.2 8.8 5.0 5.0 9.8 18.3 3.4 4.0 172.3 19.0 5.0 5.4 2.8 7.2 7.9 10.3 4.5 2.8 12.4 11.2 15.8 20.2 3.9 8.6 15.9 65.3 11.4 0.0 5.4 13.6 677.0 38.3 4.5 9.8 6.2 9.3 22.2 7.5 3.4 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "Mono-ADP ribosylhydrolase 2" A1Z1Q3 20 13995369-16053197 "Metabolic proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4" "Group enriched" "Detected in many" 5 "B-cells: 13.2;granulocytes: 3.4" "Cell line enhanced" "Detected in many" "EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 1.9 3.1 3.9 2.2 8.4 1.2 2.8 2.3 4.7 3.1 0.1 1.3 0.7 5.0 2.3 1.4 7.3 2.8 1.1 4.8 2.8 3.9 1.8 10.9 4.0 3.3 3.6 2.9 2.9 2.5 2.2 1.1 3.7 4.7 1.3 4.9 1.3 9.9 1.5 2.7 0.9 4.0 2.1 5.0 2.3 5.1 7.3 1.8 2.6 0.6 5.3 4.5 1.2 4.3 1.0 0.4 3.0 1.2 0.8 0.7 0.5 0.3 2.1 1.2 0.7 0.4 0.7 2.0 15.5 1.4 2.6 1.5 0.3 0.7 1.9 1.0 0.9 1.2 1.2 2.4 3.4 0.3 0.3 1.9 1.3 0.0 0.5 1.1 1.1 0.2 1.4 19.1 3.1 0.5 0.5 0.8 0.9 7.1 0.6 1.2 0.5 4.0 2.2 8.4 10.6 1.9 1.6 0.2 0.6 1.1 1.0 1.8 0.7 1.4 3.2 0.3 0.0 0.7 0.3 2.1 0.9 1.0 1.7 0.1 0.5 0.5 0.2 1.2 0.2 8.9 0.2 0.2 0.4 13.2 0.2 0.3 3.4 0.1 1.6 0.2 0.0 0.5 3.9 8.4 2.3 4.7 4.8 2.8 3.3 3.6 3.7 2.1 7.3 4.3 1.6 51.3 203.8 349.7 18.3 4.5 49.8 1.4 5.2 94.0 7.6 6.9 5.9 11.5 37.5 12.9 39.6 7.1 0.1 1.8 9.8 11.9 35.4 8.6 2.5 3.0 1.2 0.4 752.7 1.6 0.4 4.6 9.2 6.7 1.3 7.6 7.1 4.8 0.9 8.4 1058.5 4.5 0.0 0.3 2.1 62.2 3.4 0.9 3.6 87.1 0.0 10.2 0.0 672.0 301.4 6.6 1.7 17.7 2.8 6.2 2.4 8.6 9.8 20.3 6.6 2.1 6.0 23.7 18.8 5.8 6.7 2.1 0.9 13.2 2.8 5.4 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640941 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 21: OE19 - Mitochondria" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: AB_2672752" "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 13.3 16.2 13.6 14.1 13.8 53.5 17.3 14.1 15.8 14.6 15.4 25.9 23.6 12.4 17.3 17.6 16.7 14.4 25.4 14.3 14.9 17.5 21.9 14.9 21.7 13.8 13.2 13.0 16.7 21.1 12.6 14.0 14.2 14.4 27.7 15.2 22.8 13.5 28.5 13.2 18.8 14.5 13.6 17.4 19.3 20.4 14.3 29.3 15.6 44.6 26.6 21.4 10.6 13.8 53.9 24.4 37.7 42.2 32.1 34.7 22.7 31.7 50.9 68.5 63.8 50.3 21.4 41.6 17.6 37.3 62.2 34.4 59.2 43.9 52.6 38.5 46.0 51.5 26.1 43.8 34.6 30.6 29.9 35.3 53.0 51.1 31.0 34.5 52.2 32.8 67.2 21.8 48.4 50.6 27.4 56.5 23.3 221.1 31.3 31.3 29.3 39.4 48.9 42.5 44.7 45.3 22.8 34.5 152.2 28.6 40.6 80.3 28.7 36.5 30.7 24.4 51.3 27.7 25.8 99.0 33.2 51.3 41.0 105.4 41.4 49.4 46.3 42.8 46.5 52.6 54.7 51.4 52.7 47.9 56.5 51.2 35.2 55.6 41.3 34.9 78.9 43.6 13.6 13.8 14.1 15.8 14.3 14.9 13.8 13.2 14.2 13.6 14.3 13.8 11.6 25.6 12.7 3.3 18.2 14.4 20.5 44.9 17.6 12.8 11.6 9.3 10.8 15.7 32.5 3.7 12.5 21.1 11.1 30.7 27.4 28.0 47.0 13.2 8.6 12.5 17.4 20.6 3.0 21.2 21.5 12.0 14.3 10.8 31.6 7.8 11.4 12.7 17.6 10.1 3.2 17.1 32.6 10.4 8.6 36.5 12.2 19.6 28.4 1.9 17.3 13.9 11.3 3.0 5.0 24.7 29.5 12.0 11.1 11.5 28.2 21.2 21.1 15.1 26.3 8.3 13.4 26.4 18.3 12.6 9.7 6.2 14.8 11.9 23.4 27.2 MAD2L2 "FANCV, MAD2B, POLZ2, REV7" ENSG00000116670 "Mitotic arrest deficient 2 like 2" Q9UI95 1 11674480-11691650 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.1;Late spermatids: 522.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008110, HPA024176, HPA024612" Approved Supported Nucleoli,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Nucleoli "CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (2.43e-1)" "unprognostic (3.27e-1)" "unprognostic (2.41e-1)" "unprognostic (6.84e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.60e-2)" "unprognostic (1.24e-1)" "unprognostic (9.09e-3)" "unprognostic (1.54e-1)" "unprognostic (9.27e-2)" "unprognostic (8.43e-2)" "unprognostic (2.36e-1)" 25.6 19.5 30.3 22.2 32.0 59.8 25.2 33.2 35.9 23.5 27.6 24.6 11.6 19.3 15.0 14.6 20.4 13.4 26.5 30.2 33.1 37.7 49.8 29.6 27.7 34.9 30.2 21.7 39.9 13.3 22.7 10.6 31.7 22.3 7.5 5.0 28.6 11.2 49.3 23.5 17.1 15.5 31.6 25.2 28.8 64.3 35.3 55.1 15.4 31.5 26.1 23.1 17.8 35.9 62.8 57.2 90.8 106.8 28.6 55.1 37.3 56.5 64.8 110.4 97.8 75.2 59.2 87.6 67.6 58.1 64.4 27.4 115.1 60.1 60.5 133.3 129.6 40.1 87.5 93.4 50.2 80.5 62.7 36.1 60.7 81.0 68.9 41.6 51.4 116.7 165.6 138.3 55.5 94.6 365.6 381.3 235.1 25.9 91.2 245.6 100.2 109.6 40.8 13.5 167.8 118.1 93.6 36.5 168.1 61.2 52.6 172.1 26.8 90.7 114.1 85.6 81.8 109.5 82.0 233.7 67.2 281.5 71.8 45.3 85.2 42.8 82.1 97.3 66.8 58.5 55.4 64.8 100.8 43.8 37.0 54.9 36.7 43.3 86.8 139.1 69.9 92.0 30.3 32.0 33.2 35.9 30.2 33.1 34.9 30.2 31.7 31.6 35.3 35.9 24.8 0.0 5.0 4.2 26.1 38.6 26.5 35.7 18.8 5.7 26.9 26.9 15.9 11.5 14.1 14.7 4.2 18.2 49.6 3.7 50.9 40.8 148.1 8.4 21.6 28.2 34.0 69.5 1.7 76.6 50.7 30.6 12.2 11.4 14.0 17.3 29.6 59.1 41.7 11.8 2.3 10.6 54.9 36.4 88.1 522.5 31.1 32.5 48.0 1.9 82.6 10.8 53.5 4.0 5.5 40.7 4.5 17.0 42.9 35.8 4.5 29.6 6.0 3.5 39.5 25.1 26.5 76.0 40.6 14.3 34.7 8.3 37.7 18.8 8.6 17.6 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452127-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "epididymis: 515.9" "Cell type enhanced" "Detected in many" "Peritubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011324, HPA011971" Uncertain Supported "Nucleoli,Nucleoli rim" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Nucleoli, Nucleoli rim" "HPA011324: AB_1853499, HPA011971: " "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favorable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 20.2 29.9 46.8 17.6 48.2 5.1 18.4 40.9 59.3 29.6 59.4 21.0 10.2 30.9 515.9 10.0 45.3 18.1 24.1 47.1 60.0 25.5 19.6 23.5 22.7 41.9 47.7 36.3 28.1 25.5 54.1 20.9 45.7 48.8 11.5 22.0 18.6 44.3 12.9 11.3 17.1 27.3 45.5 20.4 25.3 33.8 50.3 32.0 28.6 16.9 17.0 17.9 16.7 48.8 0.1 5.7 32.6 0.0 51.5 31.0 0.4 36.0 32.9 9.7 26.0 0.1 7.4 0.0 48.2 36.4 18.4 4.9 12.5 13.5 15.2 42.5 2.0 11.4 0.0 4.6 17.0 0.6 14.1 25.8 1.2 5.6 4.1 9.1 15.0 12.0 6.5 43.8 10.8 22.0 30.8 9.8 9.3 0.0 6.8 19.1 4.1 24.0 17.9 0.0 0.2 24.5 0.0 9.5 15.5 24.4 4.7 8.5 17.7 13.3 15.4 8.2 1.9 25.9 35.1 4.9 24.8 15.8 17.2 14.0 9.0 20.5 21.5 14.3 19.4 18.9 35.4 24.6 13.7 17.9 48.2 30.5 1.2 18.9 18.5 28.5 52.1 19.0 46.8 48.2 40.9 59.3 47.1 60.0 41.9 47.7 45.7 45.5 50.3 48.8 24.9 6.4 14.4 4.9 18.3 8.0 7.8 20.0 5.2 36.7 8.0 14.1 10.4 18.6 12.5 12.9 10.4 2.8 15.7 1.9 13.7 32.2 1.6 2.8 33.5 29.0 15.8 3.0 14.2 10.7 2.0 42.9 3.1 1.9 12.7 11.1 32.9 14.0 15.0 37.0 17.5 8.4 4.1 3.8 11.2 4.0 47.2 6.2 21.4 6.5 9.3 56.8 23.7 18.6 28.4 4.7 8.8 63.9 39.8 13.7 0.8 20.1 6.7 19.6 26.3 44.5 35.0 1.4 2.7 3.3 6.3 1.6 19.9 19.7 4.6 4.8 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33485182-33501262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Vesicles" "HPA044417: AB_2678935, HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 9.9 6.2 4.7 9.3 4.8 9.2 8.9 5.1 5.7 6.6 4.1 5.7 5.4 7.2 5.1 8.0 5.9 6.5 7.0 4.5 6.4 7.2 9.0 5.6 11.1 5.3 6.3 7.5 9.3 5.9 4.5 7.8 5.8 6.1 6.5 4.0 5.6 5.6 8.4 7.4 5.0 7.7 5.3 6.5 5.4 5.6 5.5 8.8 8.5 8.0 10.8 12.2 5.1 6.0 14.1 19.3 13.2 30.6 15.2 18.1 19.9 25.0 16.2 26.4 24.6 28.5 12.0 49.7 23.8 22.1 22.5 18.3 45.6 27.8 35.0 10.8 12.3 46.9 13.2 25.6 22.9 19.3 27.4 19.1 24.8 34.8 40.4 9.4 19.6 33.5 59.5 27.5 22.0 16.1 68.9 22.4 71.4 34.4 13.2 23.9 20.1 22.2 22.2 23.7 33.6 26.7 15.5 21.1 30.4 16.2 14.7 19.5 17.8 24.9 19.3 32.6 28.9 13.8 16.4 50.4 15.3 39.7 27.0 0.0 2.4 0.6 3.2 5.0 3.6 2.0 3.2 2.8 2.9 2.5 4.0 4.3 0.4 4.4 7.9 3.0 2.6 2.3 4.7 4.8 5.1 5.7 4.5 6.4 5.3 6.3 5.8 5.3 5.5 6.0 12.8 16.0 9.7 3.6 12.8 15.6 15.2 5.6 13.1 5.1 7.9 9.0 12.9 10.0 11.3 9.2 2.1 11.5 7.8 3.9 7.9 10.6 1.8 9.8 19.8 12.7 1.8 15.8 5.8 7.8 15.8 15.8 8.2 10.5 9.5 10.8 5.3 7.3 8.7 10.1 6.0 6.7 6.1 5.3 4.7 1.3 9.0 7.8 1.8 2.8 7.7 2.9 10.3 7.1 4.7 11.5 5.0 7.5 12.1 15.3 4.1 10.2 10.5 5.1 6.6 17.6 14.4 13.8 19.2 12.7 14.9 7.5 9.9 13.8 7.4 12.3 MAPKBP1 "KIAA0596, NPHP20" ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Cluster 46: Basophils - DNA binding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 6.2 10.5 10.9 4.6 12.4 4.4 7.7 31.1 13.7 11.1 10.1 10.2 9.6 9.9 4.5 18.6 10.4 4.6 6.4 9.9 8.5 7.1 4.1 6.0 3.9 9.0 8.0 15.1 5.5 4.2 12.7 5.4 9.0 8.9 3.6 9.0 7.5 5.9 5.1 24.2 9.9 9.0 5.3 8.0 9.3 34.4 9.1 6.3 13.4 3.7 6.8 12.2 12.0 10.2 7.4 3.8 10.0 9.5 10.9 10.8 6.9 10.1 25.5 9.1 6.6 7.6 2.7 1.8 8.1 8.3 12.5 17.2 9.8 28.5 6.5 6.7 2.7 7.3 12.8 2.6 4.7 4.7 14.5 5.6 22.3 14.3 25.9 14.8 13.4 11.9 4.6 3.4 12.9 1.5 4.0 4.2 1.1 4.3 7.6 4.3 7.2 0.7 5.3 8.1 11.3 6.3 5.7 5.9 4.5 10.2 7.1 3.7 10.6 13.0 6.2 12.4 10.0 7.3 12.7 4.3 8.7 6.3 11.0 1.1 0.4 0.3 0.8 0.1 0.6 0.4 0.4 0.3 0.5 0.4 0.6 0.5 0.1 0.6 0.5 0.1 0.2 0.5 10.9 12.4 31.1 13.7 9.9 8.5 9.0 8.0 9.0 5.3 9.1 10.2 7.1 6.4 10.3 33.0 3.5 54.7 10.0 8.6 36.5 14.5 5.4 8.9 3.4 2.8 7.3 3.7 204.3 6.8 5.6 4.0 0.0 3.0 15.7 10.9 7.1 9.5 4.8 0.8 62.2 3.7 4.4 5.8 9.2 8.9 1.3 12.2 5.3 2.6 3.9 15.2 55.1 1.7 4.1 2.5 6.1 27.1 7.2 5.0 8.8 33.7 4.2 4.4 3.1 34.7 51.9 4.6 1.8 7.9 5.1 12.5 8.1 0.5 13.0 8.9 13.1 7.8 5.7 12.7 4.2 27.7 53.6 5.3 5.8 8.0 2.5 15.2 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298564-36320637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 30.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 1: Thyroid gland - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 11: Alveolar cells - Smell perception" Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 16.2 19.4 17.4 12.1 18.5 35.1 24.9 20.7 22.0 27.9 17.9 17.0 16.9 26.6 21.3 16.5 16.5 16.5 14.2 16.7 19.7 26.2 29.0 76.7 17.4 15.9 17.5 32.2 17.6 19.7 22.4 19.1 16.4 18.5 22.2 22.3 15.9 16.3 7.2 28.5 17.3 20.2 17.2 15.6 31.2 18.2 20.0 17.9 81.7 9.3 16.0 15.2 13.5 21.4 29.6 15.4 31.7 32.1 31.3 30.0 24.1 24.8 30.7 32.2 33.6 31.2 28.9 28.0 36.8 32.1 16.8 22.1 33.7 22.9 39.3 40.5 25.5 16.4 14.7 55.0 33.9 33.8 17.5 30.8 35.1 21.1 27.2 33.2 20.4 38.3 28.4 33.8 24.2 28.8 32.5 27.7 26.9 25.2 44.6 15.4 27.7 19.5 37.2 22.7 47.3 18.8 20.4 19.5 33.4 27.3 31.9 21.6 16.0 35.6 23.2 26.3 26.0 27.8 34.5 44.0 13.6 17.3 25.3 2.0 12.6 3.0 14.6 9.9 18.5 16.4 17.6 18.0 12.8 12.3 22.6 18.5 7.0 12.9 8.1 14.5 23.6 13.3 17.4 18.5 20.7 22.0 16.7 19.7 15.9 17.5 16.4 17.2 20.0 21.4 16.0 218.0 316.0 18.3 14.9 90.2 30.7 41.5 22.2 24.9 15.3 23.0 10.7 10.0 106.7 25.8 2.1 24.7 12.2 16.1 58.7 21.2 4.2 20.9 28.2 18.3 31.5 9.7 21.2 19.0 21.1 29.7 13.3 35.6 13.3 30.2 16.1 25.2 18.7 92.5 24.8 15.5 20.3 9.5 15.4 4.2 32.0 14.5 21.4 9.4 11.5 29.0 12.3 31.7 27.0 17.8 18.6 27.1 18.9 29.0 18.9 49.6 34.9 24.1 13.1 18.0 27.8 50.1 35.5 17.9 65.5 19.8 20.6 25.5 21.1 21.4 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161558-13211110 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.2;lymphoid tissue: 8.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 1.2 0.1 0.0 3.3 0.1 9.2 0.8 0.1 0.2 0.4 0.1 1.7 1.5 0.4 0.1 1.9 0.2 0.2 0.1 0.0 0.0 0.1 0.7 0.3 4.8 0.0 0.1 0.2 0.1 0.2 0.1 2.1 0.1 0.1 2.2 0.1 0.3 0.0 0.5 1.1 1.2 0.8 0.0 1.0 0.8 1.5 0.2 8.1 0.3 0.1 4.5 0.6 0.6 0.1 38.0 42.0 48.6 36.9 1.6 2.9 21.2 38.7 5.9 42.7 44.0 41.3 26.4 56.7 17.1 9.9 15.7 43.3 69.0 22.8 39.2 29.7 32.9 70.9 17.6 27.7 0.0 36.6 30.8 0.6 0.8 43.3 4.0 3.5 14.0 45.0 85.2 37.6 23.4 34.0 87.7 15.7 28.9 36.3 10.3 68.3 43.0 34.6 9.8 13.7 9.7 36.6 31.3 22.0 5.9 25.2 27.7 24.9 8.6 27.0 50.3 41.0 42.4 11.7 49.0 74.3 17.2 39.6 21.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.9 0.3 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 1.7 0.0 0.0 0.0 1.8 1.7 0.4 0.8 0.0 0.0 0.8 0.5 2.4 0.0 0.8 0.0 0.0 11.8 0.8 2.4 0.0 0.4 1.0 0.3 1.2 1.4 0.0 23.5 0.4 0.2 20.9 1.8 1.1 1.0 0.0 7.2 0.0 0.2 5.3 0.0 0.4 1.2 2.0 0.6 0.4 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.4 15.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 6.4 15.8 12.9 3.6 0.4 3.4 1.2 0.8 3.1 0.4 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642498-89819794 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.5;Inhibitory neurons: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 24.7;NTERA-2: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 4.2 4.6 3.4 1.9 3.6 4.2 4.3 4.4 3.3 4.5 1.7 4.4 1.2 5.6 2.1 4.9 5.0 1.2 4.9 3.1 3.3 4.4 9.1 3.9 2.6 3.3 3.1 7.6 5.9 3.0 4.6 1.2 3.7 3.6 1.8 3.0 3.9 1.5 8.3 7.1 5.0 1.7 2.2 4.5 4.6 6.5 3.3 2.8 6.0 3.4 2.5 4.2 4.3 5.7 4.2 4.1 4.1 3.8 6.6 6.3 4.1 2.8 2.1 3.1 3.8 9.4 1.5 12.5 3.1 2.9 3.3 3.6 10.7 3.8 5.5 4.9 7.1 13.5 5.6 6.1 2.5 17.7 3.2 3.9 3.1 8.3 7.6 1.9 5.6 5.6 24.7 2.9 3.1 5.0 2.8 6.6 22.7 3.4 3.5 5.5 7.8 3.1 2.7 5.8 7.5 3.3 3.9 2.3 2.5 5.4 1.6 7.7 7.2 2.1 3.8 2.8 6.5 3.3 3.9 5.9 2.8 9.8 3.7 3.2 0.3 0.6 0.7 0.2 0.6 1.0 1.0 0.8 0.2 1.3 1.3 1.0 0.0 1.1 0.3 3.0 0.4 0.1 3.4 3.6 4.4 3.3 3.1 3.3 3.3 3.1 3.7 2.2 3.3 5.7 13.2 28.9 19.1 55.2 19.2 29.3 8.2 6.0 30.7 24.4 14.0 11.0 39.2 11.5 16.9 14.7 25.0 5.5 25.2 6.6 0.0 6.3 7.5 20.1 21.9 15.0 7.7 58.5 82.5 8.1 7.2 13.3 19.4 25.2 6.3 26.4 6.4 48.5 6.6 18.5 79.5 7.7 6.1 6.3 9.5 4.3 7.2 8.6 12.4 33.7 6.6 8.0 9.2 35.7 74.8 6.9 3.7 8.6 26.0 18.1 4.7 2.5 12.9 18.7 0.0 33.1 12.7 37.5 50.1 26.1 30.1 3.4 19.4 17.4 10.3 8.5 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131852928-132079867 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 87.7;Oligodendrocytes: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 14.6 14.7 20.4 10.1 22.7 18.4 14.8 19.6 22.1 14.0 17.6 16.6 8.3 19.0 23.5 17.0 15.2 9.6 18.5 22.8 19.7 14.6 9.9 14.0 15.4 20.3 19.2 12.8 9.0 15.8 17.1 13.1 19.6 15.5 11.1 13.7 11.3 13.7 20.9 20.5 11.7 16.7 19.3 14.2 12.9 18.2 19.3 28.2 13.3 14.4 14.1 17.3 13.7 21.7 33.1 29.8 40.9 32.0 28.4 24.7 33.3 34.7 48.8 73.9 58.8 53.0 29.4 31.7 21.5 39.3 48.1 60.9 54.5 51.8 46.8 34.6 36.1 24.5 31.1 31.3 42.7 43.2 33.4 28.9 37.9 57.9 61.4 22.9 41.4 52.1 36.7 29.0 57.2 57.8 52.4 30.8 40.6 36.5 62.6 44.7 51.0 43.6 31.0 17.8 72.5 28.9 44.4 22.7 26.5 25.7 37.6 22.1 29.5 71.8 31.4 52.6 51.5 10.8 32.0 57.2 40.3 33.9 50.6 5.7 18.1 21.2 26.5 28.6 21.5 16.7 20.2 26.3 28.3 19.3 16.5 21.8 7.0 27.8 24.9 29.2 30.0 18.7 20.4 22.7 19.6 22.1 22.8 19.7 20.3 19.2 19.6 19.3 19.3 21.7 10.4 16.0 7.8 55.8 12.0 6.0 14.4 28.2 18.8 24.6 3.8 6.7 6.2 2.8 17.2 12.9 18.8 33.1 14.5 4.7 13.7 15.0 14.3 8.6 10.3 12.4 5.3 6.3 87.7 16.7 20.4 12.0 10.2 8.3 10.8 12.6 6.8 5.2 17.5 21.9 63.3 5.5 18.3 3.1 5.0 8.4 14.3 9.1 7.2 33.7 10.1 25.0 3.1 69.4 130.0 16.1 2.0 17.0 13.9 7.0 2.3 7.8 9.2 20.0 6.6 16.7 17.0 24.2 28.7 10.9 5.1 54.7 15.5 18.8 4.8 10.1 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271231 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 29.7 22.5 15.6 18.7 17.7 43.6 23.4 16.9 16.4 22.2 12.9 24.1 12.6 23.1 8.2 28.4 18.2 17.3 23.0 15.1 16.5 24.5 17.6 25.4 33.2 17.3 17.2 14.2 27.6 21.5 11.8 12.3 18.4 16.4 15.1 6.0 19.9 14.4 63.2 32.8 25.1 16.9 17.4 35.7 19.5 17.9 16.6 24.5 16.6 26.8 27.0 23.7 21.6 18.6 25.6 43.5 8.9 20.3 17.9 5.4 12.7 6.2 19.1 13.0 9.5 14.4 29.8 38.7 11.7 11.9 14.6 19.8 13.6 24.4 10.5 19.2 27.3 20.2 16.5 14.1 19.9 18.9 20.4 4.8 37.7 8.7 39.7 17.7 27.3 44.7 25.7 50.0 3.6 47.6 58.6 39.0 3.5 29.0 21.3 36.6 11.3 58.6 29.4 14.1 11.7 17.1 13.9 34.5 33.0 23.4 65.9 41.2 9.7 5.6 13.8 7.2 12.1 67.8 17.5 33.3 11.7 31.3 8.7 27.5 77.6 44.4 54.6 41.1 56.6 49.3 43.0 47.9 91.4 44.2 37.1 39.9 13.1 56.4 55.4 226.4 68.3 60.3 15.6 17.7 16.9 16.4 15.1 16.5 17.3 17.2 18.4 17.4 16.6 18.6 33.2 0.0 11.0 3.3 30.5 11.5 14.8 11.1 5.2 3.8 23.8 23.4 4.2 31.5 15.3 12.9 0.0 15.0 73.4 12.1 21.5 45.2 32.6 11.6 4.7 20.1 15.6 11.1 3.0 43.4 9.4 12.3 9.2 12.0 31.8 13.0 17.5 9.0 44.9 1.7 3.1 18.0 28.5 47.4 45.1 19.8 9.3 45.4 16.0 7.5 47.7 30.5 53.5 5.0 8.2 24.8 22.7 15.8 22.5 14.3 22.3 29.3 17.6 6.0 19.7 13.0 22.0 19.6 22.1 23.2 18.9 9.3 33.5 7.4 16.9 14.1 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831351-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 292.9;lymphoid tissue: 107.8" "Cell type enhanced" "Detected in many" "Hofbauer cells: 219.1;Kupffer cells: 408.5;Langerhans cells: 241.7;Macrophages: 412.0;monocytes: 1118.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 6012.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 6012.8" "Group enriched" "Detected in some" 14 "NB-4: 151.8;THP-1: 282.7;U-937: 185.5" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 400000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 24.2 14.9 2.7 82.4 2.8 292.9 6.0 2.9 4.4 6.3 3.2 6.7 3.7 4.0 1.4 7.4 5.7 26.6 4.3 2.6 3.1 3.6 11.5 47.3 15.6 5.2 4.3 2.2 4.8 3.7 1.6 20.4 4.3 3.8 7.7 12.1 5.7 3.5 3.8 5.1 7.7 20.7 5.1 107.8 4.5 5.1 4.2 14.4 3.8 19.0 14.5 23.4 1.8 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 282.7 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 185.5 0.0 155.4 1354.4 243.8 2.6 534.3 3.7 33.5 1.6 1.9 616.5 15.3 1.6 1.4 6012.8 2.8 270.6 9.6 1.5 1099.5 2.7 2.8 2.9 4.4 2.6 3.1 5.2 4.3 4.3 5.1 4.2 5.4 2.6 35.3 56.0 0.0 34.7 2.4 0.0 0.0 0.0 1.2 1.1 3.4 0.9 5.7 9.3 0.0 0.0 0.9 5.9 0.0 0.0 0.0 0.4 0.1 0.1 5.0 0.0 22.3 0.0 0.4 1.3 6.5 0.5 0.1 44.1 0.0 3.9 2.2 219.1 0.0 0.1 0.0 0.0 408.5 241.7 3.3 1.2 412.0 1.8 33.7 1118.9 136.1 26.8 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.7 8.0 4.8 13.1 1.5 8.2 0.9 0.3 0.4 2.3 1.0 11.7 0.0 0.0 0.1 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 32.3 19.6 34.7 19.2 36.3 24.2 28.3 37.8 39.7 27.4 36.2 61.1 18.0 30.7 36.5 51.9 34.4 27.8 43.5 35.3 36.5 18.6 20.0 24.7 26.8 36.1 36.8 28.1 32.8 34.9 11.2 25.7 36.5 32.5 34.8 14.6 35.2 42.3 50.9 50.0 28.6 49.0 36.1 25.1 27.9 14.2 37.1 34.1 24.2 70.4 27.0 39.9 31.6 37.8 29.3 31.2 18.3 15.7 44.2 30.8 17.1 22.5 30.9 40.4 31.8 20.1 39.0 20.9 16.7 50.6 26.0 34.8 28.1 48.6 24.3 28.8 44.3 16.0 11.7 26.2 30.2 21.2 24.2 25.1 57.9 21.9 25.3 32.7 43.6 27.0 26.3 21.2 20.7 20.6 27.4 37.7 23.0 54.3 29.4 19.9 19.0 22.2 34.4 26.9 34.6 37.3 27.3 34.0 27.9 23.0 15.9 21.3 37.7 25.6 13.1 8.3 14.5 21.6 22.3 21.8 17.9 20.3 19.8 9.7 8.7 11.9 16.2 9.2 13.6 8.1 14.1 13.7 10.6 11.0 11.6 10.2 7.1 12.1 13.4 7.5 15.3 10.6 34.7 36.3 37.8 39.7 35.3 36.5 36.1 36.8 36.5 36.1 37.1 37.8 84.8 6.4 10.0 6.5 20.2 82.2 30.1 39.4 12.0 18.4 27.8 33.3 14.8 12.8 18.4 7.3 12.5 31.1 64.5 58.6 27.4 33.5 24.3 18.9 17.7 58.2 20.9 36.2 15.2 38.5 31.0 23.3 16.8 29.2 24.8 20.3 33.9 9.0 26.4 43.7 10.9 32.8 32.6 18.2 39.3 12.1 23.9 28.1 56.9 11.2 29.4 21.5 81.4 6.6 14.8 39.6 63.2 51.1 17.0 48.6 54.3 23.9 12.9 21.4 85.5 20.8 68.3 29.8 41.1 13.7 82.0 59.4 36.4 20.2 27.7 37.6 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170224 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavorable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favorable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 19.8 21.3 26.7 25.5 26.8 20.0 72.5 29.6 32.8 23.6 19.1 22.7 13.8 25.8 22.4 36.2 15.9 16.5 13.9 26.7 28.3 17.8 15.9 18.7 24.7 22.1 24.7 13.4 9.0 16.2 21.3 24.4 23.1 15.3 24.9 31.6 26.0 13.0 18.0 40.1 15.9 22.8 21.7 16.7 15.7 14.1 27.5 20.7 11.6 17.5 26.2 34.7 21.0 28.4 67.8 36.2 79.0 38.9 37.7 52.7 43.5 71.1 84.7 60.6 29.3 58.5 38.4 55.2 42.0 39.2 44.7 69.2 76.2 73.6 80.8 41.3 49.9 44.5 31.2 106.5 37.5 111.9 65.9 33.6 64.7 36.2 102.8 30.5 70.6 75.7 106.2 15.3 93.4 54.8 86.5 131.2 72.4 83.4 49.5 105.5 36.6 36.5 55.3 69.8 54.1 23.3 119.6 52.5 53.6 32.4 92.2 68.6 56.0 56.5 56.3 50.2 51.3 22.4 58.0 217.9 51.0 89.9 73.2 26.1 38.3 36.9 38.2 46.5 48.5 35.6 38.7 39.9 44.9 29.2 41.1 38.8 4.9 33.1 33.8 27.2 44.3 28.3 26.7 26.8 29.6 32.8 26.7 28.3 22.1 24.7 23.1 21.7 27.5 28.4 13.2 19.2 38.3 20.5 22.9 38.7 40.3 123.9 19.4 14.5 74.3 50.0 31.5 14.3 66.2 20.2 10.4 56.9 23.0 21.7 50.9 45.2 6.5 13.9 18.5 19.3 9.0 23.1 38.5 28.1 46.1 31.4 15.8 22.0 18.3 21.9 20.0 19.0 49.6 20.2 35.6 20.7 40.7 29.1 42.7 7.5 11.1 55.9 32.0 12.2 56.0 61.1 34.0 29.7 17.1 56.4 28.4 10.1 22.3 38.6 12.2 46.5 32.7 24.5 19.7 15.4 30.1 36.9 57.5 30.6 54.0 32.8 27.4 26.3 34.0 48.1 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251805-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 18.9 18.5 17.0 16.8 17.1 13.4 20.2 14.8 17.9 13.0 13.7 13.5 16.8 15.8 12.9 23.7 17.6 8.9 14.4 17.4 16.1 17.9 20.3 11.1 20.0 15.8 16.0 17.0 23.4 12.5 8.9 12.1 16.1 12.9 16.5 7.2 12.3 10.5 22.7 17.4 19.5 16.7 15.4 13.8 15.5 14.0 16.1 14.8 11.1 11.4 22.8 21.4 14.1 16.4 90.9 65.9 51.1 67.0 24.2 38.6 44.7 69.0 38.9 116.7 76.1 92.9 92.0 133.6 56.7 60.5 50.4 70.1 142.7 104.6 114.0 47.4 109.6 98.4 55.4 80.8 30.3 133.4 38.7 34.0 69.8 131.6 69.6 31.7 66.1 59.0 151.1 42.3 68.9 68.0 106.3 96.5 65.0 95.6 95.4 99.3 62.7 100.5 64.8 31.3 82.9 59.2 54.0 73.0 75.4 37.6 50.8 76.5 44.2 61.9 77.5 97.6 118.0 33.8 64.3 178.2 61.2 172.4 102.5 1.4 11.6 1.3 11.4 12.7 22.9 23.1 13.7 15.9 17.6 19.7 18.4 16.7 1.4 16.6 10.2 19.7 10.6 11.4 17.0 17.1 14.8 17.9 17.4 16.1 15.8 16.0 16.1 15.4 16.1 16.4 30.0 6.4 14.5 6.2 31.2 37.3 59.1 45.8 42.7 20.4 23.6 37.7 10.3 38.6 26.4 7.3 10.4 50.4 14.9 15.7 41.1 61.8 23.3 19.1 46.8 32.1 21.6 31.3 8.4 55.0 69.9 29.5 19.4 21.1 26.0 36.8 15.4 16.3 47.1 15.2 7.3 25.4 36.7 13.3 18.2 36.5 23.0 21.0 19.6 1.9 32.0 25.7 16.5 4.5 4.3 57.5 17.0 20.3 29.0 57.4 6.0 37.9 15.8 16.4 19.7 44.8 35.9 55.6 49.7 48.2 33.5 26.0 18.6 58.1 34.8 36.7 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules No No "Cluster 32: T-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli, Microtubules" "HPA067903: AB_2685921, HPA069795: AB_2686198" "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favorable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favorable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 52.9 39.0 65.6 13.4 100.4 0.3 45.0 97.4 81.7 34.5 59.3 36.6 32.6 31.4 22.6 38.0 28.7 37.9 85.6 66.0 76.9 26.2 56.8 40.4 9.0 106.4 90.8 51.4 98.2 65.2 22.9 70.0 104.2 31.9 39.1 56.9 49.9 24.7 106.2 26.0 33.4 38.2 75.7 16.1 42.2 12.2 87.6 22.8 27.3 167.4 14.5 35.8 31.0 151.1 21.9 115.7 18.5 100.1 0.1 0.6 33.2 1.1 7.8 0.6 2.3 8.7 7.8 2.8 8.5 0.0 4.8 22.2 30.8 10.9 1.1 15.8 13.2 0.0 19.2 55.8 6.6 0.0 0.4 9.1 16.4 2.4 33.3 0.0 296.8 7.7 0.0 43.3 0.1 5.7 4.4 5.7 26.5 44.1 2.9 0.1 17.0 11.5 5.9 44.4 9.2 2.2 14.8 26.6 84.7 11.0 19.2 0.3 61.4 0.1 24.0 0.1 0.2 5.9 3.5 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 65.6 100.4 97.4 81.7 66.0 76.9 106.4 90.8 104.2 75.7 87.6 151.1 408.9 70.5 281.0 139.1 2.9 21.0 56.4 38.9 58.1 0.0 42.7 31.6 141.6 55.8 88.4 20.2 0.0 23.8 1.6 58.5 11.7 50.1 18.5 71.4 53.8 154.5 15.0 0.0 6.1 174.2 40.0 83.8 94.8 144.2 9.5 7.6 29.3 71.2 58.2 0.0 81.8 47.3 22.4 4.1 16.1 24.5 76.4 9.0 28.4 174.3 2.7 0.0 2.1 39.2 469.2 56.5 19.1 57.2 15.3 77.9 52.4 10.4 49.4 0.0 19.7 69.7 60.1 2.4 8.3 45.3 20.3 54.0 7.1 79.8 49.3 81.3 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555386 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles No No 47000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favorable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (8.12e-4)" "unprognostic (9.70e-2)" 12.3 11.0 3.8 13.4 3.8 11.4 15.9 1.3 7.6 13.3 0.8 11.9 9.6 14.6 4.6 17.0 15.2 6.2 11.0 5.0 4.2 9.8 10.8 11.4 13.8 5.2 4.9 14.1 24.4 6.7 12.7 5.2 3.5 17.1 5.1 3.8 18.9 10.1 27.9 22.0 12.9 7.3 2.1 14.0 12.4 8.1 3.4 7.4 11.2 8.0 8.7 14.9 13.8 3.8 60.1 90.0 11.9 56.2 15.4 17.1 40.8 39.8 17.5 39.5 30.8 67.1 24.4 80.4 47.2 23.9 19.8 74.2 50.1 61.3 19.0 40.3 133.8 38.8 58.3 62.2 25.2 45.5 34.7 25.7 34.6 58.8 29.1 11.0 26.6 45.0 64.2 37.1 18.2 51.4 54.2 19.5 56.0 19.1 48.0 69.8 19.7 54.0 9.8 45.5 25.5 48.5 40.8 29.7 28.2 8.6 27.5 19.1 34.3 35.1 31.5 32.7 118.6 32.1 26.5 34.4 32.5 53.9 45.3 0.0 1.9 0.3 2.8 1.6 3.4 2.9 2.3 3.1 2.9 1.7 2.5 2.8 0.1 2.4 3.4 2.1 1.0 2.7 3.8 3.8 1.3 7.6 5.0 4.2 5.2 4.9 3.5 2.1 3.4 3.8 13.4 9.6 14.5 4.6 13.1 12.9 6.8 7.1 12.0 8.2 12.9 14.4 4.1 8.6 13.3 3.7 12.5 2.9 5.8 9.2 0.0 7.7 0.5 6.7 15.3 17.0 11.4 7.2 11.3 12.7 5.4 10.2 10.7 8.5 5.1 12.2 8.6 7.8 6.5 10.1 6.1 8.0 4.1 4.5 6.8 0.6 5.6 6.3 3.6 7.5 3.8 3.8 6.2 3.5 6.5 8.2 4.5 12.0 13.7 13.9 4.6 3.2 12.2 6.2 6.6 10.8 12.9 2.6 11.1 12.8 11.9 1.1 9.7 13.8 12.4 6.2 MYSM1 KIAA1915 ENSG00000162601 "Myb like, SWIRM and MPN domains 1" Q5VVJ2 1 58643440-58700077 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054291, HPA057306" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA054291: AB_2682438, HPA057306: " "unprognostic (2.95e-3)" "unprognostic (3.64e-2)" "unprognostic (3.20e-2)" "unprognostic (8.68e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.09e-5)" "unprognostic (8.12e-3)" "unprognostic (9.63e-3)" "unprognostic (5.72e-3)" "unprognostic (3.74e-1)" "unprognostic (2.25e-1)" "unprognostic (4.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.22e-2)" "unprognostic (1.83e-1)" "unprognostic (8.45e-2)" "unprognostic (1.44e-2)" 11.2 7.5 4.0 4.4 3.9 12.5 12.0 4.3 5.9 11.9 4.2 11.8 5.4 10.6 6.2 10.0 10.2 3.1 10.5 4.1 3.9 7.2 8.0 10.1 6.3 3.9 3.7 13.2 12.1 5.9 8.7 4.4 3.9 9.6 4.4 8.4 11.8 4.1 10.0 10.5 12.6 3.6 3.7 11.4 9.9 4.4 3.9 5.3 11.5 3.1 4.9 9.3 11.1 4.4 10.1 2.6 5.0 6.7 6.0 7.2 10.5 5.9 5.6 5.1 3.9 5.3 4.2 10.3 1.8 3.8 4.8 7.4 7.7 2.1 11.0 6.2 4.3 11.3 2.1 5.1 7.4 19.6 9.7 5.4 5.9 7.5 3.8 6.1 1.2 4.2 12.6 6.3 6.8 2.6 7.8 16.3 11.4 3.5 3.5 7.3 16.4 6.1 4.6 3.8 5.8 6.6 4.4 9.4 13.9 9.0 3.1 10.6 4.9 9.3 4.6 6.4 11.3 10.8 5.8 13.9 5.8 13.7 11.6 0.9 0.3 0.1 0.3 0.4 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.4 1.0 0.1 0.5 0.4 0.4 0.1 4.0 3.9 4.3 5.9 4.1 3.9 3.9 3.7 3.9 3.7 3.9 4.4 36.5 22.4 33.7 47.7 26.0 19.1 22.8 13.5 30.7 19.5 25.6 21.0 28.2 10.0 35.1 11.0 25.0 8.4 36.6 22.1 15.6 8.8 3.9 22.1 34.8 25.4 16.2 14.1 87.4 9.4 5.7 20.8 19.9 36.9 56.3 30.1 23.9 16.3 11.3 18.5 58.2 17.0 24.4 13.9 14.2 6.3 12.8 22.2 8.8 35.6 21.3 12.7 22.6 58.3 106.9 12.7 13.1 17.3 29.5 19.3 19.2 8.8 21.2 27.8 26.3 28.8 21.5 15.5 20.6 25.0 18.5 11.4 30.8 22.0 18.5 26.4 NAA50 "FLJ13194, MAK3, NAT13, NAT5, San" ENSG00000121579 "N-alpha-acetyltransferase 50, NatE catalytic subunit" Q9GZZ1 3 113716458-113746300 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 320.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074489 Approved Supported Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoli "HPA074489: " "unprognostic (9.74e-2)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.32e-4)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.62e-3)" "unprognostic (6.82e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.92e-5)" "unprognostic (2.97e-3)" "unprognostic (1.09e-1)" "unprognostic (2.25e-2)" "unprognostic (9.59e-2)" "unprognostic (7.13e-3)" "unprognostic (2.43e-1)" 88.2 64.2 21.8 72.0 24.7 87.3 58.4 25.2 29.4 49.2 27.2 62.5 48.9 50.1 31.4 93.4 38.5 50.6 50.9 23.7 24.4 64.4 90.3 43.5 84.9 23.6 25.0 51.7 58.7 59.8 23.1 45.0 25.3 52.8 54.1 31.5 69.7 42.1 320.7 53.4 47.5 51.2 25.2 52.6 65.6 53.2 26.6 56.8 58.5 154.4 90.7 87.6 46.3 28.2 589.6 250.7 135.2 158.5 179.4 144.6 281.4 308.5 172.4 186.0 212.4 362.3 205.7 403.4 185.8 164.6 146.9 236.5 238.0 211.1 338.6 85.2 121.5 435.7 182.7 220.3 164.4 459.1 135.7 124.0 163.0 208.8 298.3 122.1 168.7 167.3 279.3 157.8 194.3 277.0 306.2 99.3 303.4 228.3 365.3 309.5 207.2 318.9 141.7 439.9 207.4 119.6 223.6 164.1 229.0 116.5 228.1 150.4 156.9 255.1 253.9 109.1 235.7 174.1 314.2 736.0 200.2 253.2 160.6 17.7 40.8 22.5 45.5 40.5 40.6 55.2 33.7 43.1 44.4 37.1 29.4 39.1 51.8 31.8 38.1 25.6 39.9 52.5 21.8 24.7 25.2 29.4 23.7 24.4 23.6 25.0 25.3 25.2 26.6 28.2 33.9 48.1 39.9 24.8 75.7 168.4 86.6 42.6 76.2 24.8 52.3 31.6 47.5 25.8 45.8 36.8 8.4 46.0 78.2 51.3 78.2 52.9 68.0 44.4 53.1 45.7 19.9 79.5 41.5 55.1 94.6 55.2 35.7 94.3 47.5 45.5 29.3 66.1 61.9 40.4 39.0 31.5 42.7 55.3 148.8 50.7 30.7 60.1 62.2 20.6 49.9 29.7 29.9 33.2 28.4 65.2 36.8 31.2 74.9 142.0 31.4 71.0 30.0 18.4 19.7 53.1 64.1 53.5 60.8 99.8 177.9 62.5 74.7 37.7 49.3 193.3 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 48.0;Late spermatids: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes 34000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 8.3 7.4 7.3 21.5 11.4 35.5 10.9 9.9 8.3 10.2 7.4 17.9 17.0 10.7 10.6 15.9 11.2 9.8 7.6 7.2 8.0 7.4 4.8 10.6 38.1 11.0 10.0 8.0 7.7 11.3 5.5 17.5 11.7 9.4 20.4 11.1 11.8 10.2 7.9 21.9 16.0 13.4 8.4 16.1 12.1 18.2 10.2 76.8 11.3 10.2 44.8 10.1 9.3 13.9 125.3 99.3 134.6 97.9 29.9 28.4 159.2 76.1 69.8 138.3 109.1 123.5 150.8 135.8 24.2 63.2 126.7 128.6 188.0 105.4 194.1 214.1 92.8 112.2 113.8 79.4 12.5 145.0 96.5 20.5 31.6 112.4 107.8 61.9 89.9 94.0 71.0 63.4 104.7 79.6 162.2 73.8 207.5 129.9 78.2 153.7 260.6 77.7 39.5 64.1 54.0 61.9 121.5 64.9 44.3 189.1 27.0 101.7 51.0 94.1 149.6 60.8 168.4 45.3 51.7 181.0 55.7 92.2 126.1 11.0 1.7 3.7 7.1 2.8 5.3 5.1 6.4 7.3 3.4 3.5 7.3 7.3 1.4 8.1 2.2 4.1 8.3 3.9 7.3 11.4 9.9 8.3 7.2 8.0 11.0 10.0 11.7 8.4 10.2 13.9 4.3 6.4 7.4 4.9 11.0 3.6 3.8 4.4 17.1 3.7 4.7 6.9 4.1 5.7 3.4 1.8 8.4 13.5 8.9 7.3 0.0 4.5 18.3 5.3 6.3 5.4 1.2 48.0 5.6 3.7 17.8 6.4 7.1 5.8 3.8 20.0 8.9 3.3 10.1 5.0 5.0 9.9 6.1 16.4 4.4 34.3 5.9 10.8 0.0 2.8 9.5 11.8 15.5 2.5 17.8 5.3 4.6 6.0 22.6 4.1 6.0 2.4 4.2 8.4 0.0 4.2 5.2 21.3 13.7 19.3 3.4 6.3 12.0 6.1 14.7 4.1 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002444-113019861 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Cluster 15: NK-cells - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 6.7 6.7 4.7 7.0 5.4 10.6 8.8 6.9 6.5 6.5 6.3 7.0 7.1 8.4 10.3 6.0 6.5 7.4 8.4 5.2 4.9 6.3 5.9 6.4 12.3 5.8 5.3 8.1 8.2 6.9 6.6 6.7 5.6 6.6 5.4 11.7 6.9 6.1 18.7 10.8 7.0 5.8 5.1 8.8 8.3 11.3 5.3 9.4 11.5 7.7 7.8 6.7 5.3 7.9 13.6 10.9 17.3 13.0 5.5 10.1 9.2 12.6 8.1 6.9 4.7 10.1 8.5 17.6 6.6 4.3 9.6 13.7 12.7 5.8 9.4 3.5 8.0 27.3 10.0 7.5 10.0 17.4 9.4 15.7 10.0 5.5 14.2 18.8 6.1 17.2 9.5 13.5 5.2 8.6 15.1 10.3 18.1 12.0 14.0 12.1 13.7 9.3 7.8 11.2 11.9 17.3 7.3 9.1 21.4 12.7 10.4 14.7 12.4 9.4 9.3 3.6 9.1 13.3 11.2 20.6 15.2 13.6 7.0 1.9 1.3 1.6 2.2 1.6 2.3 1.8 2.6 1.9 1.8 1.4 3.2 3.2 0.8 4.3 0.7 1.3 1.2 1.4 4.7 5.4 6.9 6.5 5.2 4.9 5.8 5.3 5.6 5.1 5.3 7.9 16.3 9.6 12.8 0.0 7.6 0.0 0.0 0.0 0.0 0.0 17.4 16.9 0.0 0.0 10.5 18.4 0.0 18.4 23.4 0.0 17.6 14.1 0.0 11.9 20.7 6.3 0.0 0.0 0.0 12.6 15.5 9.3 0.0 16.1 17.7 24.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 4.5 0.0 0.0 14.8 8.7 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 20.4 9.1 33.9 0.0 0.0 NIP7 "CGI-37, FLJ10296, HSPC031, KD93" ENSG00000132603 "Nucleolar pre-rRNA processing protein NIP7" Q9Y221 16 69337996-69343106 "Predicted intracellular proteins" "Ribosome biogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040856, HPA059850" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA040856: AB_2677171, HPA059850: AB_2684142" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.04e-3)" "unprognostic (1.37e-3)" "unprognostic (5.72e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.69e-5)" "unprognostic (6.99e-2)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 17.9 14.1 7.1 17.9 7.5 26.2 16.0 7.8 8.1 11.4 9.6 16.6 14.4 11.3 14.2 17.2 12.1 12.9 7.7 7.8 7.3 13.2 17.2 10.6 23.6 7.7 7.3 7.4 10.3 11.4 5.2 14.5 8.1 9.8 16.1 3.5 8.5 8.9 8.7 12.7 12.0 14.1 7.6 13.1 11.5 12.3 8.1 21.4 11.2 9.8 26.9 24.9 8.6 8.5 57.9 39.7 31.2 43.0 44.0 38.5 48.8 52.7 40.6 87.8 62.7 66.7 61.6 105.5 57.1 48.3 36.5 60.1 63.7 80.0 112.5 28.9 51.2 53.8 27.0 83.6 42.6 118.1 34.0 42.2 63.1 83.1 88.7 25.7 50.5 60.7 115.1 17.5 62.3 69.8 78.6 81.9 94.4 50.9 47.7 108.6 34.3 95.7 54.6 38.8 41.3 57.8 107.8 31.0 59.8 35.0 44.3 72.4 43.5 63.5 54.7 49.5 97.0 54.4 45.0 250.2 37.9 69.4 63.4 16.7 12.7 9.8 28.4 14.9 29.9 28.9 25.2 33.3 22.8 21.1 23.3 30.1 4.3 24.8 21.4 20.7 28.9 16.9 7.1 7.5 7.8 8.1 7.8 7.3 7.7 7.3 8.1 7.6 8.1 8.5 28.2 3.2 12.7 3.9 33.7 53.7 58.1 34.6 45.5 8.8 21.7 18.3 5.5 14.3 21.1 20.2 16.7 33.2 33.2 14.7 21.5 35.9 43.8 24.5 32.0 28.3 3.0 37.9 5.1 26.1 36.5 24.0 11.2 23.2 17.7 20.5 18.2 12.1 24.8 11.8 4.5 12.7 30.5 12.2 19.2 41.4 17.1 14.7 19.6 1.9 18.3 9.2 35.0 3.0 6.4 37.5 16.6 17.3 15.6 46.2 14.6 28.9 25.6 8.1 13.1 35.2 25.9 40.7 43.8 43.0 52.6 25.6 33.2 36.2 20.8 42.2 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119606443 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 4.4 6.5 11.3 5.7 11.8 6.9 5.4 9.6 16.9 4.2 7.3 3.7 4.1 3.9 4.0 5.6 4.4 3.5 4.1 11.5 13.1 6.1 6.0 4.1 8.7 11.2 10.1 6.1 3.8 5.2 5.5 6.5 11.5 4.1 3.5 5.3 4.0 3.5 5.5 6.2 4.3 4.0 9.4 5.9 4.1 1.9 11.4 9.5 4.6 4.6 8.4 6.3 4.3 10.6 17.9 18.3 10.4 11.3 8.7 8.5 15.5 10.7 8.5 14.1 15.0 19.8 15.3 31.8 18.4 9.2 12.1 20.4 43.8 16.4 17.2 16.4 28.9 16.8 20.3 12.9 8.3 33.5 11.8 9.5 13.2 16.3 19.2 9.6 14.1 15.3 18.5 12.6 12.5 27.6 20.8 25.2 23.1 26.2 19.9 16.5 15.2 32.7 18.8 12.7 16.7 14.2 15.2 23.1 16.5 10.6 9.7 20.0 12.2 8.7 9.5 19.3 27.1 10.5 14.1 32.9 9.3 36.3 10.1 1.1 0.5 0.7 1.0 0.8 1.1 1.3 1.2 1.3 0.6 1.2 1.9 1.6 0.1 0.5 0.3 0.9 1.8 0.8 11.3 11.8 9.6 16.9 11.5 13.1 11.2 10.1 11.5 9.4 11.4 10.6 5.4 6.4 8.9 5.9 11.1 19.4 10.4 4.1 6.8 13.3 6.1 6.9 4.5 8.6 3.1 5.5 27.1 14.4 8.5 3.0 1.9 4.2 0.1 6.1 7.4 7.0 10.7 2.5 20.6 3.6 14.3 6.1 3.1 8.1 14.7 6.6 3.3 3.9 6.4 8.4 20.6 4.4 10.2 7.5 33.1 0.6 7.8 11.6 5.4 7.5 5.6 4.4 1.0 9.0 9.2 4.1 1.9 6.8 5.2 10.7 3.6 4.4 3.9 7.9 0.0 10.1 7.2 1.7 1.9 6.9 25.7 14.9 15.7 6.9 7.4 9.5 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128730-35142304 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 7.3 7.4 5.0 5.8 5.0 6.2 8.8 5.1 5.3 7.4 3.4 5.6 4.0 6.8 2.9 8.4 7.4 3.1 4.2 5.0 4.5 6.5 7.3 4.6 6.8 4.7 4.0 12.0 23.7 3.9 4.2 4.9 4.0 6.0 4.0 2.5 7.6 4.6 8.0 6.8 5.1 4.1 3.5 6.2 7.6 4.4 5.0 6.6 5.1 3.5 5.4 7.4 5.8 4.6 15.9 36.8 12.5 22.7 6.9 11.4 19.6 14.0 12.7 24.4 19.3 26.1 14.8 34.9 18.6 12.0 18.0 21.0 26.8 35.6 15.1 5.6 44.2 14.9 18.2 33.2 10.3 29.9 12.0 12.9 19.0 25.6 38.3 10.7 15.5 33.9 42.4 12.7 14.6 22.1 47.1 25.5 23.6 13.5 16.6 37.6 20.9 38.5 14.3 14.8 25.6 14.8 13.1 13.4 17.1 11.1 32.4 22.4 14.5 13.3 18.3 13.0 47.4 9.8 7.8 29.1 9.3 24.9 25.8 0.1 2.2 0.0 4.0 2.4 6.2 3.4 3.8 4.2 3.4 4.6 5.2 3.5 0.3 1.8 1.2 0.8 2.1 2.2 5.0 5.0 5.1 5.3 5.0 4.5 4.7 4.0 4.0 3.5 5.0 4.6 4.7 3.2 1.1 0.3 8.6 8.7 8.6 7.4 9.6 4.7 12.3 14.0 2.6 10.0 3.7 3.7 2.1 12.1 2.4 3.9 0.0 8.9 1.0 2.1 5.4 5.0 4.9 8.8 1.3 15.4 20.9 7.4 6.6 2.8 3.8 9.4 5.3 6.6 7.6 1.7 1.5 8.1 2.0 4.6 2.6 5.4 4.1 2.8 1.8 1.0 3.8 1.9 2.1 1.0 0.7 8.5 3.6 4.9 5.1 8.6 3.4 7.1 2.8 3.1 0.0 6.5 7.2 4.2 6.5 12.5 10.1 4.9 4.1 9.2 13.4 5.5 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 26.9 21.5 13.1 18.1 13.8 64.7 32.3 19.3 14.1 27.0 12.8 18.6 17.6 26.3 15.3 24.4 20.2 22.6 40.0 11.2 14.2 29.2 77.7 19.7 22.3 10.8 13.4 26.4 34.9 21.9 12.7 25.6 11.8 27.7 21.2 17.0 32.8 20.0 60.3 17.2 15.4 28.3 12.1 21.1 42.5 16.0 13.0 18.7 25.2 34.5 24.7 39.3 16.5 13.9 68.7 39.2 37.8 38.6 46.3 63.1 51.9 76.3 57.9 55.9 64.8 66.5 54.9 86.4 94.8 53.8 39.3 43.8 60.9 56.1 86.4 90.2 37.4 89.0 31.4 41.7 50.7 108.0 51.7 53.2 40.9 39.7 129.1 59.4 61.4 29.9 66.3 46.3 66.8 155.7 49.6 41.3 47.4 82.1 61.7 59.8 54.5 87.9 53.1 153.2 59.8 37.3 43.5 105.2 63.9 40.9 78.3 49.0 54.2 44.1 31.5 51.3 93.4 75.6 54.5 87.1 55.5 69.5 61.5 30.5 16.6 8.9 16.5 17.6 25.9 17.3 19.2 20.4 19.8 15.6 25.3 20.1 3.6 35.4 11.4 11.0 26.8 20.7 13.1 13.8 19.3 14.1 11.2 14.2 10.8 13.4 11.8 12.1 13.0 13.9 30.6 19.2 14.6 22.9 25.3 64.9 52.9 23.8 34.7 24.7 26.8 16.5 43.9 21.5 25.1 11.0 14.6 33.3 25.2 14.0 35.2 25.6 19.3 13.8 29.6 30.1 13.8 32.2 16.6 38.9 48.8 34.0 31.1 19.3 25.4 20.3 22.1 41.6 23.4 30.3 15.3 19.4 26.4 33.1 47.0 7.0 25.4 21.6 24.9 12.2 26.1 12.8 21.6 19.6 18.2 33.0 13.9 27.4 20.9 46.7 19.7 39.9 18.5 20.8 26.3 29.1 87.5 39.2 27.4 33.4 74.3 56.6 25.8 24.4 21.2 72.7 NOC4L "MGC3162, NET49, Noc4, UTP19" ENSG00000184967 "Nucleolar complex associated 4 homolog" Q9BVI4 12 132144457-132152473 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 72.6;Late spermatids: 80.3;Spermatogonia: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053424 Supported Nucleoplasm,Nucleoli No No "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoli Nucleoplasm "HPA053424: AB_2682147" "unprognostic (9.44e-2)" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (8.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.63e-2)" "unprognostic (4.79e-3)" "unprognostic (8.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-1)" "unprognostic (8.36e-3)" "unprognostic (1.76e-1)" "unprognostic (3.85e-3)" "unprognostic (1.05e-1)" "unprognostic (2.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" 12.6 11.5 2.0 3.3 2.0 6.1 12.8 1.9 3.1 13.1 1.5 11.1 4.2 12.6 1.6 13.8 11.9 1.9 10.8 2.6 2.2 13.2 13.4 10.5 3.6 2.4 1.9 14.4 13.6 2.4 11.3 2.7 2.1 11.1 1.8 0.8 11.5 2.2 24.3 15.6 11.3 1.8 1.5 13.5 12.3 33.2 2.0 3.5 11.7 3.2 2.3 11.4 11.2 2.7 14.4 26.0 5.7 9.0 2.8 3.0 29.0 9.7 5.0 12.0 6.5 21.4 6.7 21.8 10.4 5.0 7.1 12.7 10.2 10.7 2.5 8.7 28.3 14.7 8.8 14.4 7.6 17.3 16.5 4.3 7.2 9.2 7.3 4.5 8.3 16.8 25.4 4.9 4.8 17.1 16.6 40.6 16.7 8.6 20.7 21.2 6.3 19.5 6.3 10.6 13.9 11.0 8.2 11.1 7.5 3.3 15.6 10.7 11.1 7.0 17.7 11.3 16.5 12.4 8.2 19.1 10.6 14.8 15.0 1.6 8.4 4.3 7.5 11.7 7.2 9.1 6.9 7.5 11.1 10.7 5.9 5.7 1.2 5.8 9.1 13.1 6.2 5.9 2.0 2.0 1.9 3.1 2.6 2.2 2.4 1.9 2.1 1.5 2.0 2.7 10.9 9.6 9.1 2.3 15.5 22.3 15.6 20.6 12.0 8.2 11.5 12.1 8.0 20.0 12.4 3.7 0.0 32.3 15.5 15.6 7.9 35.5 72.6 12.1 8.4 13.6 7.3 7.8 2.2 32.9 33.9 14.6 15.3 11.1 15.9 15.8 10.4 11.6 24.9 8.4 2.0 14.5 24.4 11.0 15.8 80.3 14.6 13.2 14.2 1.9 14.5 8.3 6.2 1.5 3.1 28.0 11.2 7.9 12.0 15.4 19.2 21.7 6.2 6.2 19.7 14.2 15.0 37.1 77.1 11.2 21.6 30.5 13.6 24.4 22.7 15.0 NOL10 "FLJ14075, PQBP5" ENSG00000115761 "Nucleolar protein 10" Q9BSC4 2 10570754-10689987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 189.3;Late spermatids: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035286, HPA043075" Approved Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoli "HPA035286: AB_2674552, HPA043075: AB_10794652" "unprognostic (6.53e-3)" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.25e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (7.51e-5)" "unprognostic (2.43e-2)" "unprognostic (2.92e-1)" "unprognostic (3.82e-1)" "unprognostic (3.87e-2)" 12.6 14.8 6.6 10.1 8.0 16.2 11.3 10.2 8.2 9.6 5.1 10.8 8.1 9.3 11.0 13.7 7.8 6.6 11.2 7.5 7.1 13.7 14.4 9.0 10.3 6.2 6.6 9.1 16.0 12.1 8.3 10.9 6.1 10.0 10.6 6.2 12.9 8.6 19.4 13.1 9.0 8.8 6.3 9.6 11.7 13.1 7.3 9.9 10.2 11.9 11.7 12.3 10.7 8.8 19.7 33.2 18.6 32.6 22.1 24.2 34.9 33.1 25.8 36.9 27.5 37.5 24.0 45.4 19.5 32.1 30.8 24.5 43.8 38.7 43.6 32.2 33.8 43.8 20.3 46.6 28.0 52.8 23.9 22.6 28.7 40.7 39.1 16.7 25.5 25.0 59.4 28.5 33.9 38.2 36.4 37.4 49.7 51.8 28.8 32.0 49.2 41.4 26.1 30.6 31.6 34.3 24.2 39.4 29.1 20.2 20.8 20.4 24.2 33.8 41.1 33.6 53.9 37.9 63.7 52.4 28.1 49.7 41.5 1.5 3.9 2.2 4.0 5.2 5.9 4.8 4.2 4.2 4.9 3.7 3.2 4.8 0.5 4.8 5.9 3.1 6.0 2.8 6.6 8.0 10.2 8.2 7.5 7.1 6.2 6.6 6.1 6.3 7.3 8.8 22.2 16.0 16.7 31.6 17.1 33.0 29.9 17.2 17.1 13.0 16.3 12.8 19.2 11.5 16.1 12.9 12.5 32.7 16.4 9.9 15.6 27.5 189.3 8.9 19.5 22.9 11.4 19.8 72.9 24.1 33.7 20.2 13.3 17.8 14.0 20.2 12.5 12.2 15.4 16.8 57.6 12.4 18.3 9.8 13.0 163.0 17.1 12.2 8.8 36.5 23.8 13.9 20.6 54.3 54.2 19.0 7.0 16.6 22.1 30.3 10.6 17.0 7.3 16.7 13.1 36.4 22.5 26.4 42.1 17.8 34.2 29.6 17.7 30.4 18.3 22.3 NOL11 DKFZP586L0724 ENSG00000130935 "Nucleolar protein 11" Q9H8H0 17 67717931-67744531 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022010 Supported Supported Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA022010: AB_2267158" "unprognostic (6.81e-2)" "unprognostic (2.85e-2)" "prognostic favorable (1.00e-6)" "unprognostic (3.07e-3)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (2.59e-6)" "unprognostic (1.37e-2)" "unprognostic (1.25e-3)" "unprognostic (4.77e-3)" "unprognostic (8.74e-2)" "unprognostic (4.41e-3)" "unprognostic (6.55e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (8.44e-2)" "unprognostic (3.11e-1)" 12.4 8.2 5.0 14.4 5.5 20.8 16.3 9.6 13.0 14.8 6.1 14.8 12.2 15.0 12.7 14.9 14.5 12.7 12.3 5.0 5.3 15.5 18.9 9.8 22.9 5.8 5.4 14.8 14.4 15.6 3.3 17.8 5.9 11.9 15.5 10.3 9.4 11.3 15.5 11.9 10.9 15.6 5.8 12.6 10.2 11.5 5.8 19.7 15.2 17.0 24.5 18.4 6.0 8.9 54.3 63.4 45.7 29.6 21.1 25.3 52.2 37.1 28.6 71.0 58.5 53.5 36.2 86.5 26.8 36.4 47.1 38.4 112.9 54.0 105.7 26.8 92.7 57.9 36.3 48.3 24.7 74.8 34.0 19.8 34.2 52.7 36.9 20.7 67.8 39.1 96.6 25.8 58.8 49.2 89.1 29.6 50.6 61.0 74.4 63.6 101.4 59.8 31.0 57.6 39.4 37.8 32.8 84.7 40.3 63.3 60.5 44.0 26.5 64.3 44.7 21.7 75.7 16.2 45.5 93.7 26.4 54.8 37.6 12.8 6.3 4.6 9.7 7.6 10.4 10.6 10.2 11.9 8.9 13.0 16.4 11.9 0.8 13.1 7.7 6.5 11.8 9.4 5.0 5.5 9.6 13.0 5.0 5.3 5.8 5.4 5.9 5.8 5.8 8.9 25.5 28.9 18.6 10.4 33.7 33.4 38.9 30.5 27.9 21.9 15.8 11.8 18.6 21.5 27.8 9.2 14.6 45.4 33.8 13.1 11.7 23.5 1.7 17.1 28.9 26.0 27.5 24.2 11.3 17.8 37.1 25.0 20.4 18.7 24.1 31.9 16.8 25.3 20.3 25.2 11.4 16.8 26.4 11.8 11.8 4.3 20.8 15.7 17.8 8.4 19.5 15.8 21.6 13.0 16.3 16.6 9.2 19.2 17.4 24.9 12.2 28.6 24.8 32.7 6.6 25.9 21.8 30.2 35.0 26.8 33.2 33.0 32.0 27.0 21.9 25.4 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615335-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 44.3 43.9 29.5 21.7 30.8 29.5 42.0 32.2 34.0 37.5 28.2 44.8 26.8 37.7 23.4 38.2 35.5 16.6 48.2 28.7 31.1 58.5 37.9 32.2 25.8 30.9 31.4 40.7 48.9 40.2 35.9 21.1 31.0 35.1 19.8 16.6 38.0 19.2 44.5 36.9 36.4 16.0 30.8 37.8 37.9 41.7 30.7 15.2 37.1 17.1 20.3 41.4 34.9 33.8 71.7 37.2 31.7 42.7 26.9 26.1 74.4 71.8 29.3 48.4 44.4 60.0 24.9 97.8 137.4 34.4 57.7 46.5 46.9 42.4 47.8 57.5 105.0 91.2 36.3 104.0 45.4 112.0 61.4 25.5 41.5 42.5 24.2 29.8 33.6 45.5 135.7 22.2 44.7 38.1 70.6 147.6 42.1 37.0 74.1 74.4 46.8 140.5 57.9 21.7 92.5 60.3 40.9 88.0 94.9 36.2 53.6 42.8 65.7 48.0 51.9 57.8 108.3 66.2 123.2 100.2 30.7 70.7 75.6 34.5 59.6 82.1 59.2 76.4 68.2 104.0 84.7 71.4 73.2 87.8 90.7 69.0 27.4 61.9 82.9 91.4 96.0 67.9 29.5 30.8 32.2 34.0 28.7 31.1 30.9 31.4 31.0 30.8 30.7 33.8 103.1 93.0 73.5 10.4 112.5 90.8 117.3 151.0 50.1 62.1 78.9 97.0 214.9 68.6 112.0 57.0 22.9 137.4 71.5 72.7 123.3 188.7 202.3 105.8 95.0 109.2 37.1 89.4 14.0 261.2 153.8 90.9 58.1 91.6 90.6 67.0 61.1 61.8 115.1 48.8 17.1 97.8 130.2 52.6 81.8 38.9 82.6 78.5 101.4 8.4 119.7 124.2 78.2 13.6 19.0 175.0 94.3 79.4 138.8 121.7 81.2 163.6 135.6 61.7 65.7 92.5 119.4 186.3 112.9 70.8 90.5 155.3 99.5 99.2 91.0 117.2 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli "Mitotic chromosome" "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 8.6 5.8 4.2 8.0 5.8 6.8 10.0 5.0 5.3 8.2 5.2 8.6 6.0 9.8 7.4 8.7 7.4 6.5 6.8 4.1 5.3 7.2 5.5 6.9 12.0 5.6 5.4 11.2 7.1 12.6 3.2 7.6 5.6 7.4 8.3 5.8 7.8 8.5 6.3 7.2 5.9 9.9 4.6 9.8 6.2 6.1 6.0 12.6 10.5 6.2 12.6 8.6 5.1 7.1 18.9 27.1 13.4 24.2 28.5 24.3 19.8 19.7 14.9 20.9 18.7 11.2 18.5 54.2 16.3 20.1 33.8 39.9 43.5 25.8 22.3 36.3 21.4 37.1 25.9 22.4 20.3 63.2 30.5 24.0 23.5 22.0 31.6 16.7 23.7 16.3 60.7 17.1 22.5 29.7 42.7 24.8 21.4 28.4 26.8 29.8 37.9 23.0 10.6 13.4 23.0 12.3 25.3 25.1 18.0 17.3 9.5 21.2 24.9 18.3 14.0 26.7 25.0 17.7 37.5 26.7 18.5 37.4 26.6 18.9 8.3 11.3 11.4 10.8 15.8 13.0 11.3 11.8 12.1 12.9 13.3 11.7 3.1 13.2 15.7 10.2 13.8 7.1 4.2 5.8 5.0 5.3 4.1 5.3 5.6 5.4 5.6 4.6 6.0 7.1 25.4 19.2 33.4 15.7 33.8 13.0 18.4 15.3 21.1 17.9 14.7 20.6 28.4 14.3 19.8 11.0 10.4 19.5 37.7 10.1 15.6 23.5 13.9 17.9 46.2 23.9 9.0 37.6 12.1 12.9 20.1 25.8 23.9 20.8 52.4 30.6 16.1 11.5 26.5 28.6 12.5 16.9 6.1 17.7 12.1 9.4 32.0 23.9 10.6 18.7 34.5 12.4 43.3 15.6 25.9 16.1 11.2 23.7 36.5 23.3 10.3 15.8 21.2 17.7 6.6 29.3 21.5 73.3 50.2 25.4 15.9 14.6 30.1 33.4 20.3 12.2 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554513 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 2: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoli "Intermediate filaments" "HPA036347: AB_2675076" "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 3.8 4.6 4.5 3.5 5.0 7.5 3.7 4.9 5.6 4.7 1.9 5.0 2.4 5.0 3.6 4.7 4.3 2.3 4.5 6.2 4.2 4.4 5.3 3.2 5.2 3.3 3.8 4.8 6.0 3.4 4.0 3.0 3.8 4.1 3.1 4.3 3.6 3.1 7.0 6.0 4.8 3.9 2.7 8.8 4.5 3.7 4.6 3.8 3.4 4.5 5.1 4.5 3.8 4.0 6.4 9.1 5.0 15.2 6.6 4.0 5.4 6.3 4.1 6.4 6.8 12.6 8.6 17.9 7.3 7.1 5.5 8.3 10.2 8.6 10.9 7.3 5.5 12.2 14.7 9.9 6.6 10.4 6.4 5.8 2.6 13.6 11.8 3.7 7.6 7.8 14.3 7.3 6.6 11.2 10.2 9.2 6.9 5.0 8.7 12.7 11.7 8.3 5.1 5.8 9.7 4.4 9.7 12.1 8.1 5.1 7.9 4.8 10.0 10.1 8.1 7.2 10.6 6.1 6.2 31.9 9.4 11.4 4.9 3.5 1.9 1.6 3.1 1.9 3.2 2.9 4.5 2.9 1.3 3.7 4.6 3.8 1.2 1.7 3.2 3.5 3.2 1.2 4.5 5.0 4.9 5.6 6.2 4.2 3.3 3.8 3.8 2.7 4.6 4.0 15.0 19.2 19.5 9.4 16.2 15.4 6.9 6.9 10.8 17.1 9.8 13.2 15.0 11.5 7.4 7.3 14.6 14.8 17.3 6.7 15.6 8.9 6.0 13.7 19.7 15.2 6.7 11.6 18.9 8.6 12.6 15.3 11.7 15.6 5.1 18.3 14.3 13.2 9.1 10.1 18.5 10.9 4.1 13.8 7.3 17.0 9.6 8.6 1.8 10.3 13.4 8.1 12.3 13.0 20.1 9.0 6.2 12.8 17.9 7.3 7.6 10.7 9.0 18.2 0.0 22.6 12.7 11.7 21.5 16.0 14.8 12.7 17.3 19.1 13.2 7.3 NOP53 "GLTSCR2, PICT-1, PICT1" ENSG00000105373 "NOP53 ribosome biogenesis factor" Q9NZM5 19 47745546-47757058 "Predicted intracellular proteins" "Host-virus interaction, Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1" "Cell line enhanced" "Detected in all" "NB-4: 1305.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018999, HPA049600" Approved Supported Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoli "HPA018999: AB_1849733, HPA049600: AB_2680831" "unprognostic (2.08e-3)" "unprognostic (1.84e-1)" "unprognostic (4.02e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.56e-2)" "unprognostic (3.62e-3)" "unprognostic (1.89e-1)" "unprognostic (9.27e-2)" "unprognostic (2.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" 400.7 245.3 101.7 175.2 105.0 242.1 420.4 97.4 125.9 589.9 106.6 440.5 185.0 405.7 77.3 320.0 424.5 39.4 273.8 93.6 99.7 259.3 224.7 219.1 213.6 114.7 103.5 790.1 1016.5 123.0 201.7 78.4 105.4 386.3 64.1 70.2 397.0 104.5 308.6 635.8 333.6 60.1 108.4 358.9 445.3 116.5 107.3 225.3 302.8 110.0 128.3 411.8 422.5 105.6 99.7 103.0 90.7 214.6 110.6 184.2 176.8 60.6 110.5 57.8 85.3 95.5 194.8 440.3 87.0 71.2 44.2 139.8 52.9 88.8 30.2 133.0 177.8 142.6 85.1 113.5 163.0 207.4 271.6 162.5 198.9 50.8 136.1 188.0 92.3 183.1 176.8 206.5 52.3 86.9 577.2 1305.4 209.4 173.4 60.0 380.4 160.8 209.8 112.6 151.9 96.8 340.9 50.6 330.7 330.0 65.8 156.2 493.7 114.4 56.4 150.2 49.2 125.8 306.3 290.6 120.9 71.2 145.4 92.4 21.5 23.3 26.3 55.3 35.3 74.5 311.8 108.2 96.0 33.1 238.5 244.1 108.6 3.3 96.7 25.1 41.6 120.0 15.8 101.7 105.0 97.4 125.9 93.6 99.7 114.7 103.5 105.4 108.4 107.3 105.6 229.4 41.7 120.7 0.0 210.4 0.0 0.0 0.0 0.0 0.0 605.5 415.5 0.0 0.0 69.3 104.8 0.0 454.3 224.1 0.0 266.1 266.5 0.0 100.6 156.9 94.5 0.0 0.0 0.0 989.2 570.3 107.2 0.0 115.5 68.1 268.3 0.0 0.0 259.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.1 0.0 0.0 269.8 0.0 0.0 0.0 0.0 348.1 0.0 0.0 61.8 0.0 0.0 369.7 18.2 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 506.8 131.3 226.3 0.0 0.0 NOVA1 NOVA-1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443090-26598033 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.9;Excitatory neurons: 414.9;Oligodendrocyte precursor cells: 1269.7;Oligodendrocytes: 319.5" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.3;ASC diff: 25.6;HAP1: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 70: Brain - Nervous system development" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 23.4 5.4 44.0 2.4 39.7 0.1 28.9 85.4 56.3 12.1 18.9 11.6 1.4 8.5 4.9 2.9 6.7 4.8 3.3 38.8 65.3 6.1 0.9 1.4 3.4 50.3 51.2 5.0 1.2 2.4 19.3 0.1 48.5 5.6 5.1 13.4 2.7 15.9 4.3 4.7 3.6 9.5 49.2 0.9 3.3 8.8 71.1 1.2 3.4 8.7 4.5 5.9 8.4 45.5 0.0 11.6 53.3 0.0 25.6 14.6 0.1 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.7 0.7 7.1 0.1 23.7 0.2 0.0 0.0 1.8 0.0 0.1 0.3 8.5 0.0 2.1 16.8 0.0 3.6 2.9 17.8 10.3 8.7 0.0 0.1 8.4 0.0 9.8 0.1 13.5 0.0 10.9 1.3 14.8 0.2 6.8 9.1 15.5 9.4 0.0 0.0 0.0 4.2 1.1 0.0 0.0 6.5 7.7 5.2 1.4 0.0 0.0 0.0 8.8 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 44.0 39.7 85.4 56.3 38.8 65.3 50.3 51.2 48.5 49.2 71.1 45.5 24.8 0.0 1.5 141.0 0.2 5.2 5.9 0.0 4.6 222.9 51.5 29.6 1.1 5.7 0.0 14.7 4.2 0.1 1.4 6.6 9.8 0.4 20.1 0.6 15.0 9.4 65.9 0.0 414.9 0.4 0.0 188.8 0.5 0.2 0.0 18.2 38.6 0.5 0.2 136.3 203.5 7.1 0.0 0.6 10.5 16.5 150.4 2.1 3.6 93.7 0.0 32.3 0.0 1269.7 319.5 2.0 11.7 65.8 1.9 6.7 0.3 30.3 4.4 12.0 6.6 28.6 17.7 163.1 64.3 0.7 3.1 0.0 1.5 30.0 8.4 0.6 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.5;Excitatory neurons: 89.9;Inhibitory neurons: 136.6;Oligodendrocyte precursor cells: 142.2;Oligodendrocytes: 50.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;HDLM-2: 4.0;Karpas-707: 4.4;PC-3: 11.1;RPTEC TERT1: 5.8;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted in other tissues" No NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: AB_2680226" "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 2.3 3.4 2.9 0.5 2.8 0.0 3.3 8.5 3.1 5.8 0.0 2.1 0.2 1.2 1.1 1.6 3.3 1.2 1.2 2.0 2.4 0.8 0.1 0.4 0.8 3.2 2.6 7.5 2.7 8.1 3.5 0.3 3.0 3.1 0.1 1.3 6.5 1.9 5.0 3.6 0.7 0.3 1.5 1.7 0.8 2.1 2.6 0.5 0.7 0.1 0.4 3.1 1.8 2.3 0.0 1.6 0.1 6.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.0 2.8 2.1 0.3 0.1 0.1 4.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.1 0.1 0.0 4.4 0.0 0.2 0.0 0.0 0.1 0.0 11.1 0.1 0.0 0.0 5.8 1.5 4.2 2.5 0.0 2.7 2.6 0.0 0.0 0.0 0.1 1.9 0.3 0.0 1.3 0.8 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.8 8.5 3.1 2.0 2.4 3.2 2.6 3.0 1.5 2.6 2.3 15.9 0.0 0.0 71.5 1.6 2.8 9.7 0.9 29.0 16.6 4.0 16.0 2.2 0.0 0.5 1.8 0.0 0.1 3.2 0.1 1.9 0.4 0.6 2.6 8.2 2.6 0.0 0.0 89.9 2.2 0.0 2.7 0.5 0.4 0.0 1.3 1.8 0.0 0.1 6.7 136.6 0.1 0.0 0.3 1.3 0.6 9.6 0.6 3.6 8.4 0.3 11.2 5.2 142.2 50.8 0.5 0.0 10.1 2.7 2.6 0.0 1.7 1.0 1.0 6.6 10.9 2.2 2.7 9.4 1.0 0.3 0.0 2.8 4.0 0.1 6.2 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 219.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 14: REH - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: AB_2679704, HPA060036: AB_2684193" "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 30.4 10.2 5.8 10.2 5.2 26.4 14.2 14.9 6.9 24.7 6.5 18.2 16.8 18.2 13.4 9.4 21.4 10.3 5.4 6.4 8.1 15.9 26.9 8.9 8.7 4.8 4.5 13.3 14.4 7.4 3.2 14.6 5.3 10.3 18.1 31.8 6.1 8.4 22.3 4.1 18.3 20.1 6.4 13.1 8.9 8.1 6.7 17.0 5.6 23.8 7.2 14.1 8.4 8.3 22.1 43.5 34.6 0.0 17.4 11.3 12.6 26.1 11.7 16.0 12.5 8.7 17.3 0.1 14.5 23.3 7.9 11.0 2.2 15.6 33.9 0.0 10.0 33.4 15.3 27.2 10.5 16.7 6.7 14.1 21.3 17.6 20.5 17.8 12.6 4.8 24.1 17.4 11.4 11.8 7.8 0.1 14.5 8.8 13.9 92.4 28.0 0.8 9.8 35.8 3.2 0.1 21.7 11.3 8.8 27.7 27.2 12.9 22.0 13.7 9.1 21.4 10.8 8.5 0.2 0.1 29.0 0.0 6.8 0.0 0.4 0.2 0.3 0.2 1.8 0.3 0.3 0.4 0.6 1.0 0.5 0.2 0.1 0.5 0.5 0.6 0.2 0.2 5.8 5.2 14.9 6.9 6.4 8.1 4.8 4.5 5.3 6.4 6.7 8.3 33.2 48.1 37.6 60.7 27.4 18.6 122.6 16.2 22.8 33.9 52.9 26.8 18.3 21.5 40.9 29.5 50.1 16.4 20.7 50.1 9.8 23.0 15.8 60.9 99.1 43.0 37.7 24.2 123.7 27.6 120.8 42.3 26.5 130.9 31.5 94.0 27.1 44.7 45.7 21.9 95.0 41.6 18.3 50.4 21.9 19.3 37.6 57.9 8.8 219.2 40.4 56.2 27.8 102.1 78.2 31.4 42.6 27.1 10.1 49.5 43.0 36.5 15.9 63.1 32.9 112.1 38.6 12.1 6.3 23.1 18.8 14.1 19.9 71.0 47.7 99.8 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8" "Cell type enhanced" "Detected in many" "Astrocytes: 239.3;Early spermatids: 119.6;Excitatory neurons: 360.0;Inhibitory neurons: 277.8;Late spermatids: 148.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 499.6" "Group enriched" "Detected in some" 4 "glioma: 2.5;testis cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-138 MG: 100.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 19000000 "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 12.8 3.7 31.3 0.8 33.2 0.1 7.8 30.7 34.3 12.8 0.0 3.4 0.5 10.4 3.2 1.3 15.0 1.6 5.8 38.8 25.8 5.1 1.0 5.3 1.2 21.5 19.6 7.2 1.0 0.1 12.2 1.0 22.1 9.0 2.0 5.2 6.8 4.3 1.8 4.8 2.2 3.7 10.9 2.5 3.2 9.8 33.4 1.2 3.0 1.9 2.0 8.7 7.4 21.5 0.0 13.1 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 2.6 0.1 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 100.6 1.8 0.0 1.3 0.0 0.0 0.0 3.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 31.3 33.2 30.7 34.3 38.8 25.8 21.5 19.6 22.1 10.9 33.4 21.5 0.5 0.0 0.0 239.3 0.0 0.5 6.4 0.0 0.0 53.8 3.7 6.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 119.6 0.4 25.0 1.2 0.0 0.0 360.0 0.0 0.0 5.7 0.0 0.5 0.0 0.0 2.2 0.0 1.0 1.7 277.8 0.0 0.0 0.0 0.6 148.9 3.4 0.6 0.0 177.1 0.0 8.6 0.0 499.6 7.4 0.0 0.0 27.4 0.0 1.3 0.0 0.1 0.0 3.7 52.6 20.3 40.9 11.0 3.7 0.0 0.1 0.1 0.2 0.0 0.0 0.7 NUDT16 FLJ31265 ENSG00000198585 "Nudix hydrolase 16" Q96DE0 3 131381671-131388830 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 179.8;Proximal enterocytes: 334.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4" "Group enriched" "Detected in all" 4 "dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060452, HPA062492" Uncertain Supported Nucleoplasm,Nucleoli NA NA 38000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 18: U-2197 - ECM organization" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nucleoli" "HPA060452: AB_2684279, HPA062492: AB_2684781" "unprognostic (4.85e-3)" "prognostic favorable (9.39e-5)" "unprognostic (3.19e-3)" "unprognostic (9.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (9.96e-2)" "unprognostic (1.15e-1)" "unprognostic (5.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-2)" "prognostic favorable (1.05e-7)" "unprognostic (3.29e-1)" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (9.44e-2)" 30.6 19.0 39.3 15.2 40.1 10.4 22.9 35.9 49.3 17.1 28.6 25.6 22.2 19.4 11.0 11.1 22.7 9.8 32.9 34.1 38.3 27.7 33.8 26.2 12.3 40.7 39.6 25.2 14.7 48.6 15.8 8.1 40.9 17.8 19.5 18.8 16.1 13.6 24.7 11.6 57.6 12.6 41.7 36.0 21.3 12.2 41.2 6.7 24.4 24.5 10.1 20.9 14.0 40.8 20.8 10.8 17.5 9.2 34.3 31.0 8.1 16.5 15.1 10.9 11.3 16.8 9.0 3.4 14.1 15.4 21.5 14.8 15.7 10.4 17.3 10.4 11.5 8.7 15.3 16.4 22.0 14.9 15.4 27.8 9.0 7.2 19.5 9.7 17.2 0.0 10.2 17.4 10.7 21.5 0.0 4.0 13.6 20.6 16.0 11.6 12.6 26.1 10.8 16.6 8.6 15.0 9.9 9.9 15.6 14.7 21.6 11.7 17.1 17.7 7.6 32.8 13.0 17.1 18.1 0.5 11.5 11.2 10.0 7.2 41.7 47.0 6.0 54.6 6.2 11.2 6.0 5.5 32.4 10.5 5.3 5.4 34.0 9.8 63.4 4.3 10.7 17.4 39.3 40.1 35.9 49.3 34.1 38.3 40.7 39.6 40.9 41.7 41.2 40.8 56.1 16.0 41.1 4.6 13.0 8.4 12.3 21.1 10.8 22.8 22.2 20.2 85.2 44.3 23.9 20.2 8.4 21.0 11.5 58.8 68.4 24.7 77.8 27.2 25.5 33.0 25.3 17.9 5.6 36.9 26.1 27.8 36.2 33.1 19.6 23.0 78.1 107.5 65.1 43.7 3.0 74.7 18.3 179.8 25.3 37.5 26.4 73.6 17.8 3.7 64.6 14.2 17.5 3.0 4.6 31.1 66.7 39.5 14.3 19.5 334.3 109.4 19.8 19.2 26.3 22.1 30.7 28.2 6.3 15.4 5.4 7.3 15.1 68.2 48.5 16.0 OARD1 "C6orf130, dJ34B21.3, MGC19570, TARG1" ENSG00000124596 "O-acyl-ADP-ribose deacylase 1" Q9Y530 6 41033627-41097787 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 294.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029036 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA029036: AB_10602336" "unprognostic (2.33e-2)" "unprognostic (5.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (6.50e-2)" "unprognostic (1.45e-1)" "unprognostic (3.62e-2)" "unprognostic (7.06e-2)" "unprognostic (5.54e-2)" "unprognostic (3.99e-3)" "unprognostic (3.46e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.13e-4)" "unprognostic (4.78e-1)" "unprognostic (7.85e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" 20.9 25.5 26.4 20.3 30.5 26.3 30.1 28.5 32.3 19.5 26.5 28.8 31.4 17.6 38.3 23.3 30.1 19.3 22.0 26.0 28.4 44.3 59.2 17.3 28.5 29.7 28.3 35.7 40.6 34.9 22.6 20.0 30.4 25.0 31.1 43.8 25.6 22.0 25.5 21.6 30.2 15.0 28.8 23.0 39.5 58.6 28.2 39.7 30.9 37.1 33.4 20.0 20.1 35.6 44.2 25.0 55.8 40.6 32.1 37.6 36.9 28.0 36.5 29.1 31.4 39.7 33.1 61.7 29.3 15.4 32.1 33.4 38.1 33.1 41.0 53.2 18.6 73.8 28.0 75.4 29.1 50.1 47.6 28.7 45.6 28.1 102.2 26.5 20.3 77.4 95.4 48.8 32.2 59.0 88.1 55.1 51.4 294.4 17.3 36.8 52.4 54.7 58.0 21.4 60.5 38.7 25.5 25.2 88.6 43.2 41.9 42.3 21.9 32.0 39.3 20.0 43.6 65.8 72.7 140.1 25.2 48.5 27.1 49.1 21.8 42.4 26.2 23.3 34.3 45.7 30.6 26.6 26.8 43.2 37.2 36.9 20.8 45.0 28.2 26.0 37.2 22.7 26.4 30.5 28.5 32.3 26.0 28.4 29.7 28.3 30.4 28.8 28.2 35.6 30.5 16.0 40.9 7.8 49.8 28.6 40.3 51.8 38.7 63.2 47.5 41.1 43.4 52.9 40.6 60.7 45.9 89.5 44.1 28.5 86.1 42.9 164.2 43.3 19.6 34.2 22.1 56.4 2.9 48.0 60.2 23.5 37.8 29.8 48.2 21.7 35.0 69.5 45.6 42.1 3.9 52.2 50.8 53.4 37.0 153.8 28.3 33.4 35.6 3.7 42.1 75.9 59.8 4.0 13.1 34.6 44.0 25.9 29.3 37.1 63.0 112.9 56.6 70.5 26.3 23.9 26.7 193.0 148.0 43.4 29.3 45.6 47.5 34.2 61.7 32.4 ORC4 "HsORC4, ORC4L, Orc4p" ENSG00000115947 "Origin recognition complex subunit 4" O43929 2 147930396-148021604 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015124, HPA064562" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli" "CAB015124: AB_2157883, HPA064562: AB_2685287" "unprognostic (5.04e-2)" "unprognostic (6.56e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.98e-8)" "unprognostic (5.55e-2)" "unprognostic (8.00e-2)" "unprognostic (1.81e-2)" "unprognostic (4.92e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.10e-6)" "unprognostic (2.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.62e-1)" "unprognostic (1.95e-3)" 9.7 11.2 11.5 10.1 13.1 19.3 14.6 21.6 16.3 9.0 8.7 12.6 12.0 12.0 11.0 10.6 14.2 9.7 11.6 12.8 10.8 20.5 12.8 9.3 10.9 9.6 7.9 16.7 8.2 16.2 7.6 10.1 10.0 12.1 13.8 19.7 13.4 10.3 15.0 9.3 11.4 11.5 7.6 8.9 9.4 15.5 10.9 15.7 15.6 10.9 11.9 10.2 6.6 14.4 22.8 19.3 37.2 20.4 14.2 13.9 39.9 25.2 21.3 31.3 31.0 47.9 22.6 29.3 26.8 15.1 27.7 22.4 43.4 25.2 32.4 20.6 36.1 40.2 19.0 32.8 18.8 25.9 14.5 11.9 29.4 34.0 13.9 23.3 21.4 27.5 38.8 14.9 21.2 23.8 20.1 20.9 42.3 18.9 28.0 21.6 24.9 26.5 34.5 46.3 35.0 27.4 22.6 24.7 30.1 33.6 18.9 12.2 15.5 23.5 23.2 17.3 23.4 14.7 37.9 27.5 19.1 20.0 14.6 24.1 13.1 18.3 13.6 17.5 13.9 14.1 12.9 13.9 16.4 14.5 13.4 13.5 18.8 19.3 14.0 8.3 15.1 11.7 11.5 13.1 21.6 16.3 12.8 10.8 9.6 7.9 10.0 7.6 10.9 14.4 21.5 83.3 62.5 53.5 26.0 26.0 21.8 47.1 27.3 48.7 20.3 24.0 25.9 11.5 66.1 12.9 39.6 40.3 27.3 21.7 45.0 31.6 34.0 47.9 17.6 23.8 22.9 46.5 88.4 17.2 48.2 27.7 14.3 26.1 45.5 28.3 19.2 17.1 23.8 53.8 91.4 18.9 28.5 18.8 20.7 15.7 22.4 19.7 21.4 34.7 22.0 33.8 24.7 69.9 71.3 18.3 15.4 21.4 12.8 24.4 23.2 55.4 85.8 37.5 32.9 23.2 31.5 61.2 26.8 22.6 24.9 32.7 25.6 16.9 21.8 20.6 OSBPL3 "KIAA0704, ORP-3, ORP3, OSBP3" ENSG00000070882 "Oxysterol binding protein like 3" Q9H4L5 7 24796540-24981634 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000691, HPA048401" Enhanced Supported Nucleoli,Cytosol NA Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoli "HPA000691: AB_1854814, HPA048401: AB_2680386" "unprognostic (3.57e-1)" "unprognostic (1.14e-1)" "unprognostic (6.11e-3)" "unprognostic (3.89e-2)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.57e-3)" "unprognostic (4.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (2.34e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" 2.6 1.2 3.6 6.8 4.2 4.1 3.9 2.8 5.9 10.2 3.8 5.9 9.3 2.2 0.8 7.6 5.1 5.0 2.6 3.9 4.4 16.0 1.2 8.6 11.3 3.8 3.7 5.2 1.9 14.1 2.0 3.9 3.5 2.2 6.0 1.3 3.7 2.5 3.3 10.3 7.6 3.7 3.1 6.8 8.5 2.8 4.5 8.3 9.8 2.0 14.4 13.3 6.5 5.1 40.2 10.7 7.8 14.4 17.3 34.5 17.5 44.5 49.3 20.4 32.1 27.0 52.0 22.2 6.2 47.8 26.9 34.6 23.6 33.4 31.4 13.5 9.8 5.3 16.4 20.4 24.5 15.3 113.8 17.0 27.2 26.7 31.8 26.0 31.0 19.0 28.4 30.1 34.9 0.0 9.4 18.7 15.3 38.1 13.7 7.5 21.6 9.1 20.4 28.2 1.6 16.1 30.3 21.5 6.7 23.0 11.1 1.5 37.1 9.1 17.9 49.4 33.7 20.7 32.8 55.6 19.5 24.7 102.0 5.8 1.9 1.5 8.5 1.7 7.3 3.3 5.3 5.6 3.3 1.6 1.8 3.5 0.4 7.7 1.2 2.3 9.5 2.5 3.6 4.2 2.8 5.9 3.9 4.4 3.8 3.7 3.5 3.1 4.5 5.1 2.2 0.0 26.1 123.1 18.3 12.1 8.0 8.8 21.6 0.3 3.8 4.4 5.5 5.7 22.2 25.8 0.0 8.4 13.2 3.8 3.9 3.5 0.3 24.6 2.3 3.6 1.8 11.1 176.1 3.9 2.1 3.1 19.4 31.9 0.0 0.4 3.6 0.5 10.8 0.0 272.2 1.7 20.3 12.7 9.3 0.3 0.6 13.2 16.0 94.6 7.8 4.8 14.4 44.2 3.6 24.4 4.5 0.0 91.7 5.2 3.3 0.5 53.1 0.2 0.0 3.4 4.6 0.5 5.0 16.5 8.0 4.0 18.5 20.3 4.5 16.5 PAK1IP1 "bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84" ENSG00000111845 "PAK1 interacting protein 1" Q9NWT1 6 10694972-10709782 "Predicted intracellular proteins" "Ribosome biogenesis" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030111, HPA030112" Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA030111: AB_2732454, HPA030112: AB_10603125" "unprognostic (9.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.67e-2)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (7.23e-2)" "unprognostic (9.29e-3)" "unprognostic (1.06e-3)" "unprognostic (2.14e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.02e-8)" "unprognostic (8.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.11e-1)" "unprognostic (2.10e-1)" 13.5 10.3 5.6 7.6 5.7 10.6 12.4 5.7 8.1 9.3 5.5 8.4 4.2 10.3 7.2 16.3 8.4 5.2 9.6 5.7 6.2 9.3 11.3 7.3 7.8 5.7 6.0 8.0 9.6 5.7 6.7 7.0 5.9 37.8 7.3 4.9 9.2 5.7 15.2 8.8 7.1 8.1 5.8 8.2 7.8 5.7 5.9 7.0 7.5 9.7 9.6 11.5 9.9 6.9 35.3 13.7 17.2 29.9 21.3 19.4 24.9 22.4 18.7 33.7 32.9 30.2 15.4 35.6 54.9 19.4 41.4 18.4 35.8 29.2 48.1 20.9 23.3 19.4 12.4 35.2 31.1 54.5 24.3 17.9 25.2 32.6 55.3 11.1 22.9 19.2 60.2 10.0 28.3 21.2 27.4 49.5 37.4 32.7 24.1 27.9 22.4 55.0 24.4 21.0 25.7 22.4 16.8 42.7 51.1 28.9 18.9 19.6 19.6 26.9 19.5 29.2 56.4 23.3 68.7 38.9 11.0 36.3 51.7 2.0 8.1 2.9 9.4 12.4 9.6 10.0 8.3 9.4 11.7 7.2 11.1 13.5 0.4 9.9 10.3 13.7 5.9 6.8 5.6 5.7 5.7 8.1 5.7 6.2 5.7 6.0 5.9 5.8 5.9 6.9 22.6 19.2 12.3 8.8 18.5 66.4 54.2 47.3 30.1 13.2 18.6 28.3 18.6 17.2 35.0 11.0 4.2 24.9 24.8 10.3 19.6 43.3 12.4 26.0 35.0 24.1 5.4 31.1 9.9 26.9 32.0 32.0 14.8 34.3 35.5 16.6 15.0 21.7 36.6 13.5 10.9 12.7 42.7 16.1 12.6 8.4 21.5 18.2 12.4 6.5 22.1 12.0 12.3 9.5 12.5 31.3 7.7 20.7 18.2 56.5 5.1 27.0 17.7 11.8 6.6 40.9 31.4 27.3 44.2 29.3 49.9 17.5 16.3 23.1 24.0 28.6 PARP2 "ADPRTL2, ARTD2" ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343615-20357904 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA052003: AB_2681689" "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 17.7 21.1 21.1 10.7 22.0 26.8 17.5 21.4 31.4 18.1 16.4 19.3 12.8 20.9 17.8 14.6 17.5 10.0 17.1 22.5 21.0 15.5 17.2 13.5 14.5 19.5 18.9 22.9 17.9 11.1 21.0 12.9 19.8 13.9 14.0 26.4 14.2 13.4 32.4 19.2 14.2 15.8 19.0 16.5 16.3 23.8 19.8 11.9 16.7 27.1 17.9 13.8 15.3 22.1 55.5 39.5 59.7 45.3 19.4 18.4 43.4 60.2 32.5 74.8 91.8 36.8 51.3 40.4 26.5 19.0 64.8 50.1 78.3 27.5 87.8 32.4 38.3 37.2 46.6 63.3 17.3 77.9 20.4 12.5 23.0 45.5 51.1 20.5 38.5 48.0 39.2 53.4 52.3 33.5 40.1 33.0 33.0 62.8 60.0 49.7 79.7 26.5 30.0 28.2 41.3 28.3 65.3 36.8 17.9 37.4 34.2 25.8 26.6 45.3 68.1 31.5 48.1 49.3 67.7 53.4 19.0 33.3 51.4 1.9 5.0 0.5 8.9 4.8 11.7 6.8 8.4 7.9 5.5 4.1 9.0 8.6 0.1 7.6 2.6 5.6 5.3 4.8 21.1 22.0 21.4 31.4 22.5 21.0 19.5 18.9 19.8 19.0 19.8 22.1 12.1 25.6 6.5 7.2 9.5 6.5 10.5 16.1 18.8 29.2 7.4 10.0 14.0 5.7 19.9 7.3 12.5 25.8 10.2 4.5 7.9 12.8 9.3 9.9 13.3 11.0 4.8 30.3 17.6 8.7 22.2 11.6 7.7 11.3 8.2 18.4 6.8 10.1 11.9 30.3 15.5 5.0 14.2 4.6 5.1 9.8 11.5 6.6 8.8 9.4 4.2 20.7 6.2 6.0 9.3 10.1 4.5 17.0 19.1 4.5 5.3 7.4 28.0 23.2 6.6 9.8 18.5 20.9 41.5 11.3 4.8 14.9 6.2 16.7 7.4 7.0 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679362 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "esophagus: 81.0;lymphoid tissue: 20.5;parathyroid gland: 43.0;salivary gland: 51.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001572, CAB016239" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoli Nucleoplasm "CAB016239: AB_2159984, HPA001572: " "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 7.3 0.1 0.7 0.0 0.2 0.3 81.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.1 43.0 2.2 0.0 0.0 3.7 0.1 0.0 51.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 20.5 0.7 0.0 8.5 0.7 7.1 0.0 5.3 2.3 0.0 2.5 2.1 3.8 2.0 0.0 0.3 0.0 0.0 1.6 1.8 1.6 0.8 0.0 0.5 11.4 2.1 12.3 0.0 58.3 7.3 0.9 1.2 0.0 0.0 0.0 4.2 0.7 6.0 0.0 1.9 0.0 0.0 5.3 2.3 0.3 0.2 7.3 0.9 0.0 0.1 1.9 18.9 0.0 0.0 0.0 0.0 6.9 3.4 0.0 1.3 7.0 1.4 0.9 5.1 0.0 0.0 0.0 0.6 2.2 1.0 0.0 0.1 4.4 0.7 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.4 45.3 174.8 0.0 1.6 1.3 0.4 0.0 25.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.4 0.0 0.2 0.2 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.7 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 20.9 0.0 0.0 26.8 0.0 0.0 0.1 2.0 2.4 0.9 172.0 0.3 0.1 0.1 0.0 0.6 12.1 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373312-134428791 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 6.7 18.0 6.6 14.2 7.9 8.4 10.8 10.3 9.3 8.3 6.2 9.1 8.9 9.7 32.7 8.2 7.9 6.6 6.7 7.1 8.4 10.2 7.7 6.8 25.3 8.3 7.8 33.3 9.5 16.3 6.2 9.3 8.4 9.2 10.3 12.0 13.2 11.0 5.0 8.3 8.8 8.1 8.6 13.3 9.3 9.2 7.7 20.8 13.2 6.8 29.8 8.6 7.1 11.5 28.2 22.9 98.7 40.8 17.9 22.9 18.7 27.6 22.1 29.1 35.6 13.9 28.5 45.1 61.8 16.9 28.3 24.6 69.4 31.3 48.6 37.2 32.1 44.3 37.7 16.1 19.2 44.2 23.3 15.3 23.2 31.7 39.2 29.1 41.1 43.1 32.6 21.8 35.8 18.7 71.3 21.8 30.1 38.3 31.0 69.6 36.0 34.5 30.7 33.8 34.1 39.9 21.2 19.3 29.5 29.0 18.0 24.0 31.5 26.8 19.2 34.0 42.9 11.1 27.3 60.5 17.7 51.4 34.3 5.9 6.3 4.1 8.0 6.6 8.7 18.7 8.2 7.3 9.5 12.4 9.6 8.2 2.6 11.0 8.4 11.7 9.1 5.5 6.6 7.9 10.3 9.3 7.1 8.4 8.3 7.8 8.4 8.6 7.7 11.5 25.5 22.4 18.4 13.1 42.7 13.0 14.3 28.7 22.2 22.4 17.5 20.3 16.3 11.5 17.8 16.5 18.8 11.8 27.1 9.9 23.5 14.2 3.7 13.0 29.1 18.7 11.4 31.3 27.8 13.8 7.6 17.2 14.8 18.7 24.6 149.5 20.0 15.2 15.1 18.5 23.4 12.5 10.2 15.5 10.2 3.1 20.8 20.2 7.2 29.0 25.3 27.9 21.6 33.2 46.7 14.4 18.7 15.4 23.1 12.3 9.5 19.8 16.5 19.7 26.3 21.0 21.9 10.3 22.0 25.7 11.5 4.7 22.6 69.3 17.7 11.5 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76031776 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 159.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1438.7;Basal squamous epithelial cells: 582.8;Urothelial cells: 760.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 6 "monocytes: 1.1;T-cells: 1.6" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 296.3;RPTEC TERT1: 233.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 21.3 31.0 9.9 17.3 10.1 21.8 28.1 8.9 11.0 23.1 6.2 8.9 6.5 13.4 4.4 59.8 7.8 39.3 20.6 10.3 11.3 14.8 67.6 27.1 5.9 10.8 16.9 19.2 17.9 5.3 8.2 14.3 11.3 8.9 10.2 13.8 159.1 8.2 5.8 11.5 8.6 14.8 9.6 19.5 22.5 3.1 11.5 7.4 27.2 1.5 7.5 60.9 33.7 11.3 60.9 71.5 54.9 30.4 25.0 51.6 3.9 50.5 134.7 22.4 30.8 39.7 72.2 0.3 14.8 21.2 73.8 30.7 1.5 84.2 47.9 9.3 1.2 1.5 3.8 68.2 36.3 1.4 15.1 16.2 60.6 93.2 182.6 296.3 54.4 0.1 5.0 1.7 115.8 7.8 0.2 7.9 20.1 36.3 108.7 0.2 14.3 1.8 233.7 135.1 4.0 10.4 8.8 0.8 169.5 67.8 35.5 0.7 50.8 75.8 7.2 89.3 50.4 0.8 0.3 0.2 127.9 0.8 96.7 0.2 0.0 0.0 0.9 0.1 1.5 0.0 0.9 1.0 0.0 0.0 0.1 0.2 0.2 0.0 1.1 0.0 1.6 0.2 9.9 10.1 8.9 11.0 10.3 11.3 10.8 16.9 11.3 9.6 11.5 11.3 98.5 12.8 12.4 7.2 13.0 195.3 1438.7 249.6 582.8 5.2 136.2 140.3 34.8 11.5 44.4 31.3 2.1 4.7 42.9 11.6 84.1 74.8 2.2 11.5 111.2 162.5 117.7 0.0 7.8 43.1 11.5 203.2 55.0 20.4 79.5 7.1 21.4 127.8 94.7 1.7 14.6 41.0 384.5 14.0 123.4 2.1 9.3 110.8 286.4 8.4 24.0 97.8 0.0 142.2 2.7 208.4 27.7 15.4 19.0 116.1 0.2 39.3 12.4 5.2 269.5 59.8 276.3 0.7 3.2 66.3 75.6 7.4 132.8 20.7 18.0 760.3 PIM1 PIM ENSG00000137193 "Pim-1 proto-oncogene, serine/threonine kinase" P11309 6 37170152-37175428 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 219.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 321.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 321.3" "Cell line enhanced" "Detected in all" "HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003941, CAB017040" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Nucleoplasm, Nucleoli" "CAB017040: , HPA003941: AB_1079618" "unprognostic (1.25e-2)" "unprognostic (4.77e-1)" "unprognostic (3.61e-2)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.91e-2)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (4.64e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (7.32e-2)" "unprognostic (2.14e-3)" "unprognostic (8.16e-3)" "unprognostic (1.04e-1)" "unprognostic (5.26e-3)" "unprognostic (2.90e-1)" 152.8 14.4 8.5 42.3 8.6 219.0 46.2 10.5 10.7 82.9 10.0 45.8 39.2 46.3 2.6 201.5 66.4 52.6 65.4 7.9 11.6 27.0 58.0 49.8 38.5 15.1 12.2 60.4 20.4 3.4 14.8 28.9 12.8 22.5 17.8 8.2 41.1 7.5 36.3 109.8 44.4 38.1 12.3 61.7 40.3 10.7 11.6 26.6 22.7 5.8 26.8 101.6 113.3 12.1 19.1 7.9 12.1 6.7 27.2 14.5 141.9 6.7 20.3 13.5 21.5 28.3 26.2 38.3 10.4 8.0 30.2 21.7 12.7 20.1 12.3 174.4 8.4 219.9 8.7 37.0 27.9 3.8 391.5 49.0 24.5 12.4 8.3 14.9 4.0 9.2 192.7 59.7 2.2 5.0 12.3 19.9 22.7 35.4 12.1 29.7 22.0 45.7 3.9 114.4 58.8 11.9 14.7 1.7 3.8 27.9 3.2 6.5 7.4 7.8 23.3 35.6 8.5 28.0 15.9 735.7 3.4 55.3 8.1 321.3 8.0 113.5 60.3 7.3 77.7 7.1 53.4 53.8 6.3 5.2 47.1 36.9 61.7 39.8 4.2 1.9 41.3 42.1 8.5 8.6 10.5 10.7 7.9 11.6 15.1 12.2 12.8 12.3 11.6 12.1 41.1 22.4 16.0 2.9 35.1 127.8 166.5 63.3 26.7 4.9 9.6 5.3 36.0 18.6 37.6 9.2 0.0 36.5 55.0 50.4 5.9 40.6 4.8 40.3 125.8 33.3 37.1 368.2 2.4 17.2 121.8 67.4 26.0 92.0 49.3 27.5 11.0 33.8 53.6 15.2 2.2 12.4 44.7 44.3 47.4 12.4 8.1 53.9 44.4 4.7 72.3 7.6 112.3 1.0 0.9 60.7 34.2 3.0 190.1 109.6 51.1 17.2 12.9 1.7 0.0 34.2 41.3 14.5 33.9 92.8 228.6 80.7 118.0 1.1 7.8 455.2 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, Pxr1" ENSG00000254093 "PIN2 (TERF1) interacting telomerase inhibitor 1" Q96BK5 8 10764961-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 20.0;Extravillous trophoblasts: 13.0;Hofbauer cells: 16.1;Syncytiotrophoblasts: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Cluster 35: T-regs - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 9.9 7.7 7.2 8.9 8.4 9.1 9.9 8.9 8.9 9.7 6.1 9.9 6.2 9.3 4.5 12.1 8.8 4.0 8.2 7.4 7.1 11.6 11.7 8.0 11.5 7.2 7.1 9.8 9.0 6.1 6.4 7.2 7.4 8.1 6.1 12.0 7.3 4.2 13.5 14.4 7.7 8.5 7.0 9.3 8.2 9.7 7.4 13.0 8.2 9.3 11.1 10.2 10.5 7.7 14.5 18.9 20.1 19.2 16.6 13.5 23.1 21.5 9.7 23.2 15.6 20.0 12.4 38.5 7.4 11.7 28.3 28.6 51.4 39.9 29.8 15.7 15.3 16.2 13.3 22.0 18.8 17.4 9.7 11.3 24.9 18.3 34.0 8.2 32.7 25.8 52.3 23.1 22.9 17.1 57.7 21.8 46.3 62.6 21.0 46.5 24.5 35.2 17.5 17.5 16.6 17.3 14.5 17.0 48.3 24.3 18.1 21.7 20.0 13.9 30.3 18.0 28.1 10.3 29.0 71.2 14.4 32.6 32.1 1.9 8.4 6.1 14.6 10.7 18.9 12.9 12.8 15.6 11.1 10.8 17.1 13.5 0.5 12.5 9.9 8.6 16.1 10.4 7.2 8.4 8.9 8.9 7.4 7.1 7.2 7.1 7.4 7.0 7.4 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 13.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 48.2 0.0 0.0 0.0 0.0 PNKP PNK ENSG00000039650 "Polynucleotide kinase 3'-phosphatase" Q96T60 19 49859882-49878351 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006782 Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA006782: AB_1855496" "prognostic favorable (9.18e-4)" "unprognostic (1.87e-1)" "unprognostic (4.31e-2)" "unprognostic (4.23e-1)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (4.55e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.24e-2)" "unprognostic (3.68e-3)" 18.9 45.1 12.0 21.0 12.9 26.4 21.2 12.8 16.2 21.1 24.2 21.6 16.0 21.3 13.5 19.4 22.9 10.6 23.9 14.4 11.9 27.3 22.4 22.2 17.5 14.0 14.0 23.7 28.6 16.7 36.8 11.1 14.3 25.3 13.1 10.1 21.6 12.4 18.5 17.8 22.8 11.5 12.8 37.2 25.0 21.2 13.3 12.3 31.9 7.8 15.3 19.4 18.0 14.1 27.5 17.4 19.1 27.2 15.8 13.4 28.6 43.4 21.2 18.7 17.7 17.5 34.2 18.4 13.6 13.6 11.3 23.5 6.1 25.9 10.9 22.3 27.2 30.0 36.7 14.8 12.2 25.8 36.3 13.2 13.0 17.9 11.0 16.9 26.3 23.4 14.9 34.3 24.7 18.8 28.7 23.5 16.0 28.3 37.4 24.3 15.9 34.7 21.0 68.5 20.6 33.4 19.3 52.5 9.2 14.5 10.2 14.8 36.0 37.6 24.9 9.6 35.8 38.7 16.5 13.0 33.8 12.3 30.8 1.8 12.3 16.7 9.2 11.5 7.9 9.1 7.8 7.3 9.8 12.2 5.7 5.0 23.4 3.9 18.1 5.5 9.1 5.8 12.0 12.9 12.8 16.2 14.4 11.9 14.0 14.0 14.3 12.8 13.3 14.1 23.6 16.0 23.6 5.9 47.2 13.4 35.4 29.9 25.6 40.9 28.1 23.7 11.1 21.5 19.1 20.2 81.3 44.5 37.7 40.0 23.5 42.5 15.0 25.2 28.5 26.6 30.5 17.1 6.0 39.9 35.1 19.1 31.6 28.0 29.1 54.6 35.0 20.1 39.5 33.7 6.0 31.7 24.4 27.7 19.0 32.9 59.4 26.8 14.2 8.4 46.1 18.4 96.8 6.0 5.7 44.6 22.3 44.8 40.4 33.6 27.1 36.1 33.8 73.9 19.7 17.9 20.1 19.4 28.9 23.3 13.1 49.3 39.2 83.0 34.1 35.6 PNO1 "KHRBP1, RRP20" ENSG00000115946 "Partner of NOB1 homolog" Q9NRX1 2 68157888-68176238 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056928 Supported Nucleoplasm,Nucleoli NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA056928: " "unprognostic (1.81e-3)" "unprognostic (4.83e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.88e-2)" "unprognostic (1.66e-3)" "prognostic unfavorable (3.04e-8)" "unprognostic (5.82e-2)" "unprognostic (2.59e-2)" "unprognostic (1.16e-1)" "unprognostic (9.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.66e-2)" 15.1 14.2 6.4 12.1 8.0 19.5 11.6 7.0 11.8 7.6 6.9 9.7 7.6 9.8 11.2 11.1 8.8 9.9 10.2 12.0 7.3 14.1 12.6 8.6 12.6 6.7 6.9 7.0 12.7 12.5 7.1 12.7 6.8 10.0 9.1 19.0 7.1 10.8 20.1 9.1 6.7 11.5 6.7 8.2 8.8 8.9 6.9 8.1 12.5 12.6 12.2 19.8 7.6 7.4 37.8 40.1 18.5 30.5 22.5 18.3 46.0 34.7 23.0 39.1 27.8 77.9 21.9 51.4 28.5 23.6 54.0 31.6 60.6 41.9 61.3 35.2 40.6 49.7 17.4 58.2 34.6 40.2 22.4 24.1 30.2 39.4 45.0 11.3 29.1 32.7 69.7 27.3 35.7 27.4 39.9 38.1 52.0 68.7 43.1 33.3 45.2 54.8 29.8 31.7 32.7 24.0 26.1 32.4 57.8 29.7 22.9 22.4 21.2 44.2 48.0 40.1 97.9 21.6 33.1 78.1 36.3 59.1 62.1 0.9 12.6 2.8 12.2 18.1 19.1 19.2 13.8 14.4 16.8 14.5 16.0 14.6 2.4 15.0 13.0 11.8 16.0 21.3 6.4 8.0 7.0 11.8 12.0 7.3 6.7 6.9 6.8 6.7 6.9 7.4 23.7 16.0 13.2 3.3 29.9 83.2 62.8 29.5 25.6 22.7 18.6 18.4 11.9 18.6 36.2 7.3 12.5 39.5 20.2 7.9 19.6 36.7 33.5 28.7 37.7 25.5 17.3 21.4 10.6 29.8 43.5 28.3 9.7 20.9 31.6 13.6 12.5 15.8 26.0 18.5 9.0 12.1 30.5 10.4 38.7 7.7 12.5 20.7 12.4 4.7 18.9 21.0 14.4 7.1 10.4 29.1 5.8 16.6 27.8 56.6 4.6 34.7 28.6 51.3 6.6 40.4 29.6 28.9 41.7 21.0 56.1 47.6 25.7 20.5 20.2 37.6 POP1 ENSG00000104356 "POP1 homolog, ribonuclease P/MRP subunit" Q99575 8 98117293-98159835 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066194 Supported Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA066194: AB_2732742" "prognostic unfavorable (2.54e-4)" "unprognostic (9.42e-2)" "unprognostic (5.96e-3)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (7.46e-2)" "prognostic unfavorable (1.26e-6)" "prognostic unfavorable (9.88e-4)" "unprognostic (4.85e-1)" "unprognostic (1.47e-1)" "unprognostic (3.79e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-1)" 2.1 1.6 1.7 3.5 1.5 1.5 2.1 3.4 2.3 1.4 1.2 1.9 1.5 1.7 1.4 3.0 1.8 1.3 1.6 1.3 1.2 2.0 1.9 1.6 3.6 1.1 1.4 2.9 1.7 1.7 1.5 1.2 1.1 1.5 4.8 2.4 1.4 1.3 1.7 3.0 1.6 1.8 0.8 2.1 1.9 3.1 1.6 2.6 1.5 1.2 4.4 2.5 1.5 1.8 21.9 12.9 13.8 12.8 4.8 3.3 9.1 18.3 15.2 18.7 13.8 13.4 13.8 15.3 25.6 12.9 9.0 14.3 40.3 18.2 18.9 11.1 17.0 30.0 10.2 9.2 2.1 16.4 18.4 2.8 3.3 20.8 8.2 5.7 14.8 7.2 17.0 13.5 17.7 17.4 23.8 8.3 10.4 25.1 17.6 19.4 7.5 11.0 13.5 11.5 32.8 7.7 8.4 14.2 6.4 7.9 19.2 6.0 18.4 16.3 11.6 20.8 36.5 13.3 13.6 32.7 12.8 17.3 14.6 9.4 5.1 3.9 7.4 5.7 6.0 4.9 5.4 5.0 5.0 8.1 6.8 6.5 0.8 3.8 2.9 6.2 4.9 2.1 1.7 1.5 3.4 2.3 1.3 1.2 1.1 1.4 1.1 0.8 1.6 1.8 2.3 3.2 3.9 10.7 4.7 3.7 8.2 3.8 4.0 7.0 2.5 2.3 3.9 0.0 3.8 5.5 0.0 4.1 4.1 2.7 5.9 8.8 13.8 2.4 6.4 4.2 0.0 5.0 17.7 5.9 3.4 5.8 6.6 2.9 1.3 5.9 1.8 5.4 3.4 1.7 19.0 1.7 2.0 2.4 0.8 3.0 5.3 3.3 0.0 3.7 7.9 2.7 10.3 8.5 11.0 7.8 1.0 4.5 5.2 4.8 1.1 8.5 2.6 9.5 6.6 4.0 6.1 7.7 19.1 9.8 2.4 3.0 4.4 6.1 3.9 5.1 POP4 RPP29 ENSG00000105171 "POP4 homolog, ribonuclease P/MRP subunit" O95707 19 29606283-29617237 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042748, HPA064577" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 9: U-2 OS - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA042748: AB_10964774, HPA064577: " "unprognostic (5.88e-2)" "unprognostic (2.78e-2)" "unprognostic (7.21e-2)" "unprognostic (4.00e-3)" "unprognostic (4.50e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (3.31e-4)" "unprognostic (8.35e-2)" "unprognostic (2.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.20e-2)" "unprognostic (9.47e-2)" "unprognostic (5.84e-2)" "unprognostic (4.21e-1)" "unprognostic (1.77e-2)" "unprognostic (5.23e-3)" "unprognostic (8.08e-3)" 11.3 13.6 8.9 5.2 9.4 6.3 10.6 10.0 9.5 8.8 8.5 11.1 4.7 9.7 3.8 13.3 7.7 2.5 14.1 9.1 9.6 13.4 14.4 8.1 5.9 10.1 9.5 7.8 9.5 3.9 8.3 3.7 9.8 8.8 2.9 3.6 10.5 3.2 18.8 11.6 10.5 3.5 9.7 11.4 11.6 12.8 9.8 5.0 9.2 4.0 4.7 9.6 9.3 10.5 44.5 61.9 5.3 5.4 7.8 3.9 26.5 42.1 4.9 9.3 9.3 28.6 10.5 35.2 72.1 7.3 10.1 20.6 10.8 10.0 5.3 79.9 65.1 42.0 19.4 18.2 7.5 51.4 21.6 4.4 8.0 7.9 4.8 5.0 8.2 18.5 34.8 8.0 8.2 36.9 29.7 8.6 10.3 13.6 39.5 19.0 44.7 18.0 5.6 17.1 15.1 16.6 44.4 15.4 18.5 5.0 15.5 12.5 30.0 13.4 40.5 23.1 37.1 30.3 59.7 44.1 17.1 24.8 13.5 73.1 39.7 40.3 35.5 52.1 26.1 48.1 34.2 37.5 39.9 36.4 27.1 32.4 23.3 36.5 43.0 33.2 53.0 45.8 8.9 9.4 10.0 9.5 9.1 9.6 10.1 9.5 9.8 9.7 9.8 10.5 26.4 22.4 20.0 4.9 29.8 12.6 20.0 61.0 15.9 16.6 18.5 21.0 26.1 27.1 29.6 33.1 8.4 53.4 25.8 29.5 80.3 59.5 18.2 29.8 21.5 27.1 17.4 21.4 4.6 78.3 45.0 22.8 17.3 22.6 26.0 22.1 25.4 40.2 62.1 11.8 4.3 27.5 46.8 26.2 18.3 15.3 16.4 27.3 24.9 0.0 57.4 34.1 52.5 4.0 5.8 66.2 26.6 28.2 33.6 20.3 39.4 72.4 38.0 15.5 26.3 18.6 27.8 71.0 15.4 21.4 16.1 47.3 27.4 31.7 26.2 19.5 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581402 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA047598: AB_2680096, HPA069204: " "unprognostic (1.50e-2)" "prognostic favorable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 27.0 51.3 5.2 5.6 6.1 9.5 25.6 6.0 8.9 20.7 6.1 24.6 6.0 21.8 2.4 25.9 20.1 5.1 42.5 5.5 5.9 38.3 40.5 19.0 10.8 6.1 5.7 17.2 25.2 7.3 26.2 2.1 6.4 24.3 2.8 1.2 25.2 4.8 22.9 22.4 24.6 3.5 6.2 31.8 25.4 10.2 5.8 7.9 27.4 3.6 4.3 24.3 21.0 6.4 22.2 43.4 3.8 8.7 10.1 4.5 14.7 14.2 5.7 13.6 11.2 36.6 6.6 13.4 26.9 7.8 6.1 15.7 8.0 30.1 1.1 41.4 42.1 13.5 20.3 26.5 12.1 11.7 11.3 14.1 11.2 13.5 2.4 3.4 8.9 30.2 18.2 5.6 7.5 45.0 18.9 11.2 8.0 14.6 36.5 20.5 9.8 28.5 11.5 18.5 7.4 8.7 27.7 6.5 15.7 2.8 27.5 20.7 11.8 8.1 13.2 13.6 19.8 16.1 35.8 16.7 20.5 21.6 13.3 4.5 12.7 3.1 17.7 14.9 16.4 25.2 14.2 16.2 16.8 18.0 17.6 16.3 0.9 16.0 14.1 26.6 15.8 20.8 5.2 6.1 6.0 8.9 5.5 5.9 6.1 5.7 6.4 6.2 5.8 6.4 24.2 12.8 27.6 10.1 47.8 19.6 38.6 83.7 34.1 22.0 37.5 50.4 60.5 37.1 59.3 77.3 14.6 51.7 49.3 21.6 154.6 44.9 1.7 39.9 30.5 25.4 22.1 30.1 6.4 44.9 42.9 33.8 32.6 24.8 54.6 24.0 24.3 58.3 53.2 18.5 6.9 30.5 54.9 19.8 21.7 5.0 36.1 35.7 49.8 7.5 33.4 79.3 52.5 10.6 8.2 40.0 21.9 37.6 56.8 23.6 31.2 136.2 45.2 34.4 19.7 27.5 39.4 22.7 43.8 53.3 24.7 17.6 46.1 106.3 44.2 33.5 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706121-100707486 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 25.6 31.7 30.1 18.1 31.6 33.9 26.6 33.4 38.6 24.2 23.8 27.9 19.3 27.7 11.0 34.0 21.3 9.8 37.6 32.3 30.8 25.8 67.1 18.2 17.3 30.1 27.8 18.1 31.3 16.6 22.8 16.6 30.8 22.6 9.2 9.6 29.0 13.5 69.0 50.2 22.3 12.1 29.4 22.7 26.4 12.5 29.1 15.6 16.8 31.9 12.0 25.4 24.9 33.9 115.7 115.3 47.2 78.4 25.1 23.9 92.0 65.6 32.4 73.7 73.1 159.8 71.0 97.5 105.1 30.0 81.4 70.4 70.1 79.5 36.8 82.7 212.4 44.9 75.0 166.5 42.1 69.2 49.8 27.6 30.2 76.2 74.8 20.9 41.6 68.9 157.4 77.8 39.8 330.4 158.0 232.9 135.2 77.8 164.4 123.6 50.0 159.4 45.3 65.2 90.4 92.3 54.5 156.2 78.7 42.0 50.0 66.2 41.3 92.0 117.7 191.0 127.6 34.0 99.4 175.8 61.0 115.1 104.6 106.3 63.2 72.4 54.7 64.7 50.7 60.3 54.6 54.3 55.3 47.7 49.5 52.0 39.0 78.9 70.3 51.2 69.8 62.5 30.1 31.6 33.4 38.6 32.3 30.8 30.1 27.8 30.8 29.4 29.1 33.9 30.5 19.2 17.0 2.9 29.7 105.0 32.0 57.2 56.3 26.1 61.6 64.1 27.9 37.1 31.5 35.0 6.2 148.2 25.8 51.8 93.9 75.4 2.1 31.2 32.3 37.2 40.2 50.1 5.2 87.4 181.3 37.3 25.0 35.1 17.7 32.4 33.5 99.0 66.1 32.0 6.0 61.7 67.1 27.3 40.7 7.9 42.0 22.4 56.9 2.8 38.7 41.8 41.2 4.0 5.8 92.2 47.6 37.2 55.1 75.6 69.8 86.1 27.8 21.3 46.0 29.8 52.2 9.2 45.5 74.7 119.2 139.3 27.2 39.9 55.8 43.5 PPID CYP-40 ENSG00000171497 "Peptidylprolyl isomerase D" Q08752 4 158709127-158723396 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Protein transport, Transport" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019520, HPA019692" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA 480000 "Cluster 2: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 10: Non-specific - Unknown function" Cytosol "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA019520: AB_1847400, HPA019692: AB_1847401" "unprognostic (4.26e-2)" "unprognostic (2.03e-2)" "unprognostic (8.91e-3)" "unprognostic (8.17e-3)" "unprognostic (1.50e-1)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.62e-2)" "unprognostic (4.72e-2)" "unprognostic (5.92e-2)" "unprognostic (4.54e-2)" "unprognostic (1.46e-2)" "unprognostic (2.66e-3)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.64e-1)" "unprognostic (1.09e-1)" 26.8 38.3 38.0 24.4 40.2 25.1 22.8 40.4 77.6 25.4 46.4 33.9 50.6 24.2 19.0 27.7 24.1 18.8 49.6 40.1 44.2 39.5 87.6 19.8 28.6 39.0 39.4 24.2 31.7 17.0 28.6 21.6 40.2 23.5 20.3 36.2 23.3 18.7 88.9 36.1 45.3 18.9 39.6 29.1 29.0 24.1 42.2 24.3 23.9 45.5 25.8 27.4 24.0 46.9 46.7 42.3 41.8 57.7 60.7 45.2 63.1 44.9 24.3 40.3 30.4 55.4 30.9 48.9 19.7 42.0 63.4 35.1 127.9 51.5 48.8 162.9 44.4 87.5 36.5 76.9 46.8 55.6 63.0 28.9 41.2 34.6 51.5 52.0 44.6 81.9 111.0 84.4 45.5 44.6 80.0 49.9 57.9 75.5 55.8 35.9 20.7 41.7 44.6 23.0 70.2 47.1 33.8 69.2 65.6 60.0 31.9 52.2 43.7 40.1 45.3 44.7 60.2 48.3 107.2 62.0 51.1 59.4 41.1 68.8 23.9 55.2 31.1 35.4 36.0 22.3 30.2 29.1 26.4 25.4 30.9 32.0 32.9 40.5 37.7 26.9 37.0 28.0 38.0 40.2 40.4 77.6 40.1 44.2 39.0 39.4 40.2 39.6 42.2 46.9 29.2 6.4 13.4 13.1 24.8 10.1 29.7 17.5 9.1 30.2 19.1 20.8 59.7 25.8 27.9 27.6 22.9 41.5 38.7 17.1 37.2 39.2 39.0 66.1 39.9 25.1 19.6 17.4 24.3 23.0 49.5 24.3 14.3 28.5 32.3 24.4 17.2 18.5 41.9 75.7 28.6 28.3 22.4 17.0 14.7 23.1 20.5 26.0 14.2 9.4 51.6 23.3 48.4 15.1 28.3 29.5 27.4 22.6 22.3 31.6 39.7 33.7 62.3 32.3 6.6 17.7 58.2 96.0 77.5 16.9 11.8 47.6 33.7 33.7 32.0 20.2 PPIL1 CYPL1 ENSG00000137168 "Peptidylprolyl isomerase like 1" Q9Y3C6 6 36854827-36874803 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062916 Supported Nucleoli NA NA 21000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli "HPA062916: AB_2684904" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-3)" "unprognostic (1.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.81e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (2.01e-1)" "unprognostic (3.37e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.58e-2)" "unprognostic (5.49e-2)" "unprognostic (8.99e-2)" "unprognostic (1.30e-1)" "unprognostic (2.30e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-2)" 12.4 21.7 20.3 19.1 21.9 11.4 18.4 22.6 27.3 15.0 23.8 14.7 13.2 15.7 19.1 17.0 23.0 10.7 42.8 20.0 25.2 18.9 21.5 10.5 21.9 22.0 22.0 17.7 14.3 21.7 12.0 22.3 23.3 16.8 17.6 29.1 19.5 17.6 18.5 9.5 11.3 22.9 24.1 9.5 12.9 23.2 22.2 18.6 33.2 20.7 24.6 20.5 8.0 22.8 69.2 50.0 111.2 78.5 19.7 31.5 77.5 60.9 41.0 82.7 70.0 89.7 39.7 87.7 75.5 41.9 105.5 55.4 135.1 92.7 96.2 81.3 114.6 102.7 33.6 147.7 53.5 89.3 40.8 24.7 48.7 62.3 118.9 31.8 75.5 79.1 202.4 48.0 63.3 71.2 101.9 69.8 92.3 108.5 57.9 79.4 100.2 92.0 63.2 53.5 140.0 68.5 41.8 51.4 102.5 83.5 76.3 100.2 44.0 66.7 69.0 58.5 98.8 57.0 145.2 153.0 23.7 183.7 139.4 1.6 4.8 1.3 14.7 6.2 19.7 10.3 12.1 13.9 9.2 7.4 13.4 15.9 1.2 7.3 3.4 7.8 10.2 9.8 20.3 21.9 22.6 27.3 20.0 25.2 22.0 22.0 23.3 24.1 22.2 22.8 5.7 6.4 7.5 2.9 10.8 3.1 18.6 12.2 5.7 16.9 9.0 10.5 45.8 8.6 8.3 5.5 4.2 58.7 6.6 3.3 23.5 25.7 32.0 10.3 14.2 12.3 3.6 22.7 6.5 20.3 72.3 12.2 7.7 7.7 10.8 16.3 5.0 8.2 30.1 16.8 8.6 11.4 4.1 3.3 3.6 11.7 6.8 6.4 7.2 1.9 9.2 41.0 11.3 7.5 5.4 22.1 5.5 12.4 15.0 13.5 3.3 17.1 13.5 15.5 6.6 6.1 12.8 25.7 51.0 10.6 4.5 25.3 9.2 21.1 11.9 8.6 PPM1D "PP2C-DELTA, Wip1" ENSG00000170836 "Protein phosphatase, Mg2+/Mn2+ dependent 1D" O15297 17 60600183-60666280 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022277, HPA061848" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA022277: AB_1858839, HPA061848: " "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "prognostic favorable (3.52e-4)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (5.50e-2)" "unprognostic (1.70e-2)" "unprognostic (6.07e-2)" "unprognostic (2.52e-3)" "unprognostic (3.46e-2)" "unprognostic (1.95e-3)" "unprognostic (7.33e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (1.98e-1)" 4.4 2.4 2.7 2.2 5.2 5.9 3.9 14.8 4.6 4.5 5.0 3.1 2.9 4.3 2.9 3.5 3.7 3.1 2.9 3.3 3.4 2.8 2.8 3.6 2.7 4.0 3.5 6.3 3.3 2.3 2.4 5.9 4.7 3.1 3.5 6.4 3.1 2.2 4.0 2.9 2.7 3.0 3.4 3.8 2.7 5.5 3.7 4.4 2.9 3.1 2.3 2.8 4.0 9.1 3.8 6.9 7.5 6.4 5.0 3.1 10.7 5.8 3.6 3.4 4.9 7.1 2.0 9.9 4.5 3.7 1.3 3.4 4.9 2.2 4.6 1.9 11.1 7.4 6.7 8.1 4.2 2.9 5.3 2.7 3.6 5.1 3.0 2.8 7.9 4.1 5.4 4.0 3.7 34.4 8.1 4.4 3.5 3.4 5.2 9.5 9.6 6.6 3.1 4.2 10.5 7.4 7.1 2.4 1.6 8.0 2.8 3.9 5.7 4.7 12.5 3.5 3.3 6.7 7.7 7.3 1.7 2.9 3.8 9.9 16.1 18.0 7.6 12.5 6.8 8.9 6.3 7.0 16.0 6.2 6.8 7.0 24.7 8.6 8.1 7.0 10.6 9.8 2.7 5.2 14.8 4.6 3.3 3.4 4.0 3.5 4.7 3.4 3.7 9.1 40.9 32.1 7.7 15.0 23.1 21.0 6.2 3.3 52.3 13.1 14.2 9.8 6.3 8.6 4.6 5.5 4.2 17.6 19.4 15.0 3.9 6.6 68.9 14.0 15.5 25.2 14.4 14.1 19.6 6.6 6.4 14.7 10.2 15.6 1.3 7.2 23.6 4.2 8.8 3.3 20.8 11.4 6.1 21.4 19.2 12.8 13.7 16.1 3.6 28.1 12.3 7.0 6.2 20.6 38.6 5.4 10.2 7.5 24.5 7.8 8.7 5.1 3.6 10.4 0.0 12.1 14.0 43.8 15.0 34.4 18.0 38.6 18.1 6.0 11.5 7.7 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "eosinophil: 7.5;neutrophil: 5.4" "Lineage enriched" "Detected in single" 32 "granulocytes: 7.5" "Cell line enhanced" "Detected in many" "U-266/84: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: AB_2681472" "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 3.0 4.0 1.8 1.6 2.0 3.5 3.0 3.2 2.0 5.2 4.2 3.2 1.3 6.0 2.8 2.2 4.6 2.4 3.0 1.6 3.2 1.9 0.4 4.2 0.9 4.1 4.0 10.3 4.8 8.6 3.9 3.5 4.0 4.1 2.9 4.7 1.8 4.3 1.6 1.5 1.8 4.4 4.7 2.4 2.1 3.6 2.9 1.4 5.8 3.0 0.8 2.9 3.3 4.4 2.2 3.4 7.8 0.1 4.5 9.3 9.2 4.7 9.9 4.7 4.2 4.4 1.2 0.4 1.2 6.2 4.5 0.1 0.0 1.0 6.0 0.0 1.4 2.9 3.1 0.3 4.9 10.0 0.1 6.6 2.9 3.3 4.1 4.3 3.4 1.2 0.0 14.2 5.7 0.4 1.5 0.1 5.7 0.8 2.7 0.0 9.3 6.1 1.6 0.0 1.4 6.2 0.0 0.1 0.9 4.0 6.4 4.1 1.4 0.2 2.7 4.8 4.6 13.0 19.7 0.1 3.6 0.1 3.6 0.1 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.0 1.8 2.0 3.2 2.0 1.6 3.2 4.1 4.0 4.0 4.7 2.9 4.4 7.1 12.8 5.6 51.2 0.5 1.7 2.7 2.4 9.1 9.1 1.1 2.4 8.2 2.8 3.8 1.8 8.4 1.0 0.2 1.5 1.9 2.3 75.6 1.4 9.4 6.3 3.6 0.0 25.0 2.5 2.6 9.6 2.6 1.4 2.5 15.5 3.6 0.0 0.8 0.0 31.9 3.6 4.1 0.3 0.7 31.0 8.7 0.6 1.8 23.4 0.2 7.6 0.0 52.8 8.0 1.5 0.8 9.4 0.7 2.6 0.1 0.2 1.8 7.5 6.6 10.1 6.6 8.2 3.5 4.6 1.7 0.5 1.2 14.9 3.0 0.7 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056674-107067636 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 308.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 4.9 10.0 5.7 7.2 5.6 4.2 8.0 5.6 5.7 6.1 13.8 7.9 6.1 7.0 8.0 6.8 8.8 6.0 3.9 5.2 6.9 12.0 7.1 4.6 9.6 6.1 6.5 8.6 10.9 9.6 8.4 7.3 5.3 8.5 7.2 6.4 6.5 7.8 1.8 5.6 7.2 5.9 5.5 8.3 7.4 6.6 8.2 10.3 7.0 3.1 8.7 7.9 5.0 6.0 13.6 0.2 25.7 11.3 16.6 18.4 7.0 17.8 13.2 16.9 17.2 17.2 9.2 33.1 24.1 16.5 9.2 18.9 23.9 26.2 13.3 0.0 25.4 20.0 35.6 25.0 16.5 41.6 11.9 17.4 14.2 15.2 15.5 11.4 14.8 18.5 27.1 5.0 15.4 308.1 24.5 14.6 11.1 10.6 24.6 30.8 56.0 12.6 41.3 27.1 47.8 58.3 24.2 34.5 12.1 15.5 24.0 30.7 17.2 12.5 25.5 26.3 26.8 5.4 4.0 5.7 18.4 19.3 10.2 2.1 10.4 1.9 7.9 11.9 9.5 7.4 8.3 7.6 14.1 10.3 11.5 11.9 0.6 17.4 12.0 17.2 9.2 9.3 5.7 5.6 5.6 5.7 5.2 6.9 6.1 6.5 5.3 5.5 8.2 6.0 3.0 0.0 4.4 1.3 6.2 4.5 6.9 9.7 8.6 14.2 8.9 5.0 2.6 5.7 5.8 14.7 0.0 18.3 8.5 3.3 27.4 10.3 1.2 5.2 6.2 4.7 17.5 15.8 1.5 7.4 14.6 6.7 4.6 4.9 1.3 9.4 7.5 2.4 10.0 15.2 2.2 7.4 8.2 7.0 1.6 3.0 8.7 3.8 1.8 3.7 3.9 6.9 3.1 2.0 2.2 4.7 8.5 9.1 2.0 5.1 4.1 18.4 7.4 5.1 13.1 5.9 6.3 9.1 8.1 8.9 6.1 7.1 5.0 13.7 10.3 5.4 PTPN6 "HCP, HCPH, PTP-1C, SHP-1, SHP1" ENSG00000111679 "Protein tyrosine phosphatase non-receptor type 6" P29350 12 6946468-6961316 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 131.8;lymphoid tissue: 153.5" "Cell type enhanced" "Detected in many" "B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001466, CAB004572, CAB072845" Enhanced Supported Nucleoplasm,Nucleoli NA NA 6000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm Nucleoli "CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930" "unprognostic (4.28e-3)" "prognostic favorable (1.87e-4)" "prognostic unfavorable (5.42e-4)" "prognostic favorable (6.65e-4)" "unprognostic (6.54e-2)" "unprognostic (7.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.44e-2)" "unprognostic (6.93e-3)" "unprognostic (3.57e-1)" "unprognostic (1.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.60e-3)" "unprognostic (1.98e-3)" "unprognostic (2.60e-2)" "unprognostic (5.91e-2)" "prognostic favorable (2.64e-8)" 14.4 15.6 3.7 102.5 3.9 131.8 11.0 4.3 4.2 11.1 6.0 21.9 30.4 6.2 10.2 12.8 13.9 20.3 4.9 3.6 5.2 12.2 19.3 49.7 153.5 7.0 4.6 2.9 11.9 13.7 10.0 19.8 6.3 11.7 21.3 0.7 17.0 9.0 2.0 18.8 42.0 12.3 5.9 128.0 28.0 3.1 6.3 71.3 12.6 4.5 127.3 27.0 7.5 10.6 16.4 30.8 0.2 0.1 0.1 0.0 28.5 0.0 0.0 0.0 0.0 16.5 36.0 11.9 8.4 0.0 0.0 18.3 0.3 21.6 0.0 7.3 6.5 170.9 3.4 13.9 0.0 154.3 648.7 0.1 15.4 0.0 6.5 0.0 0.0 60.0 0.3 1.3 0.0 34.5 55.4 92.2 8.3 38.0 5.1 50.4 0.2 86.5 16.7 30.2 2.7 0.0 5.2 24.9 0.2 20.9 7.7 259.8 0.4 0.0 0.2 0.1 0.2 0.4 0.2 5.5 0.4 66.3 0.5 676.7 368.3 1112.5 263.4 728.6 169.3 595.0 125.3 195.9 377.0 650.0 142.7 182.6 674.8 238.6 1117.7 98.7 146.8 789.3 3.7 3.9 4.3 4.2 3.6 5.2 7.0 4.6 6.3 5.9 6.3 10.6 10.5 6.4 13.8 0.7 214.6 9.1 8.2 18.8 29.6 0.0 8.6 10.0 2.1 11.5 15.3 5.5 0.0 25.6 77.7 16.0 15.6 15.8 50.4 12.1 1.5 7.5 24.7 22.9 0.9 15.4 18.3 3.0 25.0 11.8 137.3 10.9 8.9 11.6 191.6 0.0 0.9 13.2 18.3 146.5 118.2 10.5 0.9 152.1 14.2 3.7 99.7 0.5 154.5 2.0 0.1 12.6 16.9 0.0 53.5 3.9 22.8 14.3 17.2 0.5 6.6 1.6 4.0 0.3 1.3 14.6 8.7 18.5 86.2 24.5 15.6 7.8 PUM3 "HA-8, hPUF-A, KIAA0020, PEN, Puf-A, PUF6, XTP5" ENSG00000080608 "Pumilio RNA binding family member 3" Q15397 9 2720469-2844095 "Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 338.4;HEL: 327.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002353 Approved Supported Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 36: HEL - Hemostasis" "Cluster 36: Stromal cells - Cell proliferation" Nucleoli "HPA002353: AB_1852266" "unprognostic (1.39e-2)" "unprognostic (1.32e-2)" "unprognostic (7.54e-2)" "unprognostic (2.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (4.89e-5)" "unprognostic (2.02e-1)" "unprognostic (6.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (2.44e-3)" "unprognostic (8.44e-2)" "unprognostic (1.46e-1)" "unprognostic (7.11e-2)" "unprognostic (8.43e-2)" 19.5 16.7 6.2 22.3 5.9 19.0 24.7 8.1 5.6 13.8 4.9 15.8 12.8 14.7 9.8 24.8 13.5 11.7 12.0 5.5 5.7 21.8 15.2 15.4 23.2 5.0 4.7 18.3 14.8 12.2 10.1 18.0 5.3 12.5 18.7 7.4 16.8 10.6 11.1 16.6 11.7 13.6 4.2 14.7 13.2 15.4 5.2 17.1 11.9 9.4 22.0 30.7 16.0 6.7 78.9 56.7 47.0 48.2 38.6 40.8 53.5 71.7 37.6 72.3 67.3 43.6 36.0 86.4 16.1 49.5 43.2 38.8 85.8 62.0 93.5 338.4 30.7 327.8 59.3 52.9 51.0 146.2 58.7 33.3 26.8 58.8 83.5 33.0 54.3 55.6 35.0 38.1 63.8 36.0 74.6 119.9 120.4 59.9 25.1 86.7 36.8 37.3 48.8 52.7 48.4 46.4 43.2 39.8 40.3 52.0 25.2 78.4 52.1 48.6 40.2 46.8 97.1 17.7 31.0 120.5 36.8 52.4 36.1 7.7 13.7 4.1 18.8 19.9 26.3 23.4 19.3 18.9 18.5 22.4 21.2 20.7 1.9 25.2 17.1 20.8 15.7 11.8 6.2 5.9 8.1 5.6 5.5 5.7 5.0 4.7 5.3 4.2 5.2 6.7 27.7 48.1 41.4 0.0 35.8 0.0 59.6 0.0 62.6 28.0 27.5 26.7 0.0 14.3 41.5 23.9 10.4 34.7 25.5 1.9 46.9 41.2 4.8 36.7 79.1 28.3 8.5 23.8 0.0 26.5 45.4 30.9 35.2 54.9 17.7 39.8 20.0 22.1 21.6 26.9 0.0 9.2 0.0 15.8 0.0 4.9 47.2 20.6 0.0 0.0 29.4 14.2 25.7 0.0 0.0 29.1 8.0 23.0 29.2 57.7 7.6 108.3 32.1 24.0 0.0 50.2 26.8 43.7 45.3 54.3 0.0 35.0 26.5 44.5 12.7 38.2 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2 small subunit processome component" Q15269 21 44107373-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6" HPA024573 Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 4.0 3.2 3.3 3.2 4.4 0.9 3.3 3.6 4.4 4.2 2.4 3.6 1.5 3.3 2.6 3.5 5.7 0.5 3.7 3.5 3.2 2.6 3.0 3.2 3.0 3.5 3.5 2.9 4.1 1.9 2.2 2.5 4.2 3.0 0.3 1.2 3.4 1.4 5.0 4.9 3.7 0.5 3.2 4.5 4.6 3.1 3.4 5.6 2.9 7.2 6.9 4.1 3.2 5.7 4.7 0.5 1.5 3.6 10.4 11.4 28.5 39.2 16.9 44.3 29.5 82.9 1.4 84.3 1.4 0.0 4.5 4.2 1.5 26.4 24.7 24.4 59.5 10.8 15.6 19.2 6.2 6.8 2.9 0.7 0.0 27.1 0.0 10.1 1.7 39.2 32.5 33.8 17.1 1.1 0.2 2.1 1.5 4.1 3.3 4.8 0.2 44.1 0.0 1.2 26.8 5.4 2.2 3.0 24.2 14.6 0.9 3.2 20.9 19.6 3.1 42.4 4.3 47.6 66.6 3.7 1.8 10.6 28.4 0.5 2.2 2.5 4.7 2.7 5.8 5.1 4.0 5.1 1.8 3.4 3.7 4.6 1.1 2.7 3.7 2.2 3.3 3.0 3.3 4.4 3.6 4.4 3.5 3.2 3.5 3.5 4.2 3.2 3.4 5.7 0.4 0.0 2.0 0.3 3.2 10.7 0.1 9.6 3.4 0.7 1.1 0.3 4.5 0.0 5.4 0.0 0.0 0.1 2.3 4.6 1.9 0.0 0.1 0.2 0.2 2.0 2.4 4.8 0.0 0.0 2.0 1.8 1.1 0.4 0.0 0.3 2.2 0.3 1.9 0.0 0.0 3.8 6.1 5.4 4.9 0.0 1.2 0.4 1.8 0.0 0.6 0.5 3.1 0.0 0.0 0.0 2.4 0.0 1.5 1.2 1.8 0.3 4.6 0.3 0.0 1.4 3.7 1.4 1.7 0.8 8.5 0.7 2.6 0.5 4.6 0.3 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201486-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 84.7;skin 1: 90.5" "Cell type enhanced" "Detected in many" "Hofbauer cells: 425.8;Kupffer cells: 555.8;Macrophages: 344.2;Paneth cells: 360.0;Proximal enterocytes: 504.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 585.7;classical monocyte: 1098.3;eosinophil: 948.1;intermediate monocyte: 1138.3;myeloid DC: 829.2;neutrophil: 1638.4;non-classical monocyte: 1152.8;plasmacytoid DC: 769.2" "Group enriched" "Detected in all" 6 "dendritic cells: 829.2;granulocytes: 1638.4;monocytes: 1152.8" "Cell line enhanced" "Detected in many" "MCF7: 148.9;NB-4: 237.0;THP-1: 186.9;U-937: 112.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 640000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 31: Skin - Epidermis development" "Cluster 24: NB-4 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 25.6 11.4 4.1 32.9 4.0 43.4 20.4 4.6 8.6 22.1 5.0 48.1 63.9 10.7 0.0 56.1 17.4 4.9 9.7 3.7 5.2 10.9 10.4 32.8 19.1 7.8 5.1 14.9 11.3 1.7 7.7 6.1 6.7 19.9 9.5 0.1 24.6 8.7 3.4 90.5 48.5 5.8 7.6 84.7 22.1 2.3 6.7 9.5 9.1 1.2 12.7 19.8 33.1 11.3 23.9 54.8 0.5 0.2 9.2 18.9 0.6 12.6 22.6 8.8 6.5 0.1 31.7 10.6 0.1 17.6 0.0 69.7 2.9 57.4 0.3 73.0 0.0 9.3 7.9 18.3 25.6 86.9 65.7 24.7 30.3 4.0 1.2 0.2 18.4 0.1 42.9 17.5 2.9 148.9 0.2 237.0 15.7 13.2 0.1 75.5 0.0 35.2 1.3 22.3 0.7 0.2 10.4 0.0 12.4 0.3 15.5 186.9 11.8 0.4 0.7 9.9 0.3 0.6 0.1 0.2 6.4 112.1 0.1 585.7 1098.3 948.1 178.4 1138.3 112.2 213.7 146.5 183.3 829.2 210.7 102.1 139.6 1638.4 219.2 1152.8 769.2 206.4 814.2 4.1 4.0 4.6 8.6 3.7 5.2 7.8 5.1 6.7 7.6 6.7 11.3 35.7 22.4 28.9 0.0 58.5 74.1 66.3 237.0 100.7 0.2 92.2 131.7 2.5 41.5 84.3 25.8 0.0 62.5 158.8 184.5 5.9 90.5 0.8 18.6 16.8 39.2 58.9 42.9 0.1 56.5 11.3 39.3 50.4 7.3 110.9 60.2 48.9 3.3 425.8 0.0 0.1 144.6 75.3 555.8 280.2 2.9 47.2 344.2 97.8 13.1 277.8 0.0 132.8 0.0 0.1 60.4 360.0 22.6 54.1 22.6 504.8 3.6 88.2 0.7 26.3 10.5 28.5 0.3 1.4 83.9 163.7 17.8 70.8 119.9 287.1 70.6 PYM1 "PYM, WIBG" ENSG00000170473 "PYM homolog 1, exon junction complex associated factor" Q9BRP8 12 55901413-55932618 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 110.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012803, HPA039717, HPA046200" Supported Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" No No 27000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 43: THP-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli, Cytosol" "Cell Junctions" "CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556" "unprognostic (3.03e-2)" "unprognostic (1.00e-1)" "unprognostic (5.65e-2)" "unprognostic (8.82e-2)" "unprognostic (1.97e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.29e-1)" "unprognostic (1.32e-2)" "unprognostic (1.59e-2)" "unprognostic (2.22e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" 24.5 30.8 19.8 24.0 20.2 22.5 27.9 21.5 24.8 26.1 22.9 31.1 31.6 22.1 41.5 72.3 22.7 19.8 21.8 19.5 20.7 26.3 43.0 20.8 35.4 20.5 20.6 17.1 28.0 26.3 22.3 22.8 20.5 31.2 30.0 17.4 34.0 15.9 29.8 41.9 29.5 19.8 20.1 31.1 24.1 25.9 20.1 33.2 27.0 29.0 42.1 24.8 31.4 20.2 50.3 39.1 56.1 31.4 33.4 43.2 92.6 36.1 43.1 33.3 28.0 57.7 57.9 62.9 53.6 35.1 15.4 38.6 43.6 77.1 26.7 48.6 32.7 51.0 35.1 71.8 40.7 59.7 44.7 39.2 48.8 37.7 56.0 42.2 35.9 27.3 44.5 67.4 39.7 75.3 38.6 105.7 98.3 56.7 20.2 34.3 22.3 72.5 69.5 69.8 37.7 43.4 46.2 61.1 33.1 51.8 74.5 124.0 28.2 20.0 28.3 31.5 26.6 35.5 58.2 97.2 34.2 40.9 31.9 17.5 79.8 75.8 58.5 92.2 72.3 98.1 105.4 82.2 120.2 88.2 68.7 69.5 19.1 53.1 66.5 65.6 186.0 87.2 19.8 20.2 21.5 24.8 19.5 20.7 20.5 20.6 20.5 20.1 20.1 20.2 16.2 19.2 17.3 0.0 28.6 0.0 29.4 0.0 21.1 12.7 41.7 38.4 0.0 25.8 14.2 23.9 8.4 84.3 21.1 29.8 78.2 40.6 15.2 21.1 17.0 16.3 7.3 32.2 0.0 50.6 76.3 17.6 22.4 21.1 18.9 14.5 22.9 44.3 55.2 6.7 0.0 32.1 0.0 47.7 0.0 11.7 23.3 42.8 0.0 0.0 110.4 55.7 48.4 0.0 0.0 54.1 33.7 23.7 21.9 34.7 66.8 61.3 16.8 13.6 13.1 18.0 15.7 23.8 25.6 63.1 0.0 62.0 29.6 16.5 29.3 34.3 RARA "NR1B1, RAR" ENSG00000131759 "Retinoic acid receptor alpha" P10276 17 40309180-40357643 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 52.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 221.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058282, HPA071548" Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nucleoli, Actin filaments, Cytosol" "HPA058282: AB_2683666, HPA071548: " "unprognostic (8.05e-3)" "unprognostic (1.89e-1)" "unprognostic (9.48e-3)" "prognostic favorable (2.60e-4)" "unprognostic (8.67e-3)" "unprognostic (4.87e-3)" "unprognostic (2.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.45e-1)" "unprognostic (3.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.29e-3)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" 47.6 21.1 3.2 28.3 4.4 59.6 37.2 7.2 16.5 43.7 5.1 31.0 28.4 32.2 10.7 14.9 40.7 41.3 40.8 7.0 5.7 24.1 42.3 58.4 16.4 5.3 2.7 40.8 14.7 11.3 30.6 25.7 2.8 29.8 13.2 18.3 20.6 21.3 62.6 24.8 32.2 28.6 1.8 41.7 22.9 28.8 4.9 10.0 26.9 17.4 11.8 30.3 30.2 4.3 18.0 41.9 11.8 20.5 23.4 35.9 12.5 14.9 21.8 21.5 13.6 28.6 15.1 9.6 22.7 33.2 18.9 51.1 14.2 33.9 12.0 77.5 21.4 26.6 21.2 29.8 37.0 9.4 81.3 48.2 10.0 22.7 29.2 75.8 30.9 8.4 17.6 20.2 23.7 221.5 6.4 34.2 10.7 16.2 13.3 12.9 71.3 37.0 12.2 14.4 5.4 40.5 31.0 124.8 42.1 11.7 119.1 36.6 35.8 25.3 45.3 44.2 15.4 48.7 16.9 8.3 38.4 18.7 77.1 26.3 8.9 34.6 3.2 14.6 5.1 2.0 3.6 3.8 12.4 1.7 1.5 2.8 52.6 5.9 19.5 3.8 3.1 5.0 3.2 4.4 7.2 16.5 7.0 5.7 5.3 2.7 2.8 1.8 4.9 4.3 35.6 3.2 7.0 2.3 43.4 19.5 25.6 8.4 18.8 23.2 35.4 17.5 3.8 10.0 5.5 7.3 6.2 2.2 36.9 41.2 13.7 16.7 60.5 20.7 22.0 28.4 9.6 5.7 5.4 19.2 5.8 28.5 10.7 18.4 35.5 13.9 26.0 28.8 12.3 3.3 2.6 13.1 6.1 45.4 65.5 66.2 41.7 56.9 28.4 2.8 26.1 11.8 6.2 4.0 0.3 22.0 33.1 23.0 21.0 13.4 70.9 17.7 4.9 10.2 32.9 42.1 26.7 3.6 7.6 7.1 18.9 5.2 31.7 6.5 16.5 19.3 RBBP5 "RBQ3, SWD1" ENSG00000117222 "RB binding protein 5, histone lysine methyltransferase complex subunit" Q15291 1 205086142-205122015 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049042, HPA058085" Uncertain Supported Nucleoplasm,Nucleoli No No "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA049042: AB_2680610, HPA058085: AB_2683600" "unprognostic (8.72e-2)" "unprognostic (6.35e-2)" "unprognostic (2.14e-2)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-1)" "unprognostic (4.61e-3)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "unprognostic (6.90e-2)" "unprognostic (3.78e-3)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "unprognostic (4.88e-2)" 6.3 8.2 4.7 7.2 5.3 9.5 7.9 6.4 6.4 7.8 2.7 7.0 7.1 8.1 7.5 7.0 7.5 6.1 6.4 5.7 5.3 12.4 11.0 6.6 11.3 3.4 3.8 9.5 8.2 9.4 6.1 6.5 3.8 6.9 8.0 9.8 7.6 6.9 8.7 8.5 6.7 7.1 4.3 9.3 6.7 6.1 4.5 13.2 9.8 9.9 12.8 7.5 5.2 6.4 16.3 16.9 16.0 19.0 21.8 12.5 17.3 15.2 12.9 19.0 18.8 17.9 19.1 25.3 11.3 11.1 15.5 18.2 26.9 10.1 22.4 21.6 14.5 21.2 16.4 14.6 14.1 26.9 16.6 10.1 12.9 17.6 15.0 12.7 15.4 17.9 41.6 25.2 16.0 15.0 26.1 11.3 26.1 14.2 27.9 22.9 33.9 31.6 13.2 11.7 25.0 20.1 21.3 22.3 19.2 19.0 24.2 14.9 11.8 15.6 16.6 23.1 20.2 12.2 18.3 30.6 13.9 16.5 24.5 22.0 4.9 7.9 8.0 6.4 8.5 7.8 7.4 8.1 5.4 6.2 7.1 8.7 11.6 8.2 8.3 6.0 8.1 3.5 4.7 5.3 6.4 6.4 5.7 5.3 3.4 3.8 3.8 4.3 4.5 6.4 14.7 19.2 12.2 11.4 31.0 26.9 9.7 5.9 15.9 14.5 18.9 14.6 7.1 8.6 13.4 22.0 29.2 9.1 25.2 15.8 9.8 12.1 7.3 13.1 14.0 13.2 12.1 23.1 19.9 11.6 10.7 13.5 9.7 21.0 13.9 25.6 17.2 21.8 10.9 16.8 15.7 14.0 10.2 15.6 25.9 3.2 12.8 17.9 19.6 8.4 15.6 12.6 15.5 14.6 21.2 13.6 9.8 16.1 25.9 13.5 14.7 28.8 13.2 18.3 19.7 21.9 14.1 10.2 20.4 14.6 33.8 10.8 27.9 12.6 15.8 13.4 RBM19 "DKFZp586F1023, KIAA0682, Mrd1" ENSG00000122965 "RNA binding motif protein 19" Q9Y4C8 12 113816738-113966325 "Plasma proteins, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038860, HPA058732" Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA038860: AB_10697400, HPA058732: AB_2683801" "unprognostic (2.10e-1)" "unprognostic (1.54e-1)" "unprognostic (3.61e-2)" "unprognostic (4.83e-3)" "unprognostic (1.50e-1)" "unprognostic (9.14e-2)" "prognostic unfavorable (5.87e-7)" "unprognostic (9.32e-3)" "unprognostic (2.61e-1)" "unprognostic (5.14e-2)" "unprognostic (4.43e-2)" "unprognostic (3.53e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" 11.5 14.1 7.4 12.5 8.5 16.4 13.5 5.7 8.8 13.8 7.9 13.8 8.7 13.1 8.3 12.5 12.9 6.4 11.6 6.5 7.1 13.4 12.3 12.2 14.0 8.7 7.9 18.9 14.2 10.1 12.7 9.9 8.8 15.1 8.9 7.7 12.6 8.4 16.7 12.5 13.5 9.0 5.1 13.3 13.3 11.9 10.3 10.4 20.8 9.3 12.9 14.4 12.4 11.1 13.0 25.6 15.0 29.3 14.7 11.7 22.7 22.9 17.9 25.3 18.5 34.4 17.7 23.1 13.9 19.5 18.5 18.1 35.4 22.1 19.8 42.0 20.8 49.6 28.0 33.4 11.1 37.9 22.7 14.6 14.3 31.0 11.2 16.2 18.6 17.8 54.3 9.3 15.9 19.4 21.4 28.6 32.8 12.9 21.6 28.2 14.4 20.1 17.3 24.9 17.9 14.4 20.5 29.3 14.2 12.4 32.3 10.9 21.3 16.6 20.3 14.4 14.3 16.7 13.5 22.7 22.3 26.7 21.5 0.1 4.4 1.3 7.7 7.7 6.0 7.3 5.5 6.4 6.1 5.9 4.4 6.0 0.2 7.6 12.4 4.2 5.4 4.8 7.4 8.5 5.7 8.8 6.5 7.1 8.7 7.9 8.8 5.1 10.3 11.1 8.1 16.0 9.6 18.9 15.6 13.8 14.6 5.1 10.8 11.8 10.3 8.3 20.4 7.2 9.2 11.0 8.4 10.6 13.2 6.5 1.9 11.7 7.2 9.1 11.7 11.2 9.0 12.4 13.8 13.3 9.2 13.6 10.2 9.8 15.2 15.5 4.6 6.9 12.3 6.7 13.1 8.4 6.1 7.6 8.7 9.5 10.8 9.8 3.6 24.4 16.8 5.4 8.2 11.1 15.5 14.5 5.6 7.2 15.1 15.3 6.4 9.8 12.8 13.5 0.0 14.1 12.9 16.6 15.1 11.8 11.5 11.4 15.1 10.4 7.8 11.4 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161283 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" Nucleoli "Nucleoplasm, Mitotic chromosome" "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 12.2 10.3 11.7 15.0 12.5 35.5 17.0 12.1 13.7 10.0 12.3 12.4 17.9 11.5 15.6 13.9 10.9 12.2 15.5 11.8 12.6 17.1 14.8 11.9 23.2 13.3 12.5 12.8 13.1 9.2 8.7 13.2 13.1 12.0 14.1 6.3 19.9 7.4 19.7 18.2 15.8 11.6 13.1 12.7 14.3 21.3 12.5 16.3 15.6 12.3 20.6 15.7 9.6 13.5 28.6 20.9 23.8 28.8 17.9 33.3 52.8 29.3 24.6 29.4 30.1 26.9 33.7 49.4 29.9 21.0 22.1 40.5 29.0 28.9 28.2 44.4 47.8 35.7 17.0 20.1 35.1 60.4 34.5 28.0 33.2 26.5 19.6 26.5 26.8 50.5 54.5 23.7 38.7 18.0 49.9 48.3 65.3 43.8 15.8 48.0 23.2 57.3 29.5 22.7 26.2 47.1 39.2 27.0 66.4 17.0 55.2 63.5 21.0 26.2 23.0 36.1 59.9 27.8 47.5 47.4 30.8 38.0 40.8 113.9 36.0 44.1 46.1 42.5 55.6 74.1 53.0 59.8 37.2 54.5 49.0 57.4 18.3 58.2 46.4 59.5 77.5 51.5 11.7 12.5 12.1 13.7 11.8 12.6 13.3 12.5 13.1 13.1 12.5 13.5 4.3 19.2 12.8 12.1 11.9 3.2 10.0 7.3 10.2 2.6 6.3 3.7 3.4 7.2 9.1 3.7 10.4 6.2 19.3 4.1 5.9 6.6 7.2 3.2 5.1 6.9 7.8 3.8 10.6 6.2 4.5 10.3 4.6 6.0 23.4 8.0 6.1 3.6 3.3 0.0 11.5 2.7 8.2 5.4 3.2 7.9 4.1 7.1 3.6 15.9 9.4 4.0 23.7 10.1 11.9 8.6 9.6 5.7 10.2 5.3 5.3 12.8 10.7 5.7 0.0 5.0 4.4 7.1 5.3 8.0 3.8 6.2 16.2 3.3 4.5 7.7 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 11.9" "Group enriched" "Detected in some" 15 "Early spermatids: 59.4;Late spermatids: 81.9;Spermatocytes: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Cell line enhanced" "Detected in many" "HEK 293: 11.5;JURKAT: 17.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: AB_2732769" "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.1 0.1 0.6 0.5 0.4 0.5 0.3 1.2 0.6 0.2 0.1 0.5 0.8 0.0 0.5 0.3 0.2 0.1 0.0 0.6 0.5 0.1 0.2 0.1 1.1 0.2 0.3 0.0 0.0 0.0 0.3 0.4 0.4 0.1 0.8 0.4 0.0 0.1 0.0 0.7 0.6 0.1 0.0 0.3 0.4 11.9 0.5 2.4 0.3 0.0 1.5 0.1 0.1 0.3 4.8 4.2 1.8 2.4 0.1 0.0 1.9 0.9 0.1 1.1 2.1 7.0 6.6 5.6 2.2 0.4 5.1 0.9 3.6 2.9 3.6 2.6 11.5 2.9 2.0 0.0 0.0 0.3 1.5 0.0 0.4 0.3 0.6 1.5 0.1 17.7 2.1 0.0 0.4 4.3 1.5 3.0 0.7 9.0 3.1 1.1 0.0 0.0 1.3 2.4 2.8 1.1 0.4 1.4 3.7 5.1 8.9 0.7 0.0 0.1 2.6 0.0 0.6 5.5 1.5 2.2 2.9 1.7 1.0 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.8 2.6 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.2 0.6 0.4 1.2 0.6 0.6 0.5 0.2 0.3 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.5 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.0 0.0 3.7 0.4 0.1 0.0 0.1 59.4 0.9 0.2 0.1 1.2 0.4 0.6 0.0 1.0 0.3 0.5 0.3 0.0 1.5 0.4 0.6 1.8 0.0 0.3 0.7 0.0 0.0 0.3 81.9 0.6 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.4 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.3 0.2 25.6 2.7 0.4 0.0 0.7 0.6 0.1 1.6 0.7 RESF1 "C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1" ENSG00000174718 "Retroelement silencing factor 1" Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 73.9" "Cell type enhanced" "Detected in some" "Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 212.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 212.8" "Cell line enhanced" "Detected in all" "SuSa: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Nucleoli rim" "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 14.3 7.1 2.5 50.7 3.1 21.8 13.9 7.5 10.9 28.9 2.2 14.0 23.8 23.2 9.1 10.6 38.1 19.3 8.1 1.8 3.3 9.1 24.9 17.1 70.2 4.1 2.8 73.9 6.7 9.8 4.0 37.9 5.0 9.2 13.8 7.0 8.2 11.2 4.1 9.1 27.3 16.0 2.0 45.3 20.5 13.2 3.6 60.7 12.6 11.9 62.5 17.7 8.6 5.1 7.6 13.3 22.5 8.6 10.1 12.0 33.6 9.1 9.0 6.0 6.9 50.6 48.9 36.4 21.9 7.6 21.5 9.6 31.3 6.0 8.4 27.1 4.4 51.1 6.7 6.7 19.7 37.0 79.2 6.5 9.0 7.1 11.6 25.4 50.3 24.0 29.5 56.1 6.8 3.7 52.6 15.6 48.3 28.4 5.5 24.1 21.4 16.0 6.3 14.0 9.0 8.1 11.7 6.0 6.0 112.9 20.8 40.5 32.0 6.7 10.4 11.5 9.6 33.9 38.1 44.8 3.6 20.6 7.4 55.5 14.7 15.4 42.2 16.1 40.3 33.6 38.0 40.7 12.3 26.8 44.1 43.8 212.8 30.6 18.1 7.7 38.9 20.4 2.5 3.1 7.5 10.9 1.8 3.3 4.1 2.8 5.0 2.0 3.6 5.1 35.8 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 15.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 2.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 5.1 21.5 0.0 0.0 0.0 REXO4 "hPMC2, XPMC2H" ENSG00000148300 "REX4 homolog, 3'-5' exonuclease" Q9GZR2 9 133406059-133418096 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047006 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA047006: AB_2679900" "unprognostic (2.69e-2)" "unprognostic (3.76e-1)" "unprognostic (8.13e-2)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (2.15e-3)" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.14e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.25e-2)" "unprognostic (2.86e-2)" "unprognostic (9.20e-2)" "unprognostic (1.20e-1)" 12.6 15.7 8.6 6.7 8.9 5.1 12.3 9.0 9.4 16.0 8.1 14.8 5.7 12.7 3.8 18.2 12.2 4.5 16.3 8.7 8.6 15.6 22.6 10.5 8.7 8.7 8.7 18.0 21.4 5.1 13.0 5.8 8.9 15.7 3.9 3.5 13.1 4.7 35.4 17.0 14.3 3.9 8.7 18.8 14.1 18.2 8.8 8.3 12.8 9.7 6.6 16.2 15.1 9.2 9.8 22.2 10.3 15.1 10.5 10.7 18.2 16.4 9.3 17.0 11.2 26.8 12.3 31.5 11.0 9.0 13.9 26.0 21.5 17.2 9.7 20.5 19.8 17.2 23.7 21.1 13.0 39.4 16.1 10.1 14.4 17.9 24.4 13.0 12.6 16.8 38.3 13.5 11.0 28.1 27.9 23.7 20.8 35.0 32.2 19.7 16.7 31.5 10.8 9.1 29.1 15.9 17.4 20.2 19.4 10.1 24.7 15.7 11.1 30.9 16.1 14.7 20.3 8.8 11.5 21.6 11.5 22.5 18.7 0.4 1.3 2.0 1.9 1.3 2.2 2.4 2.0 2.0 1.1 2.8 2.5 2.7 0.1 3.9 1.1 1.8 2.0 1.0 8.6 8.9 9.0 9.4 8.7 8.6 8.7 8.7 8.9 8.7 8.8 9.2 16.8 22.4 15.0 4.9 29.7 25.0 22.3 12.9 10.2 26.6 27.0 23.5 9.9 21.5 8.5 25.8 22.9 37.5 27.8 24.2 19.6 29.2 38.2 36.6 34.5 17.4 13.2 7.6 4.4 28.7 36.2 14.7 7.1 32.7 17.7 24.2 19.6 26.8 21.3 16.8 4.6 22.2 4.1 22.4 11.5 83.3 28.9 13.2 7.2 1.9 37.9 17.6 51.5 1.5 5.0 30.6 21.7 24.0 18.4 25.3 30.8 28.2 10.4 34.1 19.7 13.1 16.9 51.6 65.9 10.7 27.6 31.5 24.9 16.4 35.8 13.7 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457550-41470871 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 415.4;lung: 694.9" "Cell type enhanced" "Detected in many" "Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 159.9;T-reg: 90.9" "Lineage enriched" "Detected in many" 15 "T-cells: 159.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 910000 "Cluster 20: T-cells - T-cell receptor" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 197.6 21.5 186.3 27.7 226.9 415.4 132.6 218.8 236.7 36.1 148.2 34.7 16.9 43.6 7.6 18.6 31.1 42.2 145.9 195.8 196.6 56.9 25.0 694.9 38.1 209.1 204.8 9.1 41.3 48.1 35.3 150.7 205.3 61.5 9.2 5.7 111.5 19.0 47.3 58.0 29.1 33.5 186.7 37.0 37.8 24.8 198.2 70.5 144.0 61.8 21.0 47.5 39.6 241.0 1.1 0.5 34.9 0.0 6.7 57.5 1.4 0.8 316.0 0.2 1.2 44.8 0.7 105.1 0.9 4.0 0.1 1.0 1.2 2.1 0.4 11.1 5.1 0.0 7.9 3.5 3.3 3.7 1.2 4.5 6.7 1.2 43.1 0.6 36.1 24.0 8.3 0.1 1.0 0.3 24.0 2.3 0.5 4.7 0.8 0.1 0.0 0.1 0.3 0.0 1.3 0.4 0.3 0.0 0.7 3.0 0.9 20.1 24.6 0.2 3.8 2.2 0.4 0.2 0.1 111.9 0.3 2.4 0.8 0.0 0.8 0.1 5.6 0.5 5.6 5.3 46.5 14.7 6.1 10.7 159.9 35.0 0.6 0.4 0.1 1.8 90.9 10.2 186.3 226.9 218.8 236.7 195.8 196.6 209.1 204.8 205.3 186.7 198.2 241.0 1286.2 246.8 39.8 57.5 131.8 86.5 676.2 15.2 14.2 1.0 269.9 314.7 25.8 1.5 37.5 3.7 2.1 6.4 249.2 3.0 35.2 0.6 42.3 103.0 47.2 474.6 84.8 322.7 2.5 0.0 9.3 205.1 65.2 69.0 48.9 0.3 31.8 2.5 349.1 0.0 1.2 22.1 14.2 32.0 590.1 13.2 8.1 315.9 193.9 36.5 6.4 1.5 4.1 51.8 115.3 0.3 4.5 2.2 371.2 1415.5 0.1 0.8 33.7 3.1 124.9 45.4 116.0 155.3 5.0 11.2 65.1 11.1 532.4 43.8 7.8 159.7 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 142.0;Inhibitory neurons: 170.1;Suprabasal keratinocytes: 110.0;Urothelial cells: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 8.4 6.5 13.6 2.9 46.6 2.3 8.7 10.2 20.5 16.1 10.5 8.3 4.8 8.6 4.7 30.4 9.9 3.9 6.7 12.9 8.5 11.1 17.3 10.6 3.5 9.5 8.5 12.5 4.9 3.3 13.8 3.7 8.2 16.6 1.9 3.8 9.4 4.7 12.3 20.7 6.2 2.6 7.8 6.0 6.7 10.3 8.7 3.6 8.0 4.6 3.3 10.4 20.2 10.5 4.8 6.0 11.9 8.6 3.9 3.1 4.9 5.1 4.1 5.2 3.8 4.9 2.8 1.1 3.1 4.5 7.6 4.6 2.3 16.3 1.7 0.1 1.9 0.5 3.6 12.0 3.5 0.3 6.5 2.6 10.9 2.7 3.6 4.6 11.5 4.2 5.6 0.2 4.8 4.1 0.8 13.1 5.6 2.7 5.7 12.3 4.6 4.0 2.7 14.1 13.3 13.8 3.2 2.2 11.4 2.9 5.4 8.2 8.7 10.0 6.5 2.0 5.5 5.9 4.9 2.7 5.9 7.2 7.3 0.4 0.3 0.0 0.2 1.1 0.0 0.0 0.2 0.1 0.4 0.2 0.3 0.1 0.4 0.0 1.1 0.2 0.2 0.2 13.6 46.6 10.2 20.5 12.9 8.5 9.5 8.5 8.2 7.8 8.7 10.5 16.1 6.4 6.4 66.9 2.6 84.4 142.0 69.3 71.2 17.3 11.0 14.9 8.6 8.6 28.6 5.5 29.2 6.2 1.3 6.4 3.9 10.4 5.0 22.8 13.3 26.6 14.9 4.8 44.3 10.4 1.3 14.6 7.7 11.8 14.0 57.7 27.8 28.8 20.8 10.1 170.1 10.8 8.2 12.4 11.3 5.5 14.9 21.7 17.8 47.8 7.8 29.3 2.1 71.4 25.5 14.7 2.7 7.9 0.8 53.9 6.0 23.9 34.6 18.9 0.0 12.5 12.7 24.0 15.3 84.4 110.0 6.7 4.3 11.8 9.0 153.8 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 8: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavorable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 14.6 9.7 9.8 14.5 11.3 2.2 13.9 9.5 11.2 11.6 8.3 12.4 6.9 10.7 10.6 22.3 10.4 7.3 10.1 9.5 12.3 14.4 14.3 11.0 14.2 12.4 12.4 10.4 18.2 10.8 10.2 15.6 12.0 10.4 12.3 16.8 19.8 9.6 32.0 17.8 10.3 10.4 12.9 8.4 12.8 6.7 10.9 6.9 46.4 11.3 15.0 16.4 15.5 13.6 42.6 27.8 9.1 17.4 20.5 30.3 22.8 20.1 14.3 22.0 18.5 18.6 22.8 59.7 21.2 25.1 34.3 24.3 28.9 28.2 32.5 109.9 13.8 19.2 13.5 19.1 33.4 37.1 7.0 24.5 38.8 17.6 44.4 13.1 23.9 26.4 26.2 23.3 22.1 11.5 29.7 14.5 19.9 47.3 34.4 0.0 32.2 58.7 21.4 24.1 49.6 17.6 25.7 28.7 34.4 10.1 24.7 15.3 16.3 22.9 24.0 13.7 39.9 37.7 18.3 55.5 29.1 37.8 23.8 1.9 13.2 0.7 10.3 11.9 15.8 15.9 14.9 12.0 16.9 13.3 15.0 12.5 0.8 10.8 15.8 26.0 15.2 10.5 9.8 11.3 9.5 11.2 9.5 12.3 12.4 12.4 12.0 12.9 10.9 13.6 18.3 9.6 14.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 14.9 11.2 0.0 0.0 10.5 7.3 0.0 33.7 5.7 0.0 49.0 16.4 0.0 25.7 14.9 5.8 0.0 0.0 0.0 13.2 43.5 7.3 0.0 12.6 2.5 20.2 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.5 0.0 0.0 11.6 13.8 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 31.2 2.2 24.8 0.0 0.0 RORA "NR1F1, ROR1, ROR2, ROR3, RZRA" ENSG00000069667 "RAR related orphan receptor A" P35398 15 60488284-61229302 "Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 82.8" "Cell type enhanced" "Detected in many" "Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 26.7" "Cell line enhanced" "Detected in many" "Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009861, HPA074448" Approved Supported Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoli "CAB009861: AB_2180141, HPA074448: " "unprognostic (1.57e-1)" "unprognostic (4.76e-2)" "unprognostic (2.22e-1)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (2.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (9.93e-2)" "unprognostic (1.34e-1)" "prognostic favorable (5.42e-6)" "unprognostic (6.94e-2)" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.62e-2)" 8.2 38.0 19.9 6.2 11.7 17.5 13.6 51.1 13.1 10.5 10.2 6.9 2.6 6.0 4.7 17.3 6.8 9.1 7.2 3.7 12.6 12.6 28.7 11.2 6.2 7.8 36.0 9.9 14.0 10.1 7.6 2.9 5.9 5.7 3.5 37.8 8.5 5.5 41.4 82.8 6.3 5.4 4.5 9.3 6.2 13.9 49.6 4.3 12.8 20.3 7.5 5.2 9.2 4.2 0.1 0.8 2.7 0.0 3.4 1.7 0.9 1.3 1.5 1.2 1.4 1.8 0.5 0.0 0.6 3.4 3.6 0.5 6.1 2.6 2.2 2.9 5.2 0.0 0.4 2.9 1.3 0.0 0.3 7.8 0.6 3.3 0.0 1.1 11.6 11.2 0.2 73.2 5.1 0.2 0.6 0.0 2.1 1.9 1.1 0.1 2.4 1.1 2.4 0.5 1.9 4.4 0.3 0.6 0.1 7.3 0.0 0.0 0.3 10.1 4.5 4.2 0.1 41.7 62.1 0.2 17.0 0.0 1.2 0.2 0.1 0.0 23.2 0.0 26.7 1.4 17.4 16.0 0.0 0.1 5.4 11.5 0.5 6.5 0.1 0.7 16.3 4.7 19.9 11.7 51.1 13.1 3.7 12.6 7.8 36.0 5.9 4.5 49.6 4.2 32.5 41.7 31.7 2125.3 23.4 185.2 30.1 17.0 55.2 167.5 24.7 16.1 26.3 30.0 23.4 58.8 454.5 0.7 185.3 1.4 13.7 21.4 148.8 26.9 52.9 40.8 18.5 42.5 627.1 12.3 1.9 69.4 11.7 36.1 2.5 7.9 34.2 97.2 0.8 126.2 1056.8 3.3 10.2 9.1 35.8 97.1 46.6 8.3 60.5 757.0 4.7 50.4 250.3 1524.0 114.9 8.2 0.5 87.3 88.7 24.0 0.7 44.6 16.0 160.0 39.5 57.9 32.2 1.9 3.8 73.2 423.4 4.7 237.6 11.5 2.1 61.9 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92299059-92402056 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol No No "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoli, Cytosol" "HPA046443: AB_2679669" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 1.4 1.9 3.2 2.2 4.1 3.9 2.2 12.6 8.7 1.6 0.3 1.4 1.8 2.1 3.2 1.3 1.4 1.5 1.6 3.3 0.9 2.2 3.0 1.4 2.6 1.2 0.2 2.1 2.5 2.0 1.7 1.5 1.8 2.1 1.6 9.3 2.1 1.3 3.0 3.2 1.7 1.5 0.2 2.3 1.8 2.0 1.8 2.8 2.7 2.3 1.9 1.4 1.1 8.4 4.0 2.3 4.1 3.8 3.3 4.2 3.4 3.0 2.1 2.0 1.6 1.7 1.7 5.9 5.1 2.3 2.7 2.7 3.4 1.9 3.0 4.0 2.4 3.5 4.6 2.3 1.9 6.3 3.4 2.1 2.4 2.5 2.5 2.9 2.1 3.6 3.7 3.7 3.0 2.0 5.4 3.9 3.1 2.2 2.7 3.9 5.4 2.5 2.6 3.4 3.8 2.7 4.4 4.5 2.5 3.0 2.3 4.7 3.6 2.8 3.7 3.3 4.4 3.7 4.5 3.0 2.0 3.9 1.9 1.9 0.7 0.6 1.3 0.5 1.5 1.1 1.0 1.1 0.6 1.3 1.0 1.2 1.4 1.3 0.7 1.1 1.0 0.4 3.2 4.1 12.6 8.7 3.3 0.9 1.2 0.2 1.8 0.2 1.8 8.4 23.1 64.1 78.5 66.9 20.1 9.2 16.7 15.7 23.9 63.6 16.3 16.5 24.7 10.0 44.5 7.3 110.5 21.3 31.5 6.4 11.7 19.2 68.1 18.8 48.6 23.4 12.6 13.3 97.1 13.6 14.2 24.8 13.3 17.6 62.0 37.7 9.3 8.0 9.7 35.3 91.3 13.3 14.2 8.7 4.6 9.7 19.0 15.6 1.8 43.1 16.6 31.4 42.2 68.3 78.8 13.8 13.6 21.4 28.5 15.9 11.9 15.6 45.0 95.2 26.3 44.4 20.3 27.3 20.0 16.8 9.8 23.7 35.8 42.3 12.1 10.4 RPF1 BXDC5 ENSG00000117133 "Ribosome production factor 1 homolog" Q9H9Y2 1 84479259-84498352 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024642 Supported Supported Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoli "HPA024642: AB_1856428" "unprognostic (1.56e-3)" "unprognostic (2.65e-1)" "unprognostic (3.63e-2)" "unprognostic (7.95e-3)" "unprognostic (2.16e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-2)" "unprognostic (2.45e-1)" "unprognostic (1.45e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.42e-2)" "unprognostic (2.71e-1)" 24.4 21.6 13.7 19.0 17.4 44.9 24.7 14.7 19.4 23.5 15.8 28.1 17.7 26.0 23.0 27.0 23.2 14.1 34.2 13.5 15.4 28.0 26.1 20.5 26.8 13.7 14.0 20.7 22.8 18.8 21.0 14.9 13.8 20.8 20.9 16.8 21.9 15.5 42.7 26.1 23.2 18.1 13.4 26.2 25.6 25.3 13.9 29.4 23.3 23.9 28.1 24.9 23.3 14.8 43.1 29.2 36.6 30.2 27.1 35.5 40.5 46.8 36.5 53.2 47.0 21.4 17.6 31.9 50.1 33.9 89.0 31.7 54.3 43.2 57.7 51.0 57.6 85.2 30.7 37.8 37.2 80.0 25.4 29.0 63.0 56.0 39.2 30.7 42.6 60.7 79.9 40.7 46.9 21.8 76.3 53.0 91.5 43.0 62.5 48.3 58.5 25.7 51.3 47.6 45.2 42.2 27.7 52.7 107.3 32.8 29.6 53.4 30.3 40.1 41.3 64.8 90.4 29.5 39.0 73.0 19.2 71.0 37.0 64.0 35.2 34.6 41.4 41.0 45.4 65.4 46.0 42.0 37.4 58.6 51.3 50.7 14.7 52.6 46.3 39.5 52.9 47.4 13.7 17.4 14.7 19.4 13.5 15.4 13.7 14.0 13.8 13.4 13.9 14.8 28.2 38.5 39.5 7.2 35.8 34.7 41.5 71.6 12.0 15.7 20.4 19.6 39.3 30.0 43.0 16.5 16.7 35.5 51.7 18.0 74.3 60.3 72.7 34.9 27.6 35.0 33.5 17.2 10.1 64.1 33.1 25.0 16.8 26.5 65.2 18.6 28.9 36.6 44.0 8.4 9.8 29.6 28.5 31.7 30.2 13.2 32.6 28.4 28.4 9.4 37.0 30.1 60.8 8.5 10.4 53.0 23.6 35.0 16.2 26.8 21.7 67.4 53.8 25.6 46.0 23.4 43.3 94.7 63.7 18.0 32.7 27.5 40.3 21.4 36.0 39.7 RPF2 "bA397G5.4, BXDC1, FLJ21087" ENSG00000197498 "Ribosome production factor 2 homolog" Q9H7B2 6 110982015-111028263 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 234.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035475 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 18: U-2197 - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA035475: AB_10669861" "unprognostic (2.85e-3)" "unprognostic (2.19e-2)" "unprognostic (6.00e-2)" "unprognostic (2.90e-3)" "unprognostic (4.45e-1)" "prognostic unfavorable (2.04e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.99e-1)" "unprognostic (8.43e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (2.07e-6)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-1)" 16.4 12.2 6.6 9.5 7.4 10.8 14.9 7.3 8.7 12.9 7.2 11.9 6.6 11.2 5.4 15.2 12.5 9.1 15.3 7.0 7.1 15.8 17.2 9.7 10.4 6.9 6.9 13.2 19.9 9.7 8.1 10.2 7.0 11.4 8.8 5.6 9.9 7.1 22.2 13.9 8.1 8.1 6.9 9.3 11.7 13.5 7.1 7.6 13.0 14.0 10.9 15.3 12.5 7.9 23.3 16.6 12.7 50.5 26.4 34.7 32.6 32.5 23.6 32.3 32.6 39.2 18.5 50.2 29.4 22.8 38.8 27.0 51.5 37.6 84.2 19.4 38.7 29.5 14.2 27.4 35.9 45.9 16.6 26.5 31.4 46.5 83.5 20.3 24.9 22.1 99.0 29.9 52.2 23.4 39.2 45.5 45.2 37.7 20.2 40.2 22.4 43.6 37.4 22.9 20.3 28.7 14.1 23.7 61.3 16.8 18.8 47.3 17.5 24.7 21.2 234.1 81.4 13.4 22.0 65.0 36.4 60.8 55.2 0.2 4.4 0.7 4.1 5.5 8.5 6.6 6.1 5.0 5.8 5.7 6.8 7.0 0.3 8.8 3.5 5.8 5.0 4.0 6.6 7.4 7.3 8.7 7.0 7.1 6.9 6.9 7.0 6.9 7.1 7.9 40.0 19.2 26.9 6.5 25.0 78.4 119.6 90.1 35.9 14.1 33.6 52.3 71.9 47.1 67.6 18.4 0.0 44.9 18.0 15.8 68.4 48.2 105.7 49.8 57.6 35.2 11.4 26.1 15.7 47.4 53.8 50.0 17.3 60.9 46.2 18.9 23.6 83.6 56.0 18.5 14.0 30.3 36.7 27.7 19.5 32.1 34.5 28.2 37.4 5.6 21.8 21.0 19.6 9.0 13.5 42.2 18.7 27.1 18.8 80.4 15.2 87.2 55.0 8.9 13.1 61.7 49.9 76.8 28.4 33.0 66.2 34.6 22.9 29.8 44.0 70.2 RPL10A "Csa-19, L10A, NEDD6" ENSG00000198755 "Ribosomal protein L10a" P62906 6 35468401-35470785 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053803 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 740000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA053803: AB_2682268" "unprognostic (5.47e-2)" "unprognostic (8.02e-2)" "unprognostic (1.45e-1)" "unprognostic (3.37e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (3.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.37e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.21e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (9.72e-2)" 1323.4 939.9 613.7 824.8 622.4 2051.4 2092.0 591.3 764.2 1803.2 604.3 1445.1 776.4 1350.0 1255.9 1583.0 1911.2 720.6 845.6 594.7 625.1 957.2 840.9 835.2 1625.6 619.7 603.1 3180.4 1894.4 682.3 731.1 747.7 627.8 1322.3 1178.3 255.2 1271.7 1007.2 1411.5 2166.4 1075.0 1114.2 654.0 1063.9 1188.8 230.5 628.8 1585.0 1084.1 1009.5 1733.0 1434.0 1506.3 642.7 1205.5 1211.3 1349.6 1275.9 1967.9 3560.6 1522.8 1213.7 2475.5 1671.2 1320.9 1765.5 1126.2 3571.4 1089.8 1650.2 819.4 1036.0 1832.7 2764.1 1374.0 1249.1 1618.0 1375.9 1007.0 2501.0 2909.6 2031.3 1096.1 4179.2 3172.8 1225.0 4066.4 2689.3 2481.9 1760.1 1652.9 1712.2 1920.0 2112.5 2158.4 2452.2 1421.3 1879.5 1057.5 1681.9 1298.7 2801.6 2124.0 1949.5 945.6 1384.7 747.8 1688.0 3632.5 1076.1 1831.0 3628.9 1450.9 541.4 975.4 729.4 1559.5 1073.4 1889.4 2381.8 681.1 2322.7 992.7 215.5 1232.7 120.6 1478.3 1210.1 2629.7 3176.9 2436.2 1905.6 1990.0 2806.5 3252.5 2601.9 113.1 2069.4 1077.8 1875.3 2059.9 5496.8 613.7 622.4 591.3 764.2 594.7 625.1 619.7 603.1 627.8 654.0 628.8 642.7 973.2 535.2 1036.5 19.2 3101.2 5399.7 5910.9 3550.3 2636.7 221.4 4627.1 4144.2 270.8 1742.9 1828.0 597.7 73.0 4048.8 1980.0 867.3 2983.7 1701.7 243.5 992.0 2446.8 1604.3 1512.3 1533.0 23.1 3272.4 5396.6 1667.3 884.8 1150.5 917.2 2228.2 1601.0 1519.3 2201.2 109.4 23.8 2834.0 1084.4 1989.9 3307.5 430.7 2517.0 1457.1 2406.5 17.8 2486.8 530.4 1845.5 31.7 32.4 2092.1 2269.8 1479.8 1382.6 4479.8 1447.6 2791.4 790.8 252.3 769.2 3139.6 1955.7 236.4 357.1 3510.2 6623.0 4105.6 2341.0 2848.1 3482.8 5438.5 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993522-51995895 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 190000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: AB_2686077" "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 1695.8 1400.7 669.4 719.9 687.1 2111.2 1659.2 668.9 816.3 1854.9 645.4 1352.4 866.4 1208.8 657.8 1772.7 1470.3 645.8 1073.9 646.1 673.9 1112.9 1155.6 972.4 1348.0 697.9 665.1 2740.8 2740.5 537.5 708.8 534.7 696.9 1307.1 624.9 229.3 1478.4 550.2 2689.5 2458.5 1155.7 567.4 721.7 1239.3 1341.7 440.2 684.7 1075.5 982.6 1287.3 991.6 1339.6 1643.6 729.6 1208.7 1467.7 1123.3 1808.9 1933.5 3007.1 1603.5 1299.2 1540.3 1693.7 1396.9 1757.3 1831.7 3226.6 553.5 1292.3 1044.1 1084.1 1622.7 2689.1 802.7 1335.2 2202.3 1689.2 1892.1 3037.1 2287.6 2548.8 1630.1 3714.1 3735.4 1254.5 2210.9 1936.9 1920.9 1420.6 1338.0 2536.8 1264.3 2629.0 2238.9 3210.8 1965.5 1755.6 2463.0 1038.1 1267.3 3258.5 2211.8 2509.3 948.0 1820.6 969.6 2279.1 2378.1 706.9 1710.1 4227.3 1745.3 1001.3 1324.5 1559.7 2006.9 1615.8 2498.1 2399.9 1326.2 2953.0 1357.6 556.4 1184.0 333.4 895.8 882.9 1488.2 1886.9 1446.6 1149.2 1356.0 1749.9 1662.7 1421.4 145.3 1115.6 724.8 1154.7 1444.1 3507.7 669.4 687.1 668.9 816.3 646.1 673.9 697.9 665.1 696.9 721.7 684.7 729.6 2092.1 189.1 415.6 35.3 3749.3 3975.7 5198.9 3485.6 4465.8 234.8 4763.1 7627.1 82.4 1611.4 1245.9 711.7 102.2 2537.2 2453.7 1497.3 2181.5 1773.3 1117.1 1158.9 3170.1 1957.3 1430.9 2176.2 28.2 4573.5 5119.4 1862.6 1826.2 1529.2 694.4 3951.5 2026.4 1661.0 2373.7 107.7 33.6 3051.9 1043.6 2693.9 3423.6 4294.3 3611.5 2216.3 2218.0 37.5 2893.8 989.3 2520.1 18.1 49.2 3180.2 2816.5 1583.5 2556.8 5203.2 3720.1 3760.6 507.1 405.3 1143.9 2535.7 2110.2 564.9 465.2 5714.8 5075.9 2455.2 2765.1 5917.8 3455.9 5933.8 RPL3 L3 ENSG00000100316 "Ribosomal protein L3" P39023 22 39312882-39320389 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003365, HPA055361" Uncertain Supported Nucleoli,Cytosol NA NA 470000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Cytosol" "HPA003365: AB_1079841, HPA055361: AB_2732594" "unprognostic (9.79e-3)" "unprognostic (2.06e-1)" "unprognostic (2.31e-1)" "unprognostic (1.68e-3)" "unprognostic (5.44e-3)" "unprognostic (1.72e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (3.63e-1)" "unprognostic (5.81e-2)" "unprognostic (5.87e-2)" "unprognostic (7.09e-2)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (6.09e-2)" "unprognostic (2.72e-1)" "unprognostic (4.32e-2)" 2058.6 1934.3 965.6 1484.2 985.8 2965.1 2704.2 936.9 1071.1 2705.4 1023.2 2078.1 1515.1 2007.3 1653.7 2522.3 2423.9 1128.4 1326.4 894.6 951.2 1745.2 1894.1 1421.2 2460.9 984.1 951.1 4838.0 4514.8 1462.2 1861.5 1099.8 977.1 2180.0 1361.7 809.1 2210.1 1551.8 558.4 3337.9 1722.9 1388.1 1050.0 1824.1 1982.0 752.6 1002.9 2006.1 1709.0 417.1 2320.5 2012.9 2317.5 996.1 2010.5 1836.9 2035.9 2149.6 2535.3 5394.1 2745.1 1497.8 2703.5 1400.5 1249.7 2327.8 1425.1 8262.2 2062.9 1734.1 873.2 1246.8 2275.3 3060.5 923.2 1448.3 2207.4 2039.5 2153.8 3438.2 3887.7 2932.6 1619.9 5321.2 4063.7 1265.0 4504.5 3956.7 2765.5 2217.6 2407.8 2657.6 2135.0 2597.5 2974.5 4241.1 2054.6 2172.9 1273.8 2369.5 1924.0 4017.5 2609.2 2927.6 1823.4 2180.2 936.2 2925.4 5031.9 1242.2 2226.2 4761.3 2864.1 951.4 1534.4 1027.8 1788.2 2074.0 1741.6 3606.5 2111.3 2564.4 1093.9 638.7 1690.8 351.4 3488.7 1481.6 5383.7 5629.1 4993.5 4037.9 2821.8 5113.1 6376.7 5111.7 215.7 4472.3 1339.8 3182.6 3668.7 11623.3 965.6 985.8 936.9 1071.1 894.6 951.2 984.1 951.1 977.1 1050.0 1002.9 996.1 2118.4 984.0 2299.9 16.3 4551.5 10412.0 9836.0 9475.4 2792.1 1065.7 9967.6 10172.3 182.6 4213.6 3849.3 1441.9 425.4 5623.9 4123.0 1288.7 5893.0 2943.4 2097.6 1061.7 2644.4 3666.1 2726.6 2263.9 17.0 6539.7 7508.2 2678.8 1207.4 1390.0 1784.7 4203.6 3429.3 2085.8 3282.5 358.4 18.3 3696.8 2925.6 3062.8 6215.2 4622.8 5581.1 2203.8 5104.8 17.8 3733.3 2455.8 4243.1 9.5 25.1 3814.3 2946.3 3499.2 2308.1 8261.9 3481.6 5422.4 1350.6 1305.5 1577.7 4469.5 4329.1 1074.6 1014.8 3712.4 12290.3 5489.4 4201.1 4673.7 4830.3 9407.7 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620569-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favorable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 2425.0 1591.7 1002.0 785.6 1018.3 2268.5 2730.5 987.4 1524.6 3162.1 962.2 2061.8 823.2 1963.6 1544.1 2142.7 2352.9 621.4 1521.5 956.2 997.4 1752.0 1479.4 1498.1 1670.2 1010.6 982.1 4574.1 4126.6 561.6 1616.2 716.9 1015.1 2107.6 914.8 439.0 1967.4 729.0 1791.6 2675.3 1965.7 686.3 1052.9 2223.5 2008.0 507.9 1033.0 1276.7 1700.7 739.6 1511.2 2044.7 2481.9 1055.4 825.0 541.4 1026.2 1485.8 2018.1 3044.8 1023.2 1230.1 1393.2 916.9 752.8 1358.5 1395.7 2413.4 723.7 1117.5 499.4 564.9 1064.4 1792.9 1160.3 927.5 1680.3 1034.0 1087.0 2109.6 1708.0 2628.2 1118.4 2837.7 2381.1 773.6 1701.2 1839.1 1618.7 1345.9 1731.4 1357.1 1479.3 1452.6 1625.9 3123.7 1214.4 1794.1 1095.2 1473.5 1112.4 1478.1 1929.2 1234.1 1099.4 1409.8 510.1 2915.7 1881.3 805.7 957.1 2348.2 1357.7 674.5 926.3 711.3 1121.6 1020.7 1327.3 1913.0 924.1 1533.2 859.0 1744.5 3024.8 943.1 2796.0 2242.1 4811.7 7783.4 5669.6 3854.8 3005.0 6460.3 7498.4 5716.8 610.2 3571.6 1985.1 3793.7 4557.8 12314.4 1002.0 1018.3 987.4 1524.6 956.2 997.4 1010.6 982.1 1015.1 1052.9 1033.0 1055.4 3354.3 1413.4 2496.4 19.9 8040.6 12566.5 10934.5 14134.5 6505.0 343.4 12055.8 16944.0 1156.9 4838.4 5399.5 2164.7 75.0 6443.9 5150.7 1717.5 6914.3 3577.3 1527.0 2002.3 4683.1 4313.0 2720.0 3488.0 31.4 8680.5 7464.2 3471.8 2274.2 2664.1 3308.2 3093.0 5696.3 5781.3 4151.7 154.8 29.1 6030.2 3912.2 6966.0 11139.9 2023.8 7477.3 4326.2 5839.5 43.1 7738.0 1718.3 4866.1 18.1 28.5 5645.0 4899.2 4032.5 3437.1 5962.5 5302.3 9409.4 2362.8 535.0 1913.0 6558.2 3975.1 787.2 678.5 6369.9 15308.7 6380.6 7015.5 2344.3 6469.6 8608.5 RPL5 "L5, PPP1R135, uL18" ENSG00000122406 "Ribosomal protein L5" P46777 1 92832013-92841924 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Cancer-related genes, Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043717, HPA054444" Approved Supported "Nucleoli,Nucleoli rim,Endoplasmic reticulum,Cytosol" NA NA 430000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "Nucleoli, Nucleoli rim" "HPA043717: AB_10964719, HPA054444: AB_2732584" "unprognostic (5.81e-3)" "unprognostic (3.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (9.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.03e-3)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (1.23e-1)" "unprognostic (3.98e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.81e-5)" "unprognostic (2.26e-2)" "unprognostic (3.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-1)" 1236.3 1035.1 515.2 786.9 538.3 1743.3 1798.7 522.4 778.1 1690.1 510.7 1412.8 798.0 1295.2 1388.7 1185.6 1420.7 647.6 890.3 487.5 544.8 858.2 794.9 794.7 1435.7 527.8 511.9 3356.4 2236.0 695.4 869.5 736.1 541.3 1103.1 982.0 346.6 1189.5 847.1 1115.8 1320.8 960.1 962.1 549.0 899.0 1135.5 374.3 528.7 1351.4 1179.5 830.7 1438.8 1309.6 1274.2 552.5 2211.5 924.6 1611.4 1369.2 2045.7 4096.6 2577.6 1283.0 1703.7 1560.0 1108.9 2467.5 933.6 4112.3 2002.9 1451.6 1477.1 1370.3 1871.2 2405.7 1976.3 1314.2 2557.4 2142.3 1402.4 2303.5 2447.2 3322.0 864.6 3382.6 3711.3 1390.4 3027.2 2813.9 2191.6 2129.9 2706.3 2106.7 1814.5 1247.7 2665.7 3741.2 2497.9 1659.1 1724.1 2407.7 3118.5 2702.2 1912.0 1798.7 1367.2 1632.0 836.3 2298.6 3961.6 1316.4 1268.8 4480.6 1345.5 781.6 1429.6 1498.4 2357.4 1290.8 1314.5 2793.5 531.3 2814.4 544.2 234.9 665.6 101.3 758.7 619.1 1520.2 1320.3 1385.5 1151.0 1138.3 1105.7 1729.8 1570.9 56.7 1005.7 552.2 942.7 1140.0 2356.3 515.2 538.3 522.4 778.1 487.5 544.8 527.8 511.9 541.3 549.0 528.7 552.5 1586.8 653.9 1042.2 29.7 3056.7 2843.0 4383.1 2206.0 3168.8 339.6 3182.0 5498.6 375.2 1522.7 1266.7 412.0 89.6 2557.1 2009.8 595.2 1993.7 1697.1 1438.3 840.8 2334.8 1567.8 1236.6 1980.6 35.0 2708.5 4211.6 1464.3 978.1 1009.8 1041.9 2287.9 1546.3 1087.2 1452.5 146.4 33.8 1986.9 720.2 1758.7 2200.6 1189.4 2829.9 1536.8 1406.9 35.6 2171.5 806.3 1969.1 27.2 37.7 1851.6 1567.8 2156.4 2067.8 3935.4 1225.7 2454.6 571.0 298.8 1051.8 2546.2 2122.7 682.8 501.7 3198.9 2893.0 2613.1 2318.2 2797.0 2572.8 3991.1 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 6599.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 170000000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 1100.4 864.4 197.2 397.5 201.1 1020.7 1162.7 197.3 361.6 1387.5 199.5 1138.7 688.7 1042.4 63.7 1406.6 1118.6 146.4 962.6 174.2 193.7 889.8 709.6 796.1 424.5 214.1 195.2 2192.7 2021.1 150.3 784.2 264.4 199.9 974.9 110.0 22.9 1320.1 201.8 1651.4 1800.7 885.7 115.6 222.7 918.6 1003.5 304.7 218.2 150.0 739.9 194.0 196.4 1099.7 1240.2 218.1 2486.1 2860.3 200.1 874.6 220.0 496.0 1913.2 1747.7 325.3 522.4 369.7 2518.8 1299.5 3296.6 2461.9 208.4 174.3 1470.7 263.8 609.1 95.7 1446.1 3218.7 1962.1 2166.5 1805.2 546.9 1299.9 1027.5 537.1 680.7 235.9 400.8 246.5 387.8 703.1 2695.3 742.2 226.0 6599.2 1862.9 1754.6 1865.3 674.7 3196.8 1806.5 1154.4 3160.7 280.1 1842.0 1215.9 2028.4 1677.7 899.2 2541.5 81.0 2093.2 1233.3 1573.7 689.8 2622.6 1454.9 2127.3 1344.2 1235.8 2856.3 1372.4 2117.5 968.7 534.8 1464.1 574.8 1160.0 1504.9 1934.6 2970.9 1937.9 1430.4 2051.1 2991.2 2181.6 1718.2 166.1 1469.4 1479.6 1129.7 2070.5 5473.9 197.2 201.1 197.3 361.6 174.2 193.7 214.1 195.2 199.9 222.7 218.2 218.1 2510.5 852.5 1309.5 28.7 4225.5 6439.6 7085.5 5724.6 4563.8 424.0 6122.9 9469.1 1049.0 1988.8 2513.8 1028.1 268.9 4313.8 1790.8 1780.8 4433.5 2429.1 891.2 1083.4 2465.0 2455.7 1698.3 2407.7 24.0 5851.2 6733.6 2161.3 1804.3 1452.8 1044.4 2390.5 2116.1 1309.7 3031.0 166.5 28.5 3563.5 1698.8 2811.4 5097.7 2782.3 3122.7 2281.9 3520.0 30.9 2951.5 1300.3 1607.7 16.1 32.8 3402.4 3311.1 1432.3 3168.7 6500.7 3930.7 4195.9 961.7 689.1 1078.1 2701.0 3865.8 591.8 583.4 5817.5 8224.4 4365.8 2704.6 3472.7 4291.2 7522.7 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452587-39458931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebral cortex: 2512.5" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 180000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 1868.9 1181.0 377.9 809.5 384.9 2487.2 2132.6 378.2 2512.5 2407.6 382.9 1776.6 737.5 1418.3 2338.6 1568.7 1896.6 785.0 1168.4 368.3 462.3 1318.1 1056.3 1130.2 613.9 381.0 381.1 3607.4 2794.6 510.7 1060.0 419.0 382.5 1562.6 605.5 314.2 1387.6 681.5 1550.4 2153.4 1327.8 551.1 407.5 1400.1 1484.5 386.8 388.4 43.6 1072.2 1767.5 705.8 1675.7 1773.4 395.9 52.4 41.7 2173.3 48.2 57.0 90.0 72.9 1109.3 1618.3 1306.1 981.0 131.1 1243.5 2771.5 93.8 1081.2 1040.1 1169.0 67.3 79.3 1422.3 964.2 2080.2 80.0 415.4 131.2 81.3 153.2 711.1 113.8 3249.4 56.1 1445.8 1907.5 69.6 70.4 2126.4 1196.8 60.9 69.4 1556.5 163.4 1954.7 1523.9 57.6 1417.2 2327.7 76.3 1656.7 63.7 74.3 915.0 31.6 899.8 115.5 1976.1 1864.0 98.7 63.2 51.1 72.1 1486.9 134.2 1806.3 2754.2 2483.9 1456.9 1717.2 56.6 447.2 556.1 171.7 664.4 585.3 1320.8 1566.4 1311.6 919.0 779.1 1361.8 1804.5 1436.1 94.8 927.3 456.8 1013.2 1101.2 2263.3 377.9 384.9 378.2 2512.5 368.3 462.3 381.0 381.1 382.5 407.5 388.4 395.9 1634.0 663.4 908.4 2.3 3629.4 4132.6 5621.6 3089.9 1994.2 406.0 4149.6 3833.2 428.0 2051.8 1359.8 709.9 160.6 3011.2 2723.2 1300.0 2733.2 2184.8 1549.9 1126.9 2738.2 2121.2 1850.2 1755.0 3.0 4399.8 5910.8 1698.9 828.7 1534.0 913.2 2226.7 2439.5 1991.3 2775.3 198.5 3.2 3581.7 1053.8 3282.8 3322.0 1707.8 4819.6 2242.3 1851.6 2.8 4568.2 1398.0 3045.4 3.0 3.6 3145.0 2925.6 2394.1 1420.3 4718.4 2823.2 3698.3 656.7 581.0 1512.0 3760.1 2630.9 684.0 593.6 2325.1 4675.5 3400.0 2937.1 2567.2 3793.6 5564.6 RPP38 ENSG00000152464 "Ribonuclease P/MRP subunit p38" P78345 10 15097180-15139818 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 555.3;Late spermatids: 231.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045128, HPA050398" Approved Supported Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoli "HPA045128: AB_2797230, HPA050398: AB_2732560" "unprognostic (1.75e-1)" "unprognostic (3.91e-2)" "unprognostic (3.76e-2)" "unprognostic (1.51e-1)" "unprognostic (9.93e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.41e-2)" "unprognostic (4.86e-1)" "unprognostic (1.57e-3)" "unprognostic (3.42e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (6.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.11e-2)" "prognostic favorable (2.89e-6)" 14.0 12.9 9.1 12.3 9.4 12.4 19.8 12.4 11.7 14.0 15.1 16.3 15.8 15.0 16.7 16.2 19.3 11.2 13.0 9.4 9.5 17.2 19.4 13.8 20.1 8.9 9.0 14.6 15.2 14.2 13.4 11.5 8.9 13.9 16.7 13.4 14.4 12.1 19.0 17.2 16.6 12.5 8.8 17.7 15.4 48.1 9.3 15.6 16.2 14.8 18.0 17.6 13.3 10.1 40.6 29.4 15.6 20.3 20.7 21.2 27.9 18.7 14.0 29.0 29.3 29.6 40.3 33.2 19.3 17.6 23.7 36.2 31.8 32.4 26.2 26.0 28.6 34.3 17.3 26.2 44.4 19.5 27.5 25.3 43.8 23.4 20.5 21.9 23.2 33.0 40.1 22.7 22.0 32.6 34.9 20.9 18.0 49.0 14.0 28.3 15.9 41.5 37.0 15.3 14.7 18.5 25.7 44.4 53.6 25.6 39.7 30.8 18.8 13.1 22.8 28.3 25.2 31.6 36.5 44.9 25.8 23.3 12.6 21.9 48.5 49.7 49.1 49.0 48.6 58.7 49.7 60.8 51.9 66.0 57.2 52.4 16.2 41.5 40.8 52.3 47.3 43.4 9.1 9.4 12.4 11.7 9.4 9.5 8.9 9.0 8.9 8.8 9.3 10.1 15.5 16.0 22.0 4.2 24.0 31.5 41.9 34.7 14.2 14.2 22.5 26.0 7.1 11.5 40.3 9.2 6.2 30.2 18.6 18.6 27.4 34.2 555.3 54.4 18.7 19.2 13.2 15.2 3.3 33.2 42.1 15.7 16.8 16.0 12.7 15.5 19.6 32.4 24.7 8.4 3.5 25.4 36.7 18.8 12.6 231.1 23.6 13.4 8.8 5.6 21.6 17.7 33.0 4.5 5.5 29.6 16.8 19.9 14.5 46.8 26.9 33.9 89.2 31.0 13.1 14.9 14.6 68.0 34.6 17.2 36.1 32.2 21.5 23.6 24.0 43.8 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 98.5 123.0 122.2 43.1 124.5 61.7 94.6 126.7 159.0 73.5 115.9 117.1 43.5 65.5 31.5 94.2 65.6 19.3 114.6 121.2 119.7 123.1 158.5 80.4 48.0 126.5 124.2 68.9 109.6 47.1 66.5 30.2 123.7 108.1 19.2 23.9 94.4 42.8 104.7 80.0 78.3 19.7 124.8 100.5 101.5 65.8 128.4 40.5 96.7 45.4 34.6 99.9 73.7 123.9 94.8 117.6 54.5 80.4 60.7 39.7 110.8 102.0 87.3 92.5 74.0 131.1 62.1 118.9 107.4 64.5 74.8 73.8 87.8 111.3 32.2 163.8 261.5 110.0 105.5 118.0 88.2 166.8 142.3 60.1 83.1 80.3 96.8 49.4 64.9 87.6 128.0 83.8 61.0 108.0 80.6 164.1 95.1 210.9 209.5 127.3 70.0 182.0 99.7 95.8 121.2 66.9 85.8 137.3 203.1 33.6 98.8 134.8 74.0 77.5 168.8 85.7 141.7 140.3 145.4 188.4 103.3 116.8 183.1 126.8 147.4 187.3 133.0 141.6 123.5 159.7 135.1 140.6 122.4 173.9 129.9 132.8 168.7 128.9 119.4 193.1 165.1 138.3 122.2 124.5 126.7 159.0 121.2 119.7 126.5 124.2 123.7 124.8 128.4 123.9 113.6 44.8 51.4 13.1 109.5 137.1 94.3 124.3 84.2 98.0 178.6 205.7 73.8 105.8 83.0 97.5 52.1 152.9 114.7 205.5 217.2 174.9 23.6 68.6 69.8 121.0 142.6 83.5 8.7 192.2 231.9 92.0 76.0 81.6 69.8 62.0 116.0 184.8 204.3 35.3 10.9 207.5 130.2 116.4 233.3 40.3 137.0 110.8 108.5 8.4 147.8 139.1 162.7 5.5 18.7 233.5 202.2 126.0 193.3 206.8 274.9 362.2 54.0 103.7 78.9 74.4 100.9 61.6 138.0 87.6 147.9 131.6 115.2 103.1 165.9 132.4 RPS26 "eS26, S26" ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044697 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "ovarian cancer: 494.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: AB_2682927" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 720.5 1265.1 387.6 271.7 388.8 395.5 690.2 382.8 480.4 707.7 384.0 731.2 177.1 569.7 410.7 875.4 724.0 123.3 713.0 380.9 416.6 701.8 926.6 521.9 512.9 396.3 399.7 1120.6 1170.2 274.3 476.7 251.6 389.9 627.3 403.3 69.8 592.3 335.9 778.2 857.3 744.1 307.2 383.4 832.0 717.5 208.8 394.0 616.8 544.1 390.6 715.6 734.3 698.0 389.2 639.2 763.3 853.6 319.5 1153.3 1696.4 852.0 633.4 929.5 1027.7 596.0 1182.7 281.7 1408.3 383.5 670.6 339.5 293.2 970.5 544.0 698.1 558.9 1552.8 743.9 482.1 719.0 1062.3 490.5 392.2 1036.9 1705.6 544.3 614.0 404.0 794.3 989.6 517.2 458.1 845.1 983.2 371.8 886.0 839.7 766.7 1710.8 496.7 254.8 884.3 871.4 634.9 318.2 552.4 245.8 542.2 372.2 252.1 479.4 538.6 260.8 255.0 524.3 328.0 518.0 369.3 810.2 770.9 284.0 969.2 334.4 334.8 394.8 262.5 650.7 410.2 723.2 872.3 841.4 711.8 508.4 720.3 898.4 863.6 154.8 607.5 373.0 643.6 963.7 1264.1 387.6 388.8 382.8 480.4 380.9 416.6 396.3 399.7 389.9 383.4 394.0 389.2 1114.5 224.4 237.7 5.2 2483.4 1760.6 852.7 2533.9 3266.8 131.0 1968.1 2542.2 29.2 1425.5 985.7 430.4 62.6 1237.2 1377.0 1803.5 972.4 1031.5 85.4 862.0 876.0 992.0 860.5 1977.9 5.2 2625.0 2835.4 1006.2 1666.7 861.2 514.4 1242.7 1647.4 2125.4 1369.2 75.7 5.1 1406.6 732.4 1557.8 1925.7 57.3 295.4 1146.8 1462.1 6.5 754.7 706.4 563.4 6.6 7.1 1806.8 1756.4 221.5 2590.7 1221.2 2448.3 1503.0 557.4 193.1 309.0 719.1 935.9 305.9 304.0 4236.6 1814.2 1708.2 2103.6 1318.5 1411.0 1000.6 RPS27A "S27A, Uba80, UBCEP80" ENSG00000143947 "Ribosomal protein S27a" P62979 2 55231903-55235853 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033319, HPA041344, HPA049132, HPA054087" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA Yes 230000000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Endoplasmic reticulum, Cytosol" "CAB033319: AB_793618, HPA041344: AB_2677422, HPA049132: AB_2680646, HPA054087: AB_2682373" "unprognostic (7.32e-2)" "unprognostic (1.41e-2)" "unprognostic (1.11e-1)" "unprognostic (3.20e-3)" "unprognostic (2.16e-1)" "unprognostic (9.75e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (2.46e-1)" "unprognostic (6.89e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (1.09e-1)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (3.60e-1)" 1440.7 1208.5 1115.0 1077.7 1151.0 2567.0 2511.6 1098.2 1883.7 2166.1 1099.2 1563.5 823.5 1450.9 1105.1 1698.4 1726.7 572.2 943.7 1085.1 1131.6 1254.8 1162.3 1097.1 1955.6 1133.6 1117.0 3146.7 2043.5 730.2 1057.5 872.9 1131.4 1430.2 1045.0 631.9 1387.4 917.9 1089.6 1767.3 1328.6 814.7 1172.6 1719.2 1478.2 405.9 1150.4 1520.4 1201.6 793.7 1774.4 1506.3 1694.7 1157.1 2384.4 1092.2 1412.2 1842.3 1892.6 3200.3 2412.6 1824.5 1779.4 1692.3 1069.1 2073.7 1987.4 3081.3 2833.2 1698.5 1115.0 1784.3 2061.7 2465.1 1981.0 2899.1 2419.0 2693.9 1088.0 2758.1 2705.9 3674.4 1605.2 3166.1 4213.4 1280.5 3401.6 3015.5 2415.9 1959.5 2469.0 2228.9 1937.3 1509.9 2307.6 4328.7 2831.1 2690.2 1710.6 2086.4 3051.2 3173.8 1994.3 1817.4 1546.0 1319.2 1064.4 4071.8 3843.7 2065.9 1811.0 3411.1 2108.9 1351.7 2395.8 1318.7 3006.7 2322.2 1881.5 1867.9 1923.5 3226.7 1392.6 1301.5 1656.9 637.7 2924.2 1530.8 4268.2 4727.8 4504.3 3592.2 2219.0 4232.8 5675.0 4744.3 351.6 3178.7 1388.8 3292.5 3058.2 8225.2 1115.0 1151.0 1098.2 1883.7 1085.1 1131.6 1133.6 1117.0 1131.4 1172.6 1150.4 1157.1 3051.9 1272.4 2321.3 39.8 7158.8 8321.0 8963.0 6850.9 5010.5 446.4 8189.8 10987.6 438.8 3029.7 3486.3 1397.8 214.8 5340.9 5465.1 1499.3 4055.8 3640.9 1050.2 1695.4 3081.0 3385.0 2057.4 3362.1 45.8 7348.0 6754.1 3043.5 1762.0 1917.3 3014.6 3565.0 3729.5 3181.0 3498.7 218.7 47.8 3995.4 2199.2 5051.0 6045.7 1576.9 5081.5 3382.7 3639.2 59.0 6346.8 2229.4 5579.8 29.1 61.0 5045.3 3396.0 2881.2 3458.4 8189.2 3670.3 5961.1 1726.4 760.9 1643.5 5220.3 4020.2 1047.7 863.4 5750.5 8931.2 5390.3 6365.7 3721.9 4717.6 7980.9 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 2535.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favorable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 142.2 242.4 78.6 71.3 80.6 73.2 127.1 81.5 113.1 124.7 102.5 190.8 157.4 108.4 157.9 70.8 117.9 94.8 181.0 78.1 84.2 194.5 266.0 109.4 83.5 82.9 81.7 95.9 247.4 94.0 88.6 69.3 84.5 156.2 178.0 31.8 164.7 106.7 190.1 75.9 161.4 80.7 86.0 103.2 174.7 38.1 81.4 86.3 106.5 97.7 68.2 149.2 94.1 90.0 140.4 383.0 340.4 92.9 486.4 571.3 341.3 432.1 306.0 93.8 225.3 71.1 190.0 130.8 150.9 415.9 166.0 52.9 116.5 212.9 155.7 97.8 157.5 108.3 329.1 512.7 558.7 86.8 287.0 452.1 279.0 211.2 158.4 701.2 535.2 81.2 101.6 127.7 785.1 194.1 112.4 134.9 101.0 178.0 112.6 86.9 163.1 149.5 266.7 278.8 49.2 74.7 157.6 65.8 326.2 677.8 145.4 199.1 571.1 490.6 463.8 106.7 195.3 142.3 132.3 117.5 518.5 235.6 453.8 263.8 132.5 164.6 99.4 145.2 125.2 132.0 149.9 118.1 122.0 105.2 116.9 119.4 44.3 110.9 198.2 121.3 305.2 166.0 78.6 80.6 81.5 113.1 78.1 84.2 82.9 81.7 84.5 86.0 81.4 90.0 210.9 96.1 198.6 9.4 255.9 255.4 262.6 424.8 230.5 33.4 361.3 429.1 349.0 511.9 424.6 410.1 47.9 300.1 144.9 694.7 903.9 802.7 60.9 202.3 185.3 245.8 285.4 184.5 12.6 782.4 1269.2 269.2 327.8 155.5 302.6 250.8 302.0 994.8 542.1 13.5 15.6 742.3 520.8 372.1 358.1 34.4 314.7 270.3 466.0 17.8 1049.6 184.8 221.4 16.1 18.5 1019.3 745.5 297.5 495.5 324.6 1513.1 2535.3 330.9 75.2 263.0 180.5 742.6 144.7 82.1 183.6 247.6 235.2 224.7 214.3 732.5 215.2 RPS6KA3 "CLS, HU-3, MRX19, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 236.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 21.1 18.8 6.9 33.7 10.2 16.2 14.8 12.7 12.8 16.1 8.5 32.8 24.1 17.5 8.5 18.7 15.1 26.9 21.1 8.7 9.4 19.5 45.0 32.3 31.3 8.4 10.0 10.6 17.2 59.4 5.9 19.5 8.5 19.9 31.8 15.7 13.2 18.0 51.8 15.0 27.6 27.8 8.7 29.2 21.1 5.5 10.6 32.9 21.2 40.3 32.6 34.2 8.5 8.0 44.9 77.0 28.4 14.8 27.1 47.3 8.6 38.0 57.4 27.8 37.7 87.7 56.2 29.3 12.8 40.0 40.5 30.9 32.8 32.2 51.1 24.8 26.1 34.6 46.2 236.8 27.7 67.8 34.2 30.3 25.1 43.5 54.4 24.3 101.9 30.4 23.1 81.0 29.4 21.2 44.2 20.7 20.6 57.8 45.9 23.3 60.0 33.8 23.9 36.9 13.1 12.8 51.1 15.3 54.4 35.3 0.1 20.0 57.3 30.1 20.8 96.3 21.7 64.3 42.1 32.1 56.9 33.1 72.6 11.9 3.8 7.9 4.7 5.3 8.3 2.4 5.4 5.2 5.6 3.2 3.7 4.5 5.8 6.6 6.0 6.7 2.9 2.2 6.9 10.2 12.7 12.8 8.7 9.4 8.4 10.0 8.5 8.7 10.6 8.0 60.6 44.8 67.5 31.6 34.8 54.4 37.0 21.2 10.2 37.8 20.4 10.8 22.9 34.3 41.1 16.5 22.9 4.0 70.0 63.5 3.9 26.3 0.4 10.8 24.0 61.1 25.0 19.1 142.2 30.5 6.7 31.6 24.5 26.1 44.3 8.3 34.6 65.4 22.6 13.5 108.4 59.1 28.5 40.8 104.3 1.5 13.1 62.6 37.4 126.5 53.7 27.5 46.4 116.6 27.0 37.4 57.9 21.1 25.5 56.6 33.5 25.1 23.3 9.7 19.7 41.5 21.3 6.4 8.7 13.8 55.5 3.6 66.0 14.2 61.1 63.8 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595072-6603616 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nucleoli, Cytosol" "HPA038487: AB_10672518, HPA057562: AB_2683468" "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 10.8 10.2 10.9 5.8 10.6 18.4 10.5 10.6 14.9 12.7 9.3 21.8 6.7 11.0 9.8 11.4 10.5 3.4 15.4 10.0 9.9 13.3 21.5 9.2 8.6 10.3 10.7 9.3 10.0 5.3 8.2 6.1 10.4 15.8 6.5 7.6 7.4 8.8 9.5 12.6 10.3 6.2 10.9 14.2 12.1 10.7 10.6 6.8 10.6 4.1 8.4 16.8 11.1 12.1 12.3 12.0 4.7 6.1 9.6 8.3 6.7 6.2 7.7 14.0 13.1 12.4 14.1 17.1 6.0 5.9 10.3 12.1 13.6 10.9 14.7 8.3 19.5 8.1 14.0 14.3 11.0 14.8 10.8 7.1 14.0 6.7 12.1 9.2 14.7 8.0 16.3 9.7 11.2 15.2 14.5 22.0 11.6 21.4 10.7 12.8 3.8 3.9 13.4 9.7 7.2 8.4 8.9 18.0 10.7 7.7 9.8 12.9 7.6 13.2 6.1 13.0 12.2 10.8 10.5 16.7 11.2 14.8 8.7 26.3 10.0 10.4 11.5 10.7 11.2 9.1 11.3 10.7 13.0 11.9 11.0 11.7 3.9 13.6 11.8 9.9 11.9 9.0 10.9 10.6 10.6 14.9 10.0 9.9 10.3 10.7 10.4 10.9 10.6 12.1 17.0 22.4 15.0 37.2 19.6 23.2 18.5 13.3 14.2 17.3 14.1 11.7 20.7 8.6 14.7 9.2 14.6 23.5 20.7 12.2 11.7 19.0 7.4 13.7 22.8 16.4 7.2 37.7 45.0 15.9 21.2 15.5 21.4 14.0 17.7 14.7 12.5 23.5 18.9 3.3 32.6 16.2 12.2 9.4 13.4 13.6 13.1 13.1 8.8 21.5 18.4 14.2 22.6 27.2 34.6 22.7 18.2 9.8 15.2 15.8 13.7 29.8 10.3 30.5 0.0 15.3 20.0 23.7 18.0 18.3 27.1 20.0 17.7 25.2 17.3 15.0 RRS1 KIAA0112 ENSG00000179041 "Ribosome biogenesis regulator 1 homolog" Q15050 8 66429014-66430733 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055549, HPA060937" Approved Supported Nucleoli NA No "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 32: Non-specific - Translation" Nucleoli "HPA055549: AB_2682846, HPA060937: AB_2684390" "unprognostic (7.68e-2)" "unprognostic (1.02e-1)" "unprognostic (3.72e-2)" "unprognostic (5.25e-2)" "unprognostic (2.64e-1)" "unprognostic (3.84e-3)" "unprognostic (4.93e-3)" "unprognostic (2.82e-3)" "unprognostic (3.55e-1)" "unprognostic (1.96e-2)" "unprognostic (2.13e-2)" "unprognostic (1.01e-2)" "unprognostic (3.46e-2)" "unprognostic (8.61e-2)" "unprognostic (2.30e-1)" "unprognostic (5.29e-2)" "unprognostic (8.35e-3)" 18.6 14.6 9.8 12.0 9.9 6.5 14.4 9.1 8.9 14.3 10.3 15.5 8.2 19.2 3.8 18.3 16.6 3.6 16.7 8.1 8.5 14.0 14.9 9.8 10.2 14.5 9.9 17.2 41.0 6.0 6.2 5.9 9.9 10.9 5.2 4.4 11.4 6.9 50.0 16.9 12.0 7.4 9.7 13.1 19.0 5.1 11.4 6.5 8.4 14.5 9.5 18.6 13.8 8.6 68.2 83.7 16.9 35.7 17.8 14.3 27.2 41.7 18.3 31.6 23.3 37.7 43.8 91.3 14.2 22.1 44.6 62.5 41.7 47.5 34.7 50.6 70.2 72.8 25.4 67.8 26.3 43.6 37.2 18.9 37.7 34.9 46.1 12.9 20.8 27.5 64.7 37.6 23.3 78.6 87.3 79.2 109.5 76.0 97.2 18.4 21.6 38.3 44.8 54.9 23.0 50.6 20.4 33.4 48.9 17.4 57.6 38.5 36.0 58.5 53.4 49.5 97.5 67.1 64.7 69.8 27.2 68.0 40.4 0.0 13.1 1.0 14.1 17.5 24.8 9.3 17.6 16.5 22.7 8.8 16.1 18.8 0.4 17.3 12.1 10.6 14.2 10.2 9.8 9.9 9.1 8.9 8.1 8.5 14.5 9.9 9.9 9.7 11.4 8.6 8.6 32.1 16.2 3.6 10.0 70.0 42.9 17.9 20.5 9.7 11.8 9.9 29.6 8.6 18.3 12.9 12.5 21.2 13.1 7.1 11.7 28.7 0.2 6.9 16.4 14.6 6.7 13.2 1.5 28.3 23.1 13.6 11.7 8.9 7.6 11.5 12.5 14.8 20.3 6.7 2.8 13.4 8.2 12.2 11.9 1.0 19.0 9.8 23.2 0.0 15.6 8.6 26.8 0.5 2.0 22.1 9.5 17.3 8.7 37.9 3.4 30.0 9.6 13.1 19.7 28.9 21.6 6.2 16.8 19.6 59.8 38.6 20.1 17.9 22.1 30.6 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062127-137070557 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.1;esophagus: 8.5;skin 1: 6.2" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 122.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 0.5 0.3 6.9 2.4 5.1 2.0 1.3 4.7 5.4 1.2 1.3 3.7 4.3 0.4 0.0 8.5 0.3 0.2 0.2 5.4 4.5 1.2 0.2 0.5 2.7 7.1 6.8 0.1 0.4 0.0 0.5 0.9 5.7 3.1 1.8 0.1 4.1 0.1 0.1 6.2 4.3 0.4 5.0 2.2 2.4 0.5 6.8 2.3 0.3 0.0 2.5 0.4 2.3 7.0 52.1 27.5 10.7 32.0 0.3 0.7 57.1 8.4 5.7 8.8 4.1 52.5 23.2 53.8 26.5 4.1 8.2 72.3 33.6 9.7 2.0 37.4 38.9 23.6 32.7 59.6 0.2 27.0 39.2 0.1 1.5 3.0 5.8 2.3 14.4 27.1 33.1 23.7 2.6 122.1 7.8 72.7 19.9 119.2 61.9 82.9 40.7 60.1 10.9 14.8 55.2 32.7 32.2 89.1 12.2 2.4 71.9 51.1 9.4 7.9 26.6 24.0 41.9 8.2 25.5 26.3 18.4 31.8 25.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 5.1 4.7 5.4 5.4 4.5 7.1 6.8 5.7 5.0 6.8 7.0 0.5 0.0 0.0 0.7 1.9 4.2 0.7 0.5 0.6 0.2 5.0 5.2 1.3 0.0 1.1 0.0 0.0 2.8 1.6 5.4 1.9 0.3 0.0 1.6 0.8 0.9 0.0 3.6 0.2 0.0 3.5 1.1 6.1 6.0 0.0 3.3 1.4 0.0 3.1 0.0 0.2 10.8 0.0 2.8 1.5 0.1 0.0 2.2 0.0 0.0 1.5 0.5 0.0 29.7 5.6 0.6 4.0 0.0 1.8 2.1 0.5 0.0 0.1 0.6 0.0 0.2 1.0 0.0 1.4 5.8 2.7 0.5 1.3 0.6 12.1 1.1 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Human disease related genes, Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favorable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 14.6 13.5 10.5 14.8 10.8 7.2 17.9 8.4 12.3 13.6 8.5 14.3 11.9 17.6 19.0 15.3 12.7 8.7 14.3 10.9 11.0 15.0 15.8 12.6 21.2 9.6 8.9 13.7 17.7 17.7 8.9 12.9 9.3 14.2 15.1 6.8 15.0 16.2 22.9 14.8 11.1 17.1 8.5 15.5 14.0 21.3 11.1 16.4 21.2 16.4 20.2 18.8 11.7 10.2 29.8 11.8 28.5 38.9 33.1 29.8 30.6 41.3 35.9 34.0 29.1 36.6 42.0 46.7 30.2 38.1 32.4 29.7 44.5 40.5 42.3 41.2 23.0 39.9 24.4 30.6 32.7 68.5 43.9 26.4 45.0 36.3 40.4 21.1 30.0 31.2 72.7 37.8 36.4 33.1 69.6 25.1 47.4 48.3 18.1 41.8 53.5 39.3 32.7 32.6 43.3 35.6 28.1 57.0 48.9 31.1 26.4 39.6 29.1 36.6 36.7 44.4 34.8 33.9 37.6 62.0 40.7 31.1 46.0 10.4 14.5 4.1 19.1 19.1 23.8 17.8 23.0 21.1 15.3 20.1 23.0 19.5 2.3 23.4 27.5 13.0 21.5 15.9 10.5 10.8 8.4 12.3 10.9 11.0 9.6 8.9 9.3 8.5 11.1 10.2 36.2 19.2 34.7 15.0 45.7 27.5 26.8 45.1 35.3 21.1 21.3 29.1 12.3 14.3 46.0 22.0 6.2 30.6 35.7 14.5 35.2 37.7 109.0 12.1 29.9 25.2 22.8 35.3 34.0 24.9 32.2 27.4 20.9 18.7 49.4 26.3 18.9 22.1 37.9 13.5 31.8 22.6 36.7 24.3 16.3 106.7 25.4 30.0 24.9 30.9 40.3 23.7 42.2 23.6 29.9 33.4 18.3 33.1 49.0 37.1 17.1 46.6 26.1 20.0 19.7 33.2 38.7 75.6 100.7 47.5 33.1 25.0 38.1 33.2 27.9 22.4 SELENBP1 "hSBP, hSP56, LPSB" ENSG00000143416 "Selenium binding protein 1" Q13228 1 151364304-151372707 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein transport, Transport" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 509.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enhanced" "Detected in single" "dendritic cells: 2.4" "Cell line enhanced" "Detected in many" "ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005741, CAB008366, HPA011731" Enhanced Supported Nucleoli NA NA 59000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli "CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663" "unprognostic (1.51e-1)" "unprognostic (7.01e-2)" "unprognostic (8.52e-3)" "unprognostic (6.25e-3)" "unprognostic (6.28e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.08e-2)" "unprognostic (1.21e-2)" "unprognostic (3.78e-3)" "unprognostic (2.86e-1)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-2)" "unprognostic (6.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.86e-2)" "unprognostic (6.86e-3)" 128.3 18.7 49.8 24.9 53.0 95.9 76.3 45.5 54.8 57.0 47.4 509.3 74.7 31.3 43.4 31.8 132.7 52.2 69.1 47.1 48.2 77.2 261.7 181.0 10.9 47.8 51.0 49.4 29.0 11.9 15.0 20.4 46.5 44.2 471.7 3.9 61.6 48.8 72.9 25.2 94.2 49.5 46.9 51.1 126.4 6.1 51.0 7.1 115.1 138.1 6.8 58.3 29.3 45.7 0.0 17.2 31.9 1.8 144.9 59.1 8.4 5.9 2.6 3.1 6.5 18.1 5.4 0.0 30.7 10.7 0.0 0.4 0.0 0.4 2.8 0.1 14.8 120.5 53.1 28.9 30.5 0.2 0.0 75.9 1.0 5.3 0.1 0.4 19.0 0.0 12.4 0.0 8.0 13.2 0.0 0.0 26.6 92.8 32.2 0.1 1.7 0.7 7.1 0.0 0.4 0.7 0.5 274.4 0.0 25.1 49.4 1.8 1.8 0.0 1.1 16.8 0.1 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 49.8 53.0 45.5 54.8 47.1 48.2 47.8 51.0 46.5 46.9 51.0 45.7 36.6 294.9 525.6 38.2 4.0 10.8 27.7 56.4 30.7 0.3 73.0 59.9 135.7 75.8 123.9 5.5 0.0 2.4 1.9 1056.9 115.4 17.1 0.7 30.9 14.9 27.5 155.0 590.9 0.1 9.1 2.1 85.2 163.6 14.1 27.3 10.9 26.0 501.5 15.3 0.0 0.1 137.2 79.3 39.6 12.4 4.2 66.5 3.9 33.8 13.1 0.2 37.4 0.0 0.0 2.0 6.5 451.4 80.9 0.8 25.6 251.0 148.3 101.5 1.4 52.6 15.6 102.3 0.1 0.3 22.7 9.9 4.0 5.7 30.5 452.4 71.0 SENP3 "DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1" ENSG00000161956 "SUMO specific peptidase 3" Q9H4L4 17 7561919-7571969 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" HPA060290 Supported Supported Nucleoplasm,Nucleoli Yes No "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli" "HPA060290: AB_2684244" "unprognostic (5.68e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (3.48e-1)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (7.37e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.22e-5)" "unprognostic (2.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "unprognostic (2.56e-2)" 24.2 24.0 43.7 21.0 42.6 25.4 23.7 38.5 47.9 23.7 38.5 32.4 21.2 26.7 27.4 25.4 25.9 19.3 25.2 42.6 39.8 34.1 20.5 28.6 26.5 40.4 42.2 26.8 26.4 38.1 26.4 22.5 41.1 23.0 25.4 24.7 24.8 26.0 33.5 28.6 25.2 28.9 39.5 28.3 27.0 29.0 44.0 33.8 23.9 30.9 31.2 29.7 21.8 42.0 76.4 90.8 52.7 82.5 58.6 42.8 54.8 54.8 56.0 93.4 87.2 54.9 32.5 90.3 52.6 72.7 62.3 72.0 114.4 85.8 78.0 63.7 105.0 46.7 74.8 56.9 79.1 44.0 57.9 55.1 86.5 107.1 103.5 53.3 76.0 102.1 61.5 24.7 73.0 51.4 107.9 33.6 64.2 70.9 54.5 97.1 48.8 52.4 62.9 44.0 52.5 67.6 55.3 52.7 60.0 66.6 44.1 28.5 40.5 53.0 45.9 51.3 119.0 36.3 40.4 57.3 53.9 45.7 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 43.7 42.6 38.5 47.9 42.6 39.8 40.4 42.2 41.1 39.5 44.0 42.0 4.5 3.2 5.4 0.0 4.9 8.5 6.4 1.6 10.2 6.1 6.7 11.0 7.1 7.2 3.6 1.8 22.9 3.0 4.8 2.6 0.0 2.3 1.4 4.0 4.2 4.7 6.6 1.3 0.0 2.4 2.3 3.8 3.6 4.7 1.3 5.2 8.2 2.7 1.5 6.7 0.0 3.0 2.0 6.0 6.4 0.7 4.1 4.9 3.6 0.0 4.7 5.5 4.1 0.0 0.0 2.1 0.8 2.2 6.4 6.1 4.0 1.1 2.1 7.3 0.0 5.2 4.4 3.7 4.0 7.4 11.6 4.1 4.9 3.0 3.7 6.4 SETMAR metnase ENSG00000170364 "SET domain and mariner transposase fusion gene" Q53H47 3 4303304-4317567 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA057999 Supported Nucleoli NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoli "HPA057999: AB_2683574" "unprognostic (1.59e-1)" "unprognostic (1.22e-2)" "unprognostic (5.24e-3)" "unprognostic (4.89e-2)" "unprognostic (7.73e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.58e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-1)" "unprognostic (1.19e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.61e-6)" "unprognostic (5.42e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-3)" 6.5 3.7 2.6 2.2 4.3 2.6 8.5 4.2 3.3 8.4 1.9 3.9 2.7 10.3 4.6 4.5 8.5 5.3 3.4 3.0 2.3 6.4 3.3 2.7 2.9 3.6 2.8 12.1 5.1 3.4 3.7 3.7 3.4 7.9 4.3 2.1 5.7 6.1 3.8 4.8 3.1 10.4 2.5 2.8 3.7 4.2 4.0 6.0 7.4 5.1 2.8 5.5 5.2 6.5 3.7 3.2 9.8 2.1 23.1 7.6 9.9 4.1 1.2 3.9 3.7 3.5 2.9 9.9 4.2 2.3 7.2 3.1 8.9 6.1 4.3 6.8 7.6 12.5 6.1 5.6 2.7 5.9 5.1 9.1 4.7 3.0 0.9 3.6 5.7 11.2 8.3 3.6 6.2 5.2 8.9 3.7 9.5 2.4 5.7 10.3 9.6 4.1 3.6 5.1 7.8 11.4 4.9 6.1 5.3 6.2 5.9 3.4 3.8 5.8 8.0 4.9 5.4 4.9 12.3 24.1 2.1 6.7 4.9 0.7 0.4 0.5 0.8 1.2 0.7 1.0 1.0 1.1 0.4 1.3 1.6 2.0 0.0 0.2 0.8 0.6 0.7 0.6 2.6 4.3 4.2 3.3 3.0 2.3 3.6 2.8 3.4 2.5 4.0 6.5 4.8 0.0 5.0 4.9 2.4 2.4 8.0 12.0 10.8 5.8 6.6 13.7 6.6 2.8 10.8 0.0 0.0 25.5 1.9 2.7 13.7 11.2 0.7 3.8 6.3 5.6 3.6 5.5 6.4 13.4 12.1 8.9 5.6 4.4 1.3 13.9 4.2 2.6 5.7 0.0 6.9 2.8 10.2 2.1 1.5 1.9 9.6 2.7 0.0 4.7 4.1 4.6 2.1 7.1 11.7 6.6 4.4 13.2 1.8 4.4 2.0 6.0 6.7 2.8 6.6 7.0 8.1 7.5 6.4 6.0 0.6 16.3 2.8 16.9 5.6 3.6 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523791-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No 50000 "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA041134: AB_2677317, HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 15.7 11.2 7.9 19.2 8.2 22.2 13.8 15.9 9.6 16.3 11.4 17.1 13.6 17.0 10.2 19.9 16.4 11.6 12.1 8.8 9.7 12.5 12.3 11.7 24.3 7.0 6.9 22.3 13.8 16.8 7.9 14.1 7.5 11.6 13.2 16.3 12.6 10.7 23.6 19.9 12.9 16.0 6.5 13.9 13.2 10.2 10.4 23.7 14.5 11.7 26.6 14.2 14.4 12.0 72.4 72.6 93.4 65.3 45.5 41.6 74.0 66.3 55.5 84.5 67.3 75.6 55.8 97.1 52.6 51.8 49.9 81.4 98.0 55.7 133.0 31.5 71.1 75.1 56.7 81.0 30.6 106.1 83.9 39.8 40.1 93.9 68.8 54.1 50.9 55.3 104.6 34.2 67.4 87.5 92.9 51.6 85.2 44.8 41.9 163.2 73.3 109.7 26.9 96.4 81.4 59.8 217.7 33.8 33.8 39.2 73.9 53.0 52.7 61.9 67.8 49.2 71.6 37.4 90.4 260.7 40.9 66.9 61.3 23.4 26.1 28.1 35.8 30.8 39.3 28.4 33.1 37.5 35.3 34.3 38.8 33.7 8.3 35.5 31.2 19.1 40.2 37.4 7.9 8.2 15.9 9.6 8.8 9.7 7.0 6.9 7.5 6.5 10.4 12.0 18.9 25.6 25.7 16.6 33.0 22.4 23.2 23.4 13.1 35.5 20.5 18.3 29.3 14.3 25.4 23.9 14.6 33.6 21.6 19.7 7.9 20.7 6.3 17.8 31.9 25.4 21.1 36.8 23.2 23.2 34.7 24.2 20.4 17.5 17.7 52.3 17.5 23.6 23.6 40.4 26.5 21.8 24.4 20.6 12.8 10.3 33.8 19.2 17.8 24.4 22.7 19.4 25.7 26.2 26.7 24.9 14.0 33.1 25.1 30.2 18.1 15.7 18.8 26.7 6.6 30.2 18.8 28.7 33.3 37.6 26.1 25.4 28.3 48.2 31.6 24.7 SHLD3 "AC008560.1, CTC-534A2.2, FLJ26957, RINN1" ENSG00000253251 "Shieldin complex subunit 3" Q6ZNX1 5 65625027-65630928 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 17.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 2.3 2.7 2.4 2.7 2.5 17.5 4.2 2.8 3.6 1.8 1.8 2.8 2.8 2.3 3.1 1.5 1.9 2.4 1.8 2.3 2.1 2.9 2.6 2.5 4.8 2.4 2.1 1.5 3.4 2.1 2.5 2.5 2.3 4.3 3.0 3.7 2.0 2.5 1.8 2.9 2.7 1.7 2.4 2.5 2.4 3.2 2.4 3.9 2.4 1.9 3.6 2.5 1.3 3.2 2.6 3.6 5.0 10.8 2.9 3.5 6.3 3.8 3.5 5.8 7.0 5.9 8.0 4.9 4.2 4.6 6.5 3.1 5.1 4.7 8.5 6.7 6.5 4.3 10.3 8.3 2.5 5.0 7.5 2.1 6.8 6.0 6.1 1.6 3.7 7.7 6.4 11.5 4.7 6.9 6.7 7.7 4.0 1.5 2.2 4.4 4.9 7.9 4.9 6.0 6.7 5.5 3.2 3.3 11.0 3.4 3.8 4.6 3.0 5.0 6.8 4.1 6.6 7.2 14.3 10.7 3.7 6.1 4.7 15.9 3.0 6.4 3.8 2.9 4.0 3.9 4.5 4.0 2.8 3.1 6.1 5.6 3.3 4.9 3.1 3.2 6.2 2.1 2.4 2.5 2.8 3.6 2.3 2.1 2.4 2.1 2.3 2.4 2.4 3.2 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 3.6 0.0 0.0 0.0 0.0 0.0 4.0 5.9 0.0 3.9 3.1 0.0 1.9 1.8 0.8 0.0 0.0 0.0 2.9 3.8 0.9 0.0 2.1 0.0 2.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.1 1.8 2.1 0.0 0.0 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643421-60658259 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 5.5 0.4 0.3 0.0 0.5 0.0 1.9 0.5 1.2 15.2 1.0 0.0 0.0 0.0 0.4 1.1 0.8 0.5 0.0 0.3 0.3 0.0 0.0 1.5 0.5 0.3 0.4 0.2 0.3 47.8 19.8 0.0 0.4 13.2 0.0 0.0 51.1 0.2 119.4 0.3 0.0 0.0 0.3 0.0 0.4 1.7 0.5 9.7 1.9 46.3 0.2 1.6 0.8 0.4 15.2 3.5 0.6 28.1 17.0 20.6 0.4 4.1 10.6 4.9 4.0 0.0 8.2 0.0 2.2 0.6 2.1 4.4 10.3 6.4 2.1 0.0 17.1 2.0 1.9 6.8 0.0 0.0 0.2 15.6 4.9 2.3 0.7 36.3 0.3 1.6 5.8 0.0 142.2 2.8 0.0 0.5 0.0 0.0 8.9 0.0 71.9 0.0 5.9 16.3 2.5 0.3 5.0 0.3 6.1 0.5 3.3 0.4 13.9 6.7 5.4 7.9 6.5 0.5 0.1 0.0 1.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 1.2 0.3 0.3 0.3 0.4 0.4 0.3 0.5 0.4 0.8 3.2 1.5 0.0 0.0 0.1 30.7 30.8 0.6 0.0 1.0 0.8 0.9 0.0 33.9 1.8 0.0 0.2 0.0 0.1 1.9 0.0 0.2 1.1 0.1 1.6 0.0 0.0 0.0 0.8 0.4 5.7 0.5 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.6 0.0 0.3 0.0 1.9 0.0 0.8 0.0 1.0 0.1 0.2 0.0 1.2 0.0 27.4 0.0 0.1 67.1 0.2 0.0 77.3 5.1 0.0 25.0 0.1 0.1 0.3 0.1 0.1 0.0 18.3 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692731-1712344 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 263.6;Spermatogonia: 294.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 29.9 26.4 38.6 37.6 40.2 114.2 26.7 38.0 65.7 28.4 34.4 30.6 23.9 27.3 32.9 35.9 27.6 21.9 18.4 40.9 43.6 35.1 33.9 27.2 71.7 36.4 39.1 28.0 24.4 24.0 26.7 42.0 39.3 22.8 30.6 17.1 25.6 25.3 22.6 37.7 25.6 28.8 37.7 28.3 26.9 63.1 41.8 53.5 27.3 19.2 69.5 35.0 28.0 41.1 132.7 53.9 76.6 80.7 65.3 70.0 81.9 120.1 92.5 131.4 133.8 120.3 144.7 180.6 67.4 96.0 150.9 77.8 147.0 103.0 154.1 75.4 98.5 215.9 63.3 123.6 82.6 208.3 102.8 55.0 84.7 98.1 67.3 74.4 76.5 108.8 172.7 170.3 163.2 52.8 314.6 200.6 97.4 136.7 108.6 241.1 126.3 105.3 131.0 99.5 86.1 69.3 95.4 59.6 69.5 96.8 99.0 127.7 66.3 108.0 63.8 116.1 180.4 107.4 192.2 428.3 99.6 176.0 106.0 25.7 65.4 47.5 47.1 49.7 43.3 51.6 59.7 64.8 50.6 37.8 50.6 49.6 95.8 46.3 44.8 42.2 77.9 75.4 38.6 40.2 38.0 65.7 40.9 43.6 36.4 39.1 39.3 37.7 41.8 41.1 35.2 16.0 18.8 7.2 96.3 105.2 96.3 38.8 61.5 19.4 35.9 34.0 8.2 27.1 23.6 36.8 25.0 166.3 80.5 28.8 107.6 50.6 75.9 38.8 34.9 36.1 35.9 146.0 14.6 31.3 51.8 49.1 53.5 55.5 23.5 45.9 30.0 27.0 81.3 25.2 15.1 33.6 44.7 36.8 58.6 41.6 44.1 60.3 65.8 6.5 64.4 27.4 43.3 9.0 14.4 38.7 25.3 44.0 94.2 88.6 22.5 55.4 16.3 13.6 13.1 46.3 43.8 263.6 294.0 84.1 105.8 44.7 96.6 33.2 44.1 76.5 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 48.6 52.6 38.0 38.6 42.4 37.5 46.5 46.2 36.7 43.2 35.6 47.5 36.7 38.6 41.0 55.0 46.8 39.6 53.8 32.9 48.6 43.3 35.6 46.7 44.5 50.2 43.2 52.5 40.4 44.6 20.3 42.7 51.9 36.4 48.7 70.5 36.7 44.8 57.4 34.0 37.4 47.9 47.8 47.5 45.2 51.5 42.4 72.4 75.7 55.5 55.2 53.8 31.1 59.4 81.1 113.7 68.0 66.2 106.1 128.5 77.4 86.1 102.7 87.9 101.8 43.8 75.6 124.8 60.3 110.0 123.0 86.6 77.2 96.1 116.9 136.4 39.3 106.4 164.4 71.9 123.2 149.6 104.1 95.8 121.4 75.5 172.9 102.1 98.6 99.7 50.3 101.6 109.6 52.7 103.4 71.6 33.6 4.4 26.7 74.4 98.9 85.9 197.8 137.2 62.8 73.3 103.7 70.1 85.7 65.8 53.5 97.7 111.4 129.5 74.2 35.6 63.6 99.0 102.7 108.3 89.6 99.9 97.1 58.8 33.6 38.7 23.8 38.5 29.8 16.7 32.3 29.9 32.8 13.9 35.3 27.6 34.1 38.6 33.0 23.3 40.5 31.6 38.0 42.4 46.2 36.7 32.9 48.6 50.2 43.2 51.9 47.8 42.4 59.4 55.0 44.8 36.1 55.8 36.3 54.4 44.1 38.3 54.1 48.0 44.2 30.2 49.2 41.5 45.5 77.3 212.7 48.2 53.0 42.8 39.2 36.5 68.1 58.6 53.0 53.1 51.0 36.4 63.4 43.5 40.3 40.5 44.4 68.1 21.5 80.0 56.4 29.6 43.9 35.3 50.5 46.1 38.7 57.3 41.8 131.9 41.7 48.7 51.6 104.9 63.9 44.8 72.1 96.0 130.0 44.0 31.6 53.4 34.5 66.1 37.9 39.5 41.8 88.1 32.9 53.5 39.6 37.2 39.4 59.2 61.8 69.5 47.4 41.7 42.3 77.2 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141419 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.7" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Yes No 26000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA071309: AB_2686385" "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 5.2 4.1 2.8 11.3 4.0 18.4 6.6 4.4 3.3 7.5 1.3 8.2 7.5 6.0 2.6 7.3 4.7 4.0 7.9 2.2 4.0 6.3 4.7 4.5 16.0 4.9 3.7 4.7 3.5 5.7 1.5 6.9 4.1 4.2 8.8 5.6 3.1 4.7 2.2 7.4 7.6 5.4 3.5 7.2 6.1 12.0 3.5 25.7 7.6 5.4 15.9 4.9 3.2 5.0 59.3 45.0 49.4 45.9 10.3 14.9 46.2 53.5 25.4 46.9 39.4 39.3 44.9 112.6 25.2 27.7 40.5 97.6 72.3 34.8 63.2 71.6 30.3 67.9 68.8 25.5 2.7 41.5 65.6 9.8 7.0 63.7 25.7 15.9 33.7 71.2 55.8 89.8 43.0 28.9 109.1 21.3 42.9 47.6 34.8 72.0 141.3 42.2 20.1 21.1 46.5 35.9 63.8 29.6 15.5 20.5 59.5 28.0 27.1 56.8 59.1 79.3 67.9 32.6 118.2 64.6 36.8 59.8 70.3 15.0 2.2 2.5 4.8 5.9 5.4 7.3 4.4 4.8 2.6 7.9 5.0 5.8 0.3 7.0 7.4 4.4 6.0 2.4 2.8 4.0 4.4 3.3 2.2 4.0 4.9 3.7 4.1 3.5 3.5 5.0 19.6 25.6 11.9 6.5 19.9 27.3 16.4 27.6 11.4 39.7 16.6 19.3 45.1 7.2 17.8 16.5 8.4 54.3 15.2 13.7 35.2 18.9 40.0 114.6 21.6 21.4 4.9 95.3 10.2 20.4 93.8 20.2 13.3 16.0 22.2 40.4 21.0 7.6 44.3 28.6 15.5 14.6 26.4 19.8 19.8 24.7 18.6 22.9 7.2 7.5 19.8 15.6 22.6 5.5 18.4 15.6 6.3 12.4 40.9 7.3 10.3 15.0 12.0 19.1 13.1 25.1 37.7 84.5 93.5 27.4 23.2 25.9 18.1 28.1 35.0 14.2 SMG6 "C17orf31, EST1A, KIAA0732, SMG-6" ENSG00000070366 "SMG6 nonsense mediated mRNA decay factor" Q86US8 17 2059839-2303785 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042932 Approved Supported Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoli Cytosol "HPA042932: AB_10964261" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (5.30e-1)" "unprognostic (4.41e-2)" "unprognostic (1.33e-1)" "unprognostic (9.33e-3)" "unprognostic (1.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.75e-2)" "unprognostic (7.63e-2)" "unprognostic (4.78e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.61e-1)" "unprognostic (3.08e-2)" 12.2 13.0 15.5 12.3 14.6 13.6 10.5 17.6 15.0 16.4 13.2 11.4 9.3 26.6 11.1 16.4 21.7 17.2 14.0 13.8 17.8 12.3 7.4 11.9 12.3 19.9 17.3 37.5 7.4 14.4 13.3 10.5 14.3 13.9 9.4 19.2 10.4 12.8 12.9 16.0 10.9 18.9 12.5 9.8 9.6 19.5 16.0 23.1 11.7 9.1 10.9 13.1 12.0 14.8 14.9 22.5 31.7 20.6 33.6 27.0 16.3 23.6 25.9 26.3 22.2 27.6 7.3 15.7 8.3 34.8 12.0 21.3 23.5 20.1 27.4 15.7 14.7 15.3 11.8 13.5 19.2 8.2 10.5 38.5 14.5 21.2 18.6 42.6 24.3 15.3 12.8 18.5 19.9 11.7 20.8 6.6 10.2 8.9 11.7 21.4 20.2 6.2 15.2 13.5 5.3 16.1 24.6 7.1 10.2 22.2 11.1 6.0 32.2 24.0 13.1 25.6 25.1 16.0 10.5 7.2 19.1 9.1 14.0 3.0 0.7 0.8 1.3 0.3 1.3 0.5 1.1 1.3 0.4 0.7 1.5 1.1 0.5 2.0 1.6 1.3 0.6 0.6 15.5 14.6 17.6 15.0 13.8 17.8 19.9 17.3 14.3 12.5 16.0 14.8 17.2 22.4 18.4 41.4 13.2 7.9 13.8 13.1 10.2 35.6 13.8 14.5 8.0 7.2 11.8 14.7 75.0 16.5 17.7 17.9 5.9 13.8 22.5 19.4 37.1 20.3 4.2 12.8 57.1 12.4 10.7 21.0 18.3 21.3 10.8 20.3 17.9 9.1 10.3 47.1 61.7 14.4 16.2 8.7 6.8 36.9 16.8 10.6 8.8 81.5 15.9 24.8 21.6 44.7 64.3 17.2 15.2 19.9 14.6 14.7 10.1 7.6 17.9 50.5 26.3 27.1 20.4 63.7 59.0 15.1 8.7 17.4 24.9 22.4 13.5 14.2 SNRNP35 U1SNRNPBP ENSG00000184209 "Small nuclear ribonucleoprotein U11/U12 subunit 35" Q16560 12 123458088-123473154 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059145, HPA067031" Supported Supported Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoli "HPA059145: AB_2683926, HPA067031: AB_2685766" "unprognostic (3.80e-2)" "unprognostic (1.17e-2)" "unprognostic (6.16e-2)" "unprognostic (1.35e-3)" "unprognostic (6.78e-2)" "unprognostic (1.96e-1)" "unprognostic (7.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.75e-1)" "unprognostic (6.24e-2)" "unprognostic (2.56e-3)" "unprognostic (7.24e-2)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (7.10e-2)" "unprognostic (2.30e-2)" "unprognostic (1.31e-3)" 19.0 20.0 33.1 16.0 34.8 17.6 18.7 36.2 46.3 24.2 33.4 20.8 15.4 22.2 15.1 26.2 19.0 10.3 41.2 32.7 35.3 29.2 26.4 19.1 20.1 34.6 34.0 17.1 19.2 20.5 24.5 16.8 34.1 24.9 17.8 18.3 23.7 12.7 79.5 26.5 23.3 16.2 32.0 30.8 22.9 16.4 34.8 18.7 23.3 43.3 19.3 18.4 21.4 37.2 22.8 23.7 28.1 14.4 20.0 18.6 24.6 19.5 28.4 20.1 14.6 14.9 15.3 45.0 14.0 28.4 14.5 23.0 24.3 34.9 17.2 33.0 19.7 21.1 22.0 34.6 14.0 21.8 32.5 22.7 24.0 18.0 17.1 36.3 27.8 14.0 27.5 8.9 28.4 48.0 23.6 49.1 19.6 30.5 22.4 18.0 12.3 24.0 46.8 45.2 23.9 35.3 17.3 36.1 28.2 27.8 43.6 29.1 32.4 13.3 24.3 16.9 17.7 22.0 23.8 26.6 21.7 21.1 18.6 81.0 45.6 74.3 43.3 48.5 43.0 71.5 54.3 49.2 47.0 66.2 41.9 45.2 70.2 47.9 47.0 47.8 79.3 36.8 33.1 34.8 36.2 46.3 32.7 35.3 34.6 34.0 34.1 32.0 34.8 37.2 21.4 51.3 20.1 14.0 25.0 14.0 19.1 57.3 13.1 30.9 16.3 19.3 29.5 18.6 36.7 33.1 12.5 51.6 31.3 26.9 50.9 35.2 38.3 26.1 21.2 22.5 14.9 29.2 8.4 33.6 34.8 19.3 27.0 22.9 13.3 19.9 23.9 27.1 33.1 15.2 12.1 22.4 44.7 17.0 10.2 10.9 24.2 19.3 16.0 11.2 35.9 37.1 39.1 12.1 27.1 35.0 33.4 25.9 15.9 20.6 37.4 48.9 32.5 28.6 32.9 19.0 24.1 25.3 24.2 18.9 14.5 42.0 24.4 18.3 18.1 25.4 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24 component of NDC80 kinetochore complex" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.0;lymphoid tissue: 14.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 1.9 1.7 1.3 4.8 1.5 26.0 1.2 3.9 2.1 2.1 1.7 4.7 4.5 2.7 0.8 5.0 1.3 2.3 2.7 1.6 1.5 0.8 1.6 1.6 6.3 1.1 0.8 1.3 1.1 0.4 0.4 3.2 1.3 1.6 4.3 1.2 1.3 2.0 4.0 3.9 4.1 8.1 0.5 3.1 2.9 4.3 1.4 14.7 0.9 1.1 6.5 2.5 2.0 2.4 73.6 26.9 36.9 30.1 5.0 9.7 16.6 42.3 15.7 38.6 43.6 28.4 24.6 58.2 46.0 18.5 22.8 38.8 29.0 30.3 28.7 30.9 24.9 78.5 68.9 43.2 1.1 55.5 33.7 1.9 1.1 27.8 12.8 10.0 34.7 62.3 42.8 118.3 27.6 48.7 76.4 32.9 25.5 19.8 43.9 59.8 56.7 18.6 11.2 23.8 38.4 27.2 37.0 22.4 9.6 17.5 22.0 19.8 33.2 36.8 38.3 49.6 51.2 70.5 39.8 55.6 26.9 53.9 30.5 1.9 0.4 0.4 0.5 0.5 0.4 0.8 0.9 1.5 0.2 0.7 0.9 0.6 2.2 2.0 0.5 0.5 1.7 0.3 1.3 1.5 3.9 2.1 1.6 1.5 1.1 0.8 1.3 0.5 1.4 2.4 0.2 0.0 0.5 0.3 1.5 1.1 1.2 1.3 0.0 0.0 1.0 0.4 9.0 1.5 0.8 5.5 6.2 10.0 0.9 2.8 0.0 0.2 0.3 1.0 2.2 2.2 2.4 35.0 0.3 0.0 15.5 3.5 3.6 1.8 5.7 6.5 4.6 0.7 14.0 0.0 0.3 2.6 0.0 3.0 2.5 3.0 0.6 1.0 0.0 1.0 0.0 2.1 2.1 0.5 0.3 0.3 0.0 0.4 6.3 0.3 0.7 0.6 0.2 0.6 0.0 1.3 2.4 6.9 10.8 2.1 0.3 2.1 2.2 0.5 6.6 1.2 SPG11 "ALS5, FLJ21439, KIAA1840" ENSG00000104133 "SPG11 vesicle trafficking associated, spatacsin" Q96JI7 15 44562696-44663678 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favorable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 21.1 27.1 18.4 18.2 25.7 27.4 21.6 24.4 21.3 21.5 23.9 25.6 17.1 17.9 25.3 25.6 20.2 16.1 25.5 17.5 22.2 25.0 29.8 24.8 28.4 23.8 22.1 21.4 28.6 26.7 21.3 14.9 23.9 25.3 19.9 30.5 24.7 15.0 22.9 30.4 30.1 12.7 19.1 43.0 26.0 25.5 24.6 23.7 30.9 14.3 18.6 23.8 22.6 33.4 13.2 8.8 21.9 21.6 33.7 33.0 15.8 13.4 17.4 13.0 16.6 10.8 12.5 9.7 16.5 18.2 22.5 29.0 15.1 20.8 12.5 29.3 9.0 22.1 21.1 16.4 23.7 22.2 19.2 25.3 23.3 10.7 30.5 20.4 18.6 16.6 28.8 24.2 18.6 11.5 10.1 19.7 11.5 40.3 11.6 12.9 18.5 10.6 28.0 33.6 14.2 16.8 14.6 23.3 13.1 18.0 22.0 30.2 19.9 17.1 8.5 21.4 16.5 23.8 22.6 19.2 17.6 28.8 17.9 5.7 7.7 11.8 6.5 9.2 6.9 10.0 5.4 4.9 6.2 11.3 4.3 5.3 11.6 6.2 12.4 6.3 6.1 3.7 18.4 25.7 24.4 21.3 17.5 22.2 23.8 22.1 23.9 19.1 24.6 33.4 21.0 44.8 22.2 56.2 40.4 9.3 15.6 18.8 14.2 25.1 19.0 12.6 20.1 18.6 31.3 27.6 47.9 16.5 30.1 29.3 5.9 21.3 28.2 31.7 23.2 17.6 20.0 22.3 62.9 16.9 10.1 19.3 37.2 33.6 27.3 31.9 21.8 23.5 20.1 16.8 68.1 31.2 26.4 43.3 23.5 33.2 17.7 40.4 14.2 74.9 88.1 14.0 50.4 68.3 121.4 17.7 24.0 13.9 21.4 19.3 30.8 14.9 53.6 21.7 6.6 24.8 16.3 51.7 31.6 20.1 11.1 9.3 29.5 24.4 27.3 22.2 STAG2 "SA-2, SA2, SCC3B" ENSG00000101972 "Stromal antigen 2" Q8N3U4 X 123960212-124422664 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002857 Supported Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA002857: AB_1079861" "unprognostic (1.62e-1)" "unprognostic (1.01e-2)" "unprognostic (6.75e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.70e-2)" "unprognostic (3.77e-2)" "unprognostic (9.67e-3)" "unprognostic (4.68e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-1)" "unprognostic (3.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.81e-1)" "unprognostic (2.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.97e-1)" 27.9 22.9 20.7 34.2 26.3 72.8 41.5 32.6 24.1 33.3 30.4 28.8 23.8 35.7 28.3 26.8 30.1 25.2 21.5 18.0 22.6 33.7 28.5 28.6 45.0 26.2 21.9 46.0 31.7 51.9 12.0 35.8 27.8 29.8 28.2 45.5 26.5 29.6 23.3 26.1 26.5 25.8 24.2 37.4 28.5 8.0 21.2 81.4 49.3 36.0 44.3 28.4 17.6 39.6 62.6 56.9 84.5 53.0 34.9 52.3 54.4 58.0 61.8 58.5 73.2 53.8 65.1 115.0 79.6 52.3 65.5 55.6 173.6 48.8 82.5 81.9 74.7 106.6 110.8 35.7 35.6 140.7 80.0 42.2 46.4 69.5 111.4 50.2 49.7 114.2 105.4 118.9 43.1 67.8 180.6 62.9 44.5 55.8 84.4 125.9 112.0 96.1 44.9 117.3 75.7 60.6 131.2 47.7 66.9 59.2 28.9 62.2 61.5 0.3 31.1 69.4 66.6 50.9 82.2 141.6 36.8 84.3 60.3 28.2 15.2 28.0 15.0 18.9 17.8 15.0 15.6 14.6 19.1 19.0 21.3 17.5 44.5 18.8 23.1 16.5 13.5 10.0 20.7 26.3 32.6 24.1 18.0 22.6 26.2 21.9 27.8 24.2 21.2 39.6 71.1 64.1 56.6 42.4 80.9 56.2 61.5 31.5 72.3 51.0 58.0 48.4 44.9 37.1 50.6 44.1 60.5 32.2 113.4 42.9 21.5 42.3 1.1 65.1 70.4 62.3 58.1 77.0 41.8 38.2 32.7 64.5 39.8 79.3 58.1 53.6 59.3 42.2 36.0 45.4 51.9 35.0 28.5 71.4 65.0 4.2 65.9 89.9 33.8 70.3 91.4 61.2 97.9 69.4 114.0 54.9 29.3 69.2 73.8 81.4 28.0 35.7 51.4 62.9 65.7 104.0 60.3 14.8 15.4 51.0 56.1 71.4 87.2 49.5 38.9 83.6 STK24 "MST-3, MST3, MST3B, STE20, STK3" ENSG00000102572 "Serine/threonine kinase 24" Q9Y6E0 13 98445185-98577940 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026435, HPA026502" Enhanced Supported Nucleoli,Cytosol No No 1100000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Cytosol" "HPA026435: AB_1854151, HPA026502: AB_1854152" "unprognostic (3.49e-2)" "unprognostic (2.39e-2)" "unprognostic (1.78e-1)" "unprognostic (3.44e-2)" "unprognostic (2.86e-1)" "unprognostic (3.25e-2)" "unprognostic (9.67e-3)" "prognostic unfavorable (6.23e-6)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.81e-4)" "unprognostic (9.62e-2)" "prognostic favorable (6.91e-5)" "unprognostic (3.10e-2)" "unprognostic (4.49e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-2)" 71.4 32.4 30.9 49.0 32.6 58.0 60.9 34.3 34.4 99.1 49.4 75.1 83.0 53.9 58.4 167.9 50.7 55.8 49.1 34.2 29.0 77.0 32.4 54.1 67.0 29.0 35.5 44.2 48.0 42.4 31.1 57.5 27.2 49.6 72.3 31.7 70.4 51.2 47.1 154.4 94.4 48.2 28.5 51.5 78.3 36.9 41.3 68.2 55.0 38.8 74.1 86.6 113.9 29.2 161.8 49.4 85.6 79.8 128.6 76.4 121.3 73.8 103.0 100.9 97.7 145.7 212.6 114.1 36.6 92.8 63.1 142.1 80.2 162.3 95.5 286.3 41.2 122.0 59.8 84.2 181.0 124.4 82.8 49.8 253.7 79.3 231.6 106.2 88.2 88.0 45.2 76.6 67.0 70.3 93.5 51.1 76.9 217.3 36.6 116.5 52.5 62.3 98.1 143.2 49.8 71.4 46.7 74.2 103.0 129.7 89.6 119.1 120.0 63.8 46.3 52.8 86.5 74.1 41.7 42.5 99.3 74.0 107.4 5.7 12.7 6.3 5.5 10.9 6.6 6.1 10.2 8.0 10.9 7.9 6.9 5.6 10.9 1.5 13.5 7.1 13.7 6.7 30.9 32.6 34.3 34.4 34.2 29.0 29.0 35.5 27.2 28.5 41.3 29.2 36.2 12.8 27.4 27.7 37.4 70.9 83.6 51.2 20.5 20.3 41.5 33.5 3.0 55.8 55.8 68.0 56.3 39.2 36.9 203.8 25.4 35.8 3.5 74.2 48.7 32.5 42.6 41.4 39.2 55.0 45.9 43.2 65.7 99.6 18.4 49.1 25.0 26.6 28.0 10.1 34.2 86.0 24.4 82.2 57.9 5.9 26.8 58.4 56.9 49.6 47.6 25.5 20.6 35.7 11.1 84.4 96.5 30.5 25.5 60.4 111.8 39.2 51.6 11.0 39.5 47.7 41.0 2.9 21.2 61.9 82.1 20.0 45.5 20.4 59.1 153.3 SUB1 "p14, p15, PC4" ENSG00000113387 "SUB1 regulator of transcription" P53999 5 32531633-32604079 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 1838.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 1427.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001311, CAB015351" Supported Supported Nucleoplasm,Nucleoli NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Nucleoli" "CAB015351: AB_2197157, HPA001311: AB_1080123" "unprognostic (5.19e-2)" "unprognostic (1.58e-1)" "unprognostic (5.25e-2)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.25e-6)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.46e-3)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (1.02e-3)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (2.43e-1)" "unprognostic (2.45e-1)" 142.0 98.7 88.7 130.4 100.7 251.7 122.1 72.7 152.6 109.7 69.4 110.0 88.7 85.4 83.3 108.9 66.0 74.1 113.3 104.3 98.7 129.2 135.3 91.2 159.8 80.7 87.2 68.3 62.0 107.3 88.4 103.2 94.7 73.2 107.1 83.6 76.6 65.4 105.2 69.6 83.7 79.4 86.0 144.9 97.3 71.1 92.6 204.2 69.2 108.9 137.3 124.0 73.2 85.3 199.9 161.8 315.3 295.8 187.5 329.1 197.7 340.3 245.4 300.8 275.4 236.9 307.3 101.2 231.0 236.5 307.3 132.4 266.9 278.9 402.9 420.2 244.1 337.8 365.8 450.5 264.4 594.6 441.4 233.3 235.6 321.0 228.0 166.0 228.9 378.5 399.4 1427.8 269.5 178.6 566.8 942.9 207.8 235.9 326.9 247.8 409.9 645.7 303.0 178.2 170.4 141.1 526.9 244.9 251.9 198.2 272.0 544.9 238.7 324.7 351.5 275.8 261.0 556.0 1035.0 180.5 297.7 634.9 202.4 650.7 135.8 326.2 164.7 142.3 151.4 330.4 215.9 219.8 265.1 214.8 168.2 195.2 163.7 155.2 133.4 390.1 344.6 326.1 88.7 100.7 72.7 152.6 104.3 98.7 80.7 87.2 94.7 86.0 92.6 85.3 298.9 144.2 163.4 27.1 638.2 584.9 588.7 709.9 324.4 118.1 459.2 383.9 196.7 244.5 320.1 310.8 43.8 493.0 613.5 342.1 1009.5 711.4 131.6 319.0 263.7 280.2 281.4 379.5 71.5 327.2 785.0 323.6 227.9 329.9 307.5 188.6 223.1 375.4 500.5 85.8 60.9 362.9 484.2 319.0 721.3 68.1 239.9 422.5 528.3 37.5 587.5 223.7 500.5 64.3 50.4 416.3 516.6 344.6 1838.8 536.0 342.4 921.2 291.9 79.7 203.8 224.0 468.5 447.2 439.9 411.8 565.4 836.8 575.5 357.7 394.6 645.5 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin like modifier 1" P63165 2 202206182-202238599 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.6" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: AB_2683285" "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favorable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 77.5 99.1 79.4 62.7 84.9 133.7 83.6 89.0 99.9 68.9 84.4 82.7 72.0 65.1 86.3 71.6 65.7 71.7 79.8 85.6 85.3 118.1 174.1 66.5 86.4 79.9 80.1 54.5 55.8 91.6 56.7 75.6 81.1 75.3 82.8 80.2 66.8 61.9 107.5 57.1 80.5 71.5 78.9 68.1 73.8 54.7 81.4 112.1 102.3 103.3 95.4 77.9 54.9 86.6 164.1 82.4 291.4 155.8 159.3 168.5 129.7 171.0 214.6 209.0 274.6 178.1 203.7 111.6 153.5 199.0 193.5 117.1 242.2 237.9 325.0 104.8 185.7 207.6 159.0 211.2 114.9 237.2 188.5 130.9 225.2 164.0 123.9 195.1 197.3 219.0 194.2 176.0 226.4 141.1 298.3 391.6 351.7 168.5 172.2 190.9 163.2 197.9 255.5 134.3 201.7 219.3 140.3 133.6 236.4 313.9 120.0 223.2 139.9 152.5 153.0 141.4 152.8 151.7 322.9 285.8 170.2 165.4 137.2 242.2 220.0 284.2 169.2 226.5 179.6 276.3 206.8 200.0 223.6 231.6 193.8 202.3 256.5 246.5 239.7 187.8 329.0 394.7 79.4 84.9 89.0 99.9 85.6 85.3 79.9 80.1 81.1 78.9 81.4 86.6 182.7 112.2 61.1 10.7 143.1 422.1 204.4 448.6 177.6 99.6 196.8 170.2 58.1 130.1 215.3 189.4 64.6 259.4 162.3 136.6 481.3 250.4 91.3 148.3 115.1 170.7 142.4 140.1 31.4 173.3 297.8 161.8 89.7 115.2 92.6 114.7 142.8 202.1 205.3 87.5 27.8 156.4 319.4 140.7 330.2 28.0 129.8 137.7 211.7 15.9 241.3 182.3 176.1 16.6 21.2 208.1 191.1 127.9 130.5 258.5 272.2 534.4 185.5 87.8 111.7 92.5 221.9 212.0 141.5 183.9 424.5 209.7 174.5 134.9 157.5 254.1 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937007-32001038 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies" "HPA057436: AB_2683439" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 12.3 11.8 6.3 18.8 6.3 45.4 15.0 11.1 8.5 11.6 6.8 14.9 16.0 15.2 12.0 14.0 11.0 12.0 10.3 5.4 5.8 16.4 18.1 12.6 33.0 5.4 5.9 11.4 11.5 19.8 6.6 18.7 5.6 13.3 16.4 26.5 10.5 12.2 8.1 13.0 15.3 14.7 5.2 18.4 15.2 27.4 6.1 38.5 18.3 11.0 30.0 15.6 9.0 7.1 46.5 40.4 37.2 42.9 21.1 26.8 38.2 44.2 38.8 53.0 63.7 30.9 25.5 100.7 33.2 27.7 45.4 40.1 56.0 25.5 85.7 35.8 54.0 69.9 32.9 22.3 24.8 111.5 68.7 18.7 28.1 53.1 40.4 32.1 33.1 47.3 68.8 135.6 46.2 16.2 133.3 64.4 21.3 32.4 24.4 78.5 95.3 81.9 31.1 44.6 47.5 37.1 71.3 22.7 43.3 25.8 66.0 91.5 24.7 41.9 38.0 50.8 69.3 73.5 98.4 122.5 30.7 67.4 38.7 0.6 0.7 1.6 1.4 1.1 1.1 2.4 1.6 1.6 0.6 1.8 1.5 2.1 1.6 1.8 0.7 1.9 1.8 0.4 6.3 6.3 11.1 8.5 5.4 5.8 5.4 5.9 5.6 5.2 6.1 7.1 44.5 41.7 45.8 43.1 50.1 58.5 50.2 21.8 31.9 77.6 54.2 36.8 32.3 27.1 32.6 35.0 108.4 61.5 65.2 24.0 17.6 28.3 16.2 52.8 55.8 45.1 29.4 93.6 71.6 21.9 53.1 35.1 31.1 54.2 15.8 41.4 38.2 42.3 32.9 62.2 69.5 31.8 10.2 42.1 58.2 13.9 26.8 47.3 24.9 45.0 73.1 45.7 38.1 75.4 71.3 27.8 15.4 25.6 66.2 62.8 21.5 26.6 29.6 80.9 13.1 47.2 38.4 121.7 128.9 48.6 71.7 69.5 52.5 52.8 35.6 66.7 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843443-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 7.2 7.6 4.1 8.4 4.1 7.1 8.7 5.3 4.2 6.9 6.4 5.9 5.1 9.7 6.6 9.6 9.6 7.2 4.8 3.8 5.1 13.3 6.3 8.7 11.4 3.9 5.4 5.7 4.4 14.7 3.7 13.0 3.7 9.0 5.7 9.0 8.1 9.0 2.8 8.6 4.2 8.1 3.8 7.1 6.1 11.0 5.4 11.4 10.5 3.4 12.7 7.9 6.0 4.7 25.1 20.4 29.2 9.6 14.1 21.2 52.7 29.9 23.3 25.3 23.3 19.1 18.1 27.1 13.6 21.3 26.7 15.0 26.9 31.7 27.3 31.3 35.9 31.5 8.9 28.3 19.5 22.1 32.4 17.0 16.5 21.4 28.5 20.8 37.4 14.8 19.8 27.2 25.0 15.3 16.6 20.1 37.7 15.6 17.5 10.2 27.2 8.0 24.9 24.3 12.3 33.6 23.5 28.9 21.9 18.9 10.4 17.4 20.4 31.9 39.8 31.1 35.7 14.9 19.9 39.7 18.4 24.8 26.7 3.6 9.1 6.2 12.1 15.5 12.1 11.1 10.2 14.3 13.4 11.7 6.3 10.0 0.5 10.2 12.4 10.6 11.1 5.2 4.1 4.1 5.3 4.2 3.8 5.1 3.9 5.4 3.7 3.8 5.4 4.7 12.5 19.2 22.0 22.2 13.1 16.2 29.9 17.9 19.9 24.5 8.0 6.1 4.0 2.8 26.0 12.9 27.1 25.0 12.6 2.4 13.7 19.5 11.6 26.8 21.0 15.4 1.8 10.5 38.8 18.9 37.4 18.4 13.7 17.3 8.8 12.7 6.8 4.7 12.7 15.2 27.1 3.3 8.2 12.0 11.5 3.8 19.0 14.6 0.0 15.0 15.5 25.5 15.5 32.6 23.5 15.7 3.8 13.2 16.6 9.5 1.7 26.5 29.7 21.0 19.7 15.9 16.2 47.6 33.9 19.7 13.2 23.7 15.1 24.8 4.4 18.7 TANK "I-TRAF, TRAF2" ENSG00000136560 "TRAF family member associated NFKB activator" Q92844 2 161136908-161236230 "Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010345, HPA037675, HPA037676" Approved Supported Nucleoli,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" Cytosol Nucleoli "CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601" "unprognostic (1.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.53e-1)" "unprognostic (5.27e-2)" "unprognostic (3.98e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.71e-1)" "unprognostic (2.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (2.78e-6)" "unprognostic (2.13e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (2.30e-2)" 42.9 36.2 20.9 46.2 23.6 84.2 57.7 22.1 24.7 30.5 25.3 32.4 28.0 30.7 27.0 29.8 35.0 43.0 27.1 20.1 24.1 29.1 66.5 39.7 52.8 24.0 25.5 30.8 22.9 27.8 19.7 36.9 23.5 24.6 35.8 32.1 26.6 24.7 52.3 26.7 29.1 32.5 21.4 43.2 30.2 22.3 21.9 42.1 36.4 43.3 51.4 49.0 25.0 25.1 39.2 24.5 31.7 36.3 91.3 124.9 45.2 58.0 86.4 39.3 57.7 30.8 50.5 53.1 38.7 67.6 28.2 27.5 19.2 43.4 59.5 126.6 20.5 29.8 22.5 79.1 72.4 51.1 32.2 98.3 66.6 59.6 46.6 73.5 101.7 32.0 30.5 68.7 77.7 29.3 31.4 50.7 18.2 40.9 21.5 17.9 45.5 35.2 86.3 62.1 26.4 30.7 37.4 40.6 60.4 43.2 17.5 64.9 108.2 50.4 29.3 25.7 34.0 46.6 46.1 80.9 66.9 40.3 40.8 122.2 71.4 97.1 36.0 78.5 55.9 63.8 58.8 53.1 66.5 66.7 39.9 39.6 189.4 42.4 94.0 43.4 100.7 55.0 20.9 23.6 22.1 24.7 20.1 24.1 24.0 25.5 23.5 21.4 21.9 25.1 34.7 57.7 79.6 82.3 108.9 59.9 106.3 82.7 21.6 32.7 73.0 71.5 27.3 42.9 69.2 46.0 12.5 43.1 54.8 50.4 60.7 58.8 18.0 47.2 42.3 46.7 47.4 63.8 49.9 40.5 82.9 67.8 28.5 52.4 59.5 17.0 28.2 58.1 45.6 21.9 60.9 29.3 71.2 71.5 194.0 10.0 52.8 106.8 72.9 120.9 177.7 33.5 40.2 63.3 87.4 56.0 43.9 26.4 57.1 81.8 34.4 46.5 66.2 37.4 26.3 52.1 40.3 54.3 33.9 29.3 60.9 134.9 109.3 33.0 32.2 158.4 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973868-29992261 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 31.4 36.0 23.4 14.7 21.2 12.7 30.8 18.0 26.1 24.8 11.9 21.8 17.3 25.9 11.1 20.8 22.6 12.0 32.6 23.0 18.9 22.7 17.6 34.0 14.4 21.0 20.0 24.1 19.5 17.4 29.4 19.4 18.9 22.5 8.5 14.3 20.5 13.3 23.4 22.4 24.4 13.3 15.3 33.8 21.8 34.8 20.8 13.2 25.4 12.7 10.5 22.4 21.6 19.0 22.2 41.8 22.4 35.1 25.8 17.1 34.2 40.0 21.1 26.4 24.4 33.6 28.7 23.8 32.8 28.8 18.0 33.9 20.4 20.0 14.1 37.5 43.3 25.8 46.2 34.8 18.7 25.5 47.5 20.0 17.1 28.1 11.2 18.5 44.7 22.4 23.5 23.6 25.8 41.0 29.8 36.0 21.5 16.4 27.6 54.2 32.5 22.2 16.6 20.5 26.1 20.8 22.8 30.2 12.1 14.4 37.5 28.5 62.9 45.0 20.7 32.4 23.6 34.2 23.7 22.1 27.6 28.8 33.7 0.3 0.7 0.4 0.7 0.7 0.8 0.5 0.7 0.6 0.4 0.6 0.4 0.3 1.2 0.5 0.4 0.8 0.9 0.6 23.4 21.2 18.0 26.1 23.0 18.9 21.0 20.0 18.9 15.3 20.8 19.0 52.0 9.6 11.5 21.9 6.3 10.7 4.6 7.5 7.4 14.6 10.5 5.7 9.8 7.2 9.1 9.2 39.6 7.8 7.6 27.0 1.9 8.5 3.9 8.7 9.5 35.3 13.1 3.4 7.9 12.0 6.2 9.7 14.3 8.9 3.8 16.0 47.2 11.8 9.8 10.1 10.7 16.8 12.2 11.2 11.1 4.4 12.5 8.2 7.2 7.5 9.0 8.4 11.3 9.0 12.7 16.1 14.8 12.8 5.9 7.4 27.2 8.0 10.0 21.4 6.6 8.7 8.7 19.7 21.6 9.1 9.7 12.0 9.2 16.0 14.7 7.4 TENT4B "PAPD5, TRF4-2, TUT3" ENSG00000121274 "Terminal nucleotidyltransferase 4B" Q8NDF8 16 50152911-50235310 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 82.8;Endometrial ciliated cells: 44.3;Glandular and luminal cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042968, HPA048225" Uncertain Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Nucleoli, Plasma membrane" "HPA042968: AB_2678244, HPA048225: AB_2680319" "unprognostic (1.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.27e-1)" "unprognostic (2.91e-2)" "unprognostic (4.33e-2)" "unprognostic (2.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (3.30e-2)" "prognostic favorable (1.85e-4)" "unprognostic (4.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (7.00e-2)" 6.1 6.4 2.4 1.7 2.3 7.1 4.6 3.9 2.6 7.3 3.0 6.9 4.6 6.9 2.3 5.4 6.5 2.0 3.7 2.7 3.0 4.2 8.9 5.0 2.3 2.2 2.4 6.8 4.3 3.9 4.8 2.8 2.2 5.3 1.9 1.4 4.7 1.7 5.4 5.5 5.9 2.5 2.2 4.6 5.5 5.7 3.1 1.7 4.7 2.1 1.9 7.2 6.4 2.7 5.5 1.9 0.6 3.3 3.8 2.0 4.3 3.9 2.3 3.5 1.6 3.4 2.3 6.5 5.6 2.7 1.4 3.6 3.9 2.0 3.1 3.8 4.5 3.6 1.6 5.4 3.8 2.4 4.9 1.9 2.6 2.3 3.3 2.3 1.8 2.1 4.2 1.5 4.1 1.5 3.5 4.6 4.2 1.5 4.5 4.9 4.8 6.9 1.7 0.5 4.0 2.2 4.9 2.7 2.3 1.5 1.5 0.9 3.0 2.1 4.1 4.0 1.9 4.9 3.7 6.9 1.7 2.7 2.7 0.0 0.4 0.0 0.4 0.2 0.1 0.3 0.2 0.5 0.2 0.2 0.3 0.5 0.7 0.2 0.2 0.4 0.1 0.1 2.4 2.3 3.9 2.6 2.7 3.0 2.2 2.4 2.2 2.2 3.1 2.7 17.9 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 17.8 16.3 0.0 0.0 0.0 14.7 0.0 18.1 82.8 0.0 3.9 10.9 0.0 44.3 24.4 6.1 0.0 0.0 0.0 14.9 11.5 6.7 0.0 31.5 0.0 13.5 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 3.6 0.0 0.0 0.0 0.0 15.2 0.0 0.0 22.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 18.3 14.9 17.3 0.0 0.0 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257655 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 26000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 11.0 8.8 5.8 10.8 6.3 10.7 11.3 6.7 8.7 7.8 7.4 12.3 10.6 8.1 10.8 9.1 6.6 8.5 4.8 5.4 6.6 10.2 12.6 9.3 12.4 6.5 6.8 6.6 9.1 9.4 5.5 13.2 7.0 7.9 12.2 6.8 8.3 9.2 5.2 9.8 9.3 9.9 6.9 10.7 10.4 5.0 7.0 11.6 11.4 4.4 10.5 13.0 6.6 7.0 27.0 23.8 33.8 18.4 26.0 20.3 35.5 33.5 26.8 33.2 42.2 24.9 49.0 38.8 30.0 22.6 15.6 26.1 60.3 21.5 60.4 38.6 19.6 28.4 19.4 24.7 22.4 66.2 27.4 24.4 19.5 22.2 16.3 24.0 29.7 31.2 23.6 25.9 32.1 32.6 29.7 35.5 38.3 42.2 28.5 30.9 60.9 23.4 32.2 34.8 21.1 15.5 26.6 17.8 24.6 22.2 25.8 28.6 19.0 34.9 32.2 24.8 30.9 22.4 23.9 31.4 15.4 36.6 33.5 10.5 12.2 6.2 8.6 14.7 10.6 7.7 8.8 9.0 13.6 6.3 8.5 10.1 4.3 11.5 11.0 15.7 11.0 12.4 5.8 6.3 6.7 8.7 5.4 6.6 6.5 6.8 7.0 6.9 7.0 7.0 43.0 38.5 29.1 24.5 55.9 108.6 63.1 80.5 71.2 13.7 40.7 20.8 9.2 44.3 55.7 35.0 12.5 73.9 82.6 38.2 9.8 62.1 2.5 22.0 42.2 47.5 17.4 81.2 8.9 67.6 149.3 48.4 32.1 28.0 43.6 24.4 43.2 44.0 73.2 10.1 11.2 29.2 63.1 61.1 84.3 4.3 24.8 65.7 55.2 18.7 70.0 27.0 46.4 22.1 25.2 50.3 44.0 28.6 79.2 58.4 29.3 32.4 42.2 32.6 59.2 37.3 49.4 59.5 68.7 79.0 97.3 57.7 62.5 58.7 46.5 59.5 TP53TG5 "C20orf10, CLG01, dJ453C12.5" ENSG00000124251 "TP53 target 5" Q9Y2B4 20 45372557-45407889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 17.8" "Cell type enhanced" "Detected in some" "Early spermatids: 671.5;Late spermatids: 254.4;Oligodendrocytes: 157.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041979, HPA058510, HPA077455" Enhanced Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Cluster 78: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA041979: AB_2677778, HPA058510: , HPA077455: " "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (2.18e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.29e-3)" "unprognostic (3.10e-3)" "unprognostic (9.26e-2)" "unprognostic (3.56e-2)" "unprognostic (1.72e-5)" "unprognostic (2.09e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.72e-4)" "unprognostic (1.41e-1)" 0.1 0.1 1.1 0.2 1.8 0.7 0.1 0.9 2.6 0.1 1.4 0.3 0.1 0.2 0.4 0.1 0.2 0.2 0.2 1.1 1.5 0.1 0.1 0.2 0.4 1.8 1.5 0.1 0.1 0.0 0.2 0.1 2.0 0.1 0.0 0.8 0.2 0.0 0.2 0.2 0.2 0.0 0.7 0.2 0.2 17.8 1.7 0.0 0.2 0.0 0.0 0.2 0.1 3.5 0.3 0.7 0.4 1.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.3 0.3 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.3 0.4 1.0 0.6 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.1 0.0 0.5 0.4 0.3 0.1 0.3 0.3 0.0 0.2 0.2 0.0 0.4 0.4 0.3 1.0 0.4 0.2 0.1 1.1 0.1 0.6 1.4 0.4 0.9 0.2 0.3 0.4 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.8 0.9 2.6 1.1 1.5 1.8 1.5 2.0 0.7 1.7 3.5 0.1 0.0 0.0 2.9 0.0 0.1 0.4 0.0 0.0 0.8 0.5 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 671.5 0.5 0.2 0.3 0.0 0.0 7.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 7.8 0.5 0.0 0.0 1.1 254.4 4.7 0.1 0.0 1.9 0.0 0.1 0.0 2.5 157.5 0.0 1.2 4.5 0.0 0.2 0.2 0.1 0.3 1.0 0.0 0.4 1.2 2.1 1.8 0.0 1.1 0.0 0.1 0.0 0.3 0.9 TRA2A "AWMS1, htra-2-alpha" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoli "Nucleoplasm, Vesicles" "HPA054018: AB_2682344" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 35.1 39.1 55.7 37.0 58.2 113.4 32.1 57.4 75.7 47.1 57.9 38.7 26.4 42.8 43.9 47.3 42.7 21.3 30.4 55.3 57.8 45.9 34.9 33.5 47.6 57.2 56.5 53.1 32.6 25.6 40.4 32.9 57.6 41.3 39.2 42.0 33.2 22.1 23.1 42.8 36.8 41.0 56.6 52.8 33.0 30.9 56.8 46.1 35.9 21.3 53.6 37.9 42.9 64.9 57.2 61.2 94.1 148.4 49.1 30.9 60.4 71.4 33.6 70.5 57.4 51.2 76.4 107.4 39.9 53.7 82.3 92.1 115.6 66.9 88.4 64.6 65.7 65.9 67.9 81.8 52.0 78.0 59.2 37.1 44.9 53.1 66.1 62.7 80.9 46.7 129.5 51.0 79.7 55.6 96.5 128.7 84.5 69.5 62.5 106.1 74.8 64.3 81.8 81.0 80.7 65.8 66.0 75.8 49.8 69.1 59.6 85.5 73.8 55.4 79.0 51.0 83.4 56.6 76.1 86.9 47.7 103.8 75.3 16.8 17.1 23.6 24.6 28.8 21.6 17.6 23.3 23.1 20.6 16.1 19.6 23.7 25.4 19.1 27.0 30.0 25.2 10.2 55.7 58.2 57.4 75.7 55.3 57.8 57.2 56.5 57.6 56.6 56.8 64.9 110.6 60.9 72.2 112.3 141.9 104.4 95.6 61.7 94.4 54.5 118.5 74.8 42.5 60.1 60.8 88.3 52.1 83.2 153.3 84.9 25.4 54.8 62.1 155.7 137.1 74.8 118.5 77.5 113.1 43.9 84.6 91.5 89.2 166.7 86.7 62.5 84.6 71.4 54.8 37.0 115.4 100.3 48.8 89.5 125.4 23.7 65.0 88.9 56.9 107.7 71.5 48.1 70.0 203.1 245.1 59.2 92.0 67.7 125.4 97.7 59.7 41.8 71.3 101.8 72.3 119.2 88.2 99.8 65.0 138.6 113.1 117.9 130.4 49.1 112.6 92.1 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235808 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 77.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (2.68e-2)" 7.9 9.6 52.7 7.5 57.8 8.1 5.8 48.3 50.8 6.9 31.3 6.6 8.4 7.6 5.8 10.1 6.4 3.2 9.4 42.2 44.1 9.5 12.2 6.2 4.9 57.3 57.3 6.0 9.9 11.7 10.9 4.1 53.2 6.8 2.7 7.0 7.6 5.6 26.1 9.8 7.2 3.5 54.5 8.2 8.8 13.2 53.8 10.1 11.7 12.7 5.2 6.8 6.7 54.7 9.3 24.0 8.7 14.6 10.1 10.0 20.6 13.3 7.2 9.6 9.0 20.4 13.8 16.0 21.4 9.1 18.0 17.3 9.1 31.9 5.2 77.8 29.2 17.8 24.9 11.7 9.7 13.3 11.8 8.8 16.1 12.0 4.2 9.3 5.6 23.8 22.7 18.8 5.3 33.8 20.0 14.7 8.3 7.0 11.3 18.7 13.2 20.9 5.5 14.7 13.5 12.7 12.3 14.3 18.7 3.8 28.7 14.8 11.7 13.1 8.9 8.0 10.3 41.2 28.1 21.9 13.7 15.3 11.3 0.2 0.3 0.6 0.6 0.3 0.9 0.5 0.6 1.1 0.4 0.6 0.6 0.8 1.0 0.6 0.7 0.7 0.9 0.4 52.7 57.8 48.3 50.8 42.2 44.1 57.3 57.3 53.2 54.5 53.8 54.7 9.1 3.2 12.4 11.4 10.1 8.0 9.5 7.5 8.0 19.1 10.5 8.9 13.2 12.8 10.0 11.0 18.8 14.6 13.6 12.3 11.7 8.5 8.0 15.8 12.9 10.4 12.7 5.9 5.2 12.1 10.0 7.5 16.8 12.4 2.5 12.3 10.4 21.0 8.8 28.6 5.3 13.1 12.2 15.1 7.3 4.0 5.3 10.1 8.8 5.6 11.8 15.0 14.4 1.5 5.8 9.9 12.3 11.7 11.1 9.5 16.0 8.0 24.1 30.4 0.0 24.4 10.7 33.2 23.7 12.3 11.2 13.0 13.6 10.2 12.6 8.3 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564039 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 99.5;Spermatogonia: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 4.3 3.7 2.0 3.1 2.6 2.2 4.4 2.6 2.9 1.9 1.5 3.6 4.3 2.7 3.9 3.6 5.8 3.4 2.3 1.8 2.5 4.9 9.8 2.4 4.4 2.6 2.5 3.3 5.9 3.7 2.3 3.7 2.9 4.1 3.6 2.8 3.9 2.2 3.9 3.7 4.5 2.7 2.7 3.5 4.4 9.9 2.4 4.3 6.1 2.7 4.4 2.9 2.0 4.3 8.2 5.4 10.1 5.7 6.0 8.4 7.8 9.6 3.7 5.8 4.1 4.9 9.4 10.9 3.7 5.6 5.9 4.4 10.9 5.1 8.6 13.7 5.4 8.0 4.4 7.6 5.5 19.6 7.8 5.4 14.4 5.7 14.0 3.0 6.4 10.0 17.5 9.4 4.5 9.4 16.4 3.5 6.5 13.8 5.0 9.5 10.2 7.2 8.5 6.8 6.3 5.8 5.3 28.3 9.9 8.5 9.3 7.8 4.9 6.9 7.2 5.5 11.1 7.0 12.4 10.0 4.9 10.9 4.7 2.7 3.9 2.1 1.8 3.8 1.7 3.5 3.3 3.3 5.2 5.8 3.5 3.2 4.9 3.3 3.4 3.0 3.9 1.9 2.0 2.6 2.6 2.9 1.8 2.5 2.6 2.5 2.9 2.7 2.4 4.3 7.2 3.2 10.3 8.8 8.7 8.2 5.6 8.4 10.2 4.3 12.1 8.6 6.4 11.5 6.6 11.0 4.2 16.8 6.1 10.6 43.0 13.8 46.8 33.5 12.1 7.2 7.2 2.1 5.3 19.3 16.4 6.9 8.6 21.6 8.2 11.0 8.2 32.6 8.5 5.0 4.6 11.1 12.2 8.1 4.1 17.0 6.5 5.0 5.4 1.9 8.4 8.7 5.2 3.5 19.7 14.1 11.0 7.5 10.4 4.8 19.0 31.9 20.6 5.9 13.1 5.7 8.1 99.5 55.0 10.2 9.5 17.5 5.5 8.1 10.6 6.6 TSPYL1 TSPYL ENSG00000189241 "TSPY like 1" Q9H0U9 6 116267760-116279930 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031970 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 38: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nucleoli" "HPA031970: AB_2674092" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.11e-2)" "unprognostic (9.99e-2)" "unprognostic (1.70e-1)" "unprognostic (3.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (2.76e-1)" "unprognostic (9.18e-3)" "prognostic favorable (5.40e-4)" "unprognostic (5.12e-1)" "prognostic favorable (1.48e-13)" "unprognostic (1.61e-1)" "unprognostic (1.81e-1)" "unprognostic (2.34e-2)" "unprognostic (2.47e-1)" 26.5 73.8 51.1 17.1 56.4 34.4 23.4 35.2 78.2 22.5 25.5 30.8 24.4 28.4 33.0 34.0 31.4 20.5 43.3 64.9 38.1 50.4 40.9 21.4 21.4 25.9 22.2 34.9 33.3 63.9 40.1 16.0 26.0 42.0 17.7 26.1 30.2 33.9 114.9 29.4 30.0 24.3 17.1 29.5 35.5 28.9 34.6 22.3 39.6 91.9 25.6 31.4 22.7 44.5 22.2 21.5 27.3 50.3 47.2 30.9 22.7 35.2 34.7 31.3 35.8 27.7 15.9 47.3 43.0 40.8 28.2 38.5 21.6 59.8 33.2 19.4 56.0 19.1 29.9 50.8 29.8 31.9 11.2 36.2 46.0 32.5 31.2 32.9 30.3 20.7 34.3 36.1 44.2 48.9 21.5 18.9 13.6 21.3 19.8 19.1 23.5 26.3 54.9 42.9 23.7 23.6 29.2 38.8 18.0 30.6 51.0 39.1 37.3 21.2 18.7 17.2 38.7 19.8 22.7 25.2 35.1 20.3 14.1 121.0 30.1 51.5 40.5 51.0 61.4 46.4 52.4 45.4 26.1 52.2 51.1 50.0 24.1 33.2 57.7 44.9 44.8 34.0 51.1 56.4 35.2 78.2 64.9 38.1 25.9 22.2 26.0 17.1 34.6 44.5 29.4 35.3 45.9 15.7 65.2 166.1 100.6 37.6 70.6 81.0 91.7 47.5 100.0 61.5 40.5 104.8 27.1 54.8 54.2 49.3 154.6 40.8 33.0 40.5 42.0 40.4 74.6 49.7 65.4 43.9 25.5 63.1 41.3 34.9 31.7 67.5 73.9 81.3 42.4 38.7 50.5 59.3 46.8 82.1 116.0 20.2 75.5 40.2 87.2 22.5 38.3 82.6 42.2 15.6 20.2 48.8 52.5 95.5 24.1 77.0 60.3 218.9 41.4 58.1 131.5 87.6 63.5 61.9 39.8 55.5 162.0 59.7 69.1 101.3 70.2 75.8 TTF1 ENSG00000125482 "Transcription termination factor 1" Q15361 9 132375548-132406851 "Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "DNA replication inhibitor, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054837 Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Nucleoli" "HPA054837: AB_2682621" "unprognostic (7.07e-2)" "unprognostic (5.62e-3)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-1)" "unprognostic (9.21e-3)" "unprognostic (3.08e-1)" "unprognostic (1.33e-1)" "unprognostic (6.95e-3)" "unprognostic (2.09e-2)" "unprognostic (5.93e-3)" "unprognostic (8.38e-2)" "unprognostic (3.44e-1)" "unprognostic (4.71e-2)" 8.0 5.0 7.0 6.2 7.7 16.7 9.6 9.0 8.3 7.4 6.7 9.6 4.7 8.5 9.0 6.4 7.3 5.3 13.3 6.9 7.3 6.6 4.2 7.0 10.5 7.0 7.1 8.6 6.6 7.0 5.0 6.5 7.1 7.9 6.6 8.6 6.1 7.4 13.6 7.1 6.5 7.1 6.8 7.9 6.5 9.6 7.1 18.9 10.4 10.3 10.0 7.9 6.9 8.3 12.5 11.5 16.4 14.8 9.0 11.5 14.7 14.1 10.7 16.2 12.0 11.8 13.2 20.9 11.5 10.6 18.3 29.7 18.5 10.8 17.1 13.9 12.6 9.6 17.2 9.5 9.1 25.6 14.9 7.1 12.0 13.8 10.5 13.1 14.0 34.1 19.3 17.5 12.7 19.0 59.8 15.5 30.0 22.3 16.8 37.1 22.8 24.9 13.1 10.1 14.4 24.8 19.8 14.4 10.7 15.3 17.9 13.7 13.2 25.0 15.8 21.8 16.8 8.2 24.8 25.0 14.7 20.6 25.1 17.0 5.8 12.0 6.6 6.0 8.6 13.6 8.4 7.8 3.6 12.2 9.3 7.0 20.9 8.2 7.4 11.2 9.6 3.3 7.0 7.7 9.0 8.3 6.9 7.3 7.0 7.1 7.1 6.8 7.1 8.3 26.8 25.6 21.6 12.7 35.4 9.8 21.9 26.9 7.4 27.2 11.8 15.5 40.1 25.8 18.3 18.4 60.5 23.8 33.2 14.8 19.6 28.5 22.9 26.2 21.4 29.5 12.1 68.0 12.4 21.2 22.8 17.5 15.3 16.8 22.8 28.8 27.5 8.3 18.7 30.3 10.6 15.4 20.3 22.0 12.1 6.8 23.6 17.4 1.8 14.0 30.1 20.3 41.2 9.5 19.2 25.3 18.6 25.9 14.3 22.8 16.5 19.3 29.2 55.0 26.3 21.9 24.1 47.4 61.8 7.5 8.5 25.2 28.2 16.8 19.7 24.5 TULP3 TUBL3 ENSG00000078246 "TUB like protein 3" O75386 12 2877223-2941138 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: AB_2669889" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 21.0 17.1 13.6 7.5 14.2 2.6 18.3 19.2 16.1 33.3 15.8 21.6 5.4 23.2 11.7 17.8 24.3 12.1 17.7 13.8 13.2 17.3 9.0 13.5 6.1 16.3 14.8 37.7 9.6 13.3 12.3 13.7 13.8 15.4 8.2 12.7 13.0 13.9 10.4 25.7 10.5 18.2 14.5 9.4 15.5 13.0 14.4 9.4 15.5 9.7 8.1 16.7 24.1 17.1 22.6 18.8 35.0 29.1 34.3 51.0 32.9 34.5 57.5 36.4 40.2 24.0 20.4 16.7 5.1 51.2 31.2 18.5 21.1 22.2 42.0 21.7 15.4 10.0 23.4 15.5 44.3 10.8 11.1 30.1 25.7 55.3 74.9 44.6 28.6 20.8 9.7 15.1 31.0 20.3 16.1 9.4 47.4 17.8 13.7 16.8 34.2 6.3 22.9 18.7 8.8 23.4 30.1 17.8 19.9 63.4 22.2 10.5 23.0 26.6 32.0 54.7 33.9 4.7 6.0 14.3 26.9 5.9 41.5 0.0 0.9 0.3 2.1 0.8 3.5 1.6 1.7 2.2 0.7 1.8 2.0 2.8 0.4 2.7 0.5 1.6 3.3 1.0 13.6 14.2 19.2 16.1 13.8 13.2 16.3 14.8 13.8 14.5 14.4 17.1 12.9 6.4 10.5 70.5 6.2 20.3 16.9 14.8 26.2 6.1 9.9 12.2 8.0 18.6 15.9 1.8 2.1 9.4 6.0 4.6 23.5 17.3 5.8 35.1 33.5 15.2 3.6 6.1 6.0 7.3 10.6 31.7 6.6 14.6 0.0 11.5 24.3 5.5 5.3 40.4 10.8 4.0 14.2 2.5 8.6 3.6 40.7 5.4 19.6 14.0 6.7 50.7 12.3 10.1 34.9 11.1 2.4 24.8 8.3 23.3 3.2 21.9 47.4 10.0 39.5 22.3 26.3 38.0 50.8 22.2 20.2 11.6 6.5 13.3 6.4 13.2 TWIST2 "bHLHa39, Dermo-1, DERMO1" ENSG00000233608 "Twist family bHLH transcription factor 2" Q8WVJ9 2 238848032-238910534 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 83.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 95.4;Fibroblasts: 58.9;Leydig cells: 48.1;Peritubular cells: 39.1;Theca cells: 23.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 24 "eosinophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 80.0;ASC TERT1: 50.5;BJ: 69.3;BJ hTERT+: 212.4;fHDF/TERT166: 97.4;U-2197: 81.3" "Low region specificity" "Detected in single" HPA062870 Supported Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Nucleoli "HPA062870: AB_2684888" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.83e-2)" "unprognostic (4.06e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-2)" "unprognostic (2.33e-1)" "unprognostic (2.24e-1)" "unprognostic (1.17e-1)" "unprognostic (2.40e-9)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.98e-2)" "unprognostic (4.48e-2)" 59.7 4.0 0.3 1.4 0.3 0.4 43.3 0.3 0.5 83.0 0.6 22.9 0.3 31.3 0.7 10.1 30.4 1.7 10.8 0.4 0.3 1.8 0.7 9.3 0.3 0.4 0.8 39.9 1.8 0.1 8.3 3.1 0.4 25.7 1.1 0.0 7.9 3.7 1.8 33.5 8.9 2.9 0.4 2.3 10.3 1.9 0.3 0.1 8.2 1.0 0.4 21.3 54.2 0.5 0.1 4.5 0.4 0.0 80.0 50.5 0.1 69.3 212.4 31.0 46.4 0.0 0.0 0.0 2.1 97.4 2.5 0.5 0.7 5.4 22.5 0.0 7.3 0.0 4.0 0.2 13.7 0.0 1.6 11.8 2.9 15.0 12.5 3.7 4.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.7 0.0 0.9 11.8 1.2 2.2 81.3 0.8 0.0 0.0 0.0 0.3 2.1 4.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.4 0.3 0.4 0.8 0.4 0.4 0.3 0.5 2.5 0.0 2.6 0.0 0.1 2.0 16.0 0.0 7.4 0.0 0.5 0.4 0.6 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 3.6 95.4 1.3 0.0 0.0 4.4 0.0 1.9 58.9 0.0 2.1 1.3 0.5 2.9 0.1 2.2 0.0 0.2 0.0 0.0 0.0 3.6 1.2 48.1 0.8 1.8 12.2 0.4 0.0 8.2 0.5 0.1 0.1 0.0 39.1 0.0 20.5 0.0 0.0 0.0 0.0 0.0 1.1 9.6 0.5 3.3 0.2 1.7 1.6 1.6 23.2 0.0 3.7 UBE2I UBC9 ENSG00000103275 "Ubiquitin conjugating enzyme E2 I" P63279 16 1308880-1327018 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003909, CAB009021, CAB079920" Approved Supported Nucleoplasm,Nucleoli NA NA 130000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.88e-3)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (7.60e-3)" "unprognostic (3.56e-1)" "unprognostic (7.28e-2)" "unprognostic (9.30e-2)" "unprognostic (1.57e-1)" "prognostic favorable (5.68e-4)" "unprognostic (1.15e-3)" 62.5 76.3 42.5 60.3 44.0 81.6 62.0 46.1 49.3 64.7 37.1 63.8 45.1 72.7 48.7 74.2 67.3 34.3 68.2 45.2 45.2 63.4 40.8 53.1 76.0 39.3 42.3 93.1 49.1 72.0 61.6 58.1 40.2 53.4 47.3 31.7 56.4 46.7 58.0 68.0 61.1 53.8 42.2 71.9 52.9 47.6 47.1 110.3 53.2 57.0 89.3 66.6 63.1 42.1 121.3 161.1 269.0 157.7 112.7 135.8 114.4 170.0 121.7 154.3 152.9 191.8 190.1 208.2 137.7 148.1 140.7 142.4 193.2 159.2 197.9 151.2 133.4 130.6 136.6 188.4 178.6 194.9 148.0 127.1 100.7 152.1 180.0 149.0 170.0 169.9 190.3 124.3 148.0 254.4 349.6 193.0 219.0 136.0 118.5 434.0 170.9 238.4 145.7 106.6 150.3 159.8 149.3 164.1 177.7 152.8 167.5 234.4 139.4 149.2 172.6 134.0 155.5 132.1 170.4 423.4 85.3 142.9 164.7 278.7 214.3 327.1 165.9 256.6 200.9 297.8 167.8 170.3 214.7 241.1 148.2 149.6 149.5 202.6 249.5 186.3 196.5 260.9 42.5 44.0 46.1 49.3 45.2 45.2 39.3 42.3 40.2 42.2 47.1 42.1 109.5 51.3 67.0 16.3 172.8 178.6 186.4 275.6 97.3 64.6 101.9 105.7 89.1 84.4 140.9 62.5 50.1 312.8 153.9 77.4 105.7 211.9 64.4 66.6 100.6 118.3 102.3 127.4 17.2 148.2 293.1 134.4 55.5 104.6 109.5 149.7 94.2 43.7 213.5 47.1 16.8 97.1 162.8 104.8 182.1 37.8 129.8 124.8 128.1 15.9 220.2 104.7 209.1 16.6 26.7 212.3 91.8 107.6 144.1 294.8 90.4 117.7 65.7 63.1 78.9 82.1 185.4 139.6 145.7 158.4 206.7 418.1 144.7 134.9 134.7 304.5 UBLCP1 "CPUB1, MGC10067" ENSG00000164332 "Ubiquitin like domain containing CTD phosphatase 1" Q8WVY7 5 159263290-159286036 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039615 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 16: Immune cells - Immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA039615: AB_10674425" "unprognostic (1.25e-1)" "unprognostic (3.10e-1)" "unprognostic (6.04e-3)" "unprognostic (3.45e-2)" "unprognostic (7.08e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (4.46e-5)" "unprognostic (4.01e-1)" "unprognostic (2.14e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (1.87e-1)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (2.51e-2)" 19.0 16.3 8.8 24.5 9.4 23.3 20.5 9.6 14.1 19.9 6.4 15.7 12.6 23.6 17.2 21.1 15.1 17.1 16.4 10.0 10.5 19.2 18.3 22.4 33.7 10.3 9.5 15.8 14.9 19.7 5.6 23.6 10.2 17.5 16.9 18.2 14.2 19.6 10.9 15.5 12.7 22.8 9.6 26.7 15.8 30.5 10.7 36.4 16.6 13.8 37.3 21.3 11.7 10.7 39.9 28.6 57.9 64.1 58.9 54.5 34.1 42.5 64.6 42.8 56.6 23.5 27.1 35.7 46.1 53.7 60.9 29.7 36.3 81.8 74.3 71.3 35.7 27.3 23.8 21.9 74.0 62.7 41.1 48.1 76.8 38.9 77.2 34.0 41.4 36.4 38.4 47.0 60.8 12.9 33.5 22.9 41.7 20.0 17.1 42.3 56.5 42.8 44.4 30.4 30.4 42.9 42.7 29.0 115.8 34.6 30.2 45.6 44.2 44.0 37.8 22.8 54.9 36.9 39.8 53.5 46.1 43.9 66.1 47.6 10.8 27.5 25.5 22.4 28.4 18.5 23.9 26.7 14.2 16.7 26.9 29.1 30.8 42.8 24.5 17.8 28.3 13.6 8.8 9.4 9.6 14.1 10.0 10.5 10.3 9.5 10.2 9.6 10.7 10.7 31.9 12.8 41.6 12.7 43.0 15.9 10.3 43.0 35.3 12.7 22.5 14.4 16.8 10.0 34.4 14.7 4.2 31.8 36.8 13.2 35.2 23.0 8.5 23.2 32.1 24.2 10.7 30.1 26.3 24.9 18.7 27.1 29.6 17.4 45.0 16.9 28.5 15.6 39.0 20.2 25.0 14.6 18.3 40.0 16.4 4.2 20.5 33.1 17.8 14.0 30.9 17.6 32.0 22.6 25.6 22.5 10.1 24.8 39.3 13.2 8.8 34.5 37.4 13.1 19.7 18.8 26.2 74.0 61.5 51.8 20.6 17.8 40.8 30.7 14.5 10.1 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA006069" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 18000 "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" Nucleoli "HPA005908: AB_1858585, HPA006069: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (4.33e-2)" 19.9 19.0 11.0 22.5 12.1 24.6 22.7 20.3 15.8 13.6 5.5 23.3 24.7 14.8 17.5 32.2 11.3 15.5 30.5 13.3 12.3 27.2 37.9 15.9 29.1 11.8 11.5 16.4 33.1 20.3 9.7 23.1 12.8 21.4 24.0 37.7 26.0 16.0 39.7 21.3 24.2 18.1 12.9 18.0 17.8 13.4 10.7 24.8 19.2 36.8 32.6 19.1 14.3 14.1 136.6 74.0 61.7 65.5 37.1 37.8 76.4 80.1 40.4 74.8 65.8 71.4 94.9 104.7 72.5 44.4 43.2 85.5 84.1 99.5 100.9 110.0 61.9 126.0 97.5 97.3 57.6 198.5 67.8 33.9 44.5 106.1 91.2 33.6 76.4 100.3 285.1 86.2 67.3 105.9 146.2 70.1 57.7 89.1 46.9 84.5 68.3 216.4 70.8 81.0 61.2 76.7 72.7 97.3 110.4 64.9 82.2 95.8 49.9 71.9 21.4 70.0 125.0 62.8 105.2 117.5 40.2 119.5 123.6 60.9 31.7 41.6 53.3 40.1 59.5 43.8 48.0 51.2 39.0 37.4 51.0 57.1 19.5 75.2 45.0 41.3 51.3 44.8 11.0 12.1 20.3 15.8 13.3 12.3 11.8 11.5 12.8 12.9 10.7 14.1 33.9 9.6 30.2 12.7 28.6 24.3 13.5 27.9 18.8 20.6 19.4 16.6 79.5 21.5 28.5 27.6 43.8 35.8 45.7 18.9 45.0 26.3 2.8 13.0 15.4 21.4 10.8 39.7 35.4 28.3 34.5 22.8 20.9 16.0 56.3 21.4 17.9 24.6 28.0 25.2 33.2 20.2 16.2 18.8 20.7 3.8 14.9 25.0 17.8 19.7 23.4 27.4 75.2 18.1 29.6 25.3 10.6 17.3 58.5 21.8 30.2 39.9 21.1 43.5 19.7 19.6 34.9 22.1 16.8 32.7 30.0 25.2 34.5 31.9 23.2 12.4 UPF3B "HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 157.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Cluster 6: Non-specific - Transcription" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol "Nucleoplasm, Nucleoli" "HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavorable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.9 8.1 17.0 10.2 17.2 13.6 9.5 21.1 30.0 11.9 16.3 11.8 11.8 11.7 10.5 12.7 9.9 6.9 7.5 16.5 20.0 11.4 12.4 9.0 15.4 17.5 17.3 13.3 8.1 11.3 12.9 8.8 17.4 10.8 10.5 22.0 8.8 9.0 12.9 15.5 10.0 9.3 16.0 11.3 8.6 15.7 17.8 14.7 11.5 10.9 15.6 10.5 11.7 18.6 29.2 17.3 35.1 28.8 15.7 10.3 22.5 27.4 15.3 20.9 18.3 32.7 20.4 51.9 22.6 11.5 29.9 27.1 45.9 16.6 26.5 29.9 33.9 48.3 57.9 17.2 17.9 52.7 23.0 8.7 12.4 35.8 43.3 19.0 19.7 30.5 47.4 41.8 17.6 35.9 36.8 65.6 67.7 37.1 46.8 35.9 40.2 38.2 17.3 14.5 46.7 32.1 55.6 22.4 42.4 36.2 11.9 30.4 17.3 21.6 16.6 34.9 58.6 23.1 27.5 69.5 17.5 76.1 25.7 8.1 4.4 6.5 5.9 4.8 4.8 12.5 5.6 4.8 3.3 13.7 6.3 6.4 4.9 7.7 5.6 8.7 7.4 2.2 17.0 17.2 21.1 30.0 16.5 20.0 17.5 17.3 17.4 16.0 17.8 18.6 26.3 32.1 25.7 31.6 47.4 37.7 31.1 31.6 47.8 50.7 26.4 28.2 19.0 17.2 38.7 25.8 56.3 39.0 46.1 33.5 5.9 31.6 157.3 26.1 23.5 31.1 27.6 52.2 30.6 26.4 48.2 25.5 23.0 33.8 58.9 32.8 23.2 22.9 28.5 28.6 39.5 35.5 26.4 19.1 43.3 31.7 30.4 28.2 24.9 27.2 44.9 32.6 56.7 33.7 45.4 21.5 33.6 32.7 32.5 33.8 30.4 16.5 35.2 99.0 13.1 34.4 42.0 65.8 41.4 38.8 38.1 64.3 39.9 28.1 37.6 25.0 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023, CAB079950" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Cytosol "CAB079950: , HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavorable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavorable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 11.5 7.8 5.9 11.9 7.7 9.8 13.2 6.2 8.1 10.5 5.6 10.1 7.2 11.2 11.1 11.6 10.7 7.6 7.8 5.9 7.6 9.0 8.2 7.5 13.7 6.7 7.0 12.7 16.1 9.5 5.2 10.1 6.6 8.2 11.9 5.1 8.6 8.3 12.5 10.0 8.2 11.7 5.8 9.5 10.1 2.2 7.0 12.7 9.2 6.3 17.1 14.2 9.8 7.1 34.7 38.0 19.9 52.9 32.7 33.2 33.5 37.6 28.5 37.0 29.4 39.0 33.5 81.6 73.7 27.3 40.2 43.4 80.6 40.8 45.1 27.2 40.1 46.6 32.9 29.8 36.9 66.7 34.5 40.9 35.1 50.2 52.6 23.7 29.5 29.9 47.3 25.0 32.1 57.1 48.4 50.6 41.6 65.5 42.1 37.5 30.1 56.0 25.4 26.1 20.8 54.7 21.3 38.9 45.2 26.1 21.0 38.4 25.8 16.2 21.2 45.8 73.2 30.8 38.4 71.1 24.4 81.2 37.4 29.2 9.4 5.0 13.9 16.8 16.1 12.3 11.5 13.1 13.8 14.1 14.4 13.5 1.1 18.5 15.4 11.0 17.6 8.8 5.9 7.7 6.2 8.1 5.9 7.6 6.7 7.0 6.6 5.8 7.0 7.1 10.1 12.8 15.6 3.6 11.2 8.4 17.0 11.1 17.6 5.3 10.2 13.2 10.5 11.5 20.6 0.0 4.2 24.1 16.8 7.2 13.7 16.8 0.2 12.7 24.0 10.1 7.7 12.2 7.8 12.6 20.0 11.9 9.7 15.7 14.0 10.6 6.8 5.1 13.6 1.7 7.2 10.4 12.2 9.5 5.5 0.5 6.2 11.1 5.4 3.7 17.8 6.5 16.5 3.5 8.4 13.0 9.7 7.2 14.7 12.2 4.9 9.1 8.1 5.2 13.1 17.9 13.2 1.3 2.2 18.9 8.0 40.6 13.1 13.1 13.8 11.4 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15 small subunit processome component" Q8TED0 5 73565443-73583380 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 36.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Approved "Nucleoli,Endoplasmic reticulum" No No "Cluster 32: T-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Endoplasmic reticulum" "HPA044697: AB_2679050" "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 8.7 6.5 2.0 8.0 2.4 36.9 9.7 3.2 3.2 4.6 1.2 6.8 5.5 7.2 6.4 9.2 5.0 5.1 4.8 2.2 2.5 5.1 7.5 5.9 10.8 2.1 2.3 4.9 7.4 7.5 3.1 6.0 2.7 5.9 8.3 5.5 4.9 4.7 7.2 9.5 5.2 7.6 1.6 7.8 5.7 6.1 2.1 7.6 8.1 7.5 10.7 9.3 4.5 3.6 21.2 22.3 15.8 44.6 12.6 14.9 27.9 24.8 14.1 27.1 29.8 25.0 29.6 47.5 24.9 16.6 34.2 17.3 25.5 45.5 41.6 23.9 19.2 21.7 23.7 20.2 15.5 20.2 18.1 15.2 20.0 30.8 34.3 8.3 19.1 21.2 33.8 25.3 23.2 26.4 31.7 14.0 20.6 7.5 12.7 24.5 24.7 45.9 16.1 28.5 15.8 16.9 22.7 17.6 27.4 13.4 22.8 14.4 15.4 15.9 22.5 19.4 49.3 19.0 27.6 60.5 26.0 34.3 23.8 4.9 6.8 4.6 8.2 7.0 7.6 7.9 8.1 9.1 7.4 7.0 9.6 9.4 5.1 8.2 7.2 7.0 7.3 4.9 2.0 2.4 3.2 3.2 2.2 2.5 2.1 2.3 2.7 1.6 2.1 3.6 8.4 0.0 7.3 2.3 7.7 14.7 13.1 5.0 11.4 3.8 6.7 6.5 6.8 4.3 5.2 5.5 6.2 8.0 6.0 2.7 3.9 8.9 4.3 4.9 6.8 6.9 2.4 9.4 6.4 7.8 9.5 8.0 5.6 6.8 7.0 6.7 2.9 8.1 6.8 1.7 5.4 4.1 2.0 5.8 2.1 2.8 3.1 3.9 7.2 1.9 3.6 3.0 2.1 3.5 6.9 6.5 3.6 5.3 9.1 10.0 2.2 6.3 1.7 4.7 6.6 9.5 8.8 10.0 12.4 11.7 17.0 6.6 6.1 7.6 6.7 9.8 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18 small subunit processome component" Q9Y5J1 17 51260546-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 190.6;Late spermatids: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nucleoli rim" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear membrane" "HPA052378: AB_2681805" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 17.9 20.1 12.6 24.9 13.7 40.0 25.8 19.1 15.7 18.8 14.2 17.5 17.8 15.7 15.8 21.0 17.5 12.8 10.2 13.2 13.8 21.8 22.3 17.3 33.1 13.0 12.3 23.8 21.3 23.3 20.4 26.3 13.6 16.2 18.7 17.5 17.4 14.2 24.4 32.3 16.5 12.9 13.0 24.5 18.1 58.7 13.2 27.7 24.4 16.2 34.4 24.8 18.0 15.6 90.5 87.7 54.6 50.3 35.1 52.2 142.2 48.9 40.2 83.5 79.7 55.4 49.3 113.5 67.8 36.6 89.0 48.1 89.7 52.0 123.3 74.8 117.0 119.4 52.6 97.3 48.0 127.9 56.4 33.9 39.5 71.1 57.0 42.1 50.7 55.6 98.7 50.6 63.5 56.1 115.6 86.9 78.5 127.5 91.8 103.2 124.2 89.4 61.3 59.1 60.7 76.9 56.7 66.6 114.7 67.4 82.3 64.4 44.7 85.3 71.8 71.1 102.9 97.4 192.5 131.5 53.0 87.6 62.4 19.0 48.2 27.9 40.2 46.9 49.9 54.1 50.7 49.2 55.9 52.4 53.6 51.1 8.2 40.0 49.0 35.0 56.8 56.2 12.6 13.7 19.1 15.7 13.2 13.8 13.0 12.3 13.6 13.0 13.2 15.6 20.6 16.0 23.4 11.8 37.4 60.2 62.9 40.6 33.0 15.6 19.6 17.9 4.4 20.0 25.2 14.7 14.6 66.7 27.4 11.4 39.2 38.4 190.6 26.3 27.3 25.1 16.1 20.8 18.5 46.9 71.2 24.5 14.3 24.1 31.7 19.6 8.9 17.1 62.8 10.1 18.0 20.7 34.6 37.7 26.1 182.0 26.8 33.3 23.2 15.0 42.2 21.3 25.7 17.6 24.6 34.2 16.3 22.2 24.2 50.2 13.8 37.5 38.8 11.8 13.1 24.8 35.7 140.2 104.5 27.7 52.7 79.6 30.4 30.8 25.3 48.1 UTP20 "1A6/DRIM, DRIM" ENSG00000120800 "UTP20 small subunit processome component" O75691 12 101280105-101386618 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049341 Supported "Nucleoli,Plasma membrane" No No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoli "Plasma membrane" "HPA049341: AB_2680720" "unprognostic (3.04e-2)" "unprognostic (1.22e-1)" "unprognostic (3.92e-2)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.34e-2)" "unprognostic (4.30e-2)" "unprognostic (8.15e-3)" "unprognostic (2.81e-1)" "unprognostic (2.22e-2)" "prognostic favorable (8.87e-4)" "unprognostic (2.88e-1)" "unprognostic (3.44e-1)" "unprognostic (8.30e-2)" "unprognostic (6.92e-3)" 4.3 4.2 2.2 5.0 3.7 4.2 5.7 2.9 2.7 5.7 2.5 3.2 2.1 4.6 2.6 4.0 3.8 2.4 3.0 2.3 2.5 3.3 3.0 3.0 5.0 2.8 2.8 6.4 4.8 5.3 2.2 4.3 2.9 3.5 4.2 3.5 5.6 3.3 5.2 4.6 3.1 4.0 2.4 3.6 3.2 5.6 3.3 4.3 4.2 3.9 4.8 5.1 3.5 5.0 8.1 19.9 14.8 6.9 13.0 15.1 18.2 13.8 10.8 21.5 11.8 23.1 5.7 21.6 7.1 15.4 16.2 16.6 33.0 14.2 27.8 9.8 13.4 22.8 10.0 17.3 7.3 38.4 10.2 9.9 7.3 29.9 10.3 8.2 15.0 10.9 36.7 4.3 15.8 10.6 16.8 10.9 38.9 11.3 20.6 18.8 24.2 16.8 9.1 24.4 17.0 11.5 25.8 16.1 15.7 12.2 17.0 8.5 17.1 25.3 12.5 17.8 27.1 7.8 12.6 35.1 13.8 17.2 39.6 0.0 0.2 0.0 0.5 0.3 0.5 0.9 0.5 0.7 0.4 0.6 0.6 0.7 0.0 0.6 0.2 0.8 0.5 0.2 2.2 3.7 2.9 2.7 2.3 2.5 2.8 2.8 2.9 2.4 3.3 5.0 14.3 9.6 9.9 16.0 16.7 10.1 9.7 7.7 11.4 9.9 8.7 8.4 10.3 7.2 13.6 3.7 10.4 7.8 4.4 3.4 5.9 7.6 1.5 11.4 24.5 12.6 6.6 14.9 17.0 11.6 8.8 13.0 7.7 10.1 13.3 18.6 7.1 7.6 5.8 21.9 17.0 6.3 4.1 6.3 3.5 1.2 9.6 8.6 3.6 8.4 3.3 3.3 4.1 16.1 34.2 5.9 1.9 8.2 13.2 14.5 1.1 3.0 9.0 9.4 6.6 24.9 11.0 22.6 22.3 17.3 11.1 2.9 10.0 23.7 9.8 7.2 UTP3 "CRLZ1, DKFZp761F222, FLJ23256, SAS10" ENSG00000132467 "UTP3 small subunit processome component" Q9NQZ2 4 70688532-70690551 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035655, HPA041453" Approved Supported Nucleoli,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoli Vesicles "HPA035655: AB_10601832, HPA041453: AB_2677488" "unprognostic (2.44e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-2)" "unprognostic (6.79e-3)" "unprognostic (2.13e-1)" "unprognostic (3.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (4.44e-3)" "prognostic favorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (7.95e-2)" "unprognostic (2.24e-1)" "unprognostic (2.24e-2)" 22.4 22.7 8.9 25.5 9.5 19.1 18.7 9.4 11.3 14.0 10.0 16.9 16.3 16.1 15.0 20.6 16.3 14.6 17.0 9.9 9.8 21.0 27.1 18.6 33.0 9.1 9.3 15.7 14.9 16.3 9.4 16.3 9.1 15.1 16.4 12.0 15.9 13.7 15.9 18.8 21.5 20.2 8.7 34.5 17.8 11.4 9.6 32.1 16.0 13.1 31.5 22.1 12.3 10.0 33.7 32.3 42.4 35.4 58.9 44.3 36.3 68.4 43.9 38.4 37.0 42.4 43.7 147.4 42.1 58.9 43.8 27.7 62.7 93.7 55.4 45.9 35.9 56.1 43.0 45.9 63.9 85.9 47.9 60.4 55.2 47.0 46.0 42.3 52.2 42.3 65.3 48.2 62.8 69.7 79.9 47.8 29.6 68.9 46.7 33.8 58.3 60.5 69.7 53.7 35.5 48.4 29.1 65.4 44.5 46.1 36.1 34.2 58.5 38.8 65.9 37.3 44.3 69.6 55.4 104.8 47.3 41.4 34.8 8.4 10.7 5.6 6.4 12.6 6.8 7.0 5.3 7.4 13.4 6.1 7.7 6.7 0.8 6.8 11.3 13.5 7.3 5.5 8.9 9.5 9.4 11.3 9.9 9.8 9.1 9.3 9.1 8.7 9.6 10.0 19.2 57.7 54.2 4.9 23.7 22.9 44.3 42.2 24.5 19.4 12.3 14.4 20.6 14.3 50.5 12.9 6.2 26.7 30.0 11.8 19.6 29.3 1.1 22.8 29.3 26.7 15.0 16.8 6.2 29.8 14.6 23.6 21.9 25.1 29.2 16.7 16.8 25.1 21.9 16.8 5.9 14.7 30.5 37.8 24.2 2.2 17.4 24.2 12.4 5.6 27.9 26.8 30.9 2.5 8.9 22.6 9.5 25.2 18.5 23.0 15.9 27.9 45.7 22.3 13.1 30.8 48.8 11.5 9.5 23.0 25.6 21.6 24.6 22.2 15.6 29.9 WDR36 "GLC1G, TA-WDRP, UTP21" ENSG00000134987 "WD repeat domain 36" Q8NI36 5 111091716-111130502 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Sensory transduction, Vision" "Disease variant, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 113.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037796, HPA037797" Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 3: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA037796: AB_2675673, HPA037797: AB_10672725" "unprognostic (2.14e-1)" "unprognostic (4.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (1.64e-1)" "unprognostic (9.79e-2)" "unprognostic (7.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.91e-2)" 9.1 6.3 3.5 9.4 3.5 9.9 10.1 4.7 4.5 7.4 4.1 7.0 6.5 9.0 6.6 7.9 6.8 7.2 6.0 3.9 4.1 7.5 14.1 6.3 11.3 3.6 4.0 10.1 6.4 7.3 4.5 7.5 3.8 8.3 8.1 4.7 6.0 7.0 9.1 10.1 6.8 7.5 3.8 8.8 7.3 6.3 3.9 9.1 9.7 7.2 12.0 9.8 6.1 4.2 17.0 14.9 13.7 36.6 24.7 32.2 19.2 14.6 13.9 19.5 27.9 19.1 19.7 53.8 17.0 12.2 22.7 19.2 26.8 33.8 34.8 15.9 15.7 26.6 17.2 19.5 26.3 25.6 38.8 19.2 21.4 34.6 37.5 36.5 20.3 18.4 32.3 18.1 25.8 14.3 31.7 24.9 18.3 16.8 15.6 25.6 29.9 42.4 18.1 19.3 24.3 19.5 18.6 15.2 22.4 15.0 15.2 21.3 19.1 28.1 15.6 20.0 30.5 18.1 14.0 48.6 22.4 37.9 22.2 0.3 2.5 1.0 3.3 3.3 3.8 2.7 3.0 3.7 4.0 2.4 4.3 3.6 0.1 3.3 5.0 2.1 3.8 2.6 3.5 3.5 4.7 4.5 3.9 4.1 3.6 4.0 3.8 3.8 3.9 4.2 17.2 19.2 13.8 15.3 26.0 61.1 15.4 18.3 113.3 9.9 14.5 12.1 15.6 18.6 19.6 16.5 6.2 9.4 15.4 5.3 7.9 9.5 5.1 10.6 26.0 20.4 6.0 20.6 30.5 13.8 9.9 20.7 13.7 16.2 14.0 16.9 12.5 35.1 14.7 11.8 24.8 12.9 16.2 24.1 16.0 4.2 8.7 18.2 21.4 20.6 18.3 5.7 16.5 27.6 22.3 9.9 6.4 11.3 27.5 20.8 5.3 11.3 12.3 8.6 19.7 20.2 17.3 18.5 17.8 42.3 57.8 5.3 18.0 18.1 13.4 11.2 WDR46 "BING4, C6orf11, UTP7" ENSG00000227057 "WD repeat domain 46" O15213 6 33279108-33289247 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043004, HPA055425" Uncertain Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA043004: AB_10967417, HPA055425: " "unprognostic (1.84e-1)" "unprognostic (7.54e-2)" "unprognostic (2.82e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.51e-3)" "unprognostic (2.63e-3)" "unprognostic (2.62e-1)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (9.03e-2)" "unprognostic (1.35e-1)" "unprognostic (3.97e-1)" "unprognostic (2.32e-1)" 19.4 19.0 2.2 14.1 2.4 12.6 18.9 1.8 3.8 21.2 2.5 16.4 13.5 23.6 13.6 19.1 17.4 3.2 12.8 2.7 2.7 15.6 17.1 14.7 10.6 2.2 2.4 17.3 19.2 3.0 19.7 5.5 2.6 16.8 11.2 3.0 18.7 2.7 26.1 23.9 15.6 9.6 2.2 20.4 16.7 14.8 2.5 6.3 16.4 12.6 18.8 19.6 17.8 3.5 0.9 21.1 15.3 61.2 11.4 1.6 56.2 42.3 4.9 0.2 7.0 27.8 15.5 49.4 35.5 22.5 60.2 23.4 3.9 31.0 19.3 31.6 32.2 65.6 20.3 54.0 10.4 56.6 74.2 12.5 5.2 18.4 9.5 15.6 0.0 26.6 37.5 13.8 6.8 23.3 32.1 46.8 45.1 8.5 18.3 47.1 28.1 40.3 9.3 20.7 30.9 40.3 20.4 44.4 46.9 18.3 17.2 37.8 30.9 37.9 42.8 31.6 64.3 56.5 104.3 83.5 16.4 55.9 35.3 12.1 17.3 6.2 24.9 28.7 21.4 16.1 18.2 22.4 27.9 18.9 17.0 21.7 1.2 28.1 33.9 13.7 18.6 20.1 2.2 2.4 1.8 3.8 2.7 2.7 2.2 2.4 2.6 2.2 2.5 3.5 21.0 0.0 11.7 2.9 30.4 43.7 30.8 40.7 28.5 14.4 23.8 20.2 7.2 17.2 25.7 23.9 6.2 44.0 33.9 20.4 11.7 43.5 65.0 19.0 30.9 22.9 13.8 13.7 11.1 43.0 48.7 27.7 20.4 24.3 21.6 35.1 14.6 26.4 28.9 13.5 6.5 21.5 22.4 19.0 24.1 23.3 25.7 22.0 17.8 5.6 29.0 17.9 36.0 2.5 2.8 33.1 15.6 23.0 25.0 38.0 18.2 37.8 14.7 10.1 13.1 35.7 28.3 42.3 37.2 23.6 42.6 38.2 26.1 46.8 31.9 30.0 WDR74 "FLJ10439, Nsa1" ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 565.6;choroid plexus: 711.0" "Cell type enriched" "Detected in all" 5 "Early spermatids: 616.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 21.3 21.8 352.4 20.5 274.3 127.1 21.2 485.9 291.6 19.5 711.0 19.6 17.1 20.8 14.6 25.8 22.3 11.4 23.1 251.8 208.5 21.5 28.5 14.9 30.6 220.8 221.4 25.6 30.9 15.1 11.4 18.3 292.3 19.5 16.4 33.7 25.0 13.7 59.3 31.2 17.7 17.0 305.3 30.1 22.0 15.4 244.7 62.3 28.4 25.3 23.9 24.8 18.9 565.6 64.2 76.2 28.8 49.4 22.9 31.4 85.9 35.8 37.5 73.6 49.1 108.8 77.0 111.6 97.6 28.5 59.0 84.1 88.8 69.0 56.8 72.7 64.2 55.5 84.1 97.5 65.9 112.3 36.0 30.9 75.7 47.8 153.9 24.8 36.1 80.5 126.1 32.5 33.7 120.6 106.7 178.7 117.1 70.9 96.7 108.9 49.9 193.6 52.7 35.6 65.7 72.1 40.8 84.1 115.4 27.8 58.8 83.1 28.0 44.4 52.4 98.3 88.2 81.0 120.3 137.1 47.5 68.3 57.2 40.1 140.9 11.7 40.2 61.4 49.7 66.0 42.1 38.6 105.0 121.5 56.8 52.0 51.0 93.2 44.9 154.3 52.4 47.8 352.4 274.3 485.9 291.6 251.8 208.5 220.8 221.4 292.3 305.3 244.7 565.6 36.8 38.5 67.9 1.6 112.5 104.5 47.2 45.7 60.9 15.2 37.6 57.0 2.0 40.0 108.7 16.5 16.7 55.2 57.9 32.0 43.0 42.8 616.0 22.4 34.0 41.7 41.0 26.5 3.6 40.5 53.8 39.1 65.2 32.4 43.6 23.5 20.7 34.0 37.9 3.3 3.0 32.1 20.3 33.1 69.2 97.1 32.9 45.0 30.2 1.0 22.4 15.4 45.3 2.0 2.8 39.8 24.2 21.4 74.3 50.3 44.8 54.0 32.0 11.4 19.7 53.0 89.3 19.4 31.4 50.3 109.3 34.8 66.3 30.4 41.5 39.8 YAP1 YAP65 ENSG00000137693 "Yes1 associated transcriptional regulator" P46937 11 102110447-102233424 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 145.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009370, HPA038884, HPA038885, CAB069915, HPA070359" Enhanced Supported "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nucleoli, Cell Junctions" "CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154" "unprognostic (9.56e-2)" "unprognostic (6.75e-2)" "unprognostic (2.08e-1)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.28e-1)" "unprognostic (2.66e-3)" "unprognostic (3.73e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (9.26e-2)" "unprognostic (4.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-2)" 57.2 27.8 19.1 25.9 19.1 0.3 42.7 18.6 17.1 62.5 44.3 41.5 27.2 78.1 45.9 74.7 65.6 49.3 48.1 15.9 22.1 39.3 33.5 45.7 13.0 31.8 30.2 93.1 22.3 37.0 9.9 83.1 21.8 59.2 30.1 12.9 40.6 83.7 48.3 44.2 27.4 100.5 27.3 14.7 31.6 15.0 27.0 13.8 85.9 58.2 22.7 60.9 52.6 20.2 56.9 52.1 141.5 69.6 151.1 143.1 118.7 130.4 147.8 124.2 101.5 130.2 134.9 0.0 105.4 171.6 92.1 98.0 71.0 186.4 130.6 16.8 25.5 0.1 67.3 89.5 115.3 0.1 2.5 115.2 119.4 136.6 220.2 138.4 39.4 6.7 0.0 0.1 142.1 27.2 2.6 0.4 66.8 135.9 49.3 0.1 79.7 0.3 90.9 99.5 0.4 4.7 153.6 57.2 43.5 129.1 103.2 0.8 43.4 175.4 68.8 89.6 55.7 0.1 0.2 0.8 51.0 0.2 130.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 19.1 18.6 17.1 15.9 22.1 31.8 30.2 21.8 27.3 27.0 20.2 28.4 35.3 69.4 145.3 1.5 113.7 47.8 43.5 71.2 0.4 48.1 43.8 39.2 62.9 37.2 92.0 0.0 91.4 0.4 16.2 11.7 27.6 6.7 61.8 53.3 28.9 7.3 0.0 1.5 18.3 20.3 49.0 23.9 85.1 0.0 127.2 26.0 45.2 10.6 0.0 1.6 13.1 14.2 1.6 21.5 4.6 37.9 2.2 44.4 60.0 1.0 27.6 0.0 5.0 0.7 25.2 16.3 40.6 0.1 66.0 27.2 26.1 41.6 1.2 39.5 21.6 62.0 2.5 5.3 59.5 123.2 61.6 2.1 15.9 27.8 65.6 ZBTB14 "ZFP161, ZNF478" ENSG00000198081 "Zinc finger and BTB domain containing 14" O43829 18 5289019-5297053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050758, HPA070819" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol No No "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nucleoli, Cytosol" "HPA050758: AB_2681226, HPA070819: AB_2686316" "unprognostic (5.28e-2)" "unprognostic (4.37e-2)" "unprognostic (4.25e-2)" "unprognostic (2.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-2)" "unprognostic (2.95e-2)" "unprognostic (8.64e-2)" "unprognostic (1.19e-3)" "unprognostic (4.72e-3)" "unprognostic (3.25e-2)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "unprognostic (2.03e-1)" "unprognostic (2.53e-1)" "unprognostic (3.73e-1)" "unprognostic (2.90e-2)" 10.3 8.6 9.3 14.7 10.5 9.6 12.5 11.4 12.2 9.6 7.4 10.4 8.7 9.9 16.4 12.4 10.6 12.0 8.6 8.7 9.6 11.2 13.4 11.1 24.7 9.5 10.3 15.6 14.4 12.0 4.8 9.1 9.6 9.8 10.0 7.3 12.2 12.1 8.5 14.0 9.3 8.7 10.2 16.2 11.9 5.9 9.5 21.8 15.5 8.4 21.8 9.6 5.2 11.4 9.0 11.8 15.1 11.2 11.0 14.5 10.0 8.8 13.0 12.0 10.5 11.3 11.5 31.2 7.6 10.7 13.9 8.2 11.2 13.2 12.2 6.0 6.0 12.4 11.1 10.5 7.8 15.8 14.4 11.6 10.9 8.5 7.9 13.0 19.2 22.3 8.1 10.1 12.4 9.9 23.8 10.5 13.4 11.1 6.0 14.0 9.7 9.2 10.0 10.8 13.3 13.0 13.4 8.8 14.3 15.0 10.5 17.9 10.7 15.6 12.8 12.2 13.3 6.4 6.9 19.9 16.4 13.3 14.0 9.8 5.5 14.1 8.7 7.8 8.6 7.5 11.0 10.0 8.2 10.4 11.6 11.1 1.2 7.6 7.5 6.1 7.6 7.3 9.3 10.5 11.4 12.2 8.7 9.6 9.5 10.3 9.6 10.2 9.5 11.4 8.8 6.4 6.7 5.9 8.5 2.4 1.6 2.9 5.2 7.4 5.6 4.3 3.6 1.5 2.2 5.5 0.0 5.3 6.3 5.5 5.9 4.9 0.8 4.3 5.5 7.4 1.2 9.1 2.9 3.3 5.5 4.6 0.5 3.7 15.9 6.0 11.7 6.9 7.1 5.0 3.1 5.1 8.2 7.5 4.5 2.8 5.9 6.3 1.8 1.0 7.8 10.8 6.2 2.5 6.6 3.5 4.0 5.7 2.2 2.4 5.7 5.5 2.5 5.9 0.0 6.0 5.7 1.0 9.3 4.2 3.0 2.2 8.8 5.1 5.2 1.5 ZCCHC9 "DKFZp761J139, PPP1R41" ENSG00000131732 "Zinc finger CCHC-type containing 9" Q8N567 5 81301587-81313297 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038404 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA038404: AB_10672744" "unprognostic (1.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-2)" "unprognostic (1.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.91e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.68e-2)" "unprognostic (5.20e-3)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 13.4 12.3 8.7 15.9 8.6 10.8 13.5 9.7 13.4 15.5 9.8 15.2 14.9 15.5 16.3 14.6 12.6 14.3 11.2 8.6 9.2 17.9 33.3 11.2 19.0 8.9 9.0 17.2 11.8 13.0 13.8 19.1 9.0 15.5 14.9 14.0 10.5 11.0 14.9 16.3 18.7 14.6 8.5 13.3 12.9 14.9 9.4 17.7 12.6 11.6 18.2 16.3 13.5 9.1 26.6 18.5 44.5 23.7 37.5 35.3 59.7 39.2 46.3 29.5 40.8 41.0 35.8 24.6 15.8 19.8 51.1 19.4 35.6 35.8 46.9 55.3 33.5 25.4 21.0 48.4 44.2 32.6 20.3 27.6 30.7 25.3 62.7 22.9 25.3 26.5 43.1 23.4 30.8 36.3 54.0 48.7 32.4 14.9 23.7 31.9 57.0 36.4 23.4 26.5 21.6 20.5 31.1 18.4 146.5 32.1 23.0 51.7 17.6 18.5 22.6 33.2 43.4 33.2 36.5 37.7 32.7 46.7 40.3 12.6 10.8 11.3 10.5 14.9 13.2 12.8 14.0 12.8 13.3 11.1 13.3 13.8 10.6 10.8 13.6 15.1 17.4 6.5 8.7 8.6 9.7 13.4 8.6 9.2 8.9 9.0 9.0 8.5 9.4 9.1 15.9 9.6 18.6 10.4 18.2 9.1 12.5 25.8 14.2 18.0 14.5 17.1 12.3 37.1 19.3 31.3 14.6 28.0 17.3 15.0 31.3 22.4 68.4 22.6 31.5 17.9 7.8 12.8 15.0 20.4 53.8 23.9 14.8 18.8 13.3 13.3 29.6 61.7 36.7 26.9 19.3 23.3 16.2 14.2 16.5 19.1 32.6 19.9 3.6 13.1 33.2 22.0 35.0 12.1 14.2 30.2 27.4 29.0 17.6 13.8 44.8 67.1 28.1 28.2 19.7 16.2 18.8 75.6 38.2 14.0 9.2 23.0 19.8 22.3 21.6 12.6 ZEB1 "AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a" ENSG00000148516 "Zinc finger E-box binding homeobox 1" P37275 10 31318495-31529814 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6" "Cancer enhanced" "Detected in all" "glioma: 15.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 113.1;TIME: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027524, CAB058686, CAB079943" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Nucleoli "CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (4.85e-2)" "unprognostic (7.40e-2)" "unprognostic (1.34e-2)" "unprognostic (5.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.96e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (5.59e-3)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" "unprognostic (1.66e-2)" 26.6 8.6 16.4 12.9 16.2 8.6 16.8 14.0 20.1 33.2 9.9 49.2 6.0 38.7 13.4 11.7 18.6 20.0 34.8 15.2 22.8 7.5 10.4 16.0 9.6 21.1 19.2 9.3 3.8 3.4 7.9 17.5 21.2 14.5 12.3 14.8 8.0 26.9 54.4 7.0 11.8 39.9 16.8 8.1 18.1 10.1 18.2 29.9 11.2 60.5 9.7 24.4 16.4 18.5 0.1 11.1 35.1 43.9 58.4 113.1 0.0 32.7 44.9 6.6 9.3 0.2 0.1 11.3 15.6 39.6 9.3 0.0 14.9 0.0 11.8 19.1 7.9 0.0 7.0 6.3 44.4 9.8 0.3 53.4 0.1 19.6 17.6 21.4 54.9 9.5 7.5 14.4 42.7 0.1 33.7 6.2 2.3 0.0 6.6 11.6 66.0 5.1 12.9 0.0 0.9 15.6 11.1 0.0 0.0 7.2 0.0 6.7 87.7 40.8 9.4 10.0 16.7 9.1 6.3 12.8 10.9 0.0 4.2 4.9 0.0 5.4 2.4 0.0 3.2 4.1 3.2 1.7 1.3 3.1 6.8 3.5 8.5 6.6 0.0 3.1 5.0 1.6 16.4 16.2 14.0 20.1 15.2 22.8 21.1 19.2 21.2 16.8 18.2 18.5 104.4 0.0 7.7 212.9 34.6 11.2 3.0 2.0 0.6 42.7 1.4 2.8 106.3 1.5 3.6 1.8 45.9 0.3 22.0 0.0 0.0 2.1 110.1 7.2 287.8 110.6 0.0 12.2 276.1 2.7 0.5 66.1 2.0 6.5 1.3 17.0 49.6 13.4 1.2 10.1 261.9 0.0 0.0 3.8 25.6 141.8 30.7 6.3 26.6 479.7 10.7 7.2 7.2 968.6 7.3 2.5 0.0 102.0 33.2 3.7 0.0 1.6 1.5 43.4 78.9 99.2 74.2 17.4 15.7 1.1 8.7 0.7 36.2 12.0 0.0 3.8 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144521057 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 363.7" "Cell type enhanced" "Detected in many" "Horizontal cells: 662.9;Inhibitory neurons: 539.3;Oligodendrocytes: 1489.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 154.0;THP-1: 181.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 61.3 45.2 185.6 56.8 258.3 127.5 29.5 138.3 165.5 52.4 3.0 24.5 21.9 29.6 9.6 27.9 20.3 43.9 45.7 132.5 155.4 18.2 23.3 41.2 43.2 238.3 214.5 70.5 5.7 6.7 3.3 62.1 222.8 18.5 29.9 35.5 9.6 22.7 20.8 12.8 25.9 33.3 183.2 69.4 18.0 16.2 249.6 10.6 13.3 18.8 24.2 46.6 24.1 363.7 1.6 2.0 83.4 0.1 98.9 49.7 0.3 35.1 35.1 38.5 37.1 0.0 0.8 6.6 0.1 37.4 10.6 0.4 14.5 0.1 47.6 37.6 11.2 154.0 6.3 0.2 23.0 26.4 113.2 42.1 0.9 48.9 22.9 33.7 29.4 0.0 43.0 4.1 45.2 0.2 0.4 79.9 12.3 0.0 1.9 44.1 63.5 0.2 0.4 0.6 0.7 22.1 4.2 0.2 97.3 27.5 0.2 181.4 45.9 42.9 0.7 87.5 11.0 47.1 0.3 7.5 66.7 78.4 122.6 27.8 47.7 12.2 21.0 42.6 1.9 9.2 2.7 10.7 27.0 9.4 1.9 7.7 15.2 7.3 43.9 21.5 0.6 19.0 185.6 258.3 138.3 165.5 132.5 155.4 238.3 214.5 222.8 183.2 249.6 363.7 32.6 6.4 19.2 121.8 92.4 24.9 1.2 0.6 3.4 158.6 2.2 4.3 71.0 1.5 10.1 5.5 4.2 1.7 426.2 0.1 1.9 0.7 2.2 2.1 84.7 29.2 0.0 127.0 228.2 0.8 2.0 123.0 13.3 2.5 157.5 99.3 79.2 4.6 144.5 662.9 539.3 0.0 0.0 435.0 276.3 7.2 120.5 435.0 103.2 343.8 233.6 69.3 223.5 381.0 1489.6 0.2 1.1 66.5 132.3 1.8 0.0 10.3 4.0 11.9 184.1 185.0 198.7 2.9 11.3 3.4 19.6 4.7 136.7 108.8 0.4 2.2 ZNF146 OZF ENSG00000167635 "Zinc finger protein 146" Q15072 19 36214602-36238771 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003358 Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" Nucleoli "HPA003358: AB_1080674" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (5.35e-3)" "unprognostic (2.11e-3)" "unprognostic (1.82e-2)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" "unprognostic (3.95e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-2)" "unprognostic (1.92e-1)" 25.9 21.1 22.6 25.6 30.4 12.5 41.6 26.6 33.9 33.7 20.5 26.8 23.1 37.0 21.9 24.7 28.1 22.4 23.7 21.5 26.4 29.2 32.4 23.4 35.3 28.4 30.7 40.5 22.8 33.4 28.2 32.4 30.9 30.5 31.5 31.2 24.4 26.4 46.3 27.0 21.8 32.6 24.0 27.0 25.2 12.1 27.9 39.6 33.9 46.4 37.5 34.4 23.2 36.2 70.2 96.0 79.8 77.1 57.8 64.5 42.5 60.2 55.4 57.1 56.2 43.5 49.6 67.7 94.6 56.0 37.4 31.8 102.6 70.5 102.3 105.5 57.2 113.0 37.4 52.7 67.4 180.1 74.9 52.8 106.5 55.1 156.0 60.0 71.7 72.6 122.2 72.3 69.4 45.9 84.1 42.2 108.1 122.2 57.7 96.1 80.3 58.2 69.4 67.7 100.7 63.5 74.7 93.0 66.1 81.6 41.5 90.9 55.0 64.0 76.8 50.6 107.1 50.2 63.7 95.2 44.9 88.0 83.1 7.9 11.2 8.7 15.8 13.8 22.7 19.1 18.1 16.0 13.6 17.4 23.2 21.4 2.6 14.9 22.4 6.9 16.8 14.9 22.6 30.4 26.6 33.9 21.5 26.4 28.4 30.7 30.9 24.0 27.9 36.2 21.4 44.8 29.0 21.5 29.7 23.6 30.8 20.5 22.8 10.8 26.7 22.1 45.4 21.5 28.4 20.2 10.4 34.3 26.3 11.6 35.2 27.7 18.3 16.7 35.5 22.8 14.5 25.0 29.2 18.0 48.7 26.9 16.3 23.6 20.8 28.5 20.3 20.8 18.9 11.8 33.4 24.6 14.2 17.8 14.0 20.9 25.1 15.5 10.6 19.7 18.8 9.0 28.8 37.2 121.1 25.0 13.7 19.2 18.6 38.1 9.0 21.2 23.7 10.3 6.6 30.2 29.6 13.0 10.7 24.5 29.8 23.5 29.9 20.0 26.4 29.6 ZNF16 KOX9 ENSG00000170631 "Zinc finger protein 16" P17020 8 144930358-144950888 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035782, HPA061835" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA035782: AB_10603243, HPA061835: AB_2684621" "unprognostic (4.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (2.69e-1)" "prognostic favorable (2.39e-4)" "unprognostic (7.53e-3)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.70e-2)" "unprognostic (2.96e-1)" "unprognostic (9.75e-2)" "unprognostic (4.17e-3)" 4.6 3.6 4.6 2.4 4.7 2.6 6.3 4.4 5.0 6.0 5.9 6.5 4.7 6.2 6.9 5.9 7.1 5.7 4.4 4.5 4.4 5.3 3.9 3.7 3.2 4.2 4.2 11.0 7.5 8.6 4.0 3.9 4.3 5.4 4.7 5.1 4.6 5.6 8.3 9.3 4.8 5.5 4.5 3.4 5.0 7.5 4.8 4.4 7.0 8.3 3.9 5.7 6.0 4.6 4.5 3.9 7.7 4.2 6.4 9.0 5.5 4.0 8.9 8.0 7.2 3.1 4.5 7.1 5.2 5.2 4.3 3.5 5.4 8.9 7.2 3.1 4.5 8.2 4.4 4.5 10.7 3.0 4.6 10.9 8.8 5.1 13.2 7.9 4.4 5.3 5.7 4.7 6.4 6.2 6.1 3.0 4.7 6.9 8.8 7.5 4.5 4.5 6.8 6.7 6.4 4.7 8.5 5.1 6.9 5.8 9.5 5.6 4.7 3.6 7.5 4.3 4.5 3.4 3.1 6.4 4.1 4.0 5.8 2.6 3.0 2.2 4.9 2.9 5.6 2.8 3.8 4.5 4.8 4.4 3.8 3.5 0.4 9.2 3.0 2.5 5.8 3.2 4.6 4.7 4.4 5.0 4.5 4.4 4.2 4.2 4.3 4.5 4.8 4.6 3.6 3.2 4.4 4.9 3.4 2.7 6.9 6.8 5.2 11.4 4.3 2.9 3.7 5.7 3.1 9.2 12.5 5.9 7.0 3.2 1.9 7.3 10.3 2.0 3.5 3.7 4.2 3.0 6.8 4.4 3.6 3.8 5.1 3.9 7.0 9.4 5.0 4.5 3.6 6.7 6.3 5.6 6.1 3.5 2.4 3.7 6.2 2.1 1.8 6.5 5.4 6.2 7.2 6.6 7.2 3.6 4.9 6.4 3.2 4.2 10.6 4.8 3.4 25.1 0.0 3.4 4.0 13.6 18.1 4.5 4.5 5.5 5.1 6.6 5.4 5.5 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571283-51592510 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 50.6;RT4: 45.4;TIME: 45.7" "Low region specificity" "Detected in all" "HPA002717, HPA074615" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoli Cytosol "HPA002717: AB_1080681, HPA074615: " "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (3.50e-3)" 3.1 3.9 4.6 4.3 5.0 3.5 5.4 11.2 6.2 3.9 6.7 3.9 5.5 5.9 5.2 3.1 4.7 3.1 4.4 3.9 4.8 4.4 3.1 4.9 6.0 4.7 4.4 8.9 3.3 10.0 6.2 8.0 4.5 4.0 3.8 11.3 6.0 4.9 4.6 3.6 4.3 5.1 3.9 6.0 4.5 10.3 5.9 5.2 6.9 3.6 6.1 3.8 3.2 6.7 3.6 6.3 6.2 6.6 6.5 9.0 0.1 8.1 10.3 7.4 8.9 6.4 5.5 6.6 4.6 8.2 4.6 5.9 6.8 5.6 13.2 0.0 10.0 50.6 10.5 2.2 5.7 8.5 31.1 3.5 5.1 15.1 7.3 37.2 12.1 6.3 17.3 6.7 8.1 0.0 9.2 6.3 3.5 4.4 6.4 0.0 8.1 3.2 4.0 45.4 7.9 5.7 7.6 2.5 4.7 5.0 1.8 6.9 45.7 11.3 5.1 2.6 7.9 8.8 17.6 6.8 31.4 5.0 5.8 0.0 0.4 0.0 0.4 0.1 0.5 0.5 0.4 0.4 0.4 0.5 0.6 0.5 0.2 0.2 0.1 1.4 0.1 0.2 4.6 5.0 11.2 6.2 3.9 4.8 4.7 4.4 4.5 3.9 5.9 6.7 3.6 6.4 5.4 12.1 3.4 1.1 1.5 1.7 1.8 8.0 2.7 2.5 3.5 1.5 5.3 5.5 2.1 7.9 4.1 1.5 1.9 1.9 11.6 1.4 2.9 3.9 1.8 16.2 11.6 1.6 1.5 3.4 2.6 1.5 14.0 5.5 6.4 2.4 3.2 16.8 12.8 1.3 2.0 5.9 2.1 10.6 3.4 2.4 3.6 10.3 3.1 2.6 5.2 12.5 17.5 6.9 0.6 2.6 1.6 1.8 4.4 2.0 4.4 7.8 0.0 4.3 2.6 6.3 4.3 2.1 1.4 12.0 2.4 3.2 2.0 0.8 ZNF330 "HSA6591, NOA36" ENSG00000109445 "Zinc finger protein 330" Q9Y3S2 4 141220887-141234697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 154.0;Early spermatids: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015705, HPA056325" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 38: Heart - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoli Nucleoplasm "HPA015705: AB_1859199, HPA056325: AB_2683101" "unprognostic (1.90e-1)" "unprognostic (4.65e-2)" "unprognostic (3.66e-1)" "unprognostic (1.35e-2)" "unprognostic (4.12e-1)" "unprognostic (5.93e-2)" "unprognostic (2.37e-1)" "unprognostic (2.32e-3)" "unprognostic (4.49e-3)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.66e-6)" "prognostic favorable (7.27e-6)" "unprognostic (3.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.02e-2)" "unprognostic (1.30e-2)" 29.1 26.8 11.9 20.3 12.6 35.5 22.8 14.3 15.7 23.1 15.0 30.9 18.5 26.0 17.6 25.2 25.6 19.8 100.3 11.0 12.8 26.0 51.7 25.1 28.6 13.3 12.6 25.1 26.9 23.9 15.5 20.2 13.2 21.0 22.7 25.0 48.1 20.1 67.1 19.0 21.2 32.1 12.9 23.2 22.8 26.3 13.1 21.5 37.4 43.4 26.7 23.4 18.7 14.6 20.7 24.8 29.5 23.4 51.7 46.1 41.3 54.0 31.1 34.1 32.1 33.5 38.6 87.6 32.4 34.3 19.3 16.1 52.6 35.0 51.7 40.8 34.4 40.7 39.2 47.6 55.2 103.8 31.6 46.6 40.3 32.0 46.4 41.4 36.1 53.1 84.3 57.9 43.8 46.4 80.9 48.6 26.3 63.2 46.7 65.0 42.2 55.9 36.7 22.6 51.1 23.8 19.0 42.9 55.7 33.0 21.5 28.1 38.7 43.3 29.4 26.3 39.1 96.1 74.7 83.2 36.2 63.8 31.6 16.3 27.4 16.7 15.9 22.7 22.3 21.6 20.1 20.7 28.9 17.7 21.6 20.0 4.1 20.1 18.8 19.6 25.9 16.3 11.9 12.6 14.3 15.7 11.0 12.8 13.3 12.6 13.2 12.9 13.1 14.6 32.5 54.5 32.4 8.1 31.9 49.2 53.9 22.3 35.3 63.0 21.5 29.1 154.0 27.1 26.2 9.2 14.6 38.2 29.8 21.2 58.7 32.7 197.7 34.9 58.2 31.5 16.8 29.6 13.0 51.0 37.9 35.3 18.8 26.9 22.9 25.7 32.5 70.6 73.5 16.8 13.4 25.7 20.3 56.2 36.0 50.5 39.1 48.2 46.2 20.6 38.1 38.4 14.4 11.6 17.3 43.5 27.8 28.6 27.4 43.6 26.0 78.3 20.3 26.1 13.1 42.4 34.9 46.2 17.7 33.6 51.6 34.3 29.7 38.4 26.9 56.6 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178711512-178730659 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 49.6" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" Cytosol "HPA052043: AB_2681706" "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favorable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 8.3 5.3 7.8 7.7 7.6 9.4 8.3 7.4 9.3 9.5 6.8 12.4 4.3 8.6 7.6 6.9 8.8 5.8 7.7 7.8 6.9 11.7 4.8 8.1 8.4 7.1 7.3 7.6 11.1 8.1 6.5 8.5 7.3 9.7 5.8 8.5 6.3 8.4 7.5 7.5 8.2 8.0 6.7 12.6 7.9 10.5 7.7 8.4 10.8 8.1 8.8 9.9 8.3 7.9 7.6 5.8 12.0 31.9 20.4 16.4 49.6 8.6 11.4 11.7 12.5 8.7 12.5 10.1 11.1 7.9 21.5 14.9 4.5 37.6 17.8 13.7 13.8 3.1 8.0 1.1 15.4 0.0 8.3 12.9 22.9 10.3 20.8 15.1 11.3 13.5 2.5 0.0 17.2 15.4 15.5 10.2 10.5 7.0 15.0 11.6 2.1 6.5 10.9 7.6 13.1 14.3 10.9 12.3 17.0 15.7 10.1 14.9 8.8 13.2 8.6 7.5 7.4 3.3 7.2 6.3 0.5 2.3 16.9 4.5 6.0 15.6 4.9 4.0 6.1 5.4 4.3 5.5 5.4 3.5 4.8 3.6 15.8 6.1 4.1 2.0 4.4 3.6 7.8 7.6 7.4 9.3 7.8 6.9 7.1 7.3 7.3 6.7 7.7 7.9 10.7 12.8 7.4 8.8 7.5 5.0 11.7 14.1 4.0 9.0 8.2 9.3 6.6 4.3 11.3 7.3 14.6 12.8 12.6 3.7 13.7 11.3 18.8 5.9 9.0 9.0 4.8 7.8 18.6 7.6 14.6 9.5 3.6 5.7 6.3 14.3 4.6 1.5 8.9 6.7 10.9 2.7 8.2 7.7 8.2 4.7 6.8 8.2 10.6 10.3 7.6 9.2 16.5 12.5 13.3 7.2 1.4 10.5 3.2 10.7 4.1 17.0 9.5 10.5 6.6 10.1 9.4 36.2 12.0 4.8 5.5 12.2 9.2 10.9 4.3 7.7 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872365-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 21.5;Oligodendrocytes: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2 OS: 43.7" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Nucleoli rim,Intermediate filaments" NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 9: U-2 OS - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Nucleoli rim" "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: AB_2732705" "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 2.4 3.2 9.2 1.1 10.3 0.6 2.7 9.7 11.3 3.8 8.3 5.8 0.6 2.4 9.6 2.0 6.4 2.4 9.1 8.8 9.3 3.9 2.3 2.1 3.6 9.9 9.7 6.8 2.4 2.5 14.3 2.9 9.9 6.1 1.8 18.0 2.8 2.3 2.6 3.1 2.7 2.0 9.7 5.4 3.2 4.6 10.3 2.3 4.2 1.9 1.6 4.6 2.9 12.0 3.4 0.5 3.4 0.4 8.4 11.8 2.0 4.6 2.2 2.9 4.0 0.3 1.2 0.0 4.7 2.2 0.1 0.4 0.6 2.3 3.9 0.5 3.3 1.2 0.1 1.3 3.0 0.3 0.9 7.1 5.5 2.1 2.0 9.8 2.5 0.0 0.1 0.0 2.7 0.3 0.0 0.1 2.8 0.1 0.7 0.0 1.8 0.7 2.8 2.2 1.8 1.4 1.9 0.8 2.4 6.1 0.1 1.3 1.1 4.1 43.7 3.7 2.7 5.8 8.1 0.0 5.8 0.0 2.4 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.3 0.3 0.0 0.5 0.0 0.2 0.3 0.1 9.2 10.3 9.7 11.3 8.8 9.3 9.9 9.7 9.9 9.7 10.3 12.0 1.3 0.0 3.2 21.5 1.5 0.0 0.7 1.1 0.6 3.6 1.3 1.9 7.0 0.0 0.9 0.0 0.0 1.5 0.3 0.2 0.0 0.7 1.5 1.6 3.2 1.5 2.4 0.4 6.9 0.2 1.1 1.6 0.5 1.1 7.0 2.9 1.1 0.5 0.7 5.0 6.9 0.6 4.1 0.3 0.3 0.3 0.9 0.7 0.0 1.9 0.4 3.8 2.1 3.0 19.4 0.2 0.5 3.4 0.1 0.8 0.7 0.4 1.9 3.3 0.0 0.4 1.3 1.7 3.2 0.4 0.0 1.0 1.5 0.5 0.9 0.5 ZNF507 "KIAA1084, Zfp507" ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: AB_2680864" "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 5.1 4.2 4.3 4.6 5.7 6.8 6.8 6.4 5.6 5.9 3.4 4.9 5.7 6.8 4.3 5.1 5.9 4.3 5.6 4.4 4.8 4.7 6.3 4.4 6.7 4.7 5.3 9.5 5.3 6.2 3.7 7.0 5.0 5.9 5.3 8.1 6.4 4.7 9.2 4.7 5.9 6.0 4.8 5.2 5.2 13.1 4.7 8.6 10.7 8.7 5.8 4.3 4.1 7.3 10.0 16.2 13.5 8.2 9.3 14.6 11.4 8.5 8.1 7.3 8.1 9.8 7.6 15.1 10.5 7.8 8.3 5.9 19.4 10.5 14.8 10.6 15.3 14.8 8.7 7.7 11.0 12.8 8.0 9.5 8.9 9.0 15.4 8.6 10.9 11.9 21.0 10.7 8.6 5.8 13.5 5.2 14.9 15.0 5.8 14.0 16.1 6.4 5.5 9.9 11.9 10.5 11.2 7.8 10.2 10.7 5.9 9.5 10.4 12.6 13.3 8.0 11.9 10.4 12.9 14.1 8.7 9.3 11.5 0.2 0.0 0.5 1.0 0.0 1.1 0.7 0.8 0.8 0.0 1.0 1.1 0.9 0.5 0.6 0.0 0.1 0.6 0.4 4.3 5.7 6.4 5.6 4.4 4.8 4.7 5.3 5.0 4.8 4.7 7.3 13.3 9.6 17.7 22.5 13.2 2.8 8.8 5.3 13.6 22.2 9.3 7.6 16.1 5.7 9.0 0.0 14.6 10.9 7.7 7.6 1.9 5.6 22.1 10.0 22.7 11.0 9.0 12.4 31.3 5.5 5.3 11.9 12.2 11.4 3.8 17.1 13.6 12.1 3.7 58.9 36.0 11.5 4.1 0.3 1.8 11.0 9.3 0.8 1.8 16.9 0.4 17.2 10.3 31.2 46.6 4.9 8.0 7.2 6.4 12.0 15.6 4.2 16.1 23.5 0.0 16.1 13.9 25.8 18.9 10.9 2.7 8.8 11.3 12.6 11.2 7.6 ZNF577 MGC4400 ENSG00000161551 "Zinc finger protein 577" Q9BSK1 19 51804816-51890950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 39.2;Early spermatids: 56.3;Late spermatids: 60.6;Oligodendrocytes: 50.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041499, HPA046761" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "HPA041499: AB_2677516, HPA046761: AB_2679791" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-1)" "unprognostic (8.21e-2)" "unprognostic (1.45e-3)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (3.01e-3)" "unprognostic (1.18e-1)" "unprognostic (1.04e-1)" "unprognostic (6.51e-3)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-1)" "unprognostic (7.02e-2)" "prognostic favorable (2.03e-4)" 9.4 7.2 11.9 5.4 15.0 4.2 12.2 14.2 13.2 14.3 8.0 14.5 4.6 11.7 7.1 6.8 12.7 8.0 12.2 11.5 16.1 13.6 6.8 7.9 5.5 14.0 12.3 27.1 8.8 14.9 8.4 9.3 13.3 18.4 6.6 16.9 12.0 11.3 7.2 20.6 9.0 7.2 10.2 12.7 8.9 18.8 13.5 7.7 18.7 9.1 5.7 11.1 9.3 21.0 1.6 0.1 7.8 9.5 13.1 14.1 0.0 9.3 3.4 3.5 7.1 1.0 1.3 1.6 0.9 4.3 5.2 2.5 3.1 1.9 1.9 0.0 9.0 15.6 0.2 1.4 10.2 3.4 5.1 11.1 5.8 5.2 1.5 10.9 1.8 0.0 3.5 0.1 4.5 0.0 9.7 4.4 9.0 0.0 0.2 4.2 3.9 2.9 5.8 3.4 3.2 1.6 2.3 1.1 8.0 7.9 1.6 3.7 1.2 6.4 8.8 1.8 3.4 6.3 0.0 2.0 1.7 0.6 10.6 4.4 1.6 3.7 0.9 2.5 2.7 7.2 1.8 2.2 1.8 3.5 2.2 1.4 0.6 3.3 2.0 2.0 0.9 1.1 11.9 15.0 14.2 13.2 11.5 16.1 14.0 12.3 13.3 10.2 13.5 21.0 8.8 0.0 2.6 14.4 4.0 4.5 3.7 4.0 2.2 12.2 8.1 7.9 8.5 4.3 3.0 18.4 10.4 7.2 4.8 2.7 39.2 4.3 56.3 7.2 7.4 6.6 3.0 2.1 20.1 1.1 5.4 6.3 4.1 5.6 5.1 9.8 7.1 1.8 5.7 6.7 19.3 4.7 2.0 2.2 3.7 60.6 8.1 6.7 0.0 9.4 4.0 15.2 1.0 26.2 50.1 1.2 1.9 12.8 0.9 5.9 5.1 4.9 3.0 9.9 0.0 6.9 7.6 12.3 14.0 4.2 5.3 4.5 2.5 4.2 4.4 3.0 ZNF622 "MGC17552, MGC2485, ZPR9" ENSG00000173545 "Zinc finger protein 622" Q969S3 5 16451519-16465800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036514, HPA036515" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA036514: AB_2675167, HPA036515: AB_10672224" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.00e-2)" "unprognostic (6.53e-2)" "unprognostic (8.24e-3)" "unprognostic (4.71e-3)" "unprognostic (1.06e-1)" "unprognostic (1.71e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (8.69e-2)" "unprognostic (5.93e-2)" "unprognostic (2.19e-1)" "unprognostic (7.42e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" 19.5 13.5 20.3 13.8 21.4 36.0 18.4 17.2 21.8 16.7 14.4 21.5 16.9 17.8 17.2 17.9 15.3 12.1 56.9 18.1 19.6 14.6 22.0 16.6 17.8 18.7 20.7 15.6 54.3 15.6 15.1 16.9 20.3 15.5 20.7 10.8 18.3 12.7 41.7 25.6 20.3 12.5 19.1 15.5 22.4 20.5 19.4 16.0 15.5 25.2 15.7 17.5 17.0 22.1 25.7 55.2 16.9 35.2 40.4 34.3 61.4 45.2 33.9 36.0 45.6 66.0 23.2 30.0 59.6 36.0 48.4 33.3 27.5 35.3 28.9 40.6 37.3 27.4 92.8 47.7 58.1 53.8 31.5 53.3 43.7 33.6 31.5 28.0 25.6 17.6 37.6 28.9 40.1 43.2 28.4 52.3 30.0 24.2 53.8 22.1 20.6 25.8 33.6 38.0 23.4 26.2 63.1 46.8 78.2 29.4 26.0 41.1 35.3 40.0 30.5 39.3 29.1 41.3 39.7 41.9 34.9 45.8 28.5 89.3 65.6 88.6 73.8 71.3 77.8 85.4 73.7 82.0 73.3 81.9 84.2 70.3 87.9 67.9 79.6 59.2 85.0 82.6 20.3 21.4 17.2 21.8 18.1 19.6 18.7 20.7 20.3 19.1 19.4 22.1 14.8 22.4 24.2 2.9 33.2 60.7 43.1 48.6 34.1 22.8 19.8 16.4 73.8 24.3 34.4 14.7 10.4 64.0 39.5 77.5 27.4 55.2 111.5 35.0 36.8 22.3 98.7 20.0 7.6 66.7 57.2 34.1 31.1 71.3 52.0 13.3 15.0 25.1 50.0 16.8 7.9 60.6 48.8 19.3 35.1 62.8 18.0 29.7 33.8 4.7 43.3 22.6 37.0 6.6 9.0 51.2 127.1 19.9 26.6 28.3 84.5 39.2 29.7 19.3 19.7 31.7 46.9 63.2 37.8 21.8 43.2 40.6 41.6 20.5 55.5 33.5 ZNF800 ENSG00000048405 "Zinc finger protein 800" Q2TB10 7 127346790-127431924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 74.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023090, HPA052194" Approved Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "Nucleoli, Nucleoli rim" Cytosol "HPA023090: AB_1859457, HPA052194: AB_2681757" "unprognostic (2.93e-2)" "unprognostic (1.10e-1)" "unprognostic (2.27e-1)" "unprognostic (3.34e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-2)" "unprognostic (6.19e-2)" "unprognostic (2.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (8.99e-2)" "unprognostic (7.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.08e-1)" "unprognostic (2.53e-2)" "unprognostic (8.96e-3)" 10.7 7.2 5.7 11.6 7.3 74.6 12.0 20.2 5.0 8.4 1.4 10.8 10.4 9.6 7.9 12.5 7.8 11.3 6.0 2.9 4.4 8.2 14.7 10.2 16.6 5.4 6.3 10.3 12.5 11.3 3.5 9.2 5.9 9.3 10.1 9.9 8.2 7.7 5.7 10.6 10.7 9.5 5.9 13.2 11.4 20.6 6.3 13.2 11.0 7.2 14.3 10.5 5.5 7.9 16.0 8.4 9.5 16.5 13.5 17.3 9.2 14.9 17.5 15.1 14.6 7.8 15.0 27.1 9.0 14.6 16.3 11.1 15.7 15.6 20.9 23.9 9.5 17.7 8.5 7.1 16.9 24.2 32.3 15.4 14.9 16.2 22.0 12.5 16.5 16.3 22.3 27.0 16.9 12.4 26.5 17.2 7.9 14.5 10.8 16.7 13.3 18.0 11.0 19.8 13.6 13.9 14.8 58.7 19.8 12.9 7.0 16.3 18.0 25.0 8.0 17.2 18.1 31.7 15.2 39.0 18.8 21.5 21.8 22.1 8.7 13.6 16.1 8.0 16.3 15.4 11.8 16.5 9.0 17.3 19.2 21.0 7.5 25.0 9.0 15.3 18.6 8.0 5.7 7.3 20.2 5.0 2.9 4.4 5.4 6.3 5.9 5.9 6.3 7.9 49.0 38.5 23.5 27.7 65.1 44.7 51.7 14.7 52.3 29.0 28.3 20.6 16.8 11.5 20.1 12.9 22.9 12.0 70.5 30.2 11.7 24.1 44.8 22.2 30.8 37.2 16.2 52.0 46.4 19.2 14.0 32.0 40.2 26.3 29.2 26.3 26.7 17.5 14.4 77.4 35.5 29.3 8.2 25.3 34.1 11.3 27.1 41.7 28.4 45.9 37.9 17.5 79.3 41.7 71.8 24.5 22.0 31.6 57.8 48.3 26.8 13.3 18.3 27.9 26.3 54.9 30.1 111.9 39.9 44.4 47.9 22.0 65.5 30.1 25.5 68.5 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267058-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA027521: AB_2672314" "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavorable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavorable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favorable (1.68e-4)" 9.9 11.1 18.5 10.3 19.1 6.8 15.1 24.3 23.0 20.2 14.4 16.2 8.9 18.9 13.5 9.6 14.3 12.7 13.0 19.5 20.4 12.1 9.9 10.3 11.0 19.0 17.9 30.2 11.9 14.0 16.4 9.3 18.6 17.1 10.0 26.6 10.2 18.1 11.9 9.9 11.6 16.3 17.3 17.5 10.9 7.8 18.7 11.4 14.4 10.4 12.2 13.6 12.2 22.4 8.1 6.6 18.8 16.2 19.0 18.5 4.2 16.2 15.0 19.9 19.8 4.9 5.7 4.6 22.9 10.1 15.1 5.7 8.6 11.3 21.5 9.8 9.6 12.2 10.6 9.9 13.2 10.1 7.1 15.5 10.7 15.4 14.0 25.8 20.5 7.0 10.2 9.2 16.0 6.7 10.9 13.3 5.6 4.3 10.5 10.7 16.1 7.8 17.2 7.9 13.6 10.3 9.6 4.0 13.2 15.2 6.5 6.9 13.7 16.3 11.7 5.8 19.2 9.9 14.5 8.7 5.8 11.0 14.3 17.9 7.9 14.0 16.1 6.4 19.0 16.3 16.0 17.6 12.5 19.9 19.4 16.0 5.8 22.5 5.5 6.0 15.6 12.5 18.5 19.1 24.3 23.0 19.5 20.4 19.0 17.9 18.6 17.3 18.7 22.4 8.8 0.0 5.6 15.3 9.2 0.0 2.7 0.0 4.0 8.9 4.7 8.3 10.4 2.8 6.2 0.0 4.2 4.9 9.2 1.8 3.9 5.6 5.9 3.8 7.8 7.0 6.7 7.8 23.5 5.0 2.8 8.1 2.0 3.1 6.3 11.1 4.6 1.8 5.9 1.7 26.1 2.6 0.0 5.1 0.0 2.5 9.0 4.3 0.0 8.4 2.3 12.8 14.4 30.7 28.8 3.6 4.0 13.2 3.5 2.2 4.9 4.6 1.5 9.6 19.7 7.7 7.5 7.5 8.7 2.9 0.0 1.4 7.2 8.1 3.4 0.8